data_1e4s_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1e4s _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.423 ' CE2' ' SG ' ' A' ' 37' ' ' CYS . 2.8 t80 . . . . . 0 N--CA 1.491 1.598 0 CA-C-O 121.266 0.555 . . . . 0.0 110.22 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 52.5 t30 -107.71 105.26 15.02 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.272 -0.892 . . . . 0.0 110.275 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . 0.423 ' SG ' ' CE2' ' A' ' 35' ' ' TYR . 31.1 m -80.69 2.54 25.5 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.258 -0.901 . . . . 0.0 110.241 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 69.2 t -83.22 -34.9 11.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.227 -0.921 . . . . 0.0 110.248 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 34.1 t -68.0 -29.43 68.44 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.256 -0.902 . . . . 0.0 110.162 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 5.1 m -76.23 -16.83 59.74 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.325 -0.859 . . . . 0.0 110.113 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 111.4 -14.53 27.78 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.421 -1.471 . . . . 0.0 109.421 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.522 ' CA ' ' O ' ' A' ' 67' ' ' CYS . . . -80.88 -177.67 51.73 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.496 -1.442 . . . . 0.0 109.496 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . 0.488 ' O ' ' N ' ' A' ' 67' ' ' CYS . 36.6 tt0 -133.82 160.14 38.51 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.29 -1.124 . . . . 0.0 110.211 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 38.6 t -114.92 107.43 15.38 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.245 -0.909 . . . . 0.0 110.173 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.456 HD13 ' CD ' ' A' ' 50' ' ' PRO . 82.8 mt -89.55 176.36 6.92 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.282 -0.886 . . . . 0.0 110.196 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 71.3 t80 -91.03 -24.03 20.18 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.242 -0.911 . . . . 0.0 110.232 -179.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' SER . . . . . 0.416 ' O ' ' C ' ' A' ' 48' ' ' ALA . 89.2 p -105.59 165.72 10.95 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.245 -0.91 . . . . 0.0 110.231 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.416 ' C ' ' O ' ' A' ' 47' ' ' SER . . . -43.01 130.8 4.37 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.207 -0.933 . . . . 0.0 110.202 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . 0.516 ' HB2' ' CG ' ' A' ' 65' ' ' LYS . 12.4 t -43.15 127.88 3.42 Favored Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 121.222 -0.924 . . . . 0.0 110.187 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.456 ' CD ' HD13 ' A' ' 45' ' ' LEU . 46.4 Cg_endo -72.31 147.03 46.58 Favored 'Trans proline' 0 C--N 1.306 -1.665 0 O-C-N 123.898 1.473 . . . . 0.0 110.423 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 19.4 pt -58.69 -22.06 20.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.23 -0.919 . . . . 0.0 110.135 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 82.5 m-85 -59.68 -14.77 15.35 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.207 -0.933 . . . . 0.0 110.142 179.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.522 ' CB ' ' HB3' ' A' ' 67' ' ' CYS . 72.7 p -127.45 172.85 10.31 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.254 -0.904 . . . . 0.0 110.139 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.463 ' O ' ' HA ' ' A' ' 67' ' ' CYS . 44.8 tttt -94.09 165.31 12.69 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.241 -0.912 . . . . 0.0 110.225 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.519 ' O ' ' CG2' ' A' ' 55' ' ' ILE . 16.6 tt -95.47 116.11 36.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.255 -0.903 . . . . 0.0 110.261 179.907 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . 0.496 ' NE2' ' HB3' ' A' ' 68' ' ' LYS . 64.9 mm-40 -93.77 15.8 15.6 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.263 -0.898 . . . . 0.0 110.2 -179.958 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 112.76 -114.64 3.51 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.489 -1.445 . . . . 0.0 109.489 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 16.9 p -131.4 174.02 10.49 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.26 -1.141 . . . . 0.0 110.181 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . 0.966 ' SG ' ' SG ' ' A' ' 66' ' ' CYS . 0.7 OUTLIER -114.09 -159.52 0.7 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.232 -0.918 . . . . 0.0 110.252 -179.972 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 90.9 m-85 -55.5 -43.77 75.94 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.309 -0.869 . . . . 0.0 110.192 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 80.4 mtm180 -133.43 168.95 17.68 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.242 -0.911 . . . . 0.0 110.202 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -67.7 -23.24 73.93 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.421 ' HE2' ' HA ' ' A' ' 63' ' ' LYS . 10.2 mmpt? -67.19 -24.84 65.9 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.253 -1.146 . . . . 0.0 110.186 179.965 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -112.77 162.82 15.32 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.224 -0.923 . . . . 0.0 110.191 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.516 ' CG ' ' HB2' ' A' ' 49' ' ' CYS . 48.1 tptt -141.77 144.18 33.85 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.276 -0.89 . . . . 0.0 110.226 -179.954 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' CYS . . . . . 0.966 ' SG ' ' SG ' ' A' ' 59' ' ' CYS . 99.7 m -82.96 153.54 24.96 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.192 -0.942 . . . . 0.0 110.155 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' CYS . . . . . 0.522 ' HB3' ' CB ' ' A' ' 53' ' ' THR . 75.1 m -142.51 156.22 45.12 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.258 -0.901 . . . . 0.0 110.205 -179.925 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.496 ' HB3' ' NE2' ' A' ' 56' ' ' GLN . 43.5 tttt . . . . . 0 N--CA 1.491 1.587 0 CA-C-O 117.978 -1.011 . . . . 0.0 110.24 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.412 ' CD1' ' N ' ' A' ' 36' ' ' ASN . 2.3 t80 . . . . . 0 N--CA 1.492 1.638 0 CA-C-O 121.272 0.558 . . . . 0.0 110.129 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . 0.432 ' CG ' ' O ' ' A' ' 36' ' ' ASN . 25.5 p-10 -92.22 91.86 7.93 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.3 -0.875 . . . . 0.0 110.164 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 18.8 m -73.54 -22.38 60.11 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.203 -0.936 . . . . 0.0 110.2 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.462 ' HA ' ' O ' ' A' ' 42' ' ' GLY . 70.6 t -63.62 -42.33 95.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.215 -0.928 . . . . 0.0 110.215 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' SER . . . . . 0.432 ' CB ' ' ND2' ' A' ' 36' ' ' ASN . 44.8 t -58.76 -26.59 64.15 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.198 -0.939 . . . . 0.0 110.216 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' SER . . . . . 0.447 ' O ' ' HE3' ' A' ' 68' ' ' LYS . 63.1 m -82.95 -18.34 40.35 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.267 -0.896 . . . . 0.0 110.203 179.977 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . 0.45 ' O ' ' HG3' ' A' ' 68' ' ' LYS . . . 112.18 11.89 14.92 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.432 -1.467 . . . . 0.0 109.432 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.462 ' O ' ' HA ' ' A' ' 38' ' ' VAL . . . -113.17 178.78 18.83 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . 0.464 ' O ' ' HA ' ' A' ' 66' ' ' CYS . 0.3 OUTLIER -137.1 171.86 13.86 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.261 -1.14 . . . . 0.0 110.202 179.942 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 84.6 m -108.58 104.4 13.72 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.248 -0.908 . . . . 0.0 110.227 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.452 HD11 ' HD3' ' A' ' 50' ' ' PRO . 27.3 mt -85.82 179.61 7.01 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.163 -0.96 . . . . 0.0 110.137 179.988 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 98.1 m-85 -106.23 -7.91 17.59 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.272 -0.892 . . . . 0.0 110.192 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' SER . . . . . 0.414 ' O ' ' C ' ' A' ' 48' ' ' ALA . 84.0 p -121.41 166.92 13.4 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.267 -0.895 . . . . 0.0 110.201 179.959 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.414 ' C ' ' O ' ' A' ' 47' ' ' SER . . . -43.01 131.23 4.3 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.229 -0.92 . . . . 0.0 110.204 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . 0.429 ' HB2' ' HG2' ' A' ' 65' ' ' LYS . 3.9 t -42.76 128.53 3.1 Favored Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 121.284 -0.885 . . . . 0.0 110.226 -179.911 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.488 ' HG2' ' CG2' ' A' ' 53' ' ' THR . 45.7 Cg_endo -72.83 150.42 49.63 Favored 'Trans proline' 0 C--N 1.306 -1.679 0 O-C-N 123.89 1.468 . . . . 0.0 110.427 -179.938 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 54.4 mt -63.19 -27.2 42.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.211 -0.93 . . . . 0.0 110.234 -179.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 99.4 m-85 -68.94 -9.22 50.86 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.319 -0.863 . . . . 0.0 110.12 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.488 ' CG2' ' HG2' ' A' ' 50' ' ' PRO . 46.2 p -123.79 144.57 49.62 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.208 -0.932 . . . . 0.0 110.171 179.961 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.439 ' O ' ' HA ' ' A' ' 67' ' ' CYS . 40.7 mtmt -81.0 167.9 19.3 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.193 -0.942 . . . . 0.0 110.275 -179.951 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.507 ' O ' ' CG2' ' A' ' 55' ' ' ILE . 18.8 tt -100.99 117.65 46.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.334 -0.854 . . . . 0.0 110.166 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . 0.481 ' CG ' ' HB2' ' A' ' 68' ' ' LYS . 71.8 mm-40 -96.64 3.11 52.7 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.201 -0.937 . . . . 0.0 110.206 179.966 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . 0.407 ' O ' ' HE3' ' A' ' 65' ' ' LYS . . . 125.52 -119.54 3.57 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.388 -1.485 . . . . 0.0 109.388 -179.968 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.444 ' O ' ' SG ' ' A' ' 66' ' ' CYS . 24.4 p -133.05 164.24 27.44 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.26 -1.141 . . . . 0.0 110.18 179.938 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 1.8 m -114.13 -88.66 0.55 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.245 -0.91 . . . . 0.0 110.248 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 83.0 m-85 -116.97 98.94 6.75 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.283 -0.886 . . . . 0.0 110.287 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 27.7 mmm180 54.78 -145.69 0.61 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.316 -0.865 . . . . 0.0 110.141 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -102.83 18.33 50.32 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.559 -1.416 . . . . 0.0 109.559 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 48.0 mtpt -85.07 -24.38 28.13 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.277 -1.131 . . . . 0.0 110.194 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -145.34 164.07 32.61 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.308 -0.87 . . . . 0.0 110.261 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.429 ' HG2' ' HB2' ' A' ' 49' ' ' CYS . 54.5 tptt -127.68 132.92 49.61 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.29 -0.881 . . . . 0.0 110.19 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' CYS . . . . . 0.464 ' HA ' ' O ' ' A' ' 43' ' ' GLN . 59.2 m -72.35 132.42 43.95 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.261 -0.9 . . . . 0.0 110.201 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' CYS . . . . . 0.446 ' HB3' ' CB ' ' A' ' 53' ' ' THR . 90.9 m -135.56 144.29 46.14 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.287 -0.883 . . . . 0.0 110.243 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.481 ' HB2' ' CG ' ' A' ' 56' ' ' GLN . 81.5 tttt . . . . . 0 N--CA 1.492 1.644 0 CA-C-O 117.994 -1.003 . . . . 0.0 110.126 -179.923 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 4.2 t80 . . . . . 0 N--CA 1.49 1.575 0 CA-C-O 121.243 0.544 . . . . 0.0 110.229 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . 0.538 ' ND2' ' CB ' ' A' ' 39' ' ' SER . 54.0 t30 -74.28 65.9 1.24 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.246 -0.909 . . . . 0.0 110.168 -179.906 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . 0.459 ' O ' ' HB2' ' A' ' 40' ' ' SER . 22.0 m -71.08 -53.66 13.86 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.235 -0.916 . . . . 0.0 110.305 179.97 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.465 ' HA ' ' O ' ' A' ' 42' ' ' GLY . 77.0 t -44.66 -55.09 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.178 -0.951 . . . . 0.0 110.243 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' SER . . . . . 0.538 ' CB ' ' ND2' ' A' ' 36' ' ' ASN . 53.4 m -53.62 -31.41 47.11 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.176 -0.952 . . . . 0.0 110.244 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' SER . . . . . 0.459 ' HB2' ' O ' ' A' ' 37' ' ' CYS . 50.8 m -71.5 -25.29 62.19 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.249 -0.907 . . . . 0.0 110.155 179.981 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 125.05 -16.76 7.21 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.458 -1.457 . . . . 0.0 109.458 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.475 ' CA ' ' O ' ' A' ' 67' ' ' CYS . . . -87.74 -177.45 48.07 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.485 -1.446 . . . . 0.0 109.485 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 1.3 pt20 -133.66 175.73 9.18 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.313 -1.11 . . . . 0.0 110.31 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 11.1 t -107.21 89.39 2.98 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.215 -0.928 . . . . 0.0 110.18 179.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 13.7 tp -78.63 162.1 26.48 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.203 -0.935 . . . . 0.0 110.23 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 65.6 t80 -92.13 -24.6 19.06 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.227 -0.92 . . . . 0.0 110.182 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' SER . . . . . 0.423 ' O ' ' C ' ' A' ' 48' ' ' ALA . 44.8 m -95.94 157.85 15.71 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.265 -0.897 . . . . 0.0 110.192 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.425 ' O ' ' C ' ' A' ' 49' ' ' CYS . . . -42.74 133.15 3.6 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.256 -0.902 . . . . 0.0 110.219 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . 0.425 ' C ' ' O ' ' A' ' 48' ' ' ALA . 1.8 t -43.13 127.08 3.41 Favored Pre-proline 0 N--CA 1.491 1.609 0 O-C-N 121.248 -0.907 . . . . 0.0 110.084 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -72.45 159.64 48.68 Favored 'Trans proline' 0 C--N 1.306 -1.675 0 O-C-N 123.854 1.449 . . . . 0.0 110.436 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 7.5 mt -65.61 -25.92 37.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.167 -0.958 . . . . 0.0 110.114 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 94.2 m-85 -65.92 -12.14 52.45 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.305 -0.872 . . . . 0.0 110.117 179.871 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.463 ' OG1' ' HB3' ' A' ' 67' ' ' CYS . 67.3 p -136.09 147.35 47.78 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.272 -0.892 . . . . 0.0 110.165 179.941 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 36.8 tttt -97.41 165.23 12.11 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.211 -0.931 . . . . 0.0 110.228 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.494 ' CG2' ' O ' ' A' ' 55' ' ' ILE . 15.3 tt -86.94 115.21 27.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.276 -0.89 . . . . 0.0 110.19 -179.941 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . 0.455 ' HG3' ' HB2' ' A' ' 68' ' ' LYS . 54.4 mm-40 -97.14 18.96 13.76 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.239 -0.913 . . . . 0.0 110.224 179.957 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 139.91 -156.68 25.02 Favored Glycine 0 N--CA 1.488 2.144 0 N-CA-C 109.485 -1.446 . . . . 0.0 109.485 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.447 ' O ' ' SG ' ' A' ' 66' ' ' CYS . 24.5 p -109.26 165.04 11.92 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.188 -1.183 . . . . 0.0 110.174 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -107.65 -158.46 0.65 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.258 -0.902 . . . . 0.0 110.291 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 95.2 m-85 -58.58 -55.9 29.12 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.354 -0.841 . . . . 0.0 110.163 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -126.29 172.22 10.29 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.255 -0.903 . . . . 0.0 110.171 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -65.1 -20.25 66.82 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.424 -1.47 . . . . 0.0 109.424 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 48.8 mtmt -65.93 -24.1 66.76 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.231 -1.158 . . . . 0.0 110.215 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.428 ' C ' ' HG2' ' A' ' 65' ' ' LYS . . . -118.28 161.86 19.22 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.232 -0.917 . . . . 0.0 110.166 180.0 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.428 ' HG2' ' C ' ' A' ' 64' ' ' ALA . 73.8 mmtt -146.93 138.54 24.29 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.211 -0.931 . . . . 0.0 110.22 -179.942 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' CYS . . . . . 0.447 ' SG ' ' O ' ' A' ' 58' ' ' THR . 89.4 m -64.03 139.51 58.77 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.275 -0.891 . . . . 0.0 110.085 179.949 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' CYS . . . . . 0.475 ' O ' ' CA ' ' A' ' 42' ' ' GLY . 95.1 m -141.85 136.62 30.76 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.23 -0.919 . . . . 0.0 110.223 179.967 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.459 ' HA ' ' HA3' ' A' ' 42' ' ' GLY . 73.0 tttt . . . . . 0 N--CA 1.492 1.625 0 CA-C-O 118.03 -0.986 . . . . 0.0 110.157 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 12.8 t80 . . . . . 0 N--CA 1.492 1.66 0 CA-C-O 121.281 0.562 . . . . 0.0 110.191 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . 0.498 ' ND2' ' HB2' ' A' ' 39' ' ' SER . 0.2 OUTLIER -91.43 67.92 5.71 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.203 -0.936 . . . . 0.0 110.223 179.981 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . 0.433 ' O ' ' N ' ' A' ' 40' ' ' SER . 55.8 m -64.63 -50.85 65.49 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.265 -0.897 . . . . 0.0 110.169 -179.923 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 30.8 t -45.48 -47.32 4.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.137 -0.977 . . . . 0.0 110.193 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' SER . . . . . 0.498 ' HB2' ' ND2' ' A' ' 36' ' ' ASN . 32.2 t -59.01 -21.85 59.71 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.273 -0.892 . . . . 0.0 110.265 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' SER . . . . . 0.433 ' N ' ' O ' ' A' ' 37' ' ' CYS . 74.7 m -86.31 -11.88 50.95 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.228 -0.92 . . . . 0.0 110.215 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 103.7 5.08 45.44 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.598 -1.401 . . . . 0.0 109.598 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.445 ' HA3' ' HA ' ' A' ' 68' ' ' LYS . . . -102.58 172.29 21.86 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.501 -1.439 . . . . 0.0 109.501 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . 0.456 ' O ' ' HA ' ' A' ' 66' ' ' CYS . 1.1 pt20 -123.35 175.11 6.91 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.204 -1.174 . . . . 0.0 110.219 179.939 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 22.4 t -107.93 94.16 4.93 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.23 -0.918 . . . . 0.0 110.197 -179.896 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.558 ' CD1' ' CD ' ' A' ' 50' ' ' PRO . 94.5 mt -73.24 177.9 4.83 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.206 -0.934 . . . . 0.0 110.216 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 80.3 m-85 -104.26 -11.54 17.14 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.267 -0.895 . . . . 0.0 110.278 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' SER . . . . . 0.401 ' O ' ' C ' ' A' ' 48' ' ' ALA . 60.1 p -125.74 173.23 9.18 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.307 -0.871 . . . . 0.0 110.258 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.401 ' C ' ' O ' ' A' ' 47' ' ' SER . . . -43.16 128.61 4.6 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.277 -0.89 . . . . 0.0 110.144 179.945 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 4.9 t -46.56 129.32 8.2 Favored Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.287 -0.883 . . . . 0.0 110.142 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.558 ' CD ' ' CD1' ' A' ' 45' ' ' LEU . 46.1 Cg_endo -72.84 149.76 48.38 Favored 'Trans proline' 0 C--N 1.306 -1.679 0 O-C-N 123.853 1.449 . . . . 0.0 110.406 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.43 HD11 HG22 ' A' ' 51' ' ' ILE . 46.1 pt -60.21 -24.75 31.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.299 -0.876 . . . . 0.0 110.177 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 58.4 m-85 -60.38 -13.91 15.85 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.156 -0.965 . . . . 0.0 110.202 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.459 ' OG1' ' HB3' ' A' ' 67' ' ' CYS . 77.4 p -135.87 154.72 51.07 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.15 -0.969 . . . . 0.0 110.237 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 95.7 mttt -98.11 152.55 19.22 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.294 -0.879 . . . . 0.0 110.259 179.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.449 HG22 ' O ' ' A' ' 55' ' ' ILE . 20.8 tt -89.36 124.39 42.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.329 -0.857 . . . . 0.0 110.244 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 67.1 mm-40 -97.37 -18.21 19.26 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.257 -0.902 . . . . 0.0 110.178 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -177.83 -149.59 8.05 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.453 -1.459 . . . . 0.0 109.453 -179.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.442 ' O ' ' SG ' ' A' ' 66' ' ' CYS . 33.2 p -111.32 163.33 14.08 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.288 -1.124 . . . . 0.0 110.131 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -96.75 -160.73 0.82 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.244 -0.91 . . . . 0.0 110.192 179.973 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 93.4 m-85 -60.8 -42.77 98.24 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.284 -0.885 . . . . 0.0 110.151 179.891 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 90.1 mtt-85 -135.41 170.87 15.27 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.214 -0.929 . . . . 0.0 110.212 -179.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -63.53 -18.9 61.85 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.375 -1.49 . . . . 0.0 109.375 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 12.3 tttt -70.27 -31.54 68.95 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.179 -1.189 . . . . 0.0 110.193 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.422 ' C ' ' HG2' ' A' ' 65' ' ' LYS . . . -105.19 159.53 15.79 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.302 -0.873 . . . . 0.0 110.123 -179.952 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.422 ' HG2' ' C ' ' A' ' 64' ' ' ALA . 73.9 mmtt -142.9 147.9 36.07 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.246 -0.909 . . . . 0.0 110.18 179.968 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' CYS . . . . . 0.456 ' HA ' ' O ' ' A' ' 43' ' ' GLN . 71.7 m -77.55 148.47 35.2 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.268 -0.895 . . . . 0.0 110.1 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' CYS . . . . . 0.516 ' SG ' ' CD1' ' A' ' 45' ' ' LEU . 92.6 m -145.7 131.15 18.69 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.13 -0.981 . . . . 0.0 110.256 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.445 ' HA ' ' HA3' ' A' ' 42' ' ' GLY . 82.0 tttt . . . . . 0 N--CA 1.491 1.604 0 CA-C-O 118.096 -0.954 . . . . 0.0 110.27 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.566 ' CE2' ' SG ' ' A' ' 37' ' ' CYS . 3.3 t80 . . . . . 0 N--CA 1.491 1.6 0 CA-C-O 121.201 0.524 . . . . 0.0 110.218 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . 0.504 ' ND2' ' HB3' ' A' ' 39' ' ' SER . 27.2 p-10 -94.22 85.12 4.56 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.266 -0.896 . . . . 0.0 110.234 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . 0.566 ' SG ' ' CE2' ' A' ' 35' ' ' TYR . 87.6 m -65.02 -42.66 94.2 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.271 -0.893 . . . . 0.0 110.284 179.951 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 86.4 t -52.41 -40.86 33.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.301 -0.875 . . . . 0.0 110.196 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' SER . . . . . 0.504 ' HB3' ' ND2' ' A' ' 36' ' ' ASN . 24.6 t -62.67 -26.76 68.81 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.269 -0.895 . . . . 0.0 110.251 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' SER . . . . . 0.514 ' O ' ' CE ' ' A' ' 68' ' ' LYS . 2.2 t -79.95 -16.65 54.81 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.319 -0.863 . . . . 0.0 110.163 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 116.33 -12.53 16.37 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.468 -1.453 . . . . 0.0 109.468 -179.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.452 ' HA3' ' HA ' ' A' ' 68' ' ' LYS . . . -83.55 -175.36 50.9 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 -179.988 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . 0.457 ' O ' ' HA ' ' A' ' 66' ' ' CYS . 42.5 tt0 -133.73 152.25 51.83 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.25 -1.147 . . . . 0.0 110.206 179.926 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . 0.439 ' HA ' ' HA ' ' A' ' 66' ' ' CYS . 49.2 t -100.1 127.16 46.38 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.265 -0.897 . . . . 0.0 110.219 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 28.9 mt -121.12 176.57 5.52 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.225 -0.922 . . . . 0.0 110.227 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 85.1 m-85 -104.19 -0.78 28.07 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.21 -0.931 . . . . 0.0 110.206 180.0 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 85.7 p -116.18 171.95 7.48 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.243 -0.911 . . . . 0.0 110.205 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -46.92 153.33 0.43 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.291 -0.881 . . . . 0.0 110.147 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 42.3 t -55.67 128.38 69.03 Favored Pre-proline 0 N--CA 1.492 1.641 0 O-C-N 121.325 -0.86 . . . . 0.0 110.165 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -72.64 153.69 54.43 Favored 'Trans proline' 0 C--N 1.305 -1.718 0 O-C-N 123.943 1.496 . . . . 0.0 110.485 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 28.1 pt -77.08 -6.45 9.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.26 -0.9 . . . . 0.0 110.105 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 46.6 m-85 -73.0 -22.94 60.59 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.248 -0.908 . . . . 0.0 110.14 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 69.9 p -137.62 161.81 35.47 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.317 -0.865 . . . . 0.0 110.204 179.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.497 ' O ' ' N ' ' A' ' 68' ' ' LYS . 64.3 mttt -90.32 169.54 11.01 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.289 -0.882 . . . . 0.0 110.15 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.518 ' O ' ' CG2' ' A' ' 55' ' ' ILE . 20.6 tt -95.48 111.27 25.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.262 -0.899 . . . . 0.0 110.133 -179.914 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . 0.505 ' CG ' ' HB3' ' A' ' 68' ' ' LYS . 56.6 mm-40 -90.32 -12.85 36.52 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.211 -0.931 . . . . 0.0 110.188 179.962 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . 0.525 ' HA2' ' CE2' ' A' ' 35' ' ' TYR . . . 170.79 -144.77 8.53 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.474 -1.451 . . . . 0.0 109.474 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 16.5 p -115.73 168.37 10.09 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.221 -1.164 . . . . 0.0 110.186 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . 0.47 ' SG ' ' N ' ' A' ' 66' ' ' CYS . 1.1 m -91.19 -161.6 0.83 Allowed 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.296 -0.877 . . . . 0.0 110.212 -179.92 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 94.2 m-85 -57.24 -40.82 78.37 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.31 -0.868 . . . . 0.0 110.317 179.861 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 93.8 mtt180 -132.44 178.26 6.96 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.222 -0.924 . . . . 0.0 110.214 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -76.25 -6.02 82.54 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.589 -1.404 . . . . 0.0 109.589 -179.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 40.6 mtpt -81.59 -23.75 36.9 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.197 -1.178 . . . . 0.0 110.184 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.43 ' O ' ' HB2' ' A' ' 59' ' ' CYS . . . -117.27 162.61 17.61 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.291 -0.88 . . . . 0.0 110.1 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 16.4 tppt? -141.16 123.02 15.37 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.244 -0.91 . . . . 0.0 110.16 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' CYS . . . . . 0.47 ' N ' ' SG ' ' A' ' 59' ' ' CYS . 28.9 p -87.84 151.3 22.96 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.173 -0.954 . . . . 0.0 110.188 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' CYS . . . . . 0.466 ' CA ' ' O ' ' A' ' 54' ' ' LYS . 73.1 m -148.77 143.47 26.4 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.222 -0.924 . . . . 0.0 110.192 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.514 ' CE ' ' O ' ' A' ' 40' ' ' SER . 78.3 tttt . . . . . 0 N--CA 1.492 1.633 0 CA-C-O 117.999 -1.0 . . . . 0.0 110.259 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.562 ' CD1' ' SG ' ' A' ' 37' ' ' CYS . 6.4 t80 . . . . . 0 N--CA 1.491 1.612 0 CA-C-O 121.263 0.554 . . . . 0.0 110.276 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . 0.568 ' ND2' ' CB ' ' A' ' 39' ' ' SER . 49.7 t30 65.95 54.55 1.01 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.277 -0.889 . . . . 0.0 110.168 -179.924 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . 0.562 ' SG ' ' CD1' ' A' ' 35' ' ' TYR . 31.0 m -65.14 -52.95 52.08 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.304 -0.872 . . . . 0.0 110.146 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 38.0 t -47.91 -50.01 10.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.31 -0.869 . . . . 0.0 110.224 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' SER . . . . . 0.568 ' CB ' ' ND2' ' A' ' 36' ' ' ASN . 66.0 m -56.68 -32.33 65.33 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.249 -0.907 . . . . 0.0 110.115 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' SER . . . . . 0.502 ' O ' ' NZ ' ' A' ' 68' ' ' LYS . 24.0 m -72.87 -11.5 60.62 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.288 -0.883 . . . . 0.0 110.09 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 103.95 -12.35 52.78 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.389 -1.484 . . . . 0.0 109.389 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.462 ' HA2' ' HB2' ' A' ' 68' ' ' LYS . . . -81.52 -175.14 49.98 Favored Glycine 0 N--CA 1.489 2.217 0 N-CA-C 109.469 -1.452 . . . . 0.0 109.469 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . 0.447 ' NE2' HD23 ' A' ' 45' ' ' LEU . 47.7 tt0 -126.44 147.77 49.75 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.304 -1.115 . . . . 0.0 110.221 179.95 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 20.2 t -100.51 109.11 21.2 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.203 -0.936 . . . . 0.0 110.221 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.46 HD11 ' HD3' ' A' ' 50' ' ' PRO . 59.0 mt -104.67 175.22 5.56 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.184 -0.947 . . . . 0.0 110.155 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 89.4 m-85 -107.84 -8.31 16.03 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.287 -0.883 . . . . 0.0 110.256 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' SER . . . . . 0.408 ' O ' ' C ' ' A' ' 48' ' ' ALA . 34.1 t -114.22 164.43 13.9 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.182 -0.949 . . . . 0.0 110.203 -179.984 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.418 ' O ' ' C ' ' A' ' 49' ' ' CYS . . . -42.62 132.45 3.68 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.309 -0.869 . . . . 0.0 110.159 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . 0.418 ' C ' ' O ' ' A' ' 48' ' ' ALA . 4.7 t -43.16 129.83 3.4 Favored Pre-proline 0 N--CA 1.492 1.642 0 O-C-N 121.254 -0.904 . . . . 0.0 110.15 179.997 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.46 ' HD3' HD11 ' A' ' 45' ' ' LEU . 45.7 Cg_endo -72.99 146.27 41.35 Favored 'Trans proline' 0 C--N 1.305 -1.712 0 O-C-N 123.921 1.485 . . . . 0.0 110.397 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 34.0 pt -59.54 -20.05 17.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.289 -0.882 . . . . 0.0 110.119 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . 0.416 ' C ' HG21 ' A' ' 53' ' ' THR . 67.1 m-85 -61.82 -21.54 64.71 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.318 -0.864 . . . . 0.0 110.273 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.422 ' OG1' ' HB3' ' A' ' 67' ' ' CYS . 68.3 p -144.83 152.83 40.89 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.219 -0.925 . . . . 0.0 110.219 179.895 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.459 ' O ' ' HA ' ' A' ' 67' ' ' CYS . 62.2 mttm -78.01 173.5 12.12 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.32 -0.862 . . . . 0.0 110.174 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.486 ' O ' ' CG2' ' A' ' 55' ' ' ILE . 20.8 tt -110.78 121.24 63.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.25 -0.906 . . . . 0.0 110.169 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . 0.505 ' NE2' ' HB3' ' A' ' 68' ' ' LYS . 86.4 mm-40 -78.21 -27.02 47.71 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.253 -0.904 . . . . 0.0 110.225 -179.933 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 156.9 -155.96 26.8 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.478 -1.449 . . . . 0.0 109.478 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.421 ' O ' ' SG ' ' A' ' 66' ' ' CYS . 17.1 p -74.63 175.24 8.06 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.286 -1.126 . . . . 0.0 110.245 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . 1.204 ' SG ' ' SG ' ' A' ' 66' ' ' CYS . 0.1 OUTLIER -125.54 142.03 51.72 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.322 -0.861 . . . . 0.0 110.179 179.981 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 83.0 m-85 45.33 -92.53 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.295 -0.878 . . . . 0.0 110.23 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . 0.517 ' N ' ' O ' ' A' ' 59' ' ' CYS . 66.1 mtp180 -118.11 -8.21 10.71 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.194 -0.941 . . . . 0.0 110.151 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 127.3 -14.52 6.51 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.507 -1.437 . . . . 0.0 109.507 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 52.5 mtmt -61.12 -22.18 64.42 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.226 -1.161 . . . . 0.0 110.277 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.462 ' O ' ' HD3' ' A' ' 65' ' ' LYS . . . -127.97 173.83 9.7 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.226 -0.921 . . . . 0.0 110.166 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.462 ' HD3' ' O ' ' A' ' 64' ' ' ALA . 46.2 mmtt -124.16 122.76 38.7 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.248 -0.908 . . . . 0.0 110.215 -179.977 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' CYS . . . . . 1.204 ' SG ' ' SG ' ' A' ' 59' ' ' CYS . 75.9 m -75.09 149.36 39.15 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.271 -0.893 . . . . 0.0 110.135 -179.945 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' CYS . . . . . 0.459 ' HA ' ' O ' ' A' ' 54' ' ' LYS . 89.5 m -146.11 136.36 23.8 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.315 -0.866 . . . . 0.0 110.241 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.505 ' HB3' ' NE2' ' A' ' 56' ' ' GLN . 80.6 tttt . . . . . 0 N--CA 1.493 1.695 0 CA-C-O 118.093 -0.956 . . . . 0.0 110.209 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.502 ' CD1' ' N ' ' A' ' 36' ' ' ASN . 6.3 t80 . . . . . 0 N--CA 1.491 1.6 0 CA-C-O 121.258 0.551 . . . . 0.0 110.119 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . 0.502 ' N ' ' CD1' ' A' ' 35' ' ' TYR . 28.5 p-10 -84.99 57.43 4.44 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.199 -0.938 . . . . 0.0 110.293 -179.937 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 26.1 m -67.09 -56.26 10.8 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.252 -0.905 . . . . 0.0 110.058 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 60.1 t -53.47 -29.25 16.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.265 -0.897 . . . . 0.0 110.112 179.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 39.6 t -70.91 -30.06 66.3 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.298 -0.876 . . . . 0.0 110.121 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' SER . . . . . 0.51 ' O ' ' NZ ' ' A' ' 68' ' ' LYS . 0.4 OUTLIER -78.94 -21.48 47.16 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.287 -0.883 . . . . 0.0 110.118 179.969 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 117.29 3.57 16.95 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.611 -1.396 . . . . 0.0 109.611 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.453 ' HA3' ' HA ' ' A' ' 68' ' ' LYS . . . -100.5 172.31 23.89 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 -179.974 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 36.4 tt0 -118.14 153.41 33.84 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.25 -1.147 . . . . 0.0 110.187 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 30.5 t -98.03 97.99 9.38 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.253 -0.904 . . . . 0.0 110.205 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.514 HD13 ' CD ' ' A' ' 50' ' ' PRO . 79.7 mt -82.59 174.34 11.13 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.287 -0.883 . . . . 0.0 110.197 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 98.2 m-85 -107.25 0.66 23.36 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.29 -0.881 . . . . 0.0 110.276 -179.892 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' SER . . . . . 0.414 ' O ' ' C ' ' A' ' 48' ' ' ALA . 92.3 p -125.9 172.22 10.08 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.128 -0.982 . . . . 0.0 110.194 179.929 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.414 ' C ' ' O ' ' A' ' 47' ' ' SER . . . -42.93 124.2 3.05 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.316 -0.865 . . . . 0.0 110.169 179.948 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 16.4 t -42.87 130.41 3.13 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.29 -0.881 . . . . 0.0 110.215 -179.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.514 ' CD ' HD13 ' A' ' 45' ' ' LEU . 46.9 Cg_endo -72.72 140.73 32.86 Favored 'Trans proline' 0 C--N 1.306 -1.692 0 O-C-N 123.965 1.508 . . . . 0.0 110.391 -179.955 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 43.8 pt -62.2 -22.17 28.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.285 -0.884 . . . . 0.0 110.213 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 69.0 m-85 -55.92 -17.46 6.59 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.239 -0.913 . . . . 0.0 110.207 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.423 ' OG1' ' HB3' ' A' ' 67' ' ' CYS . 35.4 p -135.93 168.09 19.99 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.257 -0.902 . . . . 0.0 110.176 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.414 ' HB2' ' O ' ' A' ' 68' ' ' LYS . 22.1 mttp -96.12 152.98 18.04 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.274 -0.891 . . . . 0.0 110.241 179.977 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.469 ' O ' ' CG2' ' A' ' 55' ' ' ILE . 13.0 tt -94.54 113.57 29.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.247 -0.908 . . . . 0.0 110.316 -179.955 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . 0.497 ' NE2' ' HB3' ' A' ' 68' ' ' LYS . 90.4 mm-40 -76.13 -26.48 56.37 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.239 -0.913 . . . . 0.0 110.097 -179.977 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 167.5 -151.85 19.81 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.467 -1.453 . . . . 0.0 109.467 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 16.5 p -94.22 165.48 12.58 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.271 -1.135 . . . . 0.0 110.205 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . 0.97 ' SG ' ' SG ' ' A' ' 66' ' ' CYS . 0.5 OUTLIER -103.28 -158.02 0.64 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.202 -0.936 . . . . 0.0 110.207 -179.952 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 61.8 m-85 -56.64 -54.95 40.18 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.307 -0.871 . . . . 0.0 110.227 179.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . 0.519 ' CZ ' ' CD ' ' A' ' 63' ' ' LYS . 52.8 ttt180 -118.12 159.66 22.89 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.272 -0.893 . . . . 0.0 110.255 -179.979 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -63.16 -16.1 57.35 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.385 -1.486 . . . . 0.0 109.385 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.519 ' CD ' ' CZ ' ' A' ' 61' ' ' ARG . 41.9 mtpt -70.2 -27.84 64.81 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.257 -1.143 . . . . 0.0 110.172 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.402 ' C ' ' HG2' ' A' ' 65' ' ' LYS . . . -110.48 166.41 11.01 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.379 -0.826 . . . . 0.0 110.192 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.402 ' HG2' ' C ' ' A' ' 64' ' ' ALA . 74.8 mmtt -141.43 150.38 42.24 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.283 -0.885 . . . . 0.0 110.202 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' CYS . . . . . 0.97 ' SG ' ' SG ' ' A' ' 59' ' ' CYS . 94.7 m -92.46 144.14 25.66 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.282 -0.886 . . . . 0.0 110.185 179.939 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' CYS . . . . . 0.429 ' SG ' ' HD2' ' A' ' 50' ' ' PRO . 65.5 m -144.15 121.39 11.55 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.206 -0.934 . . . . 0.0 110.219 -179.995 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.51 ' NZ ' ' O ' ' A' ' 40' ' ' SER . 80.4 tttt . . . . . 0 N--CA 1.491 1.606 0 CA-C-O 118.02 -0.99 . . . . 0.0 110.216 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.564 ' CZ ' ' SG ' ' A' ' 37' ' ' CYS . 26.2 p90 . . . . . 0 N--CA 1.492 1.638 0 CA-C-O 121.249 0.547 . . . . 0.0 110.112 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . 0.439 ' ND2' ' OG ' ' A' ' 39' ' ' SER . 32.1 t30 -85.63 109.92 18.9 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.34 -0.85 . . . . 0.0 110.28 -179.974 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . 0.564 ' SG ' ' CZ ' ' A' ' 35' ' ' TYR . 98.0 m -66.04 -42.74 89.17 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.278 -0.889 . . . . 0.0 110.089 179.919 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 97.5 t -48.18 -42.76 11.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.233 -0.917 . . . . 0.0 110.161 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' SER . . . . . 0.439 ' OG ' ' ND2' ' A' ' 36' ' ' ASN . 2.8 m -64.79 -24.97 67.72 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.301 -0.874 . . . . 0.0 110.206 179.959 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 69.2 m -82.61 -9.62 59.31 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.272 -0.892 . . . . 0.0 110.229 179.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 107.97 -4.78 34.06 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.496 ' CA ' ' O ' ' A' ' 67' ' ' CYS . . . -90.71 -172.94 44.16 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.507 -1.437 . . . . 0.0 109.507 179.94 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . 0.507 ' HG2' ' N ' ' A' ' 44' ' ' CYS . 44.8 tt0 -127.05 168.41 14.62 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.211 -1.17 . . . . 0.0 110.213 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . 0.507 ' N ' ' HG2' ' A' ' 43' ' ' GLN . 15.7 t -115.82 136.61 52.89 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.193 -0.942 . . . . 0.0 110.242 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.45 HD22 ' O ' ' A' ' 44' ' ' CYS . 81.6 mt -136.9 174.53 10.51 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.195 -0.941 . . . . 0.0 110.218 179.935 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 96.1 m-85 -109.44 0.55 19.39 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.185 -0.947 . . . . 0.0 110.254 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' SER . . . . . 0.419 ' O ' ' C ' ' A' ' 48' ' ' ALA . 41.4 m -122.79 164.79 17.72 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.271 -0.893 . . . . 0.0 110.237 180.0 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.419 ' C ' ' O ' ' A' ' 47' ' ' SER . . . -42.82 138.49 1.96 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.272 -0.892 . . . . 0.0 110.254 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . 0.462 ' CB ' ' HB ' ' A' ' 55' ' ' ILE . 11.6 t -44.5 131.38 4.83 Favored Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 121.201 -0.937 . . . . 0.0 110.182 -179.924 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.446 ' HD3' HD11 ' A' ' 45' ' ' LEU . 46.9 Cg_endo -72.71 161.13 44.73 Favored 'Trans proline' 0 C--N 1.306 -1.691 0 O-C-N 123.976 1.514 . . . . 0.0 110.47 179.94 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 47.1 pt -75.89 -10.69 13.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.212 -0.93 . . . . 0.0 110.274 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . 0.416 ' C ' HG21 ' A' ' 53' ' ' THR . 77.0 m-85 -70.7 -25.38 62.93 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.21 -0.931 . . . . 0.0 110.212 -179.954 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.416 HG21 ' C ' ' A' ' 52' ' ' PHE . 81.3 p -137.55 159.82 40.88 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.261 -0.899 . . . . 0.0 110.304 179.982 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.435 ' HB2' ' O ' ' A' ' 68' ' ' LYS . 86.3 mttt -78.96 155.9 28.74 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.256 -0.902 . . . . 0.0 110.254 179.927 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.486 ' O ' ' CG2' ' A' ' 55' ' ' ILE . 17.3 tt -97.07 102.15 13.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.211 -0.93 . . . . 0.0 110.199 179.992 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . 0.496 ' CG ' ' HB3' ' A' ' 68' ' ' LYS . 64.9 mm-40 -70.4 -27.55 64.39 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.179 -0.951 . . . . 0.0 109.926 179.824 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 156.54 -158.85 29.05 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.401 -1.48 . . . . 0.0 109.401 179.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.411 ' HA ' ' CD ' ' A' ' 65' ' ' LYS . 19.3 p -81.87 164.84 21.32 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.254 -1.145 . . . . 0.0 110.19 179.947 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . 0.453 ' SG ' ' HB3' ' A' ' 66' ' ' CYS . 0.5 OUTLIER -92.64 -142.41 0.21 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.23 -0.918 . . . . 0.0 110.252 179.972 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 91.9 m-85 -50.52 -46.2 57.17 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.335 -0.853 . . . . 0.0 110.223 179.886 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -132.85 174.15 10.63 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.265 -0.897 . . . . 0.0 110.171 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -69.85 -16.21 72.2 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 48.9 mtpt -67.96 -25.85 65.64 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.234 -1.156 . . . . 0.0 110.257 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -124.63 161.29 26.57 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.301 -0.874 . . . . 0.0 110.212 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.411 ' CD ' ' HA ' ' A' ' 58' ' ' THR . 40.1 mmtm -133.62 143.26 48.51 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.309 -0.87 . . . . 0.0 110.213 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' CYS . . . . . 0.453 ' HB3' ' SG ' ' A' ' 59' ' ' CYS . 19.5 p -109.93 162.78 14.18 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.318 -0.864 . . . . 0.0 110.226 179.97 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' CYS . . . . . 0.496 ' O ' ' CA ' ' A' ' 42' ' ' GLY . 75.7 m -142.41 165.29 27.82 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.302 -0.874 . . . . 0.0 110.264 179.968 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.496 ' HB3' ' CG ' ' A' ' 56' ' ' GLN . 39.6 ttpt . . . . . 0 N--CA 1.491 1.611 0 CA-C-O 117.984 -1.008 . . . . 0.0 110.152 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.485 ' CD1' ' SG ' ' A' ' 37' ' ' CYS . 6.3 t80 . . . . . 0 N--CA 1.491 1.598 0 CA-C-O 121.226 0.536 . . . . 0.0 110.149 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . 0.467 ' N ' ' CD1' ' A' ' 35' ' ' TYR . 0.2 OUTLIER -121.73 83.51 2.1 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.281 -0.887 . . . . 0.0 110.293 -179.959 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . 0.485 ' SG ' ' CD1' ' A' ' 35' ' ' TYR . 28.9 m -68.71 -52.89 25.95 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.294 -0.879 . . . . 0.0 110.128 179.954 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 60.7 t -46.02 -48.52 5.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.205 -0.935 . . . . 0.0 110.164 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 58.9 p -58.63 -24.27 60.74 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.192 -0.943 . . . . 0.0 110.207 179.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' SER . . . . . 0.456 ' HB2' ' O ' ' A' ' 37' ' ' CYS . 66.7 m -82.08 -11.59 58.7 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.252 -0.905 . . . . 0.0 110.127 -179.964 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 106.31 -20.43 35.17 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 -179.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.519 ' CA ' ' O ' ' A' ' 67' ' ' CYS . . . -75.17 -177.66 40.64 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.452 -1.459 . . . . 0.0 109.452 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . 0.495 ' N ' ' O ' ' A' ' 67' ' ' CYS . 32.0 tt0 -129.83 160.12 34.46 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.276 -1.131 . . . . 0.0 110.204 -179.98 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . 0.47 ' SG ' ' CE2' ' A' ' 60' ' ' TYR . 13.5 t -114.97 107.63 15.63 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.259 -0.901 . . . . 0.0 110.182 179.972 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.48 HD13 ' CD ' ' A' ' 50' ' ' PRO . 16.7 mt -93.74 169.31 10.41 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.212 -0.93 . . . . 0.0 110.219 -179.931 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -86.53 -22.95 26.05 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.237 -0.915 . . . . 0.0 110.203 -179.907 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' SER . . . . . 0.417 ' O ' ' C ' ' A' ' 48' ' ' ALA . 40.2 t -103.51 163.64 12.17 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.284 -0.885 . . . . 0.0 110.251 -179.973 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.417 ' C ' ' O ' ' A' ' 47' ' ' SER . . . -43.45 138.01 2.58 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.231 -0.918 . . . . 0.0 110.194 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . 0.408 ' C ' ' O ' ' A' ' 48' ' ' ALA . 7.7 t -43.72 133.11 3.89 Favored Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.266 -0.896 . . . . 0.0 110.194 -179.958 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.48 ' CD ' HD13 ' A' ' 45' ' ' LEU . 46.4 Cg_endo -72.96 143.97 37.45 Favored 'Trans proline' 0 C--N 1.306 -1.691 0 O-C-N 123.954 1.502 . . . . 0.0 110.413 -179.935 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 40.3 pt -59.84 -24.18 28.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.213 -0.93 . . . . 0.0 110.163 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . 0.461 ' O ' HG21 ' A' ' 53' ' ' THR . 97.5 m-85 -55.72 -22.23 22.66 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.261 -0.9 . . . . 0.0 110.252 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.461 HG21 ' O ' ' A' ' 52' ' ' PHE . 67.2 p -139.35 153.83 47.76 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.261 -0.899 . . . . 0.0 110.239 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 72.0 mttt -79.6 172.07 14.29 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.262 -0.898 . . . . 0.0 110.166 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.503 ' O ' ' CG2' ' A' ' 55' ' ' ILE . 11.5 tt -106.9 110.62 32.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.276 -0.89 . . . . 0.0 110.116 179.965 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . 0.51 ' CG ' ' HB2' ' A' ' 68' ' ' LYS . 72.1 mm-40 -62.02 -31.96 72.4 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.276 -0.89 . . . . 0.0 110.137 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 169.18 -144.57 8.77 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.443 -1.463 . . . . 0.0 109.443 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 17.5 p -97.91 164.97 12.15 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.184 -1.186 . . . . 0.0 110.196 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . 1.089 ' SG ' ' SG ' ' A' ' 66' ' ' CYS . 0.5 OUTLIER -106.49 -171.63 1.93 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.225 -0.922 . . . . 0.0 110.293 -179.976 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . 0.527 ' CD1' ' N ' ' A' ' 61' ' ' ARG . 7.9 p90 -50.99 -31.68 18.76 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.309 -0.87 . . . . 0.0 110.263 179.862 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . 0.527 ' N ' ' CD1' ' A' ' 60' ' ' TYR . 91.9 mtt180 -140.89 173.35 11.57 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.308 -0.87 . . . . 0.0 110.258 179.939 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -81.76 -11.08 83.34 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.586 -1.405 . . . . 0.0 109.586 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.403 ' HE2' ' CD ' ' A' ' 61' ' ' ARG . 48.7 mtmt -68.04 -18.84 64.8 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.217 -1.167 . . . . 0.0 110.135 -179.949 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.469 ' CB ' ' O ' ' A' ' 45' ' ' LEU . . . -136.42 158.58 44.08 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.263 -0.898 . . . . 0.0 110.16 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 70.1 mmtt -126.55 140.55 52.36 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.279 -0.888 . . . . 0.0 110.231 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' CYS . . . . . 1.089 ' SG ' ' SG ' ' A' ' 59' ' ' CYS . 84.1 m -74.59 148.88 40.39 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.26 -0.9 . . . . 0.0 110.263 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' CYS . . . . . 0.519 ' O ' ' CA ' ' A' ' 42' ' ' GLY . 82.8 m -142.42 154.84 44.93 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.239 -0.913 . . . . 0.0 110.145 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.51 ' HB2' ' CG ' ' A' ' 56' ' ' GLN . 68.3 tttt . . . . . 0 N--CA 1.492 1.645 0 CA-C-O 118.04 -0.981 . . . . 0.0 110.191 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.566 ' CZ ' ' SG ' ' A' ' 37' ' ' CYS . 30.4 p90 . . . . . 0 N--CA 1.491 1.608 0 CA-C-O 121.327 0.584 . . . . 0.0 110.153 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . 0.507 ' ND2' ' OG ' ' A' ' 39' ' ' SER . 23.4 p-10 -88.15 100.45 12.97 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.198 -0.939 . . . . 0.0 110.243 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . 0.566 ' SG ' ' CZ ' ' A' ' 35' ' ' TYR . 14.8 m -72.1 -22.2 61.38 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.287 -0.883 . . . . 0.0 110.086 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 35.8 m -60.98 -45.19 98.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.231 -0.918 . . . . 0.0 110.46 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' SER . . . . . 0.507 ' OG ' ' ND2' ' A' ' 36' ' ' ASN . 95.0 p -60.6 -31.61 70.76 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.202 -0.936 . . . . 0.0 110.211 -179.928 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 72.8 m -73.64 -12.43 60.74 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.304 -0.872 . . . . 0.0 110.192 179.89 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 101.83 -11.27 57.59 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.431 -1.468 . . . . 0.0 109.431 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.511 ' CA ' ' O ' ' A' ' 67' ' ' CYS . . . -85.18 172.49 47.44 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.412 -1.475 . . . . 0.0 109.412 -179.912 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . 0.465 ' O ' ' HA ' ' A' ' 66' ' ' CYS . 0.4 OUTLIER -123.28 -174.82 3.04 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.27 -1.135 . . . . 0.0 110.151 179.959 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 13.7 t -130.11 116.38 18.41 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.161 -0.962 . . . . 0.0 110.222 -179.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 93.5 mt -105.46 175.84 5.36 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.251 -0.905 . . . . 0.0 110.224 179.858 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 98.3 m-85 -102.45 -3.44 26.95 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.278 -0.889 . . . . 0.0 110.291 -179.877 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' SER . . . . . 0.407 ' O ' ' C ' ' A' ' 48' ' ' ALA . 69.3 m -122.76 166.49 14.86 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.272 -0.893 . . . . 0.0 110.246 179.967 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.422 ' O ' ' C ' ' A' ' 49' ' ' CYS . . . -42.97 131.64 4.15 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.243 -0.911 . . . . 0.0 110.19 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . 0.422 ' C ' ' O ' ' A' ' 48' ' ' ALA . 5.9 t -42.96 130.02 3.19 Favored Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 121.29 -0.881 . . . . 0.0 110.251 -179.981 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -72.81 145.6 41.08 Favored 'Trans proline' 0 C--N 1.306 -1.689 0 O-C-N 123.945 1.497 . . . . 0.0 110.412 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 45.1 pt -59.63 -18.48 14.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.254 -0.904 . . . . 0.0 110.192 179.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 91.8 m-85 -70.86 -4.49 24.54 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.293 -0.88 . . . . 0.0 110.256 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 69.5 p -137.69 170.76 15.51 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.286 -0.884 . . . . 0.0 110.248 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.451 ' O ' ' HA ' ' A' ' 67' ' ' CYS . 70.9 tttt -91.27 162.79 14.48 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.215 -0.928 . . . . 0.0 110.209 -179.953 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.518 ' O ' ' CG2' ' A' ' 55' ' ' ILE . 15.1 tt -93.47 100.65 11.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.268 -0.895 . . . . 0.0 110.145 -179.963 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . 0.525 ' HB2' ' CB ' ' A' ' 66' ' ' CYS . 79.2 mm-40 -75.45 0.01 18.53 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.245 -0.909 . . . . 0.0 110.218 179.98 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 111.75 -127.49 8.15 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.497 -1.441 . . . . 0.0 109.497 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.409 ' HA ' ' HD3' ' A' ' 65' ' ' LYS . 71.0 p -105.23 168.62 8.95 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.213 -1.169 . . . . 0.0 110.203 -179.986 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . 0.933 ' SG ' ' SG ' ' A' ' 66' ' ' CYS . 0.1 OUTLIER -117.66 -149.23 0.44 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.222 -0.924 . . . . 0.0 110.179 179.968 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 98.0 m-85 -58.34 -46.47 86.18 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.298 -0.876 . . . . 0.0 110.199 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . 0.432 ' HD2' ' HD3' ' A' ' 63' ' ' LYS . 33.1 ttm180 -129.54 164.76 23.09 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.263 -0.898 . . . . 0.0 110.161 179.989 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . 0.422 ' N ' ' HG2' ' A' ' 61' ' ' ARG . . . -61.3 -23.2 61.95 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.432 ' HD3' ' HD2' ' A' ' 61' ' ' ARG . 44.1 mtpt -72.34 -28.53 63.11 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.21 -1.171 . . . . 0.0 110.228 -179.986 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.422 ' C ' ' HG2' ' A' ' 65' ' ' LYS . . . -107.31 160.44 15.61 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.225 -0.922 . . . . 0.0 110.284 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.507 ' CA ' ' HB2' ' A' ' 59' ' ' CYS . 34.0 mmtm -142.68 144.76 32.87 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.21 -0.931 . . . . 0.0 110.086 179.984 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' CYS . . . . . 0.933 ' SG ' ' SG ' ' A' ' 59' ' ' CYS . 79.9 m -83.56 132.24 34.93 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.173 -0.955 . . . . 0.0 110.163 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' CYS . . . . . 0.511 ' O ' ' CA ' ' A' ' 42' ' ' GLY . 85.0 m -126.76 154.19 44.54 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.28 -0.888 . . . . 0.0 110.18 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.49 ' HB3' ' NE2' ' A' ' 56' ' ' GLN . 85.2 tttt . . . . . 0 N--CA 1.491 1.577 0 CA-C-O 117.951 -1.023 . . . . 0.0 110.271 179.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 3.6 t80 . . . . . 0 N--CA 1.491 1.619 0 CA-C-O 121.294 0.569 . . . . 0.0 110.252 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . 0.521 ' ND2' ' HB2' ' A' ' 39' ' ' SER . 64.2 t30 -100.79 117.27 34.54 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.236 -0.915 . . . . 0.0 110.157 179.931 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . 0.45 ' O ' ' N ' ' A' ' 40' ' ' SER . 37.7 m -85.22 -51.07 6.86 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.332 -0.855 . . . . 0.0 110.311 -179.941 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.46 HG21 ' OD1' ' A' ' 36' ' ' ASN . 21.7 m -41.75 -46.26 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.248 -0.908 . . . . 0.0 110.33 -179.896 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' SER . . . . . 0.521 ' HB2' ' ND2' ' A' ' 36' ' ' ASN . 0.8 OUTLIER -59.02 -32.18 69.49 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.177 -0.952 . . . . 0.0 110.14 179.98 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' SER . . . . . 0.513 ' O ' ' NZ ' ' A' ' 68' ' ' LYS . 50.2 m -75.43 -9.97 59.04 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.347 -0.846 . . . . 0.0 110.156 -179.991 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . 0.406 ' HA2' ' HE3' ' A' ' 68' ' ' LYS . . . 108.29 -20.54 30.31 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 179.931 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.44 ' O ' ' HA ' ' A' ' 38' ' ' VAL . . . -78.27 177.61 53.39 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.592 -1.403 . . . . 0.0 109.592 179.94 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . 0.467 ' O ' ' HA ' ' A' ' 66' ' ' CYS . 14.4 tt0 -125.38 155.93 39.58 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.206 -1.173 . . . . 0.0 110.192 179.921 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 15.7 t -104.5 104.09 13.88 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.257 -0.902 . . . . 0.0 110.281 -179.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 80.3 mt -88.7 174.63 7.91 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.217 -0.927 . . . . 0.0 110.238 179.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 88.8 m-85 -96.13 -19.48 19.35 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.21 -0.931 . . . . 0.0 110.185 -179.929 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' SER . . . . . 0.419 ' O ' ' C ' ' A' ' 48' ' ' ALA . 69.1 m -110.47 165.66 11.61 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.181 -0.949 . . . . 0.0 110.257 -179.934 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.419 ' C ' ' O ' ' A' ' 47' ' ' SER . . . -42.92 131.95 4.04 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.315 -0.866 . . . . 0.0 110.217 179.978 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 8.7 t -44.68 127.63 5.07 Favored Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.205 -0.934 . . . . 0.0 110.106 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.418 ' HD2' ' SG ' ' A' ' 67' ' ' CYS . 46.7 Cg_endo -72.4 149.46 50.51 Favored 'Trans proline' 0 C--N 1.306 -1.681 0 O-C-N 123.949 1.499 . . . . 0.0 110.402 -179.999 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.412 HG13 ' N ' ' A' ' 52' ' ' PHE . 27.8 pt -63.6 -22.28 30.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.244 -0.91 . . . . 0.0 110.211 179.933 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . 0.412 ' N ' HG13 ' A' ' 51' ' ' ILE . 91.0 m-85 -56.98 -20.28 22.93 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.215 -0.928 . . . . 0.0 110.211 -179.998 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 17.6 p -133.93 162.85 30.91 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.302 -0.874 . . . . 0.0 110.18 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 55.6 mttm -95.36 143.94 26.32 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.221 -0.924 . . . . 0.0 110.129 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.507 ' CG2' ' O ' ' A' ' 55' ' ' ILE . 18.2 tt -88.76 113.26 25.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.213 -0.929 . . . . 0.0 110.184 -179.979 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . 0.457 ' NE2' ' HB3' ' A' ' 68' ' ' LYS . 88.2 mm-40 -72.41 -28.06 62.73 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.249 -0.907 . . . . 0.0 110.153 -179.975 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 176.88 -148.92 9.24 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.457 -1.457 . . . . 0.0 109.457 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 43.2 p -99.48 163.57 12.46 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.182 -1.187 . . . . 0.0 110.199 179.93 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . 0.864 ' SG ' ' SG ' ' A' ' 66' ' ' CYS . 0.8 OUTLIER -98.07 -160.41 0.8 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.277 -0.889 . . . . 0.0 110.318 -179.976 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 85.2 m-85 -57.51 -46.91 83.25 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.355 -0.84 . . . . 0.0 110.197 179.874 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 95.3 mtt180 -127.21 167.97 15.35 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.251 -0.906 . . . . 0.0 110.14 -179.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -68.52 -12.19 63.52 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.477 -1.449 . . . . 0.0 109.477 -179.947 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 53.9 mtmt -75.84 -23.66 55.74 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.291 -1.123 . . . . 0.0 110.244 179.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -113.26 163.09 15.24 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.255 -0.903 . . . . 0.0 110.249 -179.93 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -140.03 141.05 36.31 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.306 -0.871 . . . . 0.0 110.199 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' CYS . . . . . 0.864 ' SG ' ' SG ' ' A' ' 59' ' ' CYS . 58.6 m -84.99 148.05 26.38 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.248 -0.907 . . . . 0.0 110.154 -179.982 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' CYS . . . . . 0.418 ' SG ' ' HD2' ' A' ' 50' ' ' PRO . 80.5 m -143.64 128.08 17.93 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.276 -0.89 . . . . 0.0 110.195 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.513 ' NZ ' ' O ' ' A' ' 40' ' ' SER . 75.2 tttt . . . . . 0 N--CA 1.492 1.636 0 CA-C-O 118.058 -0.972 . . . . 0.0 110.194 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 43.2 t80 . . . . . 0 N--CA 1.492 1.645 0 CA-C-O 121.248 0.547 . . . . 0.0 110.161 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 17.4 p-10 -111.1 123.82 50.96 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.291 -0.881 . . . . 0.0 110.235 -179.949 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . 0.65 ' SG ' ' SG ' ' A' ' 59' ' ' CYS . 22.3 m -68.62 -6.86 28.24 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.242 -0.912 . . . . 0.0 110.161 179.856 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 39.8 t -71.7 -41.52 70.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.236 -0.915 . . . . 0.0 110.157 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 3.1 m -51.4 -29.39 15.55 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.269 -0.894 . . . . 0.0 110.054 179.954 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' SER . . . . . 0.433 ' CB ' ' HB3' ' A' ' 56' ' ' GLN . 26.6 m -88.89 -17.36 29.76 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.236 -0.915 . . . . 0.0 110.058 179.898 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . 0.455 ' O ' ' HG3' ' A' ' 68' ' ' LYS . . . 108.06 8.75 29.11 Favored Glycine 0 N--CA 1.489 2.197 0 N-CA-C 109.488 -1.445 . . . . 0.0 109.488 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.511 ' CA ' ' O ' ' A' ' 67' ' ' CYS . . . -110.18 173.0 16.11 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.498 -1.441 . . . . 0.0 109.498 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . 0.485 ' N ' ' O ' ' A' ' 67' ' ' CYS . 2.0 pt20 -110.34 174.53 5.82 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.237 -1.155 . . . . 0.0 110.246 179.951 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 8.7 t -110.98 84.38 1.92 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.228 -0.92 . . . . 0.0 110.218 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.426 HD22 ' HD3' ' A' ' 50' ' ' PRO . 14.4 tp -69.26 167.09 17.06 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.357 -0.839 . . . . 0.0 110.191 -180.0 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 60.1 m-85 -91.77 -24.85 19.28 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.293 -0.88 . . . . 0.0 110.314 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' SER . . . . . 0.422 ' O ' ' C ' ' A' ' 48' ' ' ALA . 73.7 m -106.81 167.44 9.87 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.2 -0.937 . . . . 0.0 110.261 -179.928 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.422 ' C ' ' O ' ' A' ' 47' ' ' SER . . . -43.02 128.02 4.29 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.188 -0.945 . . . . 0.0 110.163 -179.965 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 8.2 t -46.12 130.4 7.39 Favored Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.277 -0.889 . . . . 0.0 110.3 -179.865 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.45 ' HD2' ' SG ' ' A' ' 67' ' ' CYS . 46.3 Cg_endo -72.74 151.1 51.3 Favored 'Trans proline' 0 C--N 1.307 -1.62 0 O-C-N 123.882 1.464 . . . . 0.0 110.302 179.843 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 37.0 pt -64.03 -21.23 28.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.196 -0.94 . . . . 0.0 110.305 179.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 82.1 m-85 -61.45 -19.9 62.51 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.206 -0.934 . . . . 0.0 110.174 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 38.8 p -118.57 168.64 10.5 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.25 -0.906 . . . . 0.0 110.192 -179.953 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.424 ' O ' ' HA ' ' A' ' 67' ' ' CYS . 30.1 tttt -96.83 162.38 13.44 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.223 -0.923 . . . . 0.0 110.142 179.983 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.511 ' CG2' ' O ' ' A' ' 55' ' ' ILE . 20.8 tt -97.6 116.43 40.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.247 -0.908 . . . . 0.0 110.171 179.961 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . 0.473 ' HB2' ' HB3' ' A' ' 66' ' ' CYS . 61.6 mm-40 -93.36 -1.46 55.87 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.244 -0.91 . . . . 0.0 110.177 -179.919 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 142.47 -131.61 4.75 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.423 -1.471 . . . . 0.0 109.423 -179.935 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.447 ' O ' ' SG ' ' A' ' 66' ' ' CYS . 18.5 p -120.88 164.91 15.95 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.227 -1.16 . . . . 0.0 110.189 179.988 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . 0.65 ' SG ' ' SG ' ' A' ' 37' ' ' CYS . 0.5 OUTLIER -105.86 -158.78 0.67 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.242 -0.911 . . . . 0.0 110.276 -179.902 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 99.6 m-85 -57.36 -50.6 72.43 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.257 -0.902 . . . . 0.0 110.133 179.922 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 74.2 mtm180 -123.55 165.25 17.46 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.284 -0.885 . . . . 0.0 110.128 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -61.51 -21.35 60.14 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.48 -1.448 . . . . 0.0 109.48 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 2.8 tptt -67.63 -31.35 71.31 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.26 -1.141 . . . . 0.0 110.215 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.46 ' HB2' ' HB3' ' A' ' 59' ' ' CYS . . . -102.6 158.56 16.14 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.384 -0.823 . . . . 0.0 110.145 179.983 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.405 ' HG2' ' C ' ' A' ' 64' ' ' ALA . 70.3 mmtt -141.85 160.29 40.5 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.304 -0.872 . . . . 0.0 110.132 -179.954 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' CYS . . . . . 0.473 ' HB3' ' HB2' ' A' ' 56' ' ' GLN . 66.6 m -82.1 132.07 35.24 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.206 -0.934 . . . . 0.0 110.212 -179.983 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' CYS . . . . . 0.511 ' O ' ' CA ' ' A' ' 42' ' ' GLY . 78.6 m -129.32 124.35 34.11 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.251 -0.906 . . . . 0.0 110.151 -179.951 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.458 ' HA ' ' HA3' ' A' ' 42' ' ' GLY . 47.2 tttt . . . . . 0 N--CA 1.491 1.614 0 CA-C-O 117.94 -1.029 . . . . 0.0 110.251 179.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.456 ' CD1' ' N ' ' A' ' 36' ' ' ASN . 11.2 t80 . . . . . 0 N--CA 1.492 1.629 0 CA-C-O 121.277 0.56 . . . . 0.0 110.181 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . 0.456 ' N ' ' CD1' ' A' ' 35' ' ' TYR . 28.2 p-10 -98.33 55.56 1.12 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.261 -0.899 . . . . 0.0 110.299 179.981 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . 0.429 ' SG ' ' CD1' ' A' ' 35' ' ' TYR . 60.3 m -61.31 -22.51 64.95 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.24 -0.912 . . . . 0.0 110.171 -179.999 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 72.2 t -68.83 -39.94 80.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.22 -0.925 . . . . 0.0 110.211 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' SER . . . . . 0.45 ' OG ' ' ND2' ' A' ' 36' ' ' ASN . 87.4 p -64.13 -26.5 68.56 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.203 -0.935 . . . . 0.0 110.104 179.986 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 50.0 m -81.06 -20.56 41.34 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.237 -0.915 . . . . 0.0 110.198 179.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . 0.461 ' O ' ' HG3' ' A' ' 68' ' ' LYS . . . 112.14 14.89 10.36 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.511 -1.436 . . . . 0.0 109.511 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.451 ' HA3' ' HA ' ' A' ' 68' ' ' LYS . . . -110.3 171.82 15.09 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.504 -1.439 . . . . 0.0 109.504 179.962 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . 0.443 ' N ' ' O ' ' A' ' 67' ' ' CYS . 0.3 OUTLIER -129.24 175.16 8.95 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.25 -1.147 . . . . 0.0 110.301 -179.993 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 6.1 m -110.77 97.01 6.53 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.283 -0.886 . . . . 0.0 110.132 179.885 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.462 ' O ' ' HB2' ' A' ' 64' ' ' ALA . 23.0 tp -86.39 167.22 14.93 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.259 -0.901 . . . . 0.0 110.146 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 95.2 m-85 -92.13 -31.05 15.65 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.219 -0.926 . . . . 0.0 110.345 -179.916 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' SER . . . . . 0.422 ' O ' ' C ' ' A' ' 48' ' ' ALA . 76.8 p -92.02 160.61 15.15 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.386 -0.821 . . . . 0.0 110.231 -179.948 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.422 ' C ' ' O ' ' A' ' 47' ' ' SER . . . -42.7 129.28 4.18 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.33 -0.856 . . . . 0.0 110.194 179.937 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 4.1 t -43.15 128.44 3.42 Favored Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.182 -0.949 . . . . 0.0 110.203 -179.853 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.406 ' HD2' ' SG ' ' A' ' 67' ' ' CYS . 46.7 Cg_endo -72.34 146.07 44.46 Favored 'Trans proline' 0 C--N 1.305 -1.713 0 O-C-N 123.95 1.5 . . . . 0.0 110.452 -179.94 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 39.1 pt -60.39 -15.57 10.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.28 -0.887 . . . . 0.0 110.206 -179.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 76.1 m-85 -71.63 -10.26 59.5 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.26 -0.9 . . . . 0.0 110.208 179.924 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.452 ' HB ' ' N ' ' A' ' 68' ' ' LYS . 61.5 p -127.78 167.0 17.13 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.237 -0.914 . . . . 0.0 110.189 -179.995 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.417 ' O ' ' HA ' ' A' ' 67' ' ' CYS . 38.1 mttt -103.51 173.05 6.47 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.246 -0.909 . . . . 0.0 110.214 -179.98 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.514 ' CG2' ' O ' ' A' ' 55' ' ' ILE . 10.8 tp -99.65 119.33 47.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.357 -0.839 . . . . 0.0 110.209 179.961 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 68.2 mm-40 -102.03 9.23 40.56 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.269 -0.894 . . . . 0.0 110.264 -179.928 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 129.17 -159.89 22.42 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.448 -1.461 . . . . 0.0 109.448 179.919 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.456 ' O ' ' SG ' ' A' ' 66' ' ' CYS . 19.1 p -92.48 164.28 13.52 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.217 -1.166 . . . . 0.0 110.214 -179.93 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 1.5 m -110.54 -163.14 0.83 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.227 -0.921 . . . . 0.0 110.147 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 67.0 m-85 -49.64 -59.95 3.32 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.391 -0.818 . . . . 0.0 110.151 179.761 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 30.0 mmt180 -120.22 166.3 13.65 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.169 -0.957 . . . . 0.0 110.103 -180.0 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -65.39 -23.63 70.28 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 52.4 mtmt -60.19 -25.42 65.56 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.209 -1.171 . . . . 0.0 110.164 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.462 ' HB2' ' O ' ' A' ' 45' ' ' LEU . . . -117.32 160.96 20.29 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.242 -0.911 . . . . 0.0 110.17 -179.868 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.412 ' HG2' ' C ' ' A' ' 64' ' ' ALA . 28.9 mmtp -137.94 154.64 49.38 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.23 -0.918 . . . . 0.0 110.307 179.946 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' CYS . . . . . 0.456 ' SG ' ' O ' ' A' ' 58' ' ' THR . 71.7 m -72.27 131.42 42.68 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.292 -0.88 . . . . 0.0 110.169 179.911 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' CYS . . . . . 0.443 ' O ' ' N ' ' A' ' 43' ' ' GLN . 94.7 m -129.8 131.24 46.12 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.228 -0.92 . . . . 0.0 110.247 -179.905 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.461 ' HG3' ' O ' ' A' ' 41' ' ' GLY . 84.4 tttt . . . . . 0 N--CA 1.49 1.547 0 CA-C-O 117.995 -1.002 . . . . 0.0 110.182 -179.951 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.568 ' CZ ' ' SG ' ' A' ' 37' ' ' CYS . 1.8 t80 . . . . . 0 N--CA 1.491 1.621 0 CA-C-O 121.275 0.559 . . . . 0.0 110.144 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 9.9 p-10 -121.7 114.66 21.44 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.225 -0.922 . . . . 0.0 110.213 -179.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . 0.568 ' SG ' ' CZ ' ' A' ' 35' ' ' TYR . 46.7 m -74.26 -0.35 16.7 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.258 -0.901 . . . . 0.0 110.278 179.982 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 94.7 t -67.3 -33.95 65.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.208 -0.933 . . . . 0.0 110.116 -179.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 69.3 m -71.18 -27.81 63.79 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.24 -0.913 . . . . 0.0 110.149 179.912 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' SER . . . . . 0.41 ' O ' ' HE2' ' A' ' 68' ' ' LYS . 63.7 m -82.42 -9.22 59.53 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.331 -0.855 . . . . 0.0 110.119 179.922 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . 0.422 ' C ' ' HG3' ' A' ' 68' ' ' LYS . . . 105.33 -24.61 27.17 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.341 -1.504 . . . . 0.0 109.341 -179.965 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.468 ' N ' ' HG3' ' A' ' 68' ' ' LYS . . . -67.74 -173.57 7.08 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.444 -1.462 . . . . 0.0 109.444 -179.979 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . 0.46 ' O ' ' HA ' ' A' ' 66' ' ' CYS . 36.1 tt0 -141.34 144.36 34.53 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.272 -1.134 . . . . 0.0 110.26 -179.941 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 76.4 m -94.96 137.11 34.46 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.268 -0.895 . . . . 0.0 110.144 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.494 ' O ' ' CB ' ' A' ' 64' ' ' ALA . 54.0 mt -130.01 178.8 6.27 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.276 -0.89 . . . . 0.0 110.239 -179.982 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 85.9 m-85 -109.46 -1.04 18.61 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.259 -0.901 . . . . 0.0 110.178 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' SER . . . . . 0.423 ' O ' ' C ' ' A' ' 48' ' ' ALA . 52.3 m -127.9 171.59 11.65 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.27 -0.894 . . . . 0.0 110.25 -179.984 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.423 ' C ' ' O ' ' A' ' 47' ' ' SER . . . -43.08 145.12 0.54 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.221 -0.924 . . . . 0.0 110.189 179.968 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 16.9 t -55.77 130.28 71.9 Favored Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 121.228 -0.92 . . . . 0.0 110.165 -179.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.449 ' HD2' ' SG ' ' A' ' 67' ' ' CYS . 47.5 Cg_endo -73.14 142.32 34.0 Favored 'Trans proline' 0 C--N 1.306 -1.685 0 O-C-N 123.991 1.521 . . . . 0.0 110.402 179.98 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 39.0 pt -63.68 -18.78 22.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.315 -0.866 . . . . 0.0 110.181 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 85.0 m-85 -59.45 -21.55 60.21 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.237 -0.914 . . . . 0.0 110.216 179.944 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.46 ' OG1' ' HB3' ' A' ' 67' ' ' CYS . 20.4 p -132.78 171.15 14.27 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.26 -0.9 . . . . 0.0 110.297 179.869 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.465 ' O ' ' HA ' ' A' ' 67' ' ' CYS . 45.5 tttp -83.68 165.04 19.27 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.24 -0.912 . . . . 0.0 110.21 179.943 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.518 ' O ' ' CG2' ' A' ' 55' ' ' ILE . 12.0 tt -91.28 108.67 20.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.268 -0.895 . . . . 0.0 110.162 179.895 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . 0.463 ' NE2' ' HB3' ' A' ' 68' ' ' LYS . 94.0 mm-40 -85.31 -8.84 58.29 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.251 -0.906 . . . . 0.0 110.256 179.937 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 125.43 -124.44 5.28 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 179.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.451 ' O ' ' SG ' ' A' ' 66' ' ' CYS . 16.6 p -117.98 169.49 9.61 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.31 -1.112 . . . . 0.0 110.157 -179.935 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . 0.455 ' O ' ' HB2' ' A' ' 60' ' ' TYR . 0.9 OUTLIER -133.61 140.73 47.3 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.211 -0.931 . . . . 0.0 110.202 179.959 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . 0.488 ' CB ' ' HB3' ' A' ' 63' ' ' LYS . 71.2 m-85 56.07 53.93 8.51 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.293 -0.879 . . . . 0.0 110.414 179.9 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . 0.462 ' HB2' ' O ' ' A' ' 60' ' ' TYR . 38.6 mmt180 57.38 39.95 27.87 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.25 -0.906 . . . . 0.0 110.609 179.696 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . 0.446 ' HA3' ' HB ' ' A' ' 58' ' ' THR . . . 85.86 -16.45 41.78 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.779 -1.328 . . . . 0.0 109.779 179.603 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.488 ' HB3' ' CB ' ' A' ' 60' ' ' TYR . 5.7 ttpt -55.44 -18.43 6.95 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.103 -1.234 . . . . 0.0 109.767 179.951 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.494 ' CB ' ' O ' ' A' ' 45' ' ' LEU . . . -149.56 172.09 15.57 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.405 -0.81 . . . . 0.0 109.961 179.757 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 53.2 tptt -111.15 122.33 47.6 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.147 -0.971 . . . . 0.0 110.275 -179.903 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' CYS . . . . . 0.46 ' HA ' ' O ' ' A' ' 43' ' ' GLN . 42.9 m -81.27 140.98 34.53 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.297 -0.877 . . . . 0.0 110.134 179.977 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' CYS . . . . . 0.465 ' HA ' ' O ' ' A' ' 54' ' ' LYS . 85.0 m -149.53 124.61 10.05 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.198 -0.939 . . . . 0.0 110.222 -179.969 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.468 ' HG3' ' N ' ' A' ' 42' ' ' GLY . 33.4 ttmt . . . . . 0 N--CA 1.491 1.618 0 CA-C-O 117.942 -1.028 . . . . 0.0 110.194 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 2.4 t80 . . . . . 0 N--CA 1.493 1.676 0 CA-C-O 121.271 0.557 . . . . 0.0 110.141 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 36.3 t30 -101.13 108.97 20.79 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.211 -0.931 . . . . 0.0 110.237 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 27.4 m -82.02 -3.78 55.29 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.183 -0.948 . . . . 0.0 110.191 179.948 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 91.9 t -70.18 -45.95 73.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.235 -0.915 . . . . 0.0 110.213 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 22.9 t -60.51 -26.39 66.81 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.258 -0.901 . . . . 0.0 110.175 179.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 42.5 m -83.59 -8.35 59.33 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.309 -0.869 . . . . 0.0 110.243 179.935 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . 0.427 ' C ' ' HG3' ' A' ' 68' ' ' LYS . . . 91.91 3.58 68.02 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.598 -1.401 . . . . 0.0 109.598 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.452 ' HA3' ' HA ' ' A' ' 68' ' ' LYS . . . -90.55 172.67 37.83 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 -179.986 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . 0.502 ' HG2' ' CD2' ' A' ' 45' ' ' LEU . 32.6 tt0 -127.58 137.2 52.52 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.345 -1.091 . . . . 0.0 110.217 -179.967 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . 0.517 ' SG ' ' CB ' ' A' ' 64' ' ' ALA . 24.7 t -83.68 113.17 20.67 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.234 -0.916 . . . . 0.0 110.242 179.934 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.502 ' CD2' ' HG2' ' A' ' 43' ' ' GLN . 47.3 mt -106.05 168.94 8.79 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.186 -0.946 . . . . 0.0 110.269 -179.936 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 91.1 m-85 -104.23 -1.47 27.07 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.286 -0.883 . . . . 0.0 110.231 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' SER . . . . . 0.417 ' O ' ' C ' ' A' ' 48' ' ' ALA . 89.5 p -126.99 168.36 14.65 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.211 -0.93 . . . . 0.0 110.257 -179.972 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.417 ' C ' ' O ' ' A' ' 47' ' ' SER . . . -42.86 128.66 4.27 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.251 -0.905 . . . . 0.0 110.136 179.991 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 6.0 t -44.44 132.09 4.72 Favored Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 121.238 -0.914 . . . . 0.0 110.174 179.904 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.452 ' HG2' ' OG1' ' A' ' 53' ' ' THR . 46.9 Cg_endo -73.19 148.58 44.42 Favored 'Trans proline' 0 C--N 1.306 -1.674 0 O-C-N 123.867 1.456 . . . . 0.0 110.406 -179.982 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 13.1 mt -62.96 -22.24 30.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.284 -0.885 . . . . 0.0 110.152 179.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -71.02 -3.94 22.27 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.313 -0.867 . . . . 0.0 110.218 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.492 ' CB ' ' HB3' ' A' ' 67' ' ' CYS . 54.6 p -133.27 162.55 31.5 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.241 -0.912 . . . . 0.0 110.276 179.978 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.454 ' O ' ' HA ' ' A' ' 67' ' ' CYS . 46.8 tttp -93.18 168.36 11.15 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.287 -0.883 . . . . 0.0 110.234 179.978 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.458 ' O ' ' CG2' ' A' ' 55' ' ' ILE . 18.5 tt -87.78 125.11 41.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.237 -0.914 . . . . 0.0 110.207 179.962 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . 0.509 ' HB2' ' CB ' ' A' ' 66' ' ' CYS . 86.3 mm-40 -107.49 7.96 29.15 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.193 -0.942 . . . . 0.0 110.201 179.99 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 102.31 -140.1 14.71 Favored Glycine 0 N--CA 1.489 2.176 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 179.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.446 ' O ' ' SG ' ' A' ' 66' ' ' CYS . 38.7 p -98.75 -174.11 2.7 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.23 -1.159 . . . . 0.0 110.182 179.987 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . 0.773 ' SG ' ' SG ' ' A' ' 66' ' ' CYS . 1.2 m -112.48 -161.24 0.75 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.251 -0.905 . . . . 0.0 110.27 -179.957 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 74.4 m-85 -49.83 -65.62 0.53 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.238 -0.914 . . . . 0.0 110.411 179.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 56.7 mtt180 -93.29 -14.49 26.9 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.241 -0.912 . . . . 0.0 110.446 -179.834 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 101.65 -21.02 44.04 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.366 -1.494 . . . . 0.0 109.366 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 37.0 mtmt -57.44 -30.2 64.8 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.278 -1.131 . . . . 0.0 109.98 179.77 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.517 ' CB ' ' SG ' ' A' ' 44' ' ' CYS . . . -106.54 159.41 16.2 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.498 -0.751 . . . . 0.0 110.268 -179.82 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 49.5 tptt -112.49 120.53 41.96 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.185 -0.947 . . . . 0.0 110.208 -179.902 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' CYS . . . . . 0.773 ' SG ' ' SG ' ' A' ' 59' ' ' CYS . 79.4 m -68.95 151.46 46.51 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.308 -0.87 . . . . 0.0 110.127 179.958 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' CYS . . . . . 0.497 ' O ' ' N ' ' A' ' 43' ' ' GLN . 90.4 m -149.0 125.32 10.86 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.146 -0.971 . . . . 0.0 110.219 179.994 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.487 ' HB3' ' NE2' ' A' ' 56' ' ' GLN . 26.9 tttp . . . . . 0 N--CA 1.491 1.613 0 CA-C-O 118.013 -0.994 . . . . 0.0 110.212 179.952 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.473 ' CZ ' ' SG ' ' A' ' 37' ' ' CYS . 27.6 p90 . . . . . 0 N--CA 1.491 1.611 0 CA-C-O 121.221 0.534 . . . . 0.0 110.26 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 25.2 t30 -91.09 102.43 15.18 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.277 -0.889 . . . . 0.0 110.339 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . 0.493 ' O ' ' N ' ' A' ' 40' ' ' SER . 57.5 m -59.49 -48.62 80.93 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.288 -0.882 . . . . 0.0 110.245 -179.97 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.438 ' C ' ' O ' ' A' ' 37' ' ' CYS . 39.5 t -40.45 -53.6 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.455 -0.778 . . . . 0.0 110.46 -179.862 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 5.1 t -53.16 -28.04 24.23 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.315 -0.866 . . . . 0.0 110.162 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' SER . . . . . 0.493 ' N ' ' O ' ' A' ' 37' ' ' CYS . 38.9 m -83.37 -8.0 59.48 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.272 -0.893 . . . . 0.0 110.252 179.957 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 106.03 -23.24 29.64 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.443 -1.463 . . . . 0.0 109.443 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.466 ' HA3' ' HA ' ' A' ' 68' ' ' LYS . . . -71.52 171.99 46.05 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 179.926 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 10.9 tt0 -128.01 133.77 49.18 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.234 -1.156 . . . . 0.0 110.336 -179.975 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . 0.663 ' SG ' ' SG ' ' A' ' 66' ' ' CYS . 4.2 m -91.95 111.95 23.69 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.236 -0.915 . . . . 0.0 110.208 -179.996 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 75.1 mt -107.83 175.09 5.6 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.293 -0.879 . . . . 0.0 110.178 -179.88 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 72.9 m-85 -99.64 -11.24 21.1 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.328 -0.858 . . . . 0.0 110.3 179.985 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 41.2 t -111.98 166.46 11.21 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.213 -0.929 . . . . 0.0 110.229 -179.88 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -43.69 145.23 0.68 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.211 -0.931 . . . . 0.0 110.214 179.946 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 17.2 t -49.04 131.54 15.46 Favored Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.221 -0.924 . . . . 0.0 110.238 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.449 ' HG2' ' OG1' ' A' ' 53' ' ' THR . 47.9 Cg_endo -73.23 164.37 35.49 Favored 'Trans proline' 0 C--N 1.306 -1.686 0 O-C-N 123.898 1.472 . . . . 0.0 110.471 -179.904 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 27.4 mt -74.89 -26.24 19.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.193 -0.942 . . . . 0.0 110.159 179.801 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 99.5 m-85 -66.62 -9.39 35.15 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.323 -0.86 . . . . 0.0 110.159 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.479 ' CB ' ' HB3' ' A' ' 67' ' ' CYS . 67.7 p -133.23 158.99 41.5 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.28 -0.887 . . . . 0.0 110.141 179.999 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.461 ' O ' ' HA ' ' A' ' 67' ' ' CYS . 63.1 mttt -100.58 172.42 7.11 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.206 -0.933 . . . . 0.0 110.247 -179.988 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 21.0 tt -79.85 131.19 34.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.189 -0.944 . . . . 0.0 110.22 -179.957 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 90.2 mm-40 -119.04 -3.12 10.69 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.347 -0.846 . . . . 0.0 110.228 -179.945 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 131.7 -131.85 6.5 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.418 -1.473 . . . . 0.0 109.418 -179.996 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.45 ' O ' ' SG ' ' A' ' 66' ' ' CYS . 72.7 p -123.4 168.79 12.07 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.291 -1.123 . . . . 0.0 110.263 -179.984 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . 1.298 ' SG ' ' SG ' ' A' ' 66' ' ' CYS . 9.8 m -111.55 -163.31 0.84 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.217 -0.927 . . . . 0.0 110.29 179.924 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . 0.427 ' C ' ' O ' ' A' ' 59' ' ' CYS . 68.9 m-85 -41.9 -46.85 4.15 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.312 -0.868 . . . . 0.0 110.317 179.859 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -124.42 171.62 9.8 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.198 -0.939 . . . . 0.0 110.117 179.898 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -72.5 -23.25 78.24 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.463 -1.455 . . . . 0.0 109.463 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 38.2 ttmt -65.41 -34.55 78.57 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.202 -1.176 . . . . 0.0 110.291 179.951 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.452 ' HB2' ' HB2' ' A' ' 59' ' ' CYS . . . -94.73 163.23 13.45 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.3 -0.875 . . . . 0.0 110.162 -179.923 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 50.4 tptt -140.05 135.98 33.18 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.253 -0.905 . . . . 0.0 110.118 -179.957 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' CYS . . . . . 1.298 ' SG ' ' SG ' ' A' ' 59' ' ' CYS . 73.8 m -85.17 136.61 33.46 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.279 -0.888 . . . . 0.0 110.257 179.969 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' CYS . . . . . 0.479 ' HB3' ' CB ' ' A' ' 53' ' ' THR . 76.4 m -141.51 129.78 22.31 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.266 -0.897 . . . . 0.0 110.144 -179.973 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.466 ' HA ' ' HA3' ' A' ' 42' ' ' GLY . 40.4 tttt . . . . . 0 N--CA 1.492 1.65 0 CA-C-O 118.065 -0.969 . . . . 0.0 110.169 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.548 ' CD1' ' SG ' ' A' ' 37' ' ' CYS . 2.3 t80 . . . . . 0 N--CA 1.491 1.615 0 CA-C-O 121.223 0.535 . . . . 0.0 110.17 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . 0.422 ' O ' ' CG ' ' A' ' 36' ' ' ASN . 22.0 p-10 -98.52 64.31 1.53 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.251 -0.906 . . . . 0.0 110.256 -179.918 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . 0.548 ' SG ' ' CD1' ' A' ' 35' ' ' TYR . 34.4 m -62.89 -52.0 64.79 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.221 -0.924 . . . . 0.0 110.174 179.893 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.407 ' HA ' ' O ' ' A' ' 42' ' ' GLY . 68.8 t -54.04 -40.31 45.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.236 -0.915 . . . . 0.0 110.247 179.923 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 33.6 t -60.99 -30.57 70.36 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.146 -0.972 . . . . 0.0 110.255 179.945 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' SER . . . . . 0.452 ' O ' ' HE3' ' A' ' 68' ' ' LYS . 72.1 m -82.63 -7.96 59.62 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.358 -0.839 . . . . 0.0 110.165 179.97 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 104.17 5.47 43.5 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.514 ' CA ' ' O ' ' A' ' 67' ' ' CYS . . . -93.56 176.88 37.09 Favored Glycine 0 N--CA 1.489 2.198 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 -179.985 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . 0.459 ' N ' ' O ' ' A' ' 67' ' ' CYS . 16.1 tt0 -132.39 132.87 43.28 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.249 -1.147 . . . . 0.0 110.2 -179.926 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 22.6 m -95.78 116.66 29.22 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.336 -0.853 . . . . 0.0 110.298 179.977 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.467 HD13 ' HD3' ' A' ' 50' ' ' PRO . 92.5 mt -101.76 175.32 5.59 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.296 -0.877 . . . . 0.0 110.161 179.967 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 -91.37 -3.1 57.08 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.241 -0.912 . . . . 0.0 110.227 179.957 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' SER . . . . . 0.402 ' O ' ' C ' ' A' ' 48' ' ' ALA . 59.1 p -126.56 167.85 15.08 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.18 -0.95 . . . . 0.0 110.183 -179.976 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.419 ' HA ' ' HG3' ' A' ' 65' ' ' LYS . . . -42.62 148.19 0.24 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.271 -0.893 . . . . 0.0 110.192 179.952 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 17.1 t -52.86 130.37 47.94 Favored Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.24 -0.913 . . . . 0.0 110.077 179.986 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.467 ' HD3' HD13 ' A' ' 45' ' ' LEU . 47.5 Cg_endo -72.67 149.33 48.63 Favored 'Trans proline' 0 C--N 1.306 -1.68 0 O-C-N 123.88 1.463 . . . . 0.0 110.442 -179.924 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 44.9 pt -67.24 -11.26 13.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.26 -0.9 . . . . 0.0 110.128 179.961 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . 0.433 ' O ' HG21 ' A' ' 53' ' ' THR . 55.5 m-85 -62.62 -25.56 68.17 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.255 -0.903 . . . . 0.0 110.157 179.996 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.461 ' OG1' ' HB3' ' A' ' 67' ' ' CYS . 69.1 p -143.01 158.86 43.2 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.348 -0.845 . . . . 0.0 110.218 -179.99 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.452 ' O ' ' HA ' ' A' ' 67' ' ' CYS . 84.7 mttt -77.52 176.81 8.56 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.21 -0.932 . . . . 0.0 110.161 -179.961 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.415 HG13 ' O ' ' A' ' 66' ' ' CYS . 19.7 tt -108.79 137.63 39.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.188 -0.945 . . . . 0.0 110.225 -179.982 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . 0.434 ' HG3' ' HB2' ' A' ' 68' ' ' LYS . 76.6 mm-40 -98.83 -24.87 14.83 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.282 -0.886 . . . . 0.0 110.181 179.971 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 162.89 -152.39 22.54 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.444 -1.462 . . . . 0.0 109.444 179.997 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.445 ' O ' ' SG ' ' A' ' 66' ' ' CYS . 82.6 p -90.81 161.51 15.24 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.274 -1.133 . . . . 0.0 110.214 -179.921 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . 0.504 ' SG ' ' N ' ' A' ' 66' ' ' CYS . 16.8 m -110.19 -163.03 0.83 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.348 -0.845 . . . . 0.0 110.243 -179.966 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . 0.428 ' C ' ' O ' ' A' ' 59' ' ' CYS . 80.1 m-85 -41.21 -48.38 3.49 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.422 -0.799 . . . . 0.0 110.402 179.92 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 88.8 mtm-85 -129.45 159.28 36.76 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.247 -0.908 . . . . 0.0 110.246 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -60.89 -24.65 62.91 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.436 -1.466 . . . . 0.0 109.436 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 47.4 mtpt -63.64 -32.55 74.07 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.272 -1.134 . . . . 0.0 110.203 179.891 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.458 ' HB3' ' O ' ' A' ' 45' ' ' LEU . . . -96.68 164.41 12.6 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.421 -0.799 . . . . 0.0 110.16 -179.847 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.419 ' C ' ' SG ' ' A' ' 59' ' ' CYS . 75.6 mmtt -134.54 140.74 46.37 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.244 -0.91 . . . . 0.0 110.169 -179.911 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' CYS . . . . . 0.504 ' N ' ' SG ' ' A' ' 59' ' ' CYS . 89.0 m -88.8 134.04 34.06 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.269 -0.895 . . . . 0.0 110.206 179.96 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' CYS . . . . . 0.514 ' O ' ' CA ' ' A' ' 42' ' ' GLY . 34.6 m -136.26 152.01 50.26 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.208 -0.932 . . . . 0.0 110.201 179.979 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.452 ' HE3' ' O ' ' A' ' 40' ' ' SER . 77.5 tttt . . . . . 0 N--CA 1.49 1.549 0 CA-C-O 118.005 -0.998 . . . . 0.0 110.22 -179.97 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.561 ' CD1' ' SG ' ' A' ' 37' ' ' CYS . 3.2 t80 . . . . . 0 N--CA 1.491 1.597 0 CA-C-O 121.26 0.553 . . . . 0.0 110.205 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . 0.553 ' ND2' ' CB ' ' A' ' 39' ' ' SER . 59.3 t30 -85.67 60.54 6.3 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.272 -0.893 . . . . 0.0 110.152 179.952 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . 0.561 ' SG ' ' CD1' ' A' ' 35' ' ' TYR . 25.3 m -67.81 -53.22 28.73 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.307 -0.871 . . . . 0.0 110.24 179.991 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 75.4 t -43.92 -54.89 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.263 -0.898 . . . . 0.0 110.179 179.982 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' SER . . . . . 0.553 ' CB ' ' ND2' ' A' ' 36' ' ' ASN . 62.3 m -50.31 -35.19 26.46 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.192 -0.942 . . . . 0.0 110.218 -179.968 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' SER . . . . . 0.459 ' HB2' ' O ' ' A' ' 37' ' ' CYS . 72.5 m -70.73 -15.17 62.67 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.285 -0.884 . . . . 0.0 110.145 -179.976 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . 0.415 ' C ' ' HG3' ' A' ' 68' ' ' LYS . . . 108.53 -14.85 35.49 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.475 -1.45 . . . . 0.0 109.475 -179.992 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.473 ' CA ' ' O ' ' A' ' 67' ' ' CYS . . . -85.27 175.34 49.66 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.494 -1.442 . . . . 0.0 109.494 -179.984 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . 0.425 ' N ' ' O ' ' A' ' 67' ' ' CYS . 0.9 OUTLIER -115.14 179.76 3.86 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.2 -1.176 . . . . 0.0 110.164 -179.972 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . 0.407 ' SG ' ' HB1' ' A' ' 64' ' ' ALA . 49.7 t -114.17 98.17 6.79 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.247 -0.908 . . . . 0.0 110.188 179.99 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.432 HD13 ' SG ' ' A' ' 67' ' ' CYS . 71.4 mt -88.98 173.27 8.57 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.3 -0.875 . . . . 0.0 110.181 179.901 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 83.4 m-85 -109.6 -1.99 17.81 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.24 -0.912 . . . . 0.0 110.314 -179.962 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' SER . . . . . 0.414 ' O ' ' C ' ' A' ' 48' ' ' ALA . 74.7 m -125.42 166.17 17.09 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.191 -0.943 . . . . 0.0 110.173 179.925 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.414 ' C ' ' O ' ' A' ' 47' ' ' SER . . . -42.69 131.01 4.06 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.246 -0.909 . . . . 0.0 110.177 -179.91 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . 0.412 ' C ' ' O ' ' A' ' 48' ' ' ALA . 4.4 t -43.39 130.46 3.63 Favored Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 121.223 -0.923 . . . . 0.0 110.219 -179.988 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.475 ' HG2' ' CG2' ' A' ' 53' ' ' THR . 46.4 Cg_endo -72.74 156.57 53.06 Favored 'Trans proline' 0 C--N 1.306 -1.661 0 O-C-N 123.86 1.453 . . . . 0.0 110.446 179.978 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 21.5 mt -67.85 -28.62 42.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.224 -0.923 . . . . 0.0 110.243 -179.93 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 88.8 m-85 -67.69 -11.8 59.09 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.348 -0.845 . . . . 0.0 110.191 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.475 ' CG2' ' HG2' ' A' ' 50' ' ' PRO . 34.0 p -121.79 172.63 8.02 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.256 -0.903 . . . . 0.0 110.1 179.897 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.437 ' O ' ' HA ' ' A' ' 67' ' ' CYS . 80.4 mttt -111.34 127.54 55.68 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.309 -0.869 . . . . 0.0 110.296 -179.986 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 20.6 tt -67.35 138.73 22.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.246 -0.908 . . . . 0.0 110.216 179.956 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . 0.418 ' NE2' ' HB3' ' A' ' 54' ' ' LYS . 48.9 mm-40 -128.62 13.94 6.47 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.264 -0.898 . . . . 0.0 110.217 -179.941 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . 0.406 ' O ' ' HB2' ' A' ' 66' ' ' CYS . . . 119.52 179.81 16.62 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.451 -1.46 . . . . 0.0 109.451 179.956 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 17.0 p -75.79 168.99 19.01 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.307 -1.113 . . . . 0.0 110.266 179.969 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . 0.471 ' HB3' ' CB ' ' A' ' 64' ' ' ALA . 9.7 t -109.29 -65.36 1.15 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.198 -0.938 . . . . 0.0 110.27 179.89 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . 0.515 ' HB3' ' CE ' ' A' ' 63' ' ' LYS . 78.2 m-85 -121.72 92.6 3.77 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.457 -0.777 . . . . 0.0 110.282 179.981 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 36.3 mmt180 51.52 25.39 2.69 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.269 -0.894 . . . . 0.0 110.296 179.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 89.97 -11.56 70.29 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.515 ' CE ' ' HB3' ' A' ' 60' ' ' TYR . 50.5 mtmt -58.58 -23.04 57.72 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.259 -1.142 . . . . 0.0 110.095 -179.99 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.471 ' CB ' ' HB3' ' A' ' 59' ' ' CYS . . . -138.37 161.86 35.88 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.261 -0.9 . . . . 0.0 110.148 179.936 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 65.1 mmtt -113.25 122.93 48.94 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.246 -0.909 . . . . 0.0 110.239 179.983 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' CYS . . . . . 0.448 ' SG ' ' HA ' ' A' ' 59' ' ' CYS . 99.2 m -79.21 142.73 36.01 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.231 -0.918 . . . . 0.0 110.183 179.998 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' CYS . . . . . 0.473 ' O ' ' CA ' ' A' ' 42' ' ' GLY . 82.3 m -144.47 141.52 29.64 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.253 -0.904 . . . . 0.0 110.241 179.989 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.434 ' HA ' ' HA3' ' A' ' 42' ' ' GLY . 33.9 ttpt . . . . . 0 N--CA 1.491 1.585 0 CA-C-O 118.01 -0.995 . . . . 0.0 110.213 -179.921 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.523 ' CD1' ' SG ' ' A' ' 37' ' ' CYS . 2.4 t80 . . . . . 0 N--CA 1.491 1.612 0 CA-C-O 121.179 0.514 . . . . 0.0 110.254 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . 0.422 ' CG ' ' O ' ' A' ' 36' ' ' ASN . 35.9 p-10 -90.58 68.87 6.69 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.322 -0.861 . . . . 0.0 110.215 179.963 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . 0.523 ' SG ' ' CD1' ' A' ' 35' ' ' TYR . 16.6 m -70.82 -39.88 72.79 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.33 -0.856 . . . . 0.0 110.108 -179.901 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.4 ' CG2' ' N ' ' A' ' 39' ' ' SER . 27.0 m -57.83 -44.73 86.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.334 -0.854 . . . . 0.0 110.328 179.988 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' SER . . . . . 0.4 ' N ' ' CG2' ' A' ' 38' ' ' VAL . 53.8 p -60.0 -32.52 70.94 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.272 -0.893 . . . . 0.0 110.278 179.958 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' SER . . . . . 0.43 ' O ' ' HE3' ' A' ' 68' ' ' LYS . 38.0 m -75.01 -10.3 59.34 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.306 -0.871 . . . . 0.0 110.091 179.996 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 98.63 -10.3 62.67 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.426 -1.47 . . . . 0.0 109.426 -179.889 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.533 ' CA ' ' O ' ' A' ' 67' ' ' CYS . . . -73.04 -171.65 21.13 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.426 -1.47 . . . . 0.0 109.426 -179.985 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . 0.486 ' N ' ' O ' ' A' ' 67' ' ' CYS . 6.4 tt0 -139.99 138.46 35.52 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.268 -1.137 . . . . 0.0 110.163 -179.975 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 12.5 t -95.37 108.3 20.48 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.248 -0.908 . . . . 0.0 110.064 179.894 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.417 ' O ' ' HB3' ' A' ' 64' ' ' ALA . 9.5 tp -101.57 157.7 16.62 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.293 -0.879 . . . . 0.0 110.292 -179.937 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -82.64 -25.62 32.95 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.244 -0.91 . . . . 0.0 110.225 -179.954 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' SER . . . . . 0.417 ' O ' ' C ' ' A' ' 48' ' ' ALA . 39.1 t -93.13 159.37 15.32 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.234 -0.916 . . . . 0.0 110.194 179.996 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.417 ' C ' ' O ' ' A' ' 47' ' ' SER . . . -42.95 127.5 4.12 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.254 -0.903 . . . . 0.0 110.157 179.974 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . 0.403 ' C ' ' O ' ' A' ' 48' ' ' ALA . 8.3 t -42.76 129.73 3.07 Favored Pre-proline 0 N--CA 1.491 1.621 0 O-C-N 121.304 -0.872 . . . . 0.0 110.154 -179.927 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.446 ' HG2' ' CG2' ' A' ' 53' ' ' THR . 46.3 Cg_endo -72.65 141.64 34.64 Favored 'Trans proline' 0 C--N 1.305 -1.73 0 O-C-N 123.884 1.465 . . . . 0.0 110.411 -179.943 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 47.2 pt -57.53 -22.98 18.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.316 -0.865 . . . . 0.0 110.058 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 69.1 m-85 -65.13 -11.95 45.66 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.337 -0.852 . . . . 0.0 110.118 179.816 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.508 ' CB ' ' HB3' ' A' ' 67' ' ' CYS . 30.0 p -119.9 170.73 8.99 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.293 -0.879 . . . . 0.0 110.233 -179.919 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.446 ' HB2' ' HB3' ' A' ' 68' ' ' LYS . 31.0 mttt -94.66 175.07 6.8 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.248 -0.908 . . . . 0.0 110.097 -179.991 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.516 ' O ' ' CG2' ' A' ' 55' ' ' ILE . 19.9 tt -106.01 111.41 34.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.203 -0.935 . . . . 0.0 110.245 -179.987 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . 0.552 ' NE2' ' CB ' ' A' ' 68' ' ' LYS . 69.9 mm-40 -90.41 11.38 21.73 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.295 -0.878 . . . . 0.0 110.176 179.878 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 104.12 -127.88 9.28 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.371 -1.491 . . . . 0.0 109.371 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 28.1 p -111.55 171.93 7.19 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.226 -1.161 . . . . 0.0 110.144 -179.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . 1.193 ' SG ' ' SG ' ' A' ' 66' ' ' CYS . 0.1 OUTLIER -111.72 -166.73 1.1 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.167 -0.958 . . . . 0.0 110.215 -179.937 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . 0.539 ' CD1' ' N ' ' A' ' 61' ' ' ARG . 7.2 p90 -57.27 -26.13 60.31 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.376 -0.828 . . . . 0.0 110.215 179.853 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . 0.539 ' N ' ' CD1' ' A' ' 60' ' ' TYR . 57.5 mtt85 -139.5 164.88 28.7 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.281 -0.887 . . . . 0.0 110.191 -179.999 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -80.97 -0.28 88.4 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.621 -1.392 . . . . 0.0 109.621 179.939 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 46.1 mtpt -81.56 -25.89 35.46 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.259 -1.142 . . . . 0.0 110.227 179.915 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.417 ' HB3' ' O ' ' A' ' 45' ' ' LEU . . . -123.04 164.96 17.59 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.238 -0.914 . . . . 0.0 110.243 179.987 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 74.3 mmtt -128.28 145.17 51.13 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.244 -0.91 . . . . 0.0 110.196 179.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' CYS . . . . . 1.193 ' SG ' ' SG ' ' A' ' 59' ' ' CYS . 93.4 m -81.48 137.6 35.59 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.225 -0.922 . . . . 0.0 110.256 -179.949 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' CYS . . . . . 0.533 ' O ' ' CA ' ' A' ' 42' ' ' GLY . 73.2 m -128.24 172.42 11.05 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.366 -0.834 . . . . 0.0 110.031 179.92 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.552 ' CB ' ' NE2' ' A' ' 56' ' ' GLN . 77.6 tttt . . . . . 0 N--CA 1.491 1.617 0 CA-C-O 118.007 -0.997 . . . . 0.0 110.278 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 43.6 p90 . . . . . 0 N--CA 1.492 1.649 0 CA-C-O 121.256 0.55 . . . . 0.0 110.129 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . 0.442 ' ND2' ' OG ' ' A' ' 39' ' ' SER . 12.7 p-10 -87.68 120.85 29.4 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.276 -0.89 . . . . 0.0 110.211 179.996 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 84.6 m -75.57 0.7 16.48 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.297 -0.877 . . . . 0.0 110.248 -179.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 53.6 t -68.67 -34.2 63.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.268 -0.895 . . . . 0.0 110.209 179.919 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' SER . . . . . 0.442 ' OG ' ' ND2' ' A' ' 36' ' ' ASN . 65.3 m -71.36 -22.81 61.85 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.254 -0.904 . . . . 0.0 110.128 179.856 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 61.2 m -89.44 -5.43 57.38 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.325 -0.859 . . . . 0.0 110.128 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 101.64 -19.57 49.78 Favored Glycine 0 N--CA 1.489 2.196 0 N-CA-C 109.331 -1.507 . . . . 0.0 109.331 -179.859 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.472 ' HA3' ' HA ' ' A' ' 68' ' ' LYS . . . -73.08 171.35 51.05 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.509 -1.436 . . . . 0.0 109.509 -179.966 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . 0.501 ' O ' ' N ' ' A' ' 67' ' ' CYS . 15.0 tt0 -130.53 164.04 25.74 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.341 -1.094 . . . . 0.0 110.207 -179.964 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . 0.422 ' N ' ' CG ' ' A' ' 43' ' ' GLN . 5.5 m -114.27 112.81 23.7 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.176 -0.952 . . . . 0.0 110.274 -179.964 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.415 ' O ' ' CB ' ' A' ' 64' ' ' ALA . 27.7 mt -95.92 179.55 5.05 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.239 -0.913 . . . . 0.0 110.133 179.946 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 66.4 m-85 -92.59 -27.1 17.56 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.195 -0.94 . . . . 0.0 110.218 -179.97 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' SER . . . . . 0.431 ' O ' ' C ' ' A' ' 48' ' ' ALA . 64.2 m -107.55 166.92 10.31 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.344 -0.848 . . . . 0.0 110.084 179.964 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.455 ' HA ' ' HG3' ' A' ' 65' ' ' LYS . . . -43.01 132.55 3.98 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.269 -0.894 . . . . 0.0 110.118 179.942 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . 0.419 ' C ' ' O ' ' A' ' 48' ' ' ALA . 7.7 t -42.75 130.06 3.06 Favored Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 121.23 -0.919 . . . . 0.0 110.181 -179.997 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.442 ' HD2' ' SG ' ' A' ' 67' ' ' CYS . 45.5 Cg_endo -72.15 147.08 47.59 Favored 'Trans proline' 0 C--N 1.305 -1.73 0 O-C-N 123.909 1.479 . . . . 0.0 110.376 -179.977 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 28.5 pt -58.0 -21.99 18.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.234 -0.917 . . . . 0.0 110.135 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 66.2 m-85 -57.09 -16.51 7.67 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.169 -0.957 . . . . 0.0 110.109 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 71.1 p -142.34 153.66 44.02 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.238 -0.914 . . . . 0.0 110.187 179.97 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.42 ' O ' ' HA ' ' A' ' 67' ' ' CYS . 58.2 tttt -74.16 164.66 26.34 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.199 -0.938 . . . . 0.0 110.193 -180.0 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.455 ' CG2' ' O ' ' A' ' 55' ' ' ILE . 20.1 tt -109.41 118.18 56.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.209 -0.932 . . . . 0.0 110.17 179.956 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . 0.447 ' NE2' ' HB3' ' A' ' 68' ' ' LYS . 70.4 mm-40 -69.61 -31.15 69.11 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.307 -0.871 . . . . 0.0 110.236 -179.972 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 149.24 -92.69 0.14 Allowed Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.471 -1.452 . . . . 0.0 109.471 179.956 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.401 ' O ' ' SG ' ' A' ' 66' ' ' CYS . 74.6 p -128.67 161.96 28.45 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.275 -1.132 . . . . 0.0 110.235 -179.937 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . 0.494 ' SG ' ' SG ' ' A' ' 66' ' ' CYS . 5.1 m -99.45 -68.86 0.79 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.281 -0.887 . . . . 0.0 110.145 179.883 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . 0.434 ' CD2' ' HB3' ' A' ' 59' ' ' CYS . 89.4 m-85 -141.32 -68.9 0.38 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.345 -0.847 . . . . 0.0 110.178 -179.977 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . 0.402 ' HD2' ' CD ' ' A' ' 63' ' ' LYS . 38.7 ttm-85 -95.38 -37.8 10.79 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.256 -0.902 . . . . 0.0 110.177 -179.965 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 135.42 -15.84 4.14 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 -179.951 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.402 ' CD ' ' HD2' ' A' ' 61' ' ' ARG . 46.7 mtpt -65.55 -31.49 72.58 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.268 -1.137 . . . . 0.0 110.15 -179.979 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.415 ' CB ' ' O ' ' A' ' 45' ' ' LEU . . . -109.83 159.57 17.1 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.353 -0.842 . . . . 0.0 110.146 179.929 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.455 ' HG3' ' HA ' ' A' ' 48' ' ' ALA . 60.7 mmtt -124.02 124.74 43.22 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.211 -0.931 . . . . 0.0 110.269 179.999 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' CYS . . . . . 0.494 ' SG ' ' SG ' ' A' ' 59' ' ' CYS . 60.9 m -55.11 155.13 4.92 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.229 -0.919 . . . . 0.0 110.139 179.939 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' CYS . . . . . 0.501 ' N ' ' O ' ' A' ' 43' ' ' GLN . 91.8 m -148.13 114.6 5.95 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.176 -0.952 . . . . 0.0 110.284 179.965 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.472 ' HA ' ' HA3' ' A' ' 42' ' ' GLY . 80.4 tttt . . . . . 0 N--CA 1.491 1.583 0 CA-C-O 118.019 -0.991 . . . . 0.0 110.215 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 62.0 t0 . . . . . 0 N--CA 1.491 1.619 0 CA-C-O 121.218 0.532 . . . . 0.0 110.193 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 42.1 p-80 -130.34 170.29 14.34 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.232 -0.917 . . . . 0.0 110.22 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.423 ' CE2' ' SG ' ' A' ' 37' ' ' CYS . 2.8 t80 -125.24 128.42 48.26 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.221 -0.924 . . . . 0.0 110.22 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 52.5 t30 -107.71 105.26 15.02 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.272 -0.892 . . . . 0.0 110.275 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.423 ' SG ' ' CE2' ' A' ' 35' ' ' TYR . 31.1 m -80.69 2.54 25.5 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.258 -0.901 . . . . 0.0 110.241 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 69.2 t -83.22 -34.9 11.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.227 -0.921 . . . . 0.0 110.248 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 34.1 t -68.0 -29.43 68.44 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.256 -0.902 . . . . 0.0 110.162 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 5.1 m -76.23 -16.83 59.74 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.325 -0.859 . . . . 0.0 110.113 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 111.4 -14.53 27.78 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.421 -1.471 . . . . 0.0 109.421 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.522 ' CA ' ' O ' ' A' ' 67' ' ' CYS . . . -80.88 -177.67 51.73 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.496 -1.442 . . . . 0.0 109.496 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . 0.488 ' O ' ' N ' ' A' ' 67' ' ' CYS . 36.6 tt0 -133.82 160.14 38.51 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.29 -1.124 . . . . 0.0 110.211 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 38.6 t -114.92 107.43 15.38 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.245 -0.909 . . . . 0.0 110.173 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.456 HD13 ' CD ' ' A' ' 50' ' ' PRO . 82.8 mt -89.55 176.36 6.92 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.282 -0.886 . . . . 0.0 110.196 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 71.3 t80 -91.03 -24.03 20.18 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.242 -0.911 . . . . 0.0 110.232 -179.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.416 ' O ' ' C ' ' A' ' 48' ' ' ALA . 89.2 p -105.59 165.72 10.95 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.245 -0.91 . . . . 0.0 110.231 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.416 ' C ' ' O ' ' A' ' 47' ' ' SER . . . -43.01 130.8 4.37 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.207 -0.933 . . . . 0.0 110.202 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . 0.516 ' HB2' ' CG ' ' A' ' 65' ' ' LYS . 12.4 t -43.15 127.88 3.42 Favored Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 121.222 -0.924 . . . . 0.0 110.187 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.456 ' CD ' HD13 ' A' ' 45' ' ' LEU . 46.4 Cg_endo -72.31 147.03 46.58 Favored 'Trans proline' 0 C--N 1.306 -1.665 0 O-C-N 123.898 1.473 . . . . 0.0 110.423 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 19.4 pt -58.69 -22.06 20.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.23 -0.919 . . . . 0.0 110.135 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 82.5 m-85 -59.68 -14.77 15.35 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.207 -0.933 . . . . 0.0 110.142 179.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.522 ' CB ' ' HB3' ' A' ' 67' ' ' CYS . 72.7 p -127.45 172.85 10.31 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.254 -0.904 . . . . 0.0 110.139 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.463 ' O ' ' HA ' ' A' ' 67' ' ' CYS . 44.8 tttt -94.09 165.31 12.69 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.241 -0.912 . . . . 0.0 110.225 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.519 ' O ' ' CG2' ' A' ' 55' ' ' ILE . 16.6 tt -95.47 116.11 36.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.255 -0.903 . . . . 0.0 110.261 179.907 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . 0.496 ' NE2' ' HB3' ' A' ' 68' ' ' LYS . 64.9 mm-40 -93.77 15.8 15.6 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.263 -0.898 . . . . 0.0 110.2 -179.958 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 112.76 -114.64 3.51 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.489 -1.445 . . . . 0.0 109.489 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 16.9 p -131.4 174.02 10.49 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.26 -1.141 . . . . 0.0 110.181 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . 0.966 ' SG ' ' SG ' ' A' ' 66' ' ' CYS . 0.7 OUTLIER -114.09 -159.52 0.7 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.232 -0.918 . . . . 0.0 110.252 -179.972 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 90.9 m-85 -55.5 -43.77 75.94 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.309 -0.869 . . . . 0.0 110.192 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 80.4 mtm180 -133.43 168.95 17.68 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.242 -0.911 . . . . 0.0 110.202 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -67.7 -23.24 73.93 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.421 ' HE2' ' HA ' ' A' ' 63' ' ' LYS . 10.2 mmpt? -67.19 -24.84 65.9 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.253 -1.146 . . . . 0.0 110.186 179.965 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -112.77 162.82 15.32 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.224 -0.923 . . . . 0.0 110.191 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.516 ' CG ' ' HB2' ' A' ' 49' ' ' CYS . 48.1 tptt -141.77 144.18 33.85 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.276 -0.89 . . . . 0.0 110.226 -179.954 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' CYS . . . . . 0.966 ' SG ' ' SG ' ' A' ' 59' ' ' CYS . 99.7 m -82.96 153.54 24.96 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.192 -0.942 . . . . 0.0 110.155 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' CYS . . . . . 0.522 ' HB3' ' CB ' ' A' ' 53' ' ' THR . 75.1 m -142.51 156.22 45.12 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.258 -0.901 . . . . 0.0 110.205 -179.925 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.496 ' HB3' ' NE2' ' A' ' 56' ' ' GLN . 43.5 tttt . . . . . 0 N--CA 1.491 1.587 0 CA-C-O 117.978 -1.011 . . . . 0.0 110.24 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 50.3 p-10 . . . . . 0 N--CA 1.491 1.597 0 CA-C-O 121.308 0.575 . . . . 0.0 110.179 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 97.3 m-70 -109.62 122.84 48.36 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.207 -0.933 . . . . 0.0 110.225 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.412 ' CD1' ' N ' ' A' ' 36' ' ' ASN . 2.3 t80 -116.52 127.53 54.62 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.262 -0.899 . . . . 0.0 110.129 -179.969 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . 0.432 ' CG ' ' O ' ' A' ' 36' ' ' ASN . 25.5 p-10 -92.22 91.86 7.93 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.3 -0.875 . . . . 0.0 110.164 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 18.8 m -73.54 -22.38 60.11 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.203 -0.936 . . . . 0.0 110.2 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.462 ' HA ' ' O ' ' A' ' 42' ' ' GLY . 70.6 t -63.62 -42.33 95.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.215 -0.928 . . . . 0.0 110.215 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' SER . . . . . 0.432 ' CB ' ' ND2' ' A' ' 36' ' ' ASN . 44.8 t -58.76 -26.59 64.15 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.198 -0.939 . . . . 0.0 110.216 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.447 ' O ' ' HE3' ' A' ' 68' ' ' LYS . 63.1 m -82.95 -18.34 40.35 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.267 -0.896 . . . . 0.0 110.203 179.977 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . 0.45 ' O ' ' HG3' ' A' ' 68' ' ' LYS . . . 112.18 11.89 14.92 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.432 -1.467 . . . . 0.0 109.432 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.462 ' O ' ' HA ' ' A' ' 38' ' ' VAL . . . -113.17 178.78 18.83 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . 0.464 ' O ' ' HA ' ' A' ' 66' ' ' CYS . 0.3 OUTLIER -137.1 171.86 13.86 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.261 -1.14 . . . . 0.0 110.202 179.942 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 84.6 m -108.58 104.4 13.72 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.248 -0.908 . . . . 0.0 110.227 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.452 HD11 ' HD3' ' A' ' 50' ' ' PRO . 27.3 mt -85.82 179.61 7.01 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.163 -0.96 . . . . 0.0 110.137 179.988 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 98.1 m-85 -106.23 -7.91 17.59 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.272 -0.892 . . . . 0.0 110.192 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.414 ' O ' ' C ' ' A' ' 48' ' ' ALA . 84.0 p -121.41 166.92 13.4 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.267 -0.895 . . . . 0.0 110.201 179.959 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.414 ' C ' ' O ' ' A' ' 47' ' ' SER . . . -43.01 131.23 4.3 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.229 -0.92 . . . . 0.0 110.204 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . 0.429 ' HB2' ' HG2' ' A' ' 65' ' ' LYS . 3.9 t -42.76 128.53 3.1 Favored Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 121.284 -0.885 . . . . 0.0 110.226 -179.911 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.488 ' HG2' ' CG2' ' A' ' 53' ' ' THR . 45.7 Cg_endo -72.83 150.42 49.63 Favored 'Trans proline' 0 C--N 1.306 -1.679 0 O-C-N 123.89 1.468 . . . . 0.0 110.427 -179.938 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 54.4 mt -63.19 -27.2 42.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.211 -0.93 . . . . 0.0 110.234 -179.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 99.4 m-85 -68.94 -9.22 50.86 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.319 -0.863 . . . . 0.0 110.12 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.488 ' CG2' ' HG2' ' A' ' 50' ' ' PRO . 46.2 p -123.79 144.57 49.62 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.208 -0.932 . . . . 0.0 110.171 179.961 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.439 ' O ' ' HA ' ' A' ' 67' ' ' CYS . 40.7 mtmt -81.0 167.9 19.3 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.193 -0.942 . . . . 0.0 110.275 -179.951 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.507 ' O ' ' CG2' ' A' ' 55' ' ' ILE . 18.8 tt -100.99 117.65 46.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.334 -0.854 . . . . 0.0 110.166 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . 0.481 ' CG ' ' HB2' ' A' ' 68' ' ' LYS . 71.8 mm-40 -96.64 3.11 52.7 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.201 -0.937 . . . . 0.0 110.206 179.966 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . 0.407 ' O ' ' HE3' ' A' ' 65' ' ' LYS . . . 125.52 -119.54 3.57 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.388 -1.485 . . . . 0.0 109.388 -179.968 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.444 ' O ' ' SG ' ' A' ' 66' ' ' CYS . 24.4 p -133.05 164.24 27.44 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.26 -1.141 . . . . 0.0 110.18 179.938 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 1.8 m -114.13 -88.66 0.55 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.245 -0.91 . . . . 0.0 110.248 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 83.0 m-85 -116.97 98.94 6.75 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.283 -0.886 . . . . 0.0 110.287 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 27.7 mmm180 54.78 -145.69 0.61 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.316 -0.865 . . . . 0.0 110.141 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -102.83 18.33 50.32 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.559 -1.416 . . . . 0.0 109.559 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 48.0 mtpt -85.07 -24.38 28.13 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.277 -1.131 . . . . 0.0 110.194 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -145.34 164.07 32.61 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.308 -0.87 . . . . 0.0 110.261 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.429 ' HG2' ' HB2' ' A' ' 49' ' ' CYS . 54.5 tptt -127.68 132.92 49.61 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.29 -0.881 . . . . 0.0 110.19 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' CYS . . . . . 0.464 ' HA ' ' O ' ' A' ' 43' ' ' GLN . 59.2 m -72.35 132.42 43.95 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.261 -0.9 . . . . 0.0 110.201 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' CYS . . . . . 0.446 ' HB3' ' CB ' ' A' ' 53' ' ' THR . 90.9 m -135.56 144.29 46.14 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.287 -0.883 . . . . 0.0 110.243 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.481 ' HB2' ' CG ' ' A' ' 56' ' ' GLN . 81.5 tttt . . . . . 0 N--CA 1.492 1.644 0 CA-C-O 117.994 -1.003 . . . . 0.0 110.126 -179.923 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . 0.458 ' OD1' ' N ' ' A' ' 34' ' ' HIS . 63.4 t0 . . . . . 0 N--CA 1.491 1.598 0 CA-C-O 121.312 0.577 . . . . 0.0 110.144 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . 0.458 ' N ' ' OD1' ' A' ' 33' ' ' ASP . 98.5 m-70 -120.79 133.65 55.32 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.24 -0.913 . . . . 0.0 110.186 179.936 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 4.2 t80 -74.16 131.92 41.73 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.232 -0.917 . . . . 0.0 110.229 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . 0.538 ' ND2' ' CB ' ' A' ' 39' ' ' SER . 54.0 t30 -74.28 65.9 1.24 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.246 -0.909 . . . . 0.0 110.168 -179.906 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.459 ' O ' ' HB2' ' A' ' 40' ' ' SER . 22.0 m -71.08 -53.66 13.86 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.235 -0.916 . . . . 0.0 110.305 179.97 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.465 ' HA ' ' O ' ' A' ' 42' ' ' GLY . 77.0 t -44.66 -55.09 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.178 -0.951 . . . . 0.0 110.243 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' SER . . . . . 0.538 ' CB ' ' ND2' ' A' ' 36' ' ' ASN . 53.4 m -53.62 -31.41 47.11 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.176 -0.952 . . . . 0.0 110.244 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.459 ' HB2' ' O ' ' A' ' 37' ' ' CYS . 50.8 m -71.5 -25.29 62.19 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.249 -0.907 . . . . 0.0 110.155 179.981 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 125.05 -16.76 7.21 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.458 -1.457 . . . . 0.0 109.458 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.475 ' CA ' ' O ' ' A' ' 67' ' ' CYS . . . -87.74 -177.45 48.07 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.485 -1.446 . . . . 0.0 109.485 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 1.3 pt20 -133.66 175.73 9.18 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.313 -1.11 . . . . 0.0 110.31 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 11.1 t -107.21 89.39 2.98 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.215 -0.928 . . . . 0.0 110.18 179.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 13.7 tp -78.63 162.1 26.48 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.203 -0.935 . . . . 0.0 110.23 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 65.6 t80 -92.13 -24.6 19.06 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.227 -0.92 . . . . 0.0 110.182 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.423 ' O ' ' C ' ' A' ' 48' ' ' ALA . 44.8 m -95.94 157.85 15.71 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.265 -0.897 . . . . 0.0 110.192 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.425 ' O ' ' C ' ' A' ' 49' ' ' CYS . . . -42.74 133.15 3.6 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.256 -0.902 . . . . 0.0 110.219 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . 0.425 ' C ' ' O ' ' A' ' 48' ' ' ALA . 1.8 t -43.13 127.08 3.41 Favored Pre-proline 0 N--CA 1.491 1.609 0 O-C-N 121.248 -0.907 . . . . 0.0 110.084 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -72.45 159.64 48.68 Favored 'Trans proline' 0 C--N 1.306 -1.675 0 O-C-N 123.854 1.449 . . . . 0.0 110.436 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 7.5 mt -65.61 -25.92 37.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.167 -0.958 . . . . 0.0 110.114 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 94.2 m-85 -65.92 -12.14 52.45 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.305 -0.872 . . . . 0.0 110.117 179.871 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.463 ' OG1' ' HB3' ' A' ' 67' ' ' CYS . 67.3 p -136.09 147.35 47.78 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.272 -0.892 . . . . 0.0 110.165 179.941 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 36.8 tttt -97.41 165.23 12.11 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.211 -0.931 . . . . 0.0 110.228 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.494 ' CG2' ' O ' ' A' ' 55' ' ' ILE . 15.3 tt -86.94 115.21 27.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.276 -0.89 . . . . 0.0 110.19 -179.941 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . 0.455 ' HG3' ' HB2' ' A' ' 68' ' ' LYS . 54.4 mm-40 -97.14 18.96 13.76 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.239 -0.913 . . . . 0.0 110.224 179.957 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 139.91 -156.68 25.02 Favored Glycine 0 N--CA 1.488 2.144 0 N-CA-C 109.485 -1.446 . . . . 0.0 109.485 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.447 ' O ' ' SG ' ' A' ' 66' ' ' CYS . 24.5 p -109.26 165.04 11.92 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.188 -1.183 . . . . 0.0 110.174 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -107.65 -158.46 0.65 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.258 -0.902 . . . . 0.0 110.291 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 95.2 m-85 -58.58 -55.9 29.12 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.354 -0.841 . . . . 0.0 110.163 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -126.29 172.22 10.29 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.255 -0.903 . . . . 0.0 110.171 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -65.1 -20.25 66.82 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.424 -1.47 . . . . 0.0 109.424 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 48.8 mtmt -65.93 -24.1 66.76 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.231 -1.158 . . . . 0.0 110.215 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.428 ' C ' ' HG2' ' A' ' 65' ' ' LYS . . . -118.28 161.86 19.22 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.232 -0.917 . . . . 0.0 110.166 180.0 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.428 ' HG2' ' C ' ' A' ' 64' ' ' ALA . 73.8 mmtt -146.93 138.54 24.29 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.211 -0.931 . . . . 0.0 110.22 -179.942 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' CYS . . . . . 0.447 ' SG ' ' O ' ' A' ' 58' ' ' THR . 89.4 m -64.03 139.51 58.77 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.275 -0.891 . . . . 0.0 110.085 179.949 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' CYS . . . . . 0.475 ' O ' ' CA ' ' A' ' 42' ' ' GLY . 95.1 m -141.85 136.62 30.76 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.23 -0.919 . . . . 0.0 110.223 179.967 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.459 ' HA ' ' HA3' ' A' ' 42' ' ' GLY . 73.0 tttt . . . . . 0 N--CA 1.492 1.625 0 CA-C-O 118.03 -0.986 . . . . 0.0 110.157 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 82.2 m-20 . . . . . 0 N--CA 1.492 1.653 0 CA-C-O 121.236 0.541 . . . . 0.0 110.152 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 84.5 t60 -66.77 140.09 57.83 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.212 -0.93 . . . . 0.0 110.202 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 12.8 t80 -115.48 143.06 45.86 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.311 -0.868 . . . . 0.0 110.191 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . 0.498 ' ND2' ' HB2' ' A' ' 39' ' ' SER . 0.2 OUTLIER -91.43 67.92 5.71 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.203 -0.936 . . . . 0.0 110.223 179.981 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.433 ' O ' ' N ' ' A' ' 40' ' ' SER . 55.8 m -64.63 -50.85 65.49 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.265 -0.897 . . . . 0.0 110.169 -179.923 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 30.8 t -45.48 -47.32 4.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.137 -0.977 . . . . 0.0 110.193 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' SER . . . . . 0.498 ' HB2' ' ND2' ' A' ' 36' ' ' ASN . 32.2 t -59.01 -21.85 59.71 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.273 -0.892 . . . . 0.0 110.265 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.433 ' N ' ' O ' ' A' ' 37' ' ' CYS . 74.7 m -86.31 -11.88 50.95 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.228 -0.92 . . . . 0.0 110.215 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 103.7 5.08 45.44 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.598 -1.401 . . . . 0.0 109.598 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.445 ' HA3' ' HA ' ' A' ' 68' ' ' LYS . . . -102.58 172.29 21.86 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.501 -1.439 . . . . 0.0 109.501 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . 0.456 ' O ' ' HA ' ' A' ' 66' ' ' CYS . 1.1 pt20 -123.35 175.11 6.91 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.204 -1.174 . . . . 0.0 110.219 179.939 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 22.4 t -107.93 94.16 4.93 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.23 -0.918 . . . . 0.0 110.197 -179.896 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.558 ' CD1' ' CD ' ' A' ' 50' ' ' PRO . 94.5 mt -73.24 177.9 4.83 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.206 -0.934 . . . . 0.0 110.216 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 80.3 m-85 -104.26 -11.54 17.14 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.267 -0.895 . . . . 0.0 110.278 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.401 ' O ' ' C ' ' A' ' 48' ' ' ALA . 60.1 p -125.74 173.23 9.18 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.307 -0.871 . . . . 0.0 110.258 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.401 ' C ' ' O ' ' A' ' 47' ' ' SER . . . -43.16 128.61 4.6 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.277 -0.89 . . . . 0.0 110.144 179.945 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 4.9 t -46.56 129.32 8.2 Favored Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.287 -0.883 . . . . 0.0 110.142 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.558 ' CD ' ' CD1' ' A' ' 45' ' ' LEU . 46.1 Cg_endo -72.84 149.76 48.38 Favored 'Trans proline' 0 C--N 1.306 -1.679 0 O-C-N 123.853 1.449 . . . . 0.0 110.406 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.43 HD11 HG22 ' A' ' 51' ' ' ILE . 46.1 pt -60.21 -24.75 31.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.299 -0.876 . . . . 0.0 110.177 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 58.4 m-85 -60.38 -13.91 15.85 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.156 -0.965 . . . . 0.0 110.202 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.459 ' OG1' ' HB3' ' A' ' 67' ' ' CYS . 77.4 p -135.87 154.72 51.07 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.15 -0.969 . . . . 0.0 110.237 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 95.7 mttt -98.11 152.55 19.22 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.294 -0.879 . . . . 0.0 110.259 179.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.449 HG22 ' O ' ' A' ' 55' ' ' ILE . 20.8 tt -89.36 124.39 42.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.329 -0.857 . . . . 0.0 110.244 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 67.1 mm-40 -97.37 -18.21 19.26 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.257 -0.902 . . . . 0.0 110.178 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -177.83 -149.59 8.05 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.453 -1.459 . . . . 0.0 109.453 -179.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.442 ' O ' ' SG ' ' A' ' 66' ' ' CYS . 33.2 p -111.32 163.33 14.08 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.288 -1.124 . . . . 0.0 110.131 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -96.75 -160.73 0.82 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.244 -0.91 . . . . 0.0 110.192 179.973 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 93.4 m-85 -60.8 -42.77 98.24 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.284 -0.885 . . . . 0.0 110.151 179.891 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 90.1 mtt-85 -135.41 170.87 15.27 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.214 -0.929 . . . . 0.0 110.212 -179.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -63.53 -18.9 61.85 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.375 -1.49 . . . . 0.0 109.375 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 12.3 tttt -70.27 -31.54 68.95 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.179 -1.189 . . . . 0.0 110.193 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.422 ' C ' ' HG2' ' A' ' 65' ' ' LYS . . . -105.19 159.53 15.79 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.302 -0.873 . . . . 0.0 110.123 -179.952 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.422 ' HG2' ' C ' ' A' ' 64' ' ' ALA . 73.9 mmtt -142.9 147.9 36.07 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.246 -0.909 . . . . 0.0 110.18 179.968 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' CYS . . . . . 0.456 ' HA ' ' O ' ' A' ' 43' ' ' GLN . 71.7 m -77.55 148.47 35.2 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.268 -0.895 . . . . 0.0 110.1 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' CYS . . . . . 0.516 ' SG ' ' CD1' ' A' ' 45' ' ' LEU . 92.6 m -145.7 131.15 18.69 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.13 -0.981 . . . . 0.0 110.256 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.445 ' HA ' ' HA3' ' A' ' 42' ' ' GLY . 82.0 tttt . . . . . 0 N--CA 1.491 1.604 0 CA-C-O 118.096 -0.954 . . . . 0.0 110.27 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 56.1 p-10 . . . . . 0 N--CA 1.492 1.664 0 CA-C-O 121.311 0.577 . . . . 0.0 110.221 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 88.3 m-70 -104.23 128.33 51.95 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.217 -0.927 . . . . 0.0 110.214 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.566 ' CE2' ' SG ' ' A' ' 37' ' ' CYS . 3.3 t80 -114.49 127.4 55.79 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.253 -0.904 . . . . 0.0 110.218 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . 0.504 ' ND2' ' HB3' ' A' ' 39' ' ' SER . 27.2 p-10 -94.22 85.12 4.56 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.266 -0.896 . . . . 0.0 110.234 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.566 ' SG ' ' CE2' ' A' ' 35' ' ' TYR . 87.6 m -65.02 -42.66 94.2 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.271 -0.893 . . . . 0.0 110.284 179.951 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 86.4 t -52.41 -40.86 33.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.301 -0.875 . . . . 0.0 110.196 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' SER . . . . . 0.504 ' HB3' ' ND2' ' A' ' 36' ' ' ASN . 24.6 t -62.67 -26.76 68.81 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.269 -0.895 . . . . 0.0 110.251 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.514 ' O ' ' CE ' ' A' ' 68' ' ' LYS . 2.2 t -79.95 -16.65 54.81 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.319 -0.863 . . . . 0.0 110.163 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 116.33 -12.53 16.37 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.468 -1.453 . . . . 0.0 109.468 -179.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.452 ' HA3' ' HA ' ' A' ' 68' ' ' LYS . . . -83.55 -175.36 50.9 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 -179.988 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . 0.457 ' O ' ' HA ' ' A' ' 66' ' ' CYS . 42.5 tt0 -133.73 152.25 51.83 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.25 -1.147 . . . . 0.0 110.206 179.926 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . 0.439 ' HA ' ' HA ' ' A' ' 66' ' ' CYS . 49.2 t -100.1 127.16 46.38 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.265 -0.897 . . . . 0.0 110.219 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 28.9 mt -121.12 176.57 5.52 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.225 -0.922 . . . . 0.0 110.227 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 85.1 m-85 -104.19 -0.78 28.07 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.21 -0.931 . . . . 0.0 110.206 180.0 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 85.7 p -116.18 171.95 7.48 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.243 -0.911 . . . . 0.0 110.205 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -46.92 153.33 0.43 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.291 -0.881 . . . . 0.0 110.147 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 42.3 t -55.67 128.38 69.03 Favored Pre-proline 0 N--CA 1.492 1.641 0 O-C-N 121.325 -0.86 . . . . 0.0 110.165 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -72.64 153.69 54.43 Favored 'Trans proline' 0 C--N 1.305 -1.718 0 O-C-N 123.943 1.496 . . . . 0.0 110.485 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 28.1 pt -77.08 -6.45 9.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.26 -0.9 . . . . 0.0 110.105 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 46.6 m-85 -73.0 -22.94 60.59 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.248 -0.908 . . . . 0.0 110.14 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 69.9 p -137.62 161.81 35.47 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.317 -0.865 . . . . 0.0 110.204 179.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.497 ' O ' ' N ' ' A' ' 68' ' ' LYS . 64.3 mttt -90.32 169.54 11.01 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.289 -0.882 . . . . 0.0 110.15 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.518 ' O ' ' CG2' ' A' ' 55' ' ' ILE . 20.6 tt -95.48 111.27 25.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.262 -0.899 . . . . 0.0 110.133 -179.914 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . 0.505 ' CG ' ' HB3' ' A' ' 68' ' ' LYS . 56.6 mm-40 -90.32 -12.85 36.52 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.211 -0.931 . . . . 0.0 110.188 179.962 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . 0.525 ' HA2' ' CE2' ' A' ' 35' ' ' TYR . . . 170.79 -144.77 8.53 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.474 -1.451 . . . . 0.0 109.474 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 16.5 p -115.73 168.37 10.09 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.221 -1.164 . . . . 0.0 110.186 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . 0.47 ' SG ' ' N ' ' A' ' 66' ' ' CYS . 1.1 m -91.19 -161.6 0.83 Allowed 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.296 -0.877 . . . . 0.0 110.212 -179.92 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 94.2 m-85 -57.24 -40.82 78.37 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.31 -0.868 . . . . 0.0 110.317 179.861 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 93.8 mtt180 -132.44 178.26 6.96 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.222 -0.924 . . . . 0.0 110.214 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -76.25 -6.02 82.54 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.589 -1.404 . . . . 0.0 109.589 -179.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 40.6 mtpt -81.59 -23.75 36.9 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.197 -1.178 . . . . 0.0 110.184 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.43 ' O ' ' HB2' ' A' ' 59' ' ' CYS . . . -117.27 162.61 17.61 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.291 -0.88 . . . . 0.0 110.1 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 16.4 tppt? -141.16 123.02 15.37 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.244 -0.91 . . . . 0.0 110.16 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' CYS . . . . . 0.47 ' N ' ' SG ' ' A' ' 59' ' ' CYS . 28.9 p -87.84 151.3 22.96 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.173 -0.954 . . . . 0.0 110.188 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' CYS . . . . . 0.466 ' CA ' ' O ' ' A' ' 54' ' ' LYS . 73.1 m -148.77 143.47 26.4 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.222 -0.924 . . . . 0.0 110.192 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.514 ' CE ' ' O ' ' A' ' 40' ' ' SER . 78.3 tttt . . . . . 0 N--CA 1.492 1.633 0 CA-C-O 117.999 -1.0 . . . . 0.0 110.259 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 58.4 p-10 . . . . . 0 N--CA 1.491 1.598 0 CA-C-O 121.291 0.567 . . . . 0.0 110.205 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 93.6 m-70 -125.3 120.92 32.53 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.203 -0.936 . . . . 0.0 110.164 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.562 ' CD1' ' SG ' ' A' ' 37' ' ' CYS . 6.4 t80 -50.14 -37.23 33.36 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.24 -0.912 . . . . 0.0 110.276 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . 0.568 ' ND2' ' CB ' ' A' ' 39' ' ' SER . 49.7 t30 65.95 54.55 1.01 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.277 -0.889 . . . . 0.0 110.168 -179.924 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.562 ' SG ' ' CD1' ' A' ' 35' ' ' TYR . 31.0 m -65.14 -52.95 52.08 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.304 -0.872 . . . . 0.0 110.146 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 38.0 t -47.91 -50.01 10.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.31 -0.869 . . . . 0.0 110.224 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' SER . . . . . 0.568 ' CB ' ' ND2' ' A' ' 36' ' ' ASN . 66.0 m -56.68 -32.33 65.33 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.249 -0.907 . . . . 0.0 110.115 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.502 ' O ' ' NZ ' ' A' ' 68' ' ' LYS . 24.0 m -72.87 -11.5 60.62 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.288 -0.883 . . . . 0.0 110.09 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 103.95 -12.35 52.78 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.389 -1.484 . . . . 0.0 109.389 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.462 ' HA2' ' HB2' ' A' ' 68' ' ' LYS . . . -81.52 -175.14 49.98 Favored Glycine 0 N--CA 1.489 2.217 0 N-CA-C 109.469 -1.452 . . . . 0.0 109.469 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . 0.447 ' NE2' HD23 ' A' ' 45' ' ' LEU . 47.7 tt0 -126.44 147.77 49.75 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.304 -1.115 . . . . 0.0 110.221 179.95 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 20.2 t -100.51 109.11 21.2 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.203 -0.936 . . . . 0.0 110.221 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.46 HD11 ' HD3' ' A' ' 50' ' ' PRO . 59.0 mt -104.67 175.22 5.56 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.184 -0.947 . . . . 0.0 110.155 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 89.4 m-85 -107.84 -8.31 16.03 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.287 -0.883 . . . . 0.0 110.256 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.408 ' O ' ' C ' ' A' ' 48' ' ' ALA . 34.1 t -114.22 164.43 13.9 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.182 -0.949 . . . . 0.0 110.203 -179.984 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.418 ' O ' ' C ' ' A' ' 49' ' ' CYS . . . -42.62 132.45 3.68 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.309 -0.869 . . . . 0.0 110.159 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . 0.418 ' C ' ' O ' ' A' ' 48' ' ' ALA . 4.7 t -43.16 129.83 3.4 Favored Pre-proline 0 N--CA 1.492 1.642 0 O-C-N 121.254 -0.904 . . . . 0.0 110.15 179.997 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.46 ' HD3' HD11 ' A' ' 45' ' ' LEU . 45.7 Cg_endo -72.99 146.27 41.35 Favored 'Trans proline' 0 C--N 1.305 -1.712 0 O-C-N 123.921 1.485 . . . . 0.0 110.397 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 34.0 pt -59.54 -20.05 17.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.289 -0.882 . . . . 0.0 110.119 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . 0.416 ' C ' HG21 ' A' ' 53' ' ' THR . 67.1 m-85 -61.82 -21.54 64.71 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.318 -0.864 . . . . 0.0 110.273 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.422 ' OG1' ' HB3' ' A' ' 67' ' ' CYS . 68.3 p -144.83 152.83 40.89 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.219 -0.925 . . . . 0.0 110.219 179.895 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.459 ' O ' ' HA ' ' A' ' 67' ' ' CYS . 62.2 mttm -78.01 173.5 12.12 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.32 -0.862 . . . . 0.0 110.174 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.486 ' O ' ' CG2' ' A' ' 55' ' ' ILE . 20.8 tt -110.78 121.24 63.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.25 -0.906 . . . . 0.0 110.169 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . 0.505 ' NE2' ' HB3' ' A' ' 68' ' ' LYS . 86.4 mm-40 -78.21 -27.02 47.71 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.253 -0.904 . . . . 0.0 110.225 -179.933 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 156.9 -155.96 26.8 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.478 -1.449 . . . . 0.0 109.478 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.421 ' O ' ' SG ' ' A' ' 66' ' ' CYS . 17.1 p -74.63 175.24 8.06 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.286 -1.126 . . . . 0.0 110.245 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . 1.204 ' SG ' ' SG ' ' A' ' 66' ' ' CYS . 0.1 OUTLIER -125.54 142.03 51.72 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.322 -0.861 . . . . 0.0 110.179 179.981 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 83.0 m-85 45.33 -92.53 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.295 -0.878 . . . . 0.0 110.23 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . 0.517 ' N ' ' O ' ' A' ' 59' ' ' CYS . 66.1 mtp180 -118.11 -8.21 10.71 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.194 -0.941 . . . . 0.0 110.151 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 127.3 -14.52 6.51 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.507 -1.437 . . . . 0.0 109.507 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 52.5 mtmt -61.12 -22.18 64.42 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.226 -1.161 . . . . 0.0 110.277 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.462 ' O ' ' HD3' ' A' ' 65' ' ' LYS . . . -127.97 173.83 9.7 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.226 -0.921 . . . . 0.0 110.166 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.462 ' HD3' ' O ' ' A' ' 64' ' ' ALA . 46.2 mmtt -124.16 122.76 38.7 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.248 -0.908 . . . . 0.0 110.215 -179.977 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' CYS . . . . . 1.204 ' SG ' ' SG ' ' A' ' 59' ' ' CYS . 75.9 m -75.09 149.36 39.15 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.271 -0.893 . . . . 0.0 110.135 -179.945 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' CYS . . . . . 0.459 ' HA ' ' O ' ' A' ' 54' ' ' LYS . 89.5 m -146.11 136.36 23.8 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.315 -0.866 . . . . 0.0 110.241 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.505 ' HB3' ' NE2' ' A' ' 56' ' ' GLN . 80.6 tttt . . . . . 0 N--CA 1.493 1.695 0 CA-C-O 118.093 -0.956 . . . . 0.0 110.209 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 73.3 m-20 . . . . . 0 N--CA 1.492 1.637 0 CA-C-O 121.26 0.552 . . . . 0.0 110.195 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 44.0 p-80 -148.6 152.39 36.67 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.229 -0.919 . . . . 0.0 110.247 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.502 ' CD1' ' N ' ' A' ' 36' ' ' ASN . 6.3 t80 -121.45 147.72 45.37 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.281 -0.887 . . . . 0.0 110.119 179.995 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . 0.502 ' N ' ' CD1' ' A' ' 35' ' ' TYR . 28.5 p-10 -84.99 57.43 4.44 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.199 -0.938 . . . . 0.0 110.293 -179.937 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 26.1 m -67.09 -56.26 10.8 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.252 -0.905 . . . . 0.0 110.058 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 60.1 t -53.47 -29.25 16.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.265 -0.897 . . . . 0.0 110.112 179.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 39.6 t -70.91 -30.06 66.3 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.298 -0.876 . . . . 0.0 110.121 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.51 ' O ' ' NZ ' ' A' ' 68' ' ' LYS . 0.4 OUTLIER -78.94 -21.48 47.16 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.287 -0.883 . . . . 0.0 110.118 179.969 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 117.29 3.57 16.95 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.611 -1.396 . . . . 0.0 109.611 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.453 ' HA3' ' HA ' ' A' ' 68' ' ' LYS . . . -100.5 172.31 23.89 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 -179.974 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 36.4 tt0 -118.14 153.41 33.84 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.25 -1.147 . . . . 0.0 110.187 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 30.5 t -98.03 97.99 9.38 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.253 -0.904 . . . . 0.0 110.205 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.514 HD13 ' CD ' ' A' ' 50' ' ' PRO . 79.7 mt -82.59 174.34 11.13 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.287 -0.883 . . . . 0.0 110.197 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 98.2 m-85 -107.25 0.66 23.36 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.29 -0.881 . . . . 0.0 110.276 -179.892 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.414 ' O ' ' C ' ' A' ' 48' ' ' ALA . 92.3 p -125.9 172.22 10.08 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.128 -0.982 . . . . 0.0 110.194 179.929 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.414 ' C ' ' O ' ' A' ' 47' ' ' SER . . . -42.93 124.2 3.05 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.316 -0.865 . . . . 0.0 110.169 179.948 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 16.4 t -42.87 130.41 3.13 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.29 -0.881 . . . . 0.0 110.215 -179.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.514 ' CD ' HD13 ' A' ' 45' ' ' LEU . 46.9 Cg_endo -72.72 140.73 32.86 Favored 'Trans proline' 0 C--N 1.306 -1.692 0 O-C-N 123.965 1.508 . . . . 0.0 110.391 -179.955 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 43.8 pt -62.2 -22.17 28.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.285 -0.884 . . . . 0.0 110.213 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 69.0 m-85 -55.92 -17.46 6.59 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.239 -0.913 . . . . 0.0 110.207 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.423 ' OG1' ' HB3' ' A' ' 67' ' ' CYS . 35.4 p -135.93 168.09 19.99 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.257 -0.902 . . . . 0.0 110.176 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.414 ' HB2' ' O ' ' A' ' 68' ' ' LYS . 22.1 mttp -96.12 152.98 18.04 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.274 -0.891 . . . . 0.0 110.241 179.977 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.469 ' O ' ' CG2' ' A' ' 55' ' ' ILE . 13.0 tt -94.54 113.57 29.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.247 -0.908 . . . . 0.0 110.316 -179.955 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . 0.497 ' NE2' ' HB3' ' A' ' 68' ' ' LYS . 90.4 mm-40 -76.13 -26.48 56.37 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.239 -0.913 . . . . 0.0 110.097 -179.977 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 167.5 -151.85 19.81 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.467 -1.453 . . . . 0.0 109.467 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 16.5 p -94.22 165.48 12.58 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.271 -1.135 . . . . 0.0 110.205 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . 0.97 ' SG ' ' SG ' ' A' ' 66' ' ' CYS . 0.5 OUTLIER -103.28 -158.02 0.64 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.202 -0.936 . . . . 0.0 110.207 -179.952 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 61.8 m-85 -56.64 -54.95 40.18 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.307 -0.871 . . . . 0.0 110.227 179.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . 0.519 ' CZ ' ' CD ' ' A' ' 63' ' ' LYS . 52.8 ttt180 -118.12 159.66 22.89 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.272 -0.893 . . . . 0.0 110.255 -179.979 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -63.16 -16.1 57.35 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.385 -1.486 . . . . 0.0 109.385 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.519 ' CD ' ' CZ ' ' A' ' 61' ' ' ARG . 41.9 mtpt -70.2 -27.84 64.81 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.257 -1.143 . . . . 0.0 110.172 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.402 ' C ' ' HG2' ' A' ' 65' ' ' LYS . . . -110.48 166.41 11.01 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.379 -0.826 . . . . 0.0 110.192 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.402 ' HG2' ' C ' ' A' ' 64' ' ' ALA . 74.8 mmtt -141.43 150.38 42.24 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.283 -0.885 . . . . 0.0 110.202 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' CYS . . . . . 0.97 ' SG ' ' SG ' ' A' ' 59' ' ' CYS . 94.7 m -92.46 144.14 25.66 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.282 -0.886 . . . . 0.0 110.185 179.939 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' CYS . . . . . 0.429 ' SG ' ' HD2' ' A' ' 50' ' ' PRO . 65.5 m -144.15 121.39 11.55 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.206 -0.934 . . . . 0.0 110.219 -179.995 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.51 ' NZ ' ' O ' ' A' ' 40' ' ' SER . 80.4 tttt . . . . . 0 N--CA 1.491 1.606 0 CA-C-O 118.02 -0.99 . . . . 0.0 110.216 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 85.9 m-20 . . . . . 0 N--CA 1.492 1.626 0 CA-C-O 121.168 0.509 . . . . 0.0 110.181 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 48.5 m80 -112.98 115.19 28.0 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.339 -0.85 . . . . 0.0 110.188 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.564 ' CZ ' ' SG ' ' A' ' 37' ' ' CYS . 26.2 p90 -125.38 156.99 37.91 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.23 -0.919 . . . . 0.0 110.112 -179.965 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . 0.439 ' ND2' ' OG ' ' A' ' 39' ' ' SER . 32.1 t30 -85.63 109.92 18.9 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.34 -0.85 . . . . 0.0 110.28 -179.974 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.564 ' SG ' ' CZ ' ' A' ' 35' ' ' TYR . 98.0 m -66.04 -42.74 89.17 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.278 -0.889 . . . . 0.0 110.089 179.919 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 97.5 t -48.18 -42.76 11.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.233 -0.917 . . . . 0.0 110.161 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' SER . . . . . 0.439 ' OG ' ' ND2' ' A' ' 36' ' ' ASN . 2.8 m -64.79 -24.97 67.72 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.301 -0.874 . . . . 0.0 110.206 179.959 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 69.2 m -82.61 -9.62 59.31 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.272 -0.892 . . . . 0.0 110.229 179.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 107.97 -4.78 34.06 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.496 ' CA ' ' O ' ' A' ' 67' ' ' CYS . . . -90.71 -172.94 44.16 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.507 -1.437 . . . . 0.0 109.507 179.94 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . 0.507 ' HG2' ' N ' ' A' ' 44' ' ' CYS . 44.8 tt0 -127.05 168.41 14.62 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.211 -1.17 . . . . 0.0 110.213 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . 0.507 ' N ' ' HG2' ' A' ' 43' ' ' GLN . 15.7 t -115.82 136.61 52.89 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.193 -0.942 . . . . 0.0 110.242 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.45 HD22 ' O ' ' A' ' 44' ' ' CYS . 81.6 mt -136.9 174.53 10.51 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.195 -0.941 . . . . 0.0 110.218 179.935 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 96.1 m-85 -109.44 0.55 19.39 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.185 -0.947 . . . . 0.0 110.254 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.419 ' O ' ' C ' ' A' ' 48' ' ' ALA . 41.4 m -122.79 164.79 17.72 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.271 -0.893 . . . . 0.0 110.237 180.0 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.419 ' C ' ' O ' ' A' ' 47' ' ' SER . . . -42.82 138.49 1.96 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.272 -0.892 . . . . 0.0 110.254 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . 0.462 ' CB ' ' HB ' ' A' ' 55' ' ' ILE . 11.6 t -44.5 131.38 4.83 Favored Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 121.201 -0.937 . . . . 0.0 110.182 -179.924 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.446 ' HD3' HD11 ' A' ' 45' ' ' LEU . 46.9 Cg_endo -72.71 161.13 44.73 Favored 'Trans proline' 0 C--N 1.306 -1.691 0 O-C-N 123.976 1.514 . . . . 0.0 110.47 179.94 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 47.1 pt -75.89 -10.69 13.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.212 -0.93 . . . . 0.0 110.274 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . 0.416 ' C ' HG21 ' A' ' 53' ' ' THR . 77.0 m-85 -70.7 -25.38 62.93 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.21 -0.931 . . . . 0.0 110.212 -179.954 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.416 HG21 ' C ' ' A' ' 52' ' ' PHE . 81.3 p -137.55 159.82 40.88 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.261 -0.899 . . . . 0.0 110.304 179.982 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.435 ' HB2' ' O ' ' A' ' 68' ' ' LYS . 86.3 mttt -78.96 155.9 28.74 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.256 -0.902 . . . . 0.0 110.254 179.927 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.486 ' O ' ' CG2' ' A' ' 55' ' ' ILE . 17.3 tt -97.07 102.15 13.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.211 -0.93 . . . . 0.0 110.199 179.992 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . 0.496 ' CG ' ' HB3' ' A' ' 68' ' ' LYS . 64.9 mm-40 -70.4 -27.55 64.39 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.179 -0.951 . . . . 0.0 109.926 179.824 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 156.54 -158.85 29.05 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.401 -1.48 . . . . 0.0 109.401 179.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.411 ' HA ' ' CD ' ' A' ' 65' ' ' LYS . 19.3 p -81.87 164.84 21.32 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.254 -1.145 . . . . 0.0 110.19 179.947 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . 0.453 ' SG ' ' HB3' ' A' ' 66' ' ' CYS . 0.5 OUTLIER -92.64 -142.41 0.21 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.23 -0.918 . . . . 0.0 110.252 179.972 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 91.9 m-85 -50.52 -46.2 57.17 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.335 -0.853 . . . . 0.0 110.223 179.886 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -132.85 174.15 10.63 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.265 -0.897 . . . . 0.0 110.171 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -69.85 -16.21 72.2 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 48.9 mtpt -67.96 -25.85 65.64 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.234 -1.156 . . . . 0.0 110.257 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -124.63 161.29 26.57 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.301 -0.874 . . . . 0.0 110.212 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.411 ' CD ' ' HA ' ' A' ' 58' ' ' THR . 40.1 mmtm -133.62 143.26 48.51 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.309 -0.87 . . . . 0.0 110.213 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' CYS . . . . . 0.453 ' HB3' ' SG ' ' A' ' 59' ' ' CYS . 19.5 p -109.93 162.78 14.18 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.318 -0.864 . . . . 0.0 110.226 179.97 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' CYS . . . . . 0.496 ' O ' ' CA ' ' A' ' 42' ' ' GLY . 75.7 m -142.41 165.29 27.82 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.302 -0.874 . . . . 0.0 110.264 179.968 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.496 ' HB3' ' CG ' ' A' ' 56' ' ' GLN . 39.6 ttpt . . . . . 0 N--CA 1.491 1.611 0 CA-C-O 117.984 -1.008 . . . . 0.0 110.152 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 44.0 t0 . . . . . 0 N--CA 1.49 1.571 0 CA-C-O 121.302 0.572 . . . . 0.0 110.182 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 91.3 m-70 -110.81 119.51 39.33 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.258 -0.901 . . . . 0.0 110.301 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.485 ' CD1' ' SG ' ' A' ' 37' ' ' CYS . 6.3 t80 -92.31 146.39 23.73 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.273 -0.892 . . . . 0.0 110.149 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . 0.467 ' N ' ' CD1' ' A' ' 35' ' ' TYR . 0.2 OUTLIER -121.73 83.51 2.1 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.281 -0.887 . . . . 0.0 110.293 -179.959 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.485 ' SG ' ' CD1' ' A' ' 35' ' ' TYR . 28.9 m -68.71 -52.89 25.95 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.294 -0.879 . . . . 0.0 110.128 179.954 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 60.7 t -46.02 -48.52 5.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.205 -0.935 . . . . 0.0 110.164 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 58.9 p -58.63 -24.27 60.74 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.192 -0.943 . . . . 0.0 110.207 179.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.456 ' HB2' ' O ' ' A' ' 37' ' ' CYS . 66.7 m -82.08 -11.59 58.7 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.252 -0.905 . . . . 0.0 110.127 -179.964 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 106.31 -20.43 35.17 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 -179.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.519 ' CA ' ' O ' ' A' ' 67' ' ' CYS . . . -75.17 -177.66 40.64 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.452 -1.459 . . . . 0.0 109.452 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . 0.495 ' N ' ' O ' ' A' ' 67' ' ' CYS . 32.0 tt0 -129.83 160.12 34.46 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.276 -1.131 . . . . 0.0 110.204 -179.98 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . 0.47 ' SG ' ' CE2' ' A' ' 60' ' ' TYR . 13.5 t -114.97 107.63 15.63 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.259 -0.901 . . . . 0.0 110.182 179.972 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.48 HD13 ' CD ' ' A' ' 50' ' ' PRO . 16.7 mt -93.74 169.31 10.41 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.212 -0.93 . . . . 0.0 110.219 -179.931 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -86.53 -22.95 26.05 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.237 -0.915 . . . . 0.0 110.203 -179.907 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.417 ' O ' ' C ' ' A' ' 48' ' ' ALA . 40.2 t -103.51 163.64 12.17 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.284 -0.885 . . . . 0.0 110.251 -179.973 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.417 ' C ' ' O ' ' A' ' 47' ' ' SER . . . -43.45 138.01 2.58 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.231 -0.918 . . . . 0.0 110.194 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . 0.408 ' C ' ' O ' ' A' ' 48' ' ' ALA . 7.7 t -43.72 133.11 3.89 Favored Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.266 -0.896 . . . . 0.0 110.194 -179.958 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.48 ' CD ' HD13 ' A' ' 45' ' ' LEU . 46.4 Cg_endo -72.96 143.97 37.45 Favored 'Trans proline' 0 C--N 1.306 -1.691 0 O-C-N 123.954 1.502 . . . . 0.0 110.413 -179.935 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 40.3 pt -59.84 -24.18 28.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.213 -0.93 . . . . 0.0 110.163 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . 0.461 ' O ' HG21 ' A' ' 53' ' ' THR . 97.5 m-85 -55.72 -22.23 22.66 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.261 -0.9 . . . . 0.0 110.252 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.461 HG21 ' O ' ' A' ' 52' ' ' PHE . 67.2 p -139.35 153.83 47.76 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.261 -0.899 . . . . 0.0 110.239 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 72.0 mttt -79.6 172.07 14.29 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.262 -0.898 . . . . 0.0 110.166 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.503 ' O ' ' CG2' ' A' ' 55' ' ' ILE . 11.5 tt -106.9 110.62 32.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.276 -0.89 . . . . 0.0 110.116 179.965 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . 0.51 ' CG ' ' HB2' ' A' ' 68' ' ' LYS . 72.1 mm-40 -62.02 -31.96 72.4 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.276 -0.89 . . . . 0.0 110.137 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 169.18 -144.57 8.77 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.443 -1.463 . . . . 0.0 109.443 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 17.5 p -97.91 164.97 12.15 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.184 -1.186 . . . . 0.0 110.196 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . 1.089 ' SG ' ' SG ' ' A' ' 66' ' ' CYS . 0.5 OUTLIER -106.49 -171.63 1.93 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.225 -0.922 . . . . 0.0 110.293 -179.976 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . 0.527 ' CD1' ' N ' ' A' ' 61' ' ' ARG . 7.9 p90 -50.99 -31.68 18.76 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.309 -0.87 . . . . 0.0 110.263 179.862 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . 0.527 ' N ' ' CD1' ' A' ' 60' ' ' TYR . 91.9 mtt180 -140.89 173.35 11.57 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.308 -0.87 . . . . 0.0 110.258 179.939 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -81.76 -11.08 83.34 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.586 -1.405 . . . . 0.0 109.586 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.403 ' HE2' ' CD ' ' A' ' 61' ' ' ARG . 48.7 mtmt -68.04 -18.84 64.8 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.217 -1.167 . . . . 0.0 110.135 -179.949 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.469 ' CB ' ' O ' ' A' ' 45' ' ' LEU . . . -136.42 158.58 44.08 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.263 -0.898 . . . . 0.0 110.16 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 70.1 mmtt -126.55 140.55 52.36 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.279 -0.888 . . . . 0.0 110.231 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' CYS . . . . . 1.089 ' SG ' ' SG ' ' A' ' 59' ' ' CYS . 84.1 m -74.59 148.88 40.39 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.26 -0.9 . . . . 0.0 110.263 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' CYS . . . . . 0.519 ' O ' ' CA ' ' A' ' 42' ' ' GLY . 82.8 m -142.42 154.84 44.93 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.239 -0.913 . . . . 0.0 110.145 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.51 ' HB2' ' CG ' ' A' ' 56' ' ' GLN . 68.3 tttt . . . . . 0 N--CA 1.492 1.645 0 CA-C-O 118.04 -0.981 . . . . 0.0 110.191 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 81.6 m-20 . . . . . 0 N--CA 1.492 1.655 0 CA-C-O 121.253 0.549 . . . . 0.0 110.196 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . 0.591 ' CE1' ' CD1' ' A' ' 60' ' ' TYR . 64.7 t60 -118.69 129.45 55.29 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.203 -0.936 . . . . 0.0 110.165 179.98 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.566 ' CZ ' ' SG ' ' A' ' 37' ' ' CYS . 30.4 p90 -130.81 173.35 11.03 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.236 -0.915 . . . . 0.0 110.153 -179.965 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . 0.507 ' ND2' ' OG ' ' A' ' 39' ' ' SER . 23.4 p-10 -88.15 100.45 12.97 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.198 -0.939 . . . . 0.0 110.243 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.566 ' SG ' ' CZ ' ' A' ' 35' ' ' TYR . 14.8 m -72.1 -22.2 61.38 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.287 -0.883 . . . . 0.0 110.086 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 35.8 m -60.98 -45.19 98.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.231 -0.918 . . . . 0.0 110.46 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' SER . . . . . 0.507 ' OG ' ' ND2' ' A' ' 36' ' ' ASN . 95.0 p -60.6 -31.61 70.76 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.202 -0.936 . . . . 0.0 110.211 -179.928 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 72.8 m -73.64 -12.43 60.74 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.304 -0.872 . . . . 0.0 110.192 179.89 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 101.83 -11.27 57.59 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.431 -1.468 . . . . 0.0 109.431 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.511 ' CA ' ' O ' ' A' ' 67' ' ' CYS . . . -85.18 172.49 47.44 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.412 -1.475 . . . . 0.0 109.412 -179.912 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . 0.465 ' O ' ' HA ' ' A' ' 66' ' ' CYS . 0.4 OUTLIER -123.28 -174.82 3.04 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.27 -1.135 . . . . 0.0 110.151 179.959 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 13.7 t -130.11 116.38 18.41 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.161 -0.962 . . . . 0.0 110.222 -179.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 93.5 mt -105.46 175.84 5.36 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.251 -0.905 . . . . 0.0 110.224 179.858 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 98.3 m-85 -102.45 -3.44 26.95 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.278 -0.889 . . . . 0.0 110.291 -179.877 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.407 ' O ' ' C ' ' A' ' 48' ' ' ALA . 69.3 m -122.76 166.49 14.86 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.272 -0.893 . . . . 0.0 110.246 179.967 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.422 ' O ' ' C ' ' A' ' 49' ' ' CYS . . . -42.97 131.64 4.15 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.243 -0.911 . . . . 0.0 110.19 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . 0.422 ' C ' ' O ' ' A' ' 48' ' ' ALA . 5.9 t -42.96 130.02 3.19 Favored Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 121.29 -0.881 . . . . 0.0 110.251 -179.981 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -72.81 145.6 41.08 Favored 'Trans proline' 0 C--N 1.306 -1.689 0 O-C-N 123.945 1.497 . . . . 0.0 110.412 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 45.1 pt -59.63 -18.48 14.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.254 -0.904 . . . . 0.0 110.192 179.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 91.8 m-85 -70.86 -4.49 24.54 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.293 -0.88 . . . . 0.0 110.256 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 69.5 p -137.69 170.76 15.51 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.286 -0.884 . . . . 0.0 110.248 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.451 ' O ' ' HA ' ' A' ' 67' ' ' CYS . 70.9 tttt -91.27 162.79 14.48 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.215 -0.928 . . . . 0.0 110.209 -179.953 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.518 ' O ' ' CG2' ' A' ' 55' ' ' ILE . 15.1 tt -93.47 100.65 11.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.268 -0.895 . . . . 0.0 110.145 -179.963 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . 0.525 ' HB2' ' CB ' ' A' ' 66' ' ' CYS . 79.2 mm-40 -75.45 0.01 18.53 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.245 -0.909 . . . . 0.0 110.218 179.98 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 111.75 -127.49 8.15 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.497 -1.441 . . . . 0.0 109.497 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.409 ' HA ' ' HD3' ' A' ' 65' ' ' LYS . 71.0 p -105.23 168.62 8.95 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.213 -1.169 . . . . 0.0 110.203 -179.986 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . 0.933 ' SG ' ' SG ' ' A' ' 66' ' ' CYS . 0.1 OUTLIER -117.66 -149.23 0.44 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.222 -0.924 . . . . 0.0 110.179 179.968 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . 0.591 ' CD1' ' CE1' ' A' ' 34' ' ' HIS . 98.0 m-85 -58.34 -46.47 86.18 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.298 -0.876 . . . . 0.0 110.199 179.947 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . 0.432 ' HD2' ' HD3' ' A' ' 63' ' ' LYS . 33.1 ttm180 -129.54 164.76 23.09 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.263 -0.898 . . . . 0.0 110.161 179.989 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.422 ' N ' ' HG2' ' A' ' 61' ' ' ARG . . . -61.3 -23.2 61.95 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.432 ' HD3' ' HD2' ' A' ' 61' ' ' ARG . 44.1 mtpt -72.34 -28.53 63.11 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.21 -1.171 . . . . 0.0 110.228 -179.986 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.422 ' C ' ' HG2' ' A' ' 65' ' ' LYS . . . -107.31 160.44 15.61 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.225 -0.922 . . . . 0.0 110.284 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.507 ' CA ' ' HB2' ' A' ' 59' ' ' CYS . 34.0 mmtm -142.68 144.76 32.87 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.21 -0.931 . . . . 0.0 110.086 179.984 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' CYS . . . . . 0.933 ' SG ' ' SG ' ' A' ' 59' ' ' CYS . 79.9 m -83.56 132.24 34.93 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.173 -0.955 . . . . 0.0 110.163 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' CYS . . . . . 0.511 ' O ' ' CA ' ' A' ' 42' ' ' GLY . 85.0 m -126.76 154.19 44.54 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.28 -0.888 . . . . 0.0 110.18 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.49 ' HB3' ' NE2' ' A' ' 56' ' ' GLN . 85.2 tttt . . . . . 0 N--CA 1.491 1.577 0 CA-C-O 117.951 -1.023 . . . . 0.0 110.271 179.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 63.5 t0 . . . . . 0 N--CA 1.491 1.618 0 CA-C-O 121.159 0.504 . . . . 0.0 110.246 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 75.5 t60 -124.52 123.54 40.33 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.325 -0.859 . . . . 0.0 110.205 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 3.6 t80 -119.89 128.73 53.92 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.204 -0.935 . . . . 0.0 110.252 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . 0.521 ' ND2' ' HB2' ' A' ' 39' ' ' SER . 64.2 t30 -100.79 117.27 34.54 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.236 -0.915 . . . . 0.0 110.157 179.931 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.45 ' O ' ' N ' ' A' ' 40' ' ' SER . 37.7 m -85.22 -51.07 6.86 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.332 -0.855 . . . . 0.0 110.311 -179.941 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.46 HG21 ' OD1' ' A' ' 36' ' ' ASN . 21.7 m -41.75 -46.26 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.248 -0.908 . . . . 0.0 110.33 -179.896 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' SER . . . . . 0.521 ' HB2' ' ND2' ' A' ' 36' ' ' ASN . 0.8 OUTLIER -59.02 -32.18 69.49 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.177 -0.952 . . . . 0.0 110.14 179.98 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.513 ' O ' ' NZ ' ' A' ' 68' ' ' LYS . 50.2 m -75.43 -9.97 59.04 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.347 -0.846 . . . . 0.0 110.156 -179.991 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . 0.406 ' HA2' ' HE3' ' A' ' 68' ' ' LYS . . . 108.29 -20.54 30.31 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 179.931 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.44 ' O ' ' HA ' ' A' ' 38' ' ' VAL . . . -78.27 177.61 53.39 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.592 -1.403 . . . . 0.0 109.592 179.94 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . 0.467 ' O ' ' HA ' ' A' ' 66' ' ' CYS . 14.4 tt0 -125.38 155.93 39.58 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.206 -1.173 . . . . 0.0 110.192 179.921 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 15.7 t -104.5 104.09 13.88 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.257 -0.902 . . . . 0.0 110.281 -179.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 80.3 mt -88.7 174.63 7.91 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.217 -0.927 . . . . 0.0 110.238 179.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 88.8 m-85 -96.13 -19.48 19.35 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.21 -0.931 . . . . 0.0 110.185 -179.929 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.419 ' O ' ' C ' ' A' ' 48' ' ' ALA . 69.1 m -110.47 165.66 11.61 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.181 -0.949 . . . . 0.0 110.257 -179.934 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.419 ' C ' ' O ' ' A' ' 47' ' ' SER . . . -42.92 131.95 4.04 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.315 -0.866 . . . . 0.0 110.217 179.978 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 8.7 t -44.68 127.63 5.07 Favored Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.205 -0.934 . . . . 0.0 110.106 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.418 ' HD2' ' SG ' ' A' ' 67' ' ' CYS . 46.7 Cg_endo -72.4 149.46 50.51 Favored 'Trans proline' 0 C--N 1.306 -1.681 0 O-C-N 123.949 1.499 . . . . 0.0 110.402 -179.999 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.412 HG13 ' N ' ' A' ' 52' ' ' PHE . 27.8 pt -63.6 -22.28 30.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.244 -0.91 . . . . 0.0 110.211 179.933 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . 0.412 ' N ' HG13 ' A' ' 51' ' ' ILE . 91.0 m-85 -56.98 -20.28 22.93 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.215 -0.928 . . . . 0.0 110.211 -179.998 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 17.6 p -133.93 162.85 30.91 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.302 -0.874 . . . . 0.0 110.18 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 55.6 mttm -95.36 143.94 26.32 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.221 -0.924 . . . . 0.0 110.129 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.507 ' CG2' ' O ' ' A' ' 55' ' ' ILE . 18.2 tt -88.76 113.26 25.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.213 -0.929 . . . . 0.0 110.184 -179.979 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . 0.457 ' NE2' ' HB3' ' A' ' 68' ' ' LYS . 88.2 mm-40 -72.41 -28.06 62.73 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.249 -0.907 . . . . 0.0 110.153 -179.975 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 176.88 -148.92 9.24 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.457 -1.457 . . . . 0.0 109.457 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 43.2 p -99.48 163.57 12.46 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.182 -1.187 . . . . 0.0 110.199 179.93 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . 0.864 ' SG ' ' SG ' ' A' ' 66' ' ' CYS . 0.8 OUTLIER -98.07 -160.41 0.8 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.277 -0.889 . . . . 0.0 110.318 -179.976 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 85.2 m-85 -57.51 -46.91 83.25 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.355 -0.84 . . . . 0.0 110.197 179.874 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 95.3 mtt180 -127.21 167.97 15.35 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.251 -0.906 . . . . 0.0 110.14 -179.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -68.52 -12.19 63.52 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.477 -1.449 . . . . 0.0 109.477 -179.947 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 53.9 mtmt -75.84 -23.66 55.74 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.291 -1.123 . . . . 0.0 110.244 179.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -113.26 163.09 15.24 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.255 -0.903 . . . . 0.0 110.249 -179.93 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -140.03 141.05 36.31 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.306 -0.871 . . . . 0.0 110.199 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' CYS . . . . . 0.864 ' SG ' ' SG ' ' A' ' 59' ' ' CYS . 58.6 m -84.99 148.05 26.38 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.248 -0.907 . . . . 0.0 110.154 -179.982 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' CYS . . . . . 0.418 ' SG ' ' HD2' ' A' ' 50' ' ' PRO . 80.5 m -143.64 128.08 17.93 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.276 -0.89 . . . . 0.0 110.195 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.513 ' NZ ' ' O ' ' A' ' 40' ' ' SER . 75.2 tttt . . . . . 0 N--CA 1.492 1.636 0 CA-C-O 118.058 -0.972 . . . . 0.0 110.194 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 55.1 t0 . . . . . 0 N--CA 1.492 1.627 0 CA-C-O 121.247 0.546 . . . . 0.0 110.212 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 94.8 m-70 -117.96 134.36 55.03 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.206 -0.934 . . . . 0.0 110.238 -179.902 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 43.2 t80 -129.09 142.39 50.91 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.255 -0.903 . . . . 0.0 110.161 179.905 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 17.4 p-10 -111.1 123.82 50.96 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.291 -0.881 . . . . 0.0 110.235 -179.949 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.65 ' SG ' ' SG ' ' A' ' 59' ' ' CYS . 22.3 m -68.62 -6.86 28.24 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.242 -0.912 . . . . 0.0 110.161 179.856 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 39.8 t -71.7 -41.52 70.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.236 -0.915 . . . . 0.0 110.157 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 3.1 m -51.4 -29.39 15.55 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.269 -0.894 . . . . 0.0 110.054 179.954 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.433 ' CB ' ' HB3' ' A' ' 56' ' ' GLN . 26.6 m -88.89 -17.36 29.76 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.236 -0.915 . . . . 0.0 110.058 179.898 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . 0.455 ' O ' ' HG3' ' A' ' 68' ' ' LYS . . . 108.06 8.75 29.11 Favored Glycine 0 N--CA 1.489 2.197 0 N-CA-C 109.488 -1.445 . . . . 0.0 109.488 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.511 ' CA ' ' O ' ' A' ' 67' ' ' CYS . . . -110.18 173.0 16.11 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.498 -1.441 . . . . 0.0 109.498 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . 0.485 ' N ' ' O ' ' A' ' 67' ' ' CYS . 2.0 pt20 -110.34 174.53 5.82 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.237 -1.155 . . . . 0.0 110.246 179.951 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 8.7 t -110.98 84.38 1.92 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.228 -0.92 . . . . 0.0 110.218 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.426 HD22 ' HD3' ' A' ' 50' ' ' PRO . 14.4 tp -69.26 167.09 17.06 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.357 -0.839 . . . . 0.0 110.191 -180.0 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 60.1 m-85 -91.77 -24.85 19.28 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.293 -0.88 . . . . 0.0 110.314 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.422 ' O ' ' C ' ' A' ' 48' ' ' ALA . 73.7 m -106.81 167.44 9.87 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.2 -0.937 . . . . 0.0 110.261 -179.928 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.422 ' C ' ' O ' ' A' ' 47' ' ' SER . . . -43.02 128.02 4.29 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.188 -0.945 . . . . 0.0 110.163 -179.965 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 8.2 t -46.12 130.4 7.39 Favored Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.277 -0.889 . . . . 0.0 110.3 -179.865 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.45 ' HD2' ' SG ' ' A' ' 67' ' ' CYS . 46.3 Cg_endo -72.74 151.1 51.3 Favored 'Trans proline' 0 C--N 1.307 -1.62 0 O-C-N 123.882 1.464 . . . . 0.0 110.302 179.843 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 37.0 pt -64.03 -21.23 28.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.196 -0.94 . . . . 0.0 110.305 179.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 82.1 m-85 -61.45 -19.9 62.51 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.206 -0.934 . . . . 0.0 110.174 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 38.8 p -118.57 168.64 10.5 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.25 -0.906 . . . . 0.0 110.192 -179.953 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.424 ' O ' ' HA ' ' A' ' 67' ' ' CYS . 30.1 tttt -96.83 162.38 13.44 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.223 -0.923 . . . . 0.0 110.142 179.983 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.511 ' CG2' ' O ' ' A' ' 55' ' ' ILE . 20.8 tt -97.6 116.43 40.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.247 -0.908 . . . . 0.0 110.171 179.961 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . 0.473 ' HB2' ' HB3' ' A' ' 66' ' ' CYS . 61.6 mm-40 -93.36 -1.46 55.87 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.244 -0.91 . . . . 0.0 110.177 -179.919 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 142.47 -131.61 4.75 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.423 -1.471 . . . . 0.0 109.423 -179.935 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.447 ' O ' ' SG ' ' A' ' 66' ' ' CYS . 18.5 p -120.88 164.91 15.95 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.227 -1.16 . . . . 0.0 110.189 179.988 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . 0.65 ' SG ' ' SG ' ' A' ' 37' ' ' CYS . 0.5 OUTLIER -105.86 -158.78 0.67 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.242 -0.911 . . . . 0.0 110.276 -179.902 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 99.6 m-85 -57.36 -50.6 72.43 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.257 -0.902 . . . . 0.0 110.133 179.922 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 74.2 mtm180 -123.55 165.25 17.46 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.284 -0.885 . . . . 0.0 110.128 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -61.51 -21.35 60.14 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.48 -1.448 . . . . 0.0 109.48 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 2.8 tptt -67.63 -31.35 71.31 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.26 -1.141 . . . . 0.0 110.215 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.46 ' HB2' ' HB3' ' A' ' 59' ' ' CYS . . . -102.6 158.56 16.14 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.384 -0.823 . . . . 0.0 110.145 179.983 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.405 ' HG2' ' C ' ' A' ' 64' ' ' ALA . 70.3 mmtt -141.85 160.29 40.5 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.304 -0.872 . . . . 0.0 110.132 -179.954 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' CYS . . . . . 0.473 ' HB3' ' HB2' ' A' ' 56' ' ' GLN . 66.6 m -82.1 132.07 35.24 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.206 -0.934 . . . . 0.0 110.212 -179.983 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' CYS . . . . . 0.511 ' O ' ' CA ' ' A' ' 42' ' ' GLY . 78.6 m -129.32 124.35 34.11 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.251 -0.906 . . . . 0.0 110.151 -179.951 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.458 ' HA ' ' HA3' ' A' ' 42' ' ' GLY . 47.2 tttt . . . . . 0 N--CA 1.491 1.614 0 CA-C-O 117.94 -1.029 . . . . 0.0 110.251 179.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 80.7 m-20 . . . . . 0 N--CA 1.491 1.616 0 CA-C-O 121.239 0.542 . . . . 0.0 110.21 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 69.6 t60 -98.87 109.43 22.19 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.179 -0.95 . . . . 0.0 110.173 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.456 ' CD1' ' N ' ' A' ' 36' ' ' ASN . 11.2 t80 -108.35 154.3 22.02 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.203 -0.935 . . . . 0.0 110.181 179.945 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . 0.456 ' N ' ' CD1' ' A' ' 35' ' ' TYR . 28.2 p-10 -98.33 55.56 1.12 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.261 -0.899 . . . . 0.0 110.299 179.981 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.429 ' SG ' ' CD1' ' A' ' 35' ' ' TYR . 60.3 m -61.31 -22.51 64.95 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.24 -0.912 . . . . 0.0 110.171 -179.999 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 72.2 t -68.83 -39.94 80.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.22 -0.925 . . . . 0.0 110.211 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' SER . . . . . 0.45 ' OG ' ' ND2' ' A' ' 36' ' ' ASN . 87.4 p -64.13 -26.5 68.56 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.203 -0.935 . . . . 0.0 110.104 179.986 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 50.0 m -81.06 -20.56 41.34 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.237 -0.915 . . . . 0.0 110.198 179.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . 0.461 ' O ' ' HG3' ' A' ' 68' ' ' LYS . . . 112.14 14.89 10.36 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.511 -1.436 . . . . 0.0 109.511 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.451 ' HA3' ' HA ' ' A' ' 68' ' ' LYS . . . -110.3 171.82 15.09 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.504 -1.439 . . . . 0.0 109.504 179.962 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . 0.443 ' N ' ' O ' ' A' ' 67' ' ' CYS . 0.3 OUTLIER -129.24 175.16 8.95 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.25 -1.147 . . . . 0.0 110.301 -179.993 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 6.1 m -110.77 97.01 6.53 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.283 -0.886 . . . . 0.0 110.132 179.885 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.462 ' O ' ' HB2' ' A' ' 64' ' ' ALA . 23.0 tp -86.39 167.22 14.93 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.259 -0.901 . . . . 0.0 110.146 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 95.2 m-85 -92.13 -31.05 15.65 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.219 -0.926 . . . . 0.0 110.345 -179.916 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.422 ' O ' ' C ' ' A' ' 48' ' ' ALA . 76.8 p -92.02 160.61 15.15 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.386 -0.821 . . . . 0.0 110.231 -179.948 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.422 ' C ' ' O ' ' A' ' 47' ' ' SER . . . -42.7 129.28 4.18 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.33 -0.856 . . . . 0.0 110.194 179.937 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 4.1 t -43.15 128.44 3.42 Favored Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.182 -0.949 . . . . 0.0 110.203 -179.853 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.406 ' HD2' ' SG ' ' A' ' 67' ' ' CYS . 46.7 Cg_endo -72.34 146.07 44.46 Favored 'Trans proline' 0 C--N 1.305 -1.713 0 O-C-N 123.95 1.5 . . . . 0.0 110.452 -179.94 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 39.1 pt -60.39 -15.57 10.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.28 -0.887 . . . . 0.0 110.206 -179.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 76.1 m-85 -71.63 -10.26 59.5 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.26 -0.9 . . . . 0.0 110.208 179.924 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.452 ' HB ' ' N ' ' A' ' 68' ' ' LYS . 61.5 p -127.78 167.0 17.13 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.237 -0.914 . . . . 0.0 110.189 -179.995 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.417 ' O ' ' HA ' ' A' ' 67' ' ' CYS . 38.1 mttt -103.51 173.05 6.47 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.246 -0.909 . . . . 0.0 110.214 -179.98 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.514 ' CG2' ' O ' ' A' ' 55' ' ' ILE . 10.8 tp -99.65 119.33 47.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.357 -0.839 . . . . 0.0 110.209 179.961 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 68.2 mm-40 -102.03 9.23 40.56 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.269 -0.894 . . . . 0.0 110.264 -179.928 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 129.17 -159.89 22.42 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.448 -1.461 . . . . 0.0 109.448 179.919 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.456 ' O ' ' SG ' ' A' ' 66' ' ' CYS . 19.1 p -92.48 164.28 13.52 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.217 -1.166 . . . . 0.0 110.214 -179.93 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 1.5 m -110.54 -163.14 0.83 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.227 -0.921 . . . . 0.0 110.147 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 67.0 m-85 -49.64 -59.95 3.32 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.391 -0.818 . . . . 0.0 110.151 179.761 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 30.0 mmt180 -120.22 166.3 13.65 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.169 -0.957 . . . . 0.0 110.103 -180.0 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -65.39 -23.63 70.28 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 52.4 mtmt -60.19 -25.42 65.56 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.209 -1.171 . . . . 0.0 110.164 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.462 ' HB2' ' O ' ' A' ' 45' ' ' LEU . . . -117.32 160.96 20.29 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.242 -0.911 . . . . 0.0 110.17 -179.868 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.412 ' HG2' ' C ' ' A' ' 64' ' ' ALA . 28.9 mmtp -137.94 154.64 49.38 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.23 -0.918 . . . . 0.0 110.307 179.946 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' CYS . . . . . 0.456 ' SG ' ' O ' ' A' ' 58' ' ' THR . 71.7 m -72.27 131.42 42.68 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.292 -0.88 . . . . 0.0 110.169 179.911 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' CYS . . . . . 0.443 ' O ' ' N ' ' A' ' 43' ' ' GLN . 94.7 m -129.8 131.24 46.12 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.228 -0.92 . . . . 0.0 110.247 -179.905 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.461 ' HG3' ' O ' ' A' ' 41' ' ' GLY . 84.4 tttt . . . . . 0 N--CA 1.49 1.547 0 CA-C-O 117.995 -1.002 . . . . 0.0 110.182 -179.951 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 72.2 m-20 . . . . . 0 N--CA 1.491 1.621 0 CA-C-O 121.3 0.571 . . . . 0.0 110.221 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 69.1 m80 -69.21 149.76 48.21 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.223 -0.923 . . . . 0.0 110.205 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.568 ' CZ ' ' SG ' ' A' ' 37' ' ' CYS . 1.8 t80 -126.77 122.25 34.27 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.264 -0.898 . . . . 0.0 110.144 179.927 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 9.9 p-10 -121.7 114.66 21.44 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.225 -0.922 . . . . 0.0 110.213 -179.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.568 ' SG ' ' CZ ' ' A' ' 35' ' ' TYR . 46.7 m -74.26 -0.35 16.7 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.258 -0.901 . . . . 0.0 110.278 179.982 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 94.7 t -67.3 -33.95 65.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.208 -0.933 . . . . 0.0 110.116 -179.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 69.3 m -71.18 -27.81 63.79 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.24 -0.913 . . . . 0.0 110.149 179.912 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.41 ' O ' ' HE2' ' A' ' 68' ' ' LYS . 63.7 m -82.42 -9.22 59.53 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.331 -0.855 . . . . 0.0 110.119 179.922 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . 0.422 ' C ' ' HG3' ' A' ' 68' ' ' LYS . . . 105.33 -24.61 27.17 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.341 -1.504 . . . . 0.0 109.341 -179.965 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.468 ' N ' ' HG3' ' A' ' 68' ' ' LYS . . . -67.74 -173.57 7.08 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.444 -1.462 . . . . 0.0 109.444 -179.979 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . 0.46 ' O ' ' HA ' ' A' ' 66' ' ' CYS . 36.1 tt0 -141.34 144.36 34.53 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.272 -1.134 . . . . 0.0 110.26 -179.941 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 76.4 m -94.96 137.11 34.46 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.268 -0.895 . . . . 0.0 110.144 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.494 ' O ' ' CB ' ' A' ' 64' ' ' ALA . 54.0 mt -130.01 178.8 6.27 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.276 -0.89 . . . . 0.0 110.239 -179.982 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 85.9 m-85 -109.46 -1.04 18.61 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.259 -0.901 . . . . 0.0 110.178 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.423 ' O ' ' C ' ' A' ' 48' ' ' ALA . 52.3 m -127.9 171.59 11.65 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.27 -0.894 . . . . 0.0 110.25 -179.984 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.423 ' C ' ' O ' ' A' ' 47' ' ' SER . . . -43.08 145.12 0.54 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.221 -0.924 . . . . 0.0 110.189 179.968 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 16.9 t -55.77 130.28 71.9 Favored Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 121.228 -0.92 . . . . 0.0 110.165 -179.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.449 ' HD2' ' SG ' ' A' ' 67' ' ' CYS . 47.5 Cg_endo -73.14 142.32 34.0 Favored 'Trans proline' 0 C--N 1.306 -1.685 0 O-C-N 123.991 1.521 . . . . 0.0 110.402 179.98 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 39.0 pt -63.68 -18.78 22.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.315 -0.866 . . . . 0.0 110.181 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 85.0 m-85 -59.45 -21.55 60.21 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.237 -0.914 . . . . 0.0 110.216 179.944 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.46 ' OG1' ' HB3' ' A' ' 67' ' ' CYS . 20.4 p -132.78 171.15 14.27 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.26 -0.9 . . . . 0.0 110.297 179.869 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.465 ' O ' ' HA ' ' A' ' 67' ' ' CYS . 45.5 tttp -83.68 165.04 19.27 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.24 -0.912 . . . . 0.0 110.21 179.943 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.518 ' O ' ' CG2' ' A' ' 55' ' ' ILE . 12.0 tt -91.28 108.67 20.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.268 -0.895 . . . . 0.0 110.162 179.895 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . 0.463 ' NE2' ' HB3' ' A' ' 68' ' ' LYS . 94.0 mm-40 -85.31 -8.84 58.29 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.251 -0.906 . . . . 0.0 110.256 179.937 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 125.43 -124.44 5.28 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 179.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.451 ' O ' ' SG ' ' A' ' 66' ' ' CYS . 16.6 p -117.98 169.49 9.61 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.31 -1.112 . . . . 0.0 110.157 -179.935 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . 0.455 ' O ' ' HB2' ' A' ' 60' ' ' TYR . 0.9 OUTLIER -133.61 140.73 47.3 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.211 -0.931 . . . . 0.0 110.202 179.959 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . 0.488 ' CB ' ' HB3' ' A' ' 63' ' ' LYS . 71.2 m-85 56.07 53.93 8.51 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.293 -0.879 . . . . 0.0 110.414 179.9 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . 0.462 ' HB2' ' O ' ' A' ' 60' ' ' TYR . 38.6 mmt180 57.38 39.95 27.87 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.25 -0.906 . . . . 0.0 110.609 179.696 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.446 ' HA3' ' HB ' ' A' ' 58' ' ' THR . . . 85.86 -16.45 41.78 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.779 -1.328 . . . . 0.0 109.779 179.603 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.488 ' HB3' ' CB ' ' A' ' 60' ' ' TYR . 5.7 ttpt -55.44 -18.43 6.95 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.103 -1.234 . . . . 0.0 109.767 179.951 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.494 ' CB ' ' O ' ' A' ' 45' ' ' LEU . . . -149.56 172.09 15.57 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.405 -0.81 . . . . 0.0 109.961 179.757 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 53.2 tptt -111.15 122.33 47.6 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.147 -0.971 . . . . 0.0 110.275 -179.903 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' CYS . . . . . 0.46 ' HA ' ' O ' ' A' ' 43' ' ' GLN . 42.9 m -81.27 140.98 34.53 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.297 -0.877 . . . . 0.0 110.134 179.977 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' CYS . . . . . 0.465 ' HA ' ' O ' ' A' ' 54' ' ' LYS . 85.0 m -149.53 124.61 10.05 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.198 -0.939 . . . . 0.0 110.222 -179.969 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.468 ' HG3' ' N ' ' A' ' 42' ' ' GLY . 33.4 ttmt . . . . . 0 N--CA 1.491 1.618 0 CA-C-O 117.942 -1.028 . . . . 0.0 110.194 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 46.5 m-20 . . . . . 0 N--CA 1.491 1.602 0 CA-C-O 121.234 0.54 . . . . 0.0 110.236 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 91.8 m-70 -111.3 143.16 42.53 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.248 -0.907 . . . . 0.0 110.186 -179.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 2.4 t80 -128.01 123.02 33.69 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.245 -0.909 . . . . 0.0 110.141 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 36.3 t30 -101.13 108.97 20.79 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.211 -0.931 . . . . 0.0 110.237 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 27.4 m -82.02 -3.78 55.29 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.183 -0.948 . . . . 0.0 110.191 179.948 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 91.9 t -70.18 -45.95 73.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.235 -0.915 . . . . 0.0 110.213 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 22.9 t -60.51 -26.39 66.81 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.258 -0.901 . . . . 0.0 110.175 179.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 42.5 m -83.59 -8.35 59.33 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.309 -0.869 . . . . 0.0 110.243 179.935 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . 0.427 ' C ' ' HG3' ' A' ' 68' ' ' LYS . . . 91.91 3.58 68.02 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.598 -1.401 . . . . 0.0 109.598 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.452 ' HA3' ' HA ' ' A' ' 68' ' ' LYS . . . -90.55 172.67 37.83 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 -179.986 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . 0.502 ' HG2' ' CD2' ' A' ' 45' ' ' LEU . 32.6 tt0 -127.58 137.2 52.52 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.345 -1.091 . . . . 0.0 110.217 -179.967 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . 0.517 ' SG ' ' CB ' ' A' ' 64' ' ' ALA . 24.7 t -83.68 113.17 20.67 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.234 -0.916 . . . . 0.0 110.242 179.934 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.502 ' CD2' ' HG2' ' A' ' 43' ' ' GLN . 47.3 mt -106.05 168.94 8.79 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.186 -0.946 . . . . 0.0 110.269 -179.936 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 91.1 m-85 -104.23 -1.47 27.07 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.286 -0.883 . . . . 0.0 110.231 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.417 ' O ' ' C ' ' A' ' 48' ' ' ALA . 89.5 p -126.99 168.36 14.65 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.211 -0.93 . . . . 0.0 110.257 -179.972 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.417 ' C ' ' O ' ' A' ' 47' ' ' SER . . . -42.86 128.66 4.27 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.251 -0.905 . . . . 0.0 110.136 179.991 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 6.0 t -44.44 132.09 4.72 Favored Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 121.238 -0.914 . . . . 0.0 110.174 179.904 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.452 ' HG2' ' OG1' ' A' ' 53' ' ' THR . 46.9 Cg_endo -73.19 148.58 44.42 Favored 'Trans proline' 0 C--N 1.306 -1.674 0 O-C-N 123.867 1.456 . . . . 0.0 110.406 -179.982 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 13.1 mt -62.96 -22.24 30.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.284 -0.885 . . . . 0.0 110.152 179.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -71.02 -3.94 22.27 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.313 -0.867 . . . . 0.0 110.218 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.492 ' CB ' ' HB3' ' A' ' 67' ' ' CYS . 54.6 p -133.27 162.55 31.5 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.241 -0.912 . . . . 0.0 110.276 179.978 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.454 ' O ' ' HA ' ' A' ' 67' ' ' CYS . 46.8 tttp -93.18 168.36 11.15 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.287 -0.883 . . . . 0.0 110.234 179.978 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.458 ' O ' ' CG2' ' A' ' 55' ' ' ILE . 18.5 tt -87.78 125.11 41.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.237 -0.914 . . . . 0.0 110.207 179.962 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . 0.509 ' HB2' ' CB ' ' A' ' 66' ' ' CYS . 86.3 mm-40 -107.49 7.96 29.15 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.193 -0.942 . . . . 0.0 110.201 179.99 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 102.31 -140.1 14.71 Favored Glycine 0 N--CA 1.489 2.176 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 179.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.446 ' O ' ' SG ' ' A' ' 66' ' ' CYS . 38.7 p -98.75 -174.11 2.7 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.23 -1.159 . . . . 0.0 110.182 179.987 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . 0.773 ' SG ' ' SG ' ' A' ' 66' ' ' CYS . 1.2 m -112.48 -161.24 0.75 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.251 -0.905 . . . . 0.0 110.27 -179.957 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 74.4 m-85 -49.83 -65.62 0.53 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.238 -0.914 . . . . 0.0 110.411 179.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 56.7 mtt180 -93.29 -14.49 26.9 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.241 -0.912 . . . . 0.0 110.446 -179.834 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 101.65 -21.02 44.04 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.366 -1.494 . . . . 0.0 109.366 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 37.0 mtmt -57.44 -30.2 64.8 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.278 -1.131 . . . . 0.0 109.98 179.77 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.517 ' CB ' ' SG ' ' A' ' 44' ' ' CYS . . . -106.54 159.41 16.2 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.498 -0.751 . . . . 0.0 110.268 -179.82 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 49.5 tptt -112.49 120.53 41.96 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.185 -0.947 . . . . 0.0 110.208 -179.902 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' CYS . . . . . 0.773 ' SG ' ' SG ' ' A' ' 59' ' ' CYS . 79.4 m -68.95 151.46 46.51 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.308 -0.87 . . . . 0.0 110.127 179.958 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' CYS . . . . . 0.497 ' O ' ' N ' ' A' ' 43' ' ' GLN . 90.4 m -149.0 125.32 10.86 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.146 -0.971 . . . . 0.0 110.219 179.994 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.487 ' HB3' ' NE2' ' A' ' 56' ' ' GLN . 26.9 tttp . . . . . 0 N--CA 1.491 1.613 0 CA-C-O 118.013 -0.994 . . . . 0.0 110.212 179.952 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 95.4 m-20 . . . . . 0 N--CA 1.491 1.607 0 CA-C-O 121.21 0.529 . . . . 0.0 110.222 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 64.6 m170 -113.99 131.6 56.28 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.259 -0.9 . . . . 0.0 110.104 179.966 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.473 ' CZ ' ' SG ' ' A' ' 37' ' ' CYS . 27.6 p90 -139.55 165.36 27.45 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.308 -0.87 . . . . 0.0 110.26 -179.959 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 25.2 t30 -91.09 102.43 15.18 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.277 -0.889 . . . . 0.0 110.339 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.493 ' O ' ' N ' ' A' ' 40' ' ' SER . 57.5 m -59.49 -48.62 80.93 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.288 -0.882 . . . . 0.0 110.245 -179.97 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.438 ' C ' ' O ' ' A' ' 37' ' ' CYS . 39.5 t -40.45 -53.6 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.455 -0.778 . . . . 0.0 110.46 -179.862 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 5.1 t -53.16 -28.04 24.23 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.315 -0.866 . . . . 0.0 110.162 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.493 ' N ' ' O ' ' A' ' 37' ' ' CYS . 38.9 m -83.37 -8.0 59.48 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.272 -0.893 . . . . 0.0 110.252 179.957 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 106.03 -23.24 29.64 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.443 -1.463 . . . . 0.0 109.443 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.466 ' HA3' ' HA ' ' A' ' 68' ' ' LYS . . . -71.52 171.99 46.05 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 179.926 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 10.9 tt0 -128.01 133.77 49.18 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.234 -1.156 . . . . 0.0 110.336 -179.975 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . 0.663 ' SG ' ' SG ' ' A' ' 66' ' ' CYS . 4.2 m -91.95 111.95 23.69 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.236 -0.915 . . . . 0.0 110.208 -179.996 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 75.1 mt -107.83 175.09 5.6 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.293 -0.879 . . . . 0.0 110.178 -179.88 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 72.9 m-85 -99.64 -11.24 21.1 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.328 -0.858 . . . . 0.0 110.3 179.985 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 41.2 t -111.98 166.46 11.21 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.213 -0.929 . . . . 0.0 110.229 -179.88 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -43.69 145.23 0.68 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.211 -0.931 . . . . 0.0 110.214 179.946 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 17.2 t -49.04 131.54 15.46 Favored Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.221 -0.924 . . . . 0.0 110.238 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.449 ' HG2' ' OG1' ' A' ' 53' ' ' THR . 47.9 Cg_endo -73.23 164.37 35.49 Favored 'Trans proline' 0 C--N 1.306 -1.686 0 O-C-N 123.898 1.472 . . . . 0.0 110.471 -179.904 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 27.4 mt -74.89 -26.24 19.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.193 -0.942 . . . . 0.0 110.159 179.801 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 99.5 m-85 -66.62 -9.39 35.15 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.323 -0.86 . . . . 0.0 110.159 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.479 ' CB ' ' HB3' ' A' ' 67' ' ' CYS . 67.7 p -133.23 158.99 41.5 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.28 -0.887 . . . . 0.0 110.141 179.999 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.461 ' O ' ' HA ' ' A' ' 67' ' ' CYS . 63.1 mttt -100.58 172.42 7.11 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.206 -0.933 . . . . 0.0 110.247 -179.988 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 21.0 tt -79.85 131.19 34.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.189 -0.944 . . . . 0.0 110.22 -179.957 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 90.2 mm-40 -119.04 -3.12 10.69 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.347 -0.846 . . . . 0.0 110.228 -179.945 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 131.7 -131.85 6.5 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.418 -1.473 . . . . 0.0 109.418 -179.996 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.45 ' O ' ' SG ' ' A' ' 66' ' ' CYS . 72.7 p -123.4 168.79 12.07 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.291 -1.123 . . . . 0.0 110.263 -179.984 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . 1.298 ' SG ' ' SG ' ' A' ' 66' ' ' CYS . 9.8 m -111.55 -163.31 0.84 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.217 -0.927 . . . . 0.0 110.29 179.924 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . 0.427 ' C ' ' O ' ' A' ' 59' ' ' CYS . 68.9 m-85 -41.9 -46.85 4.15 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.312 -0.868 . . . . 0.0 110.317 179.859 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -124.42 171.62 9.8 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.198 -0.939 . . . . 0.0 110.117 179.898 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -72.5 -23.25 78.24 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.463 -1.455 . . . . 0.0 109.463 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 38.2 ttmt -65.41 -34.55 78.57 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.202 -1.176 . . . . 0.0 110.291 179.951 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.452 ' HB2' ' HB2' ' A' ' 59' ' ' CYS . . . -94.73 163.23 13.45 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.3 -0.875 . . . . 0.0 110.162 -179.923 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 50.4 tptt -140.05 135.98 33.18 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.253 -0.905 . . . . 0.0 110.118 -179.957 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' CYS . . . . . 1.298 ' SG ' ' SG ' ' A' ' 59' ' ' CYS . 73.8 m -85.17 136.61 33.46 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.279 -0.888 . . . . 0.0 110.257 179.969 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' CYS . . . . . 0.479 ' HB3' ' CB ' ' A' ' 53' ' ' THR . 76.4 m -141.51 129.78 22.31 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.266 -0.897 . . . . 0.0 110.144 -179.973 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.466 ' HA ' ' HA3' ' A' ' 42' ' ' GLY . 40.4 tttt . . . . . 0 N--CA 1.492 1.65 0 CA-C-O 118.065 -0.969 . . . . 0.0 110.169 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . 0.416 ' OD2' ' CE1' ' A' ' 34' ' ' HIS . 56.9 t0 . . . . . 0 N--CA 1.491 1.586 0 CA-C-O 121.306 0.574 . . . . 0.0 110.207 . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . 0.416 ' CE1' ' OD2' ' A' ' 33' ' ' ASP . 61.0 m80 -110.61 116.43 31.32 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.221 -0.924 . . . . 0.0 110.235 -179.986 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.548 ' CD1' ' SG ' ' A' ' 37' ' ' CYS . 2.3 t80 -54.23 138.63 38.19 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.202 -0.937 . . . . 0.0 110.17 179.913 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . 0.422 ' O ' ' CG ' ' A' ' 36' ' ' ASN . 22.0 p-10 -98.52 64.31 1.53 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.251 -0.906 . . . . 0.0 110.256 -179.918 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.548 ' SG ' ' CD1' ' A' ' 35' ' ' TYR . 34.4 m -62.89 -52.0 64.79 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.221 -0.924 . . . . 0.0 110.174 179.893 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.407 ' HA ' ' O ' ' A' ' 42' ' ' GLY . 68.8 t -54.04 -40.31 45.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.236 -0.915 . . . . 0.0 110.247 179.923 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 33.6 t -60.99 -30.57 70.36 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.146 -0.972 . . . . 0.0 110.255 179.945 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.452 ' O ' ' HE3' ' A' ' 68' ' ' LYS . 72.1 m -82.63 -7.96 59.62 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.358 -0.839 . . . . 0.0 110.165 179.97 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 104.17 5.47 43.5 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.514 ' CA ' ' O ' ' A' ' 67' ' ' CYS . . . -93.56 176.88 37.09 Favored Glycine 0 N--CA 1.489 2.198 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 -179.985 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . 0.459 ' N ' ' O ' ' A' ' 67' ' ' CYS . 16.1 tt0 -132.39 132.87 43.28 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.249 -1.147 . . . . 0.0 110.2 -179.926 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 22.6 m -95.78 116.66 29.22 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.336 -0.853 . . . . 0.0 110.298 179.977 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.467 HD13 ' HD3' ' A' ' 50' ' ' PRO . 92.5 mt -101.76 175.32 5.59 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.296 -0.877 . . . . 0.0 110.161 179.967 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 -91.37 -3.1 57.08 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.241 -0.912 . . . . 0.0 110.227 179.957 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.402 ' O ' ' C ' ' A' ' 48' ' ' ALA . 59.1 p -126.56 167.85 15.08 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.18 -0.95 . . . . 0.0 110.183 -179.976 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.419 ' HA ' ' HG3' ' A' ' 65' ' ' LYS . . . -42.62 148.19 0.24 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.271 -0.893 . . . . 0.0 110.192 179.952 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 17.1 t -52.86 130.37 47.94 Favored Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.24 -0.913 . . . . 0.0 110.077 179.986 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.467 ' HD3' HD13 ' A' ' 45' ' ' LEU . 47.5 Cg_endo -72.67 149.33 48.63 Favored 'Trans proline' 0 C--N 1.306 -1.68 0 O-C-N 123.88 1.463 . . . . 0.0 110.442 -179.924 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 44.9 pt -67.24 -11.26 13.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.26 -0.9 . . . . 0.0 110.128 179.961 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . 0.433 ' O ' HG21 ' A' ' 53' ' ' THR . 55.5 m-85 -62.62 -25.56 68.17 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.255 -0.903 . . . . 0.0 110.157 179.996 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.461 ' OG1' ' HB3' ' A' ' 67' ' ' CYS . 69.1 p -143.01 158.86 43.2 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.348 -0.845 . . . . 0.0 110.218 -179.99 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.452 ' O ' ' HA ' ' A' ' 67' ' ' CYS . 84.7 mttt -77.52 176.81 8.56 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.21 -0.932 . . . . 0.0 110.161 -179.961 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.415 HG13 ' O ' ' A' ' 66' ' ' CYS . 19.7 tt -108.79 137.63 39.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.188 -0.945 . . . . 0.0 110.225 -179.982 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . 0.434 ' HG3' ' HB2' ' A' ' 68' ' ' LYS . 76.6 mm-40 -98.83 -24.87 14.83 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.282 -0.886 . . . . 0.0 110.181 179.971 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 162.89 -152.39 22.54 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.444 -1.462 . . . . 0.0 109.444 179.997 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.445 ' O ' ' SG ' ' A' ' 66' ' ' CYS . 82.6 p -90.81 161.51 15.24 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.274 -1.133 . . . . 0.0 110.214 -179.921 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . 0.504 ' SG ' ' N ' ' A' ' 66' ' ' CYS . 16.8 m -110.19 -163.03 0.83 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.348 -0.845 . . . . 0.0 110.243 -179.966 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . 0.428 ' C ' ' O ' ' A' ' 59' ' ' CYS . 80.1 m-85 -41.21 -48.38 3.49 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.422 -0.799 . . . . 0.0 110.402 179.92 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 88.8 mtm-85 -129.45 159.28 36.76 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.247 -0.908 . . . . 0.0 110.246 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -60.89 -24.65 62.91 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.436 -1.466 . . . . 0.0 109.436 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 47.4 mtpt -63.64 -32.55 74.07 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.272 -1.134 . . . . 0.0 110.203 179.891 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.458 ' HB3' ' O ' ' A' ' 45' ' ' LEU . . . -96.68 164.41 12.6 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.421 -0.799 . . . . 0.0 110.16 -179.847 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.419 ' C ' ' SG ' ' A' ' 59' ' ' CYS . 75.6 mmtt -134.54 140.74 46.37 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.244 -0.91 . . . . 0.0 110.169 -179.911 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' CYS . . . . . 0.504 ' N ' ' SG ' ' A' ' 59' ' ' CYS . 89.0 m -88.8 134.04 34.06 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.269 -0.895 . . . . 0.0 110.206 179.96 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' CYS . . . . . 0.514 ' O ' ' CA ' ' A' ' 42' ' ' GLY . 34.6 m -136.26 152.01 50.26 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.208 -0.932 . . . . 0.0 110.201 179.979 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.452 ' HE3' ' O ' ' A' ' 40' ' ' SER . 77.5 tttt . . . . . 0 N--CA 1.49 1.549 0 CA-C-O 118.005 -0.998 . . . . 0.0 110.22 -179.97 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 49.2 t0 . . . . . 0 N--CA 1.491 1.597 0 CA-C-O 121.215 0.531 . . . . 0.0 110.174 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 28.8 p-80 -142.97 162.75 34.64 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.302 -0.874 . . . . 0.0 110.22 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.561 ' CD1' ' SG ' ' A' ' 37' ' ' CYS . 3.2 t80 -71.42 140.19 50.0 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.222 -0.924 . . . . 0.0 110.205 179.986 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . 0.553 ' ND2' ' CB ' ' A' ' 39' ' ' SER . 59.3 t30 -85.67 60.54 6.3 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.272 -0.893 . . . . 0.0 110.152 179.952 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.561 ' SG ' ' CD1' ' A' ' 35' ' ' TYR . 25.3 m -67.81 -53.22 28.73 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.307 -0.871 . . . . 0.0 110.24 179.991 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 75.4 t -43.92 -54.89 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.263 -0.898 . . . . 0.0 110.179 179.982 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' SER . . . . . 0.553 ' CB ' ' ND2' ' A' ' 36' ' ' ASN . 62.3 m -50.31 -35.19 26.46 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.192 -0.942 . . . . 0.0 110.218 -179.968 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.459 ' HB2' ' O ' ' A' ' 37' ' ' CYS . 72.5 m -70.73 -15.17 62.67 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.285 -0.884 . . . . 0.0 110.145 -179.976 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . 0.415 ' C ' ' HG3' ' A' ' 68' ' ' LYS . . . 108.53 -14.85 35.49 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.475 -1.45 . . . . 0.0 109.475 -179.992 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.473 ' CA ' ' O ' ' A' ' 67' ' ' CYS . . . -85.27 175.34 49.66 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.494 -1.442 . . . . 0.0 109.494 -179.984 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . 0.425 ' N ' ' O ' ' A' ' 67' ' ' CYS . 0.9 OUTLIER -115.14 179.76 3.86 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.2 -1.176 . . . . 0.0 110.164 -179.972 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . 0.407 ' SG ' ' HB1' ' A' ' 64' ' ' ALA . 49.7 t -114.17 98.17 6.79 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.247 -0.908 . . . . 0.0 110.188 179.99 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.432 HD13 ' SG ' ' A' ' 67' ' ' CYS . 71.4 mt -88.98 173.27 8.57 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.3 -0.875 . . . . 0.0 110.181 179.901 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 83.4 m-85 -109.6 -1.99 17.81 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.24 -0.912 . . . . 0.0 110.314 -179.962 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.414 ' O ' ' C ' ' A' ' 48' ' ' ALA . 74.7 m -125.42 166.17 17.09 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.191 -0.943 . . . . 0.0 110.173 179.925 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.414 ' C ' ' O ' ' A' ' 47' ' ' SER . . . -42.69 131.01 4.06 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.246 -0.909 . . . . 0.0 110.177 -179.91 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . 0.412 ' C ' ' O ' ' A' ' 48' ' ' ALA . 4.4 t -43.39 130.46 3.63 Favored Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 121.223 -0.923 . . . . 0.0 110.219 -179.988 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.475 ' HG2' ' CG2' ' A' ' 53' ' ' THR . 46.4 Cg_endo -72.74 156.57 53.06 Favored 'Trans proline' 0 C--N 1.306 -1.661 0 O-C-N 123.86 1.453 . . . . 0.0 110.446 179.978 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 21.5 mt -67.85 -28.62 42.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.224 -0.923 . . . . 0.0 110.243 -179.93 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 88.8 m-85 -67.69 -11.8 59.09 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.348 -0.845 . . . . 0.0 110.191 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.475 ' CG2' ' HG2' ' A' ' 50' ' ' PRO . 34.0 p -121.79 172.63 8.02 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.256 -0.903 . . . . 0.0 110.1 179.897 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.437 ' O ' ' HA ' ' A' ' 67' ' ' CYS . 80.4 mttt -111.34 127.54 55.68 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.309 -0.869 . . . . 0.0 110.296 -179.986 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 20.6 tt -67.35 138.73 22.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.246 -0.908 . . . . 0.0 110.216 179.956 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . 0.418 ' NE2' ' HB3' ' A' ' 54' ' ' LYS . 48.9 mm-40 -128.62 13.94 6.47 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.264 -0.898 . . . . 0.0 110.217 -179.941 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . 0.406 ' O ' ' HB2' ' A' ' 66' ' ' CYS . . . 119.52 179.81 16.62 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.451 -1.46 . . . . 0.0 109.451 179.956 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 17.0 p -75.79 168.99 19.01 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.307 -1.113 . . . . 0.0 110.266 179.969 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . 0.471 ' HB3' ' CB ' ' A' ' 64' ' ' ALA . 9.7 t -109.29 -65.36 1.15 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.198 -0.938 . . . . 0.0 110.27 179.89 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . 0.515 ' HB3' ' CE ' ' A' ' 63' ' ' LYS . 78.2 m-85 -121.72 92.6 3.77 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.457 -0.777 . . . . 0.0 110.282 179.981 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 36.3 mmt180 51.52 25.39 2.69 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.269 -0.894 . . . . 0.0 110.296 179.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 89.97 -11.56 70.29 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.515 ' CE ' ' HB3' ' A' ' 60' ' ' TYR . 50.5 mtmt -58.58 -23.04 57.72 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.259 -1.142 . . . . 0.0 110.095 -179.99 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.471 ' CB ' ' HB3' ' A' ' 59' ' ' CYS . . . -138.37 161.86 35.88 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.261 -0.9 . . . . 0.0 110.148 179.936 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 65.1 mmtt -113.25 122.93 48.94 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.246 -0.909 . . . . 0.0 110.239 179.983 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' CYS . . . . . 0.448 ' SG ' ' HA ' ' A' ' 59' ' ' CYS . 99.2 m -79.21 142.73 36.01 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.231 -0.918 . . . . 0.0 110.183 179.998 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' CYS . . . . . 0.473 ' O ' ' CA ' ' A' ' 42' ' ' GLY . 82.3 m -144.47 141.52 29.64 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.253 -0.904 . . . . 0.0 110.241 179.989 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.434 ' HA ' ' HA3' ' A' ' 42' ' ' GLY . 33.9 ttpt . . . . . 0 N--CA 1.491 1.585 0 CA-C-O 118.01 -0.995 . . . . 0.0 110.213 -179.921 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 77.5 m-20 . . . . . 0 N--CA 1.492 1.626 0 CA-C-O 121.269 0.557 . . . . 0.0 110.198 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 70.8 m80 -112.98 129.24 56.56 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.255 -0.903 . . . . 0.0 110.17 179.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.523 ' CD1' ' SG ' ' A' ' 37' ' ' CYS . 2.4 t80 -55.08 135.67 48.87 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.25 -0.906 . . . . 0.0 110.254 -179.917 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . 0.422 ' CG ' ' O ' ' A' ' 36' ' ' ASN . 35.9 p-10 -90.58 68.87 6.69 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.322 -0.861 . . . . 0.0 110.215 179.963 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.523 ' SG ' ' CD1' ' A' ' 35' ' ' TYR . 16.6 m -70.82 -39.88 72.79 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.33 -0.856 . . . . 0.0 110.108 -179.901 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.4 ' CG2' ' N ' ' A' ' 39' ' ' SER . 27.0 m -57.83 -44.73 86.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.334 -0.854 . . . . 0.0 110.328 179.988 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' SER . . . . . 0.4 ' N ' ' CG2' ' A' ' 38' ' ' VAL . 53.8 p -60.0 -32.52 70.94 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.272 -0.893 . . . . 0.0 110.278 179.958 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.43 ' O ' ' HE3' ' A' ' 68' ' ' LYS . 38.0 m -75.01 -10.3 59.34 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.306 -0.871 . . . . 0.0 110.091 179.996 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 98.63 -10.3 62.67 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.426 -1.47 . . . . 0.0 109.426 -179.889 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.533 ' CA ' ' O ' ' A' ' 67' ' ' CYS . . . -73.04 -171.65 21.13 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.426 -1.47 . . . . 0.0 109.426 -179.985 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . 0.486 ' N ' ' O ' ' A' ' 67' ' ' CYS . 6.4 tt0 -139.99 138.46 35.52 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.268 -1.137 . . . . 0.0 110.163 -179.975 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 12.5 t -95.37 108.3 20.48 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.248 -0.908 . . . . 0.0 110.064 179.894 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.417 ' O ' ' HB3' ' A' ' 64' ' ' ALA . 9.5 tp -101.57 157.7 16.62 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.293 -0.879 . . . . 0.0 110.292 -179.937 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -82.64 -25.62 32.95 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.244 -0.91 . . . . 0.0 110.225 -179.954 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.417 ' O ' ' C ' ' A' ' 48' ' ' ALA . 39.1 t -93.13 159.37 15.32 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.234 -0.916 . . . . 0.0 110.194 179.996 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.417 ' C ' ' O ' ' A' ' 47' ' ' SER . . . -42.95 127.5 4.12 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.254 -0.903 . . . . 0.0 110.157 179.974 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . 0.403 ' C ' ' O ' ' A' ' 48' ' ' ALA . 8.3 t -42.76 129.73 3.07 Favored Pre-proline 0 N--CA 1.491 1.621 0 O-C-N 121.304 -0.872 . . . . 0.0 110.154 -179.927 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.446 ' HG2' ' CG2' ' A' ' 53' ' ' THR . 46.3 Cg_endo -72.65 141.64 34.64 Favored 'Trans proline' 0 C--N 1.305 -1.73 0 O-C-N 123.884 1.465 . . . . 0.0 110.411 -179.943 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 47.2 pt -57.53 -22.98 18.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.316 -0.865 . . . . 0.0 110.058 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 69.1 m-85 -65.13 -11.95 45.66 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.337 -0.852 . . . . 0.0 110.118 179.816 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.508 ' CB ' ' HB3' ' A' ' 67' ' ' CYS . 30.0 p -119.9 170.73 8.99 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.293 -0.879 . . . . 0.0 110.233 -179.919 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.446 ' HB2' ' HB3' ' A' ' 68' ' ' LYS . 31.0 mttt -94.66 175.07 6.8 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.248 -0.908 . . . . 0.0 110.097 -179.991 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.516 ' O ' ' CG2' ' A' ' 55' ' ' ILE . 19.9 tt -106.01 111.41 34.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.203 -0.935 . . . . 0.0 110.245 -179.987 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . 0.552 ' NE2' ' CB ' ' A' ' 68' ' ' LYS . 69.9 mm-40 -90.41 11.38 21.73 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.295 -0.878 . . . . 0.0 110.176 179.878 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 104.12 -127.88 9.28 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.371 -1.491 . . . . 0.0 109.371 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 28.1 p -111.55 171.93 7.19 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.226 -1.161 . . . . 0.0 110.144 -179.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . 1.193 ' SG ' ' SG ' ' A' ' 66' ' ' CYS . 0.1 OUTLIER -111.72 -166.73 1.1 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.167 -0.958 . . . . 0.0 110.215 -179.937 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . 0.539 ' CD1' ' N ' ' A' ' 61' ' ' ARG . 7.2 p90 -57.27 -26.13 60.31 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.376 -0.828 . . . . 0.0 110.215 179.853 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . 0.539 ' N ' ' CD1' ' A' ' 60' ' ' TYR . 57.5 mtt85 -139.5 164.88 28.7 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.281 -0.887 . . . . 0.0 110.191 -179.999 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -80.97 -0.28 88.4 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.621 -1.392 . . . . 0.0 109.621 179.939 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 46.1 mtpt -81.56 -25.89 35.46 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.259 -1.142 . . . . 0.0 110.227 179.915 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.417 ' HB3' ' O ' ' A' ' 45' ' ' LEU . . . -123.04 164.96 17.59 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.238 -0.914 . . . . 0.0 110.243 179.987 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 74.3 mmtt -128.28 145.17 51.13 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.244 -0.91 . . . . 0.0 110.196 179.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' CYS . . . . . 1.193 ' SG ' ' SG ' ' A' ' 59' ' ' CYS . 93.4 m -81.48 137.6 35.59 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.225 -0.922 . . . . 0.0 110.256 -179.949 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' CYS . . . . . 0.533 ' O ' ' CA ' ' A' ' 42' ' ' GLY . 73.2 m -128.24 172.42 11.05 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.366 -0.834 . . . . 0.0 110.031 179.92 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.552 ' CB ' ' NE2' ' A' ' 56' ' ' GLN . 77.6 tttt . . . . . 0 N--CA 1.491 1.617 0 CA-C-O 118.007 -0.997 . . . . 0.0 110.278 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 26.6 p30 . . . . . 0 N--CA 1.491 1.602 0 CA-C-O 121.238 0.542 . . . . 0.0 110.229 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 83.4 m-70 -116.08 136.14 53.3 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.21 -0.931 . . . . 0.0 110.235 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 43.6 p90 -135.08 164.1 28.42 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.263 -0.898 . . . . 0.0 110.129 179.939 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . 0.442 ' ND2' ' OG ' ' A' ' 39' ' ' SER . 12.7 p-10 -87.68 120.85 29.4 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.276 -0.89 . . . . 0.0 110.211 179.996 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 84.6 m -75.57 0.7 16.48 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.297 -0.877 . . . . 0.0 110.248 -179.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 53.6 t -68.67 -34.2 63.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.268 -0.895 . . . . 0.0 110.209 179.919 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' SER . . . . . 0.442 ' OG ' ' ND2' ' A' ' 36' ' ' ASN . 65.3 m -71.36 -22.81 61.85 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.254 -0.904 . . . . 0.0 110.128 179.856 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 61.2 m -89.44 -5.43 57.38 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.325 -0.859 . . . . 0.0 110.128 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 101.64 -19.57 49.78 Favored Glycine 0 N--CA 1.489 2.196 0 N-CA-C 109.331 -1.507 . . . . 0.0 109.331 -179.859 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.472 ' HA3' ' HA ' ' A' ' 68' ' ' LYS . . . -73.08 171.35 51.05 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.509 -1.436 . . . . 0.0 109.509 -179.966 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . 0.501 ' O ' ' N ' ' A' ' 67' ' ' CYS . 15.0 tt0 -130.53 164.04 25.74 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.341 -1.094 . . . . 0.0 110.207 -179.964 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . 0.422 ' N ' ' CG ' ' A' ' 43' ' ' GLN . 5.5 m -114.27 112.81 23.7 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.176 -0.952 . . . . 0.0 110.274 -179.964 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.415 ' O ' ' CB ' ' A' ' 64' ' ' ALA . 27.7 mt -95.92 179.55 5.05 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.239 -0.913 . . . . 0.0 110.133 179.946 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 66.4 m-85 -92.59 -27.1 17.56 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.195 -0.94 . . . . 0.0 110.218 -179.97 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.431 ' O ' ' C ' ' A' ' 48' ' ' ALA . 64.2 m -107.55 166.92 10.31 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.344 -0.848 . . . . 0.0 110.084 179.964 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.455 ' HA ' ' HG3' ' A' ' 65' ' ' LYS . . . -43.01 132.55 3.98 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.269 -0.894 . . . . 0.0 110.118 179.942 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . 0.419 ' C ' ' O ' ' A' ' 48' ' ' ALA . 7.7 t -42.75 130.06 3.06 Favored Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 121.23 -0.919 . . . . 0.0 110.181 -179.997 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.442 ' HD2' ' SG ' ' A' ' 67' ' ' CYS . 45.5 Cg_endo -72.15 147.08 47.59 Favored 'Trans proline' 0 C--N 1.305 -1.73 0 O-C-N 123.909 1.479 . . . . 0.0 110.376 -179.977 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 28.5 pt -58.0 -21.99 18.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.234 -0.917 . . . . 0.0 110.135 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 66.2 m-85 -57.09 -16.51 7.67 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.169 -0.957 . . . . 0.0 110.109 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 71.1 p -142.34 153.66 44.02 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.238 -0.914 . . . . 0.0 110.187 179.97 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.42 ' O ' ' HA ' ' A' ' 67' ' ' CYS . 58.2 tttt -74.16 164.66 26.34 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.199 -0.938 . . . . 0.0 110.193 -180.0 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.455 ' CG2' ' O ' ' A' ' 55' ' ' ILE . 20.1 tt -109.41 118.18 56.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.209 -0.932 . . . . 0.0 110.17 179.956 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . 0.447 ' NE2' ' HB3' ' A' ' 68' ' ' LYS . 70.4 mm-40 -69.61 -31.15 69.11 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.307 -0.871 . . . . 0.0 110.236 -179.972 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 149.24 -92.69 0.14 Allowed Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.471 -1.452 . . . . 0.0 109.471 179.956 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.401 ' O ' ' SG ' ' A' ' 66' ' ' CYS . 74.6 p -128.67 161.96 28.45 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.275 -1.132 . . . . 0.0 110.235 -179.937 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . 0.494 ' SG ' ' SG ' ' A' ' 66' ' ' CYS . 5.1 m -99.45 -68.86 0.79 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.281 -0.887 . . . . 0.0 110.145 179.883 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . 0.434 ' CD2' ' HB3' ' A' ' 59' ' ' CYS . 89.4 m-85 -141.32 -68.9 0.38 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.345 -0.847 . . . . 0.0 110.178 -179.977 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . 0.402 ' HD2' ' CD ' ' A' ' 63' ' ' LYS . 38.7 ttm-85 -95.38 -37.8 10.79 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.256 -0.902 . . . . 0.0 110.177 -179.965 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 135.42 -15.84 4.14 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 -179.951 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.402 ' CD ' ' HD2' ' A' ' 61' ' ' ARG . 46.7 mtpt -65.55 -31.49 72.58 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.268 -1.137 . . . . 0.0 110.15 -179.979 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.415 ' CB ' ' O ' ' A' ' 45' ' ' LEU . . . -109.83 159.57 17.1 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.353 -0.842 . . . . 0.0 110.146 179.929 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.455 ' HG3' ' HA ' ' A' ' 48' ' ' ALA . 60.7 mmtt -124.02 124.74 43.22 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.211 -0.931 . . . . 0.0 110.269 179.999 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' CYS . . . . . 0.494 ' SG ' ' SG ' ' A' ' 59' ' ' CYS . 60.9 m -55.11 155.13 4.92 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.229 -0.919 . . . . 0.0 110.139 179.939 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' CYS . . . . . 0.501 ' N ' ' O ' ' A' ' 43' ' ' GLN . 91.8 m -148.13 114.6 5.95 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.176 -0.952 . . . . 0.0 110.284 179.965 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.472 ' HA ' ' HA3' ' A' ' 42' ' ' GLY . 80.4 tttt . . . . . 0 N--CA 1.491 1.583 0 CA-C-O 118.019 -0.991 . . . . 0.0 110.215 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.423 ' CE2' ' SG ' ' A' ' 37' ' ' CYS . 2.8 t80 . . . . . 0 N--CA 1.491 1.598 0 CA-C-O 121.266 0.555 . . . . 0.0 110.22 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 14.7 t-20 -107.71 105.26 15.02 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.272 -0.892 . . . . 0.0 110.275 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.423 ' SG ' ' CE2' ' A' ' 35' ' ' TYR . 31.1 m -80.69 2.54 25.5 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.258 -0.901 . . . . 0.0 110.241 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 69.2 t -83.22 -34.9 11.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.227 -0.921 . . . . 0.0 110.248 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 34.1 t -68.0 -29.43 68.44 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.256 -0.902 . . . . 0.0 110.162 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 5.1 m -76.23 -16.83 59.74 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.325 -0.859 . . . . 0.0 110.113 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 111.4 -14.53 27.78 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.421 -1.471 . . . . 0.0 109.421 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.522 ' CA ' ' O ' ' A' ' 67' ' ' CYS . . . -80.88 -177.67 51.73 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.496 -1.442 . . . . 0.0 109.496 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' GLN . . . . . 0.517 ' N ' ' O ' ' A' ' 67' ' ' CYS . 36.6 tt0 -133.82 160.14 38.51 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.29 -1.124 . . . . 0.0 110.211 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 38.6 t -114.92 107.43 15.38 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.245 -0.909 . . . . 0.0 110.173 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.591 HD12 ' CD ' ' A' ' 50' ' ' PRO . 82.8 mt -89.55 176.36 6.92 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.282 -0.886 . . . . 0.0 110.196 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 71.3 t80 -91.03 -24.03 20.18 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.242 -0.911 . . . . 0.0 110.232 -179.923 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.416 ' O ' ' C ' ' A' ' 48' ' ' ALA . 89.2 p -105.59 165.72 10.95 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.245 -0.91 . . . . 0.0 110.231 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.416 ' C ' ' O ' ' A' ' 47' ' ' SER . . . -43.01 130.8 4.37 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.207 -0.933 . . . . 0.0 110.202 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' CYS . . . . . 0.533 ' HB2' ' CG ' ' A' ' 65' ' ' LYS . 12.4 t -43.15 127.88 3.42 Favored Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 121.222 -0.924 . . . . 0.0 110.187 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.591 ' CD ' HD12 ' A' ' 45' ' ' LEU . 46.4 Cg_endo -72.31 147.03 46.58 Favored 'Trans proline' 0 C--N 1.306 -1.665 0 O-C-N 123.898 1.473 . . . . 0.0 110.423 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.416 ' H ' HG23 ' A' ' 51' ' ' ILE . 19.4 pt -58.69 -22.06 20.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.23 -0.919 . . . . 0.0 110.135 -179.918 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 82.5 m-85 -59.68 -14.77 15.35 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.207 -0.933 . . . . 0.0 110.142 179.901 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.529 ' CB ' ' HB3' ' A' ' 67' ' ' CYS . 72.7 p -127.45 172.85 10.31 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.254 -0.904 . . . . 0.0 110.139 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.496 ' O ' ' HA ' ' A' ' 67' ' ' CYS . 44.8 tttt -94.09 165.31 12.69 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.241 -0.912 . . . . 0.0 110.225 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.705 HG23 ' O ' ' A' ' 55' ' ' ILE . 16.6 tt -95.47 116.11 36.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.255 -0.903 . . . . 0.0 110.261 179.907 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' GLN . . . . . 0.521 ' NE2' ' HB3' ' A' ' 68' ' ' LYS . 64.9 mm-40 -93.77 15.8 15.6 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.263 -0.898 . . . . 0.0 110.2 -179.958 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 112.76 -114.64 3.51 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.489 -1.445 . . . . 0.0 109.489 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 16.9 p -131.4 174.02 10.49 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.26 -1.141 . . . . 0.0 110.181 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' CYS . . . . . 0.966 ' SG ' ' SG ' ' A' ' 66' ' ' CYS . 0.7 OUTLIER -114.09 -159.52 0.7 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.232 -0.918 . . . . 0.0 110.252 -179.972 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 90.9 m-85 -55.5 -43.77 75.94 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.309 -0.869 . . . . 0.0 110.192 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 80.4 mtm180 -133.43 168.95 17.68 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.242 -0.911 . . . . 0.0 110.202 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -67.7 -23.24 73.93 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 10.2 mmpt? -67.19 -24.84 65.9 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.253 -1.146 . . . . 0.0 110.186 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -112.77 162.82 15.32 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.224 -0.923 . . . . 0.0 110.191 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.533 ' CG ' ' HB2' ' A' ' 49' ' ' CYS . 48.1 tptt -141.77 144.18 33.85 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.276 -0.89 . . . . 0.0 110.226 -179.954 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' CYS . . . . . 0.966 ' SG ' ' SG ' ' A' ' 59' ' ' CYS . 99.7 m -82.96 153.54 24.96 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.192 -0.942 . . . . 0.0 110.155 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' CYS . . . . . 0.529 ' HB3' ' CB ' ' A' ' 53' ' ' THR . 75.1 m -142.51 156.22 45.12 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.258 -0.901 . . . . 0.0 110.205 -179.925 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.521 ' HB3' ' NE2' ' A' ' 56' ' ' GLN . 43.5 tttt . . . . . 0 N--CA 1.491 1.587 0 CA-C-O 117.978 -1.011 . . . . 0.0 110.24 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.412 ' CD1' ' N ' ' A' ' 36' ' ' ASN . 2.3 t80 . . . . . 0 N--CA 1.492 1.638 0 CA-C-O 121.272 0.558 . . . . 0.0 110.129 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' ASN . . . . . 0.44 ' ND2' ' HB3' ' A' ' 39' ' ' SER . 25.5 p-10 -92.22 91.86 7.93 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.3 -0.875 . . . . 0.0 110.164 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 18.8 m -73.54 -22.38 60.11 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.203 -0.936 . . . . 0.0 110.2 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.445 ' HA ' ' O ' ' A' ' 42' ' ' GLY . 70.6 t -63.62 -42.33 95.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.215 -0.928 . . . . 0.0 110.215 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' SER . . . . . 0.44 ' HB3' ' ND2' ' A' ' 36' ' ' ASN . 44.8 t -58.76 -26.59 64.15 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.198 -0.939 . . . . 0.0 110.216 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.437 ' O ' ' HE3' ' A' ' 68' ' ' LYS . 63.1 m -82.95 -18.34 40.35 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.267 -0.896 . . . . 0.0 110.203 179.977 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' GLY . . . . . 0.467 ' O ' ' HG3' ' A' ' 68' ' ' LYS . . . 112.18 11.89 14.92 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.432 -1.467 . . . . 0.0 109.432 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.445 ' O ' ' HA ' ' A' ' 38' ' ' VAL . . . -113.17 178.78 18.83 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' GLN . . . . . 0.512 ' O ' ' HA ' ' A' ' 66' ' ' CYS . 0.3 OUTLIER -137.1 171.86 13.86 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.261 -1.14 . . . . 0.0 110.202 179.942 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 84.6 m -108.58 104.4 13.72 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.248 -0.908 . . . . 0.0 110.227 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.514 HD12 ' HD3' ' A' ' 50' ' ' PRO . 27.3 mt -85.82 179.61 7.01 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.163 -0.96 . . . . 0.0 110.137 179.988 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 98.1 m-85 -106.23 -7.91 17.59 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.272 -0.892 . . . . 0.0 110.192 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.414 ' O ' ' C ' ' A' ' 48' ' ' ALA . 84.0 p -121.41 166.92 13.4 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.267 -0.895 . . . . 0.0 110.201 179.959 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.414 ' C ' ' O ' ' A' ' 47' ' ' SER . . . -43.01 131.23 4.3 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.229 -0.92 . . . . 0.0 110.204 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' CYS . . . . . 0.461 ' HB2' ' HG2' ' A' ' 65' ' ' LYS . 3.9 t -42.76 128.53 3.1 Favored Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 121.284 -0.885 . . . . 0.0 110.226 -179.911 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.514 ' HD3' HD12 ' A' ' 45' ' ' LEU . 45.7 Cg_endo -72.83 150.42 49.63 Favored 'Trans proline' 0 C--N 1.306 -1.679 0 O-C-N 123.89 1.468 . . . . 0.0 110.427 -179.938 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 54.4 mt -63.19 -27.2 42.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.211 -0.93 . . . . 0.0 110.234 -179.931 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 99.4 m-85 -68.94 -9.22 50.86 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.319 -0.863 . . . . 0.0 110.12 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.509 ' CG2' ' HG2' ' A' ' 50' ' ' PRO . 46.2 p -123.79 144.57 49.62 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.208 -0.932 . . . . 0.0 110.171 179.961 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.484 ' O ' ' HA ' ' A' ' 67' ' ' CYS . 40.7 mtmt -81.0 167.9 19.3 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.193 -0.942 . . . . 0.0 110.275 -179.951 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.681 HG23 ' O ' ' A' ' 55' ' ' ILE . 18.8 tt -100.99 117.65 46.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.334 -0.854 . . . . 0.0 110.166 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' GLN . . . . . 0.503 ' CG ' ' HB2' ' A' ' 68' ' ' LYS . 71.8 mm-40 -96.64 3.11 52.7 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.201 -0.937 . . . . 0.0 110.206 179.966 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 125.52 -119.54 3.57 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.388 -1.485 . . . . 0.0 109.388 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.444 ' O ' ' SG ' ' A' ' 66' ' ' CYS . 24.4 p -133.05 164.24 27.44 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.26 -1.141 . . . . 0.0 110.18 179.938 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 1.8 m -114.13 -88.66 0.55 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.245 -0.91 . . . . 0.0 110.248 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 83.0 m-85 -116.97 98.94 6.75 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.283 -0.886 . . . . 0.0 110.287 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 27.7 mmm180 54.78 -145.69 0.61 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.316 -0.865 . . . . 0.0 110.141 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -102.83 18.33 50.32 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.559 -1.416 . . . . 0.0 109.559 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 48.0 mtpt -85.07 -24.38 28.13 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.277 -1.131 . . . . 0.0 110.194 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -145.34 164.07 32.61 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.308 -0.87 . . . . 0.0 110.261 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.461 ' HG2' ' HB2' ' A' ' 49' ' ' CYS . 54.5 tptt -127.68 132.92 49.61 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.29 -0.881 . . . . 0.0 110.19 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' CYS . . . . . 0.512 ' HA ' ' O ' ' A' ' 43' ' ' GLN . 59.2 m -72.35 132.42 43.95 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.261 -0.9 . . . . 0.0 110.201 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' CYS . . . . . 0.484 ' HA ' ' O ' ' A' ' 54' ' ' LYS . 90.9 m -135.56 144.29 46.14 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.287 -0.883 . . . . 0.0 110.243 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.503 ' HB2' ' CG ' ' A' ' 56' ' ' GLN . 81.5 tttt . . . . . 0 N--CA 1.492 1.644 0 CA-C-O 117.994 -1.003 . . . . 0.0 110.126 -179.923 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 4.2 t80 . . . . . 0 N--CA 1.49 1.575 0 CA-C-O 121.243 0.544 . . . . 0.0 110.229 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 36' ' ' ASN . . . . . 0.538 ' ND2' ' CB ' ' A' ' 39' ' ' SER . 54.0 t30 -74.28 65.9 1.24 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.246 -0.909 . . . . 0.0 110.168 -179.906 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.448 ' O ' ' HB2' ' A' ' 40' ' ' SER . 22.0 m -71.08 -53.66 13.86 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.235 -0.916 . . . . 0.0 110.305 179.97 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.466 ' HA ' ' O ' ' A' ' 42' ' ' GLY . 77.0 t -44.66 -55.09 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.178 -0.951 . . . . 0.0 110.243 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' SER . . . . . 0.538 ' CB ' ' ND2' ' A' ' 36' ' ' ASN . 53.4 m -53.62 -31.41 47.11 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.176 -0.952 . . . . 0.0 110.244 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.448 ' HB2' ' O ' ' A' ' 37' ' ' CYS . 50.8 m -71.5 -25.29 62.19 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.249 -0.907 . . . . 0.0 110.155 179.981 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 125.05 -16.76 7.21 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.458 -1.457 . . . . 0.0 109.458 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.475 ' CA ' ' O ' ' A' ' 67' ' ' CYS . . . -87.74 -177.45 48.07 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.485 -1.446 . . . . 0.0 109.485 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' GLN . . . . . 0.456 ' N ' ' O ' ' A' ' 67' ' ' CYS . 1.3 pt20 -133.66 175.73 9.18 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.313 -1.11 . . . . 0.0 110.31 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 11.1 t -107.21 89.39 2.98 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.215 -0.928 . . . . 0.0 110.18 179.939 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.451 HD12 ' HA ' ' A' ' 45' ' ' LEU . 13.7 tp -78.63 162.1 26.48 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.203 -0.935 . . . . 0.0 110.23 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 65.6 t80 -92.13 -24.6 19.06 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.227 -0.92 . . . . 0.0 110.182 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.423 ' O ' ' C ' ' A' ' 48' ' ' ALA . 44.8 m -95.94 157.85 15.71 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.265 -0.897 . . . . 0.0 110.192 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.425 ' O ' ' C ' ' A' ' 49' ' ' CYS . . . -42.74 133.15 3.6 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.256 -0.902 . . . . 0.0 110.219 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' CYS . . . . . 0.425 ' C ' ' O ' ' A' ' 48' ' ' ALA . 1.8 t -43.13 127.08 3.41 Favored Pre-proline 0 N--CA 1.491 1.609 0 O-C-N 121.248 -0.907 . . . . 0.0 110.084 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -72.45 159.64 48.68 Favored 'Trans proline' 0 C--N 1.306 -1.675 0 O-C-N 123.854 1.449 . . . . 0.0 110.436 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 7.5 mt -65.61 -25.92 37.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.167 -0.958 . . . . 0.0 110.114 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 94.2 m-85 -65.92 -12.14 52.45 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.305 -0.872 . . . . 0.0 110.117 179.871 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.465 ' OG1' ' HB3' ' A' ' 67' ' ' CYS . 67.3 p -136.09 147.35 47.78 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.272 -0.892 . . . . 0.0 110.165 179.941 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 36.8 tttt -97.41 165.23 12.11 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.211 -0.931 . . . . 0.0 110.228 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.689 HG23 ' O ' ' A' ' 55' ' ' ILE . 15.3 tt -86.94 115.21 27.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.276 -0.89 . . . . 0.0 110.19 -179.941 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' GLN . . . . . 0.503 ' HG3' ' HB2' ' A' ' 68' ' ' LYS . 54.4 mm-40 -97.14 18.96 13.76 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.239 -0.913 . . . . 0.0 110.224 179.957 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 139.91 -156.68 25.02 Favored Glycine 0 N--CA 1.488 2.144 0 N-CA-C 109.485 -1.446 . . . . 0.0 109.485 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.447 ' O ' ' SG ' ' A' ' 66' ' ' CYS . 24.5 p -109.26 165.04 11.92 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.188 -1.183 . . . . 0.0 110.174 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -107.65 -158.46 0.65 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.258 -0.902 . . . . 0.0 110.291 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 95.2 m-85 -58.58 -55.9 29.12 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.354 -0.841 . . . . 0.0 110.163 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -126.29 172.22 10.29 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.255 -0.903 . . . . 0.0 110.171 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -65.1 -20.25 66.82 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.424 -1.47 . . . . 0.0 109.424 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 48.8 mtmt -65.93 -24.1 66.76 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.231 -1.158 . . . . 0.0 110.215 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.412 ' C ' ' HG2' ' A' ' 65' ' ' LYS . . . -118.28 161.86 19.22 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.232 -0.917 . . . . 0.0 110.166 180.0 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.412 ' HG2' ' C ' ' A' ' 64' ' ' ALA . 73.8 mmtt -146.93 138.54 24.29 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.211 -0.931 . . . . 0.0 110.22 -179.942 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' CYS . . . . . 0.447 ' SG ' ' O ' ' A' ' 58' ' ' THR . 89.4 m -64.03 139.51 58.77 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.275 -0.891 . . . . 0.0 110.085 179.949 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' CYS . . . . . 0.475 ' O ' ' CA ' ' A' ' 42' ' ' GLY . 95.1 m -141.85 136.62 30.76 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.23 -0.919 . . . . 0.0 110.223 179.967 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.503 ' HB2' ' HG3' ' A' ' 56' ' ' GLN . 73.0 tttt . . . . . 0 N--CA 1.492 1.625 0 CA-C-O 118.03 -0.986 . . . . 0.0 110.157 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 12.8 t80 . . . . . 0 N--CA 1.492 1.66 0 CA-C-O 121.281 0.562 . . . . 0.0 110.191 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 14.7 t-20 -91.43 67.92 5.71 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.203 -0.936 . . . . 0.0 110.223 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.409 ' O ' ' HB2' ' A' ' 40' ' ' SER . 55.8 m -64.63 -50.85 65.49 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.265 -0.897 . . . . 0.0 110.169 -179.923 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.432 HG23 ' H ' ' A' ' 38' ' ' VAL . 30.8 t -45.48 -47.32 4.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.137 -0.977 . . . . 0.0 110.193 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 32.2 t -59.01 -21.85 59.71 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.273 -0.892 . . . . 0.0 110.265 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.409 ' HB2' ' O ' ' A' ' 37' ' ' CYS . 74.7 m -86.31 -11.88 50.95 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.228 -0.92 . . . . 0.0 110.215 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 103.7 5.08 45.44 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.598 -1.401 . . . . 0.0 109.598 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.419 ' HA2' ' HA ' ' A' ' 68' ' ' LYS . . . -102.58 172.29 21.86 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.501 -1.439 . . . . 0.0 109.501 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' GLN . . . . . 0.498 ' O ' ' HA ' ' A' ' 66' ' ' CYS . 0.0 OUTLIER -123.35 175.11 6.91 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.204 -1.174 . . . . 0.0 110.219 179.939 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 22.4 t -107.93 94.16 4.93 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.23 -0.918 . . . . 0.0 110.197 -179.896 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.891 HD12 ' SG ' ' A' ' 67' ' ' CYS . 94.5 mt -73.24 177.9 4.83 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.206 -0.934 . . . . 0.0 110.216 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 80.3 m-85 -104.26 -11.54 17.14 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.267 -0.895 . . . . 0.0 110.278 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.401 ' O ' ' C ' ' A' ' 48' ' ' ALA . 60.1 p -125.74 173.23 9.18 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.307 -0.871 . . . . 0.0 110.258 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.401 ' C ' ' O ' ' A' ' 47' ' ' SER . . . -43.16 128.61 4.6 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.277 -0.89 . . . . 0.0 110.144 179.945 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 4.9 t -46.56 129.32 8.2 Favored Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.287 -0.883 . . . . 0.0 110.142 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.558 ' CD ' ' CD1' ' A' ' 45' ' ' LEU . 46.1 Cg_endo -72.84 149.76 48.38 Favored 'Trans proline' 0 C--N 1.306 -1.679 0 O-C-N 123.853 1.449 . . . . 0.0 110.406 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 46.1 pt -60.21 -24.75 31.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.299 -0.876 . . . . 0.0 110.177 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 58.4 m-85 -60.38 -13.91 15.85 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.156 -0.965 . . . . 0.0 110.202 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.455 ' OG1' ' HB3' ' A' ' 67' ' ' CYS . 77.4 p -135.87 154.72 51.07 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.15 -0.969 . . . . 0.0 110.237 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 95.7 mttt -98.11 152.55 19.22 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.294 -0.879 . . . . 0.0 110.259 179.941 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.59 HG23 ' O ' ' A' ' 55' ' ' ILE . 20.8 tt -89.36 124.39 42.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.329 -0.857 . . . . 0.0 110.244 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 67.1 mm-40 -97.37 -18.21 19.26 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.257 -0.902 . . . . 0.0 110.178 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -177.83 -149.59 8.05 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.453 -1.459 . . . . 0.0 109.453 -179.932 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.442 ' O ' ' SG ' ' A' ' 66' ' ' CYS . 33.2 p -111.32 163.33 14.08 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.288 -1.124 . . . . 0.0 110.131 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' CYS . . . . . 0.474 ' HB3' ' HB3' ' A' ' 64' ' ' ALA . 0.8 OUTLIER -96.75 -160.73 0.82 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.244 -0.91 . . . . 0.0 110.192 179.973 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 93.4 m-85 -60.8 -42.77 98.24 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.284 -0.885 . . . . 0.0 110.151 179.891 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 90.1 mtt-85 -135.41 170.87 15.27 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.214 -0.929 . . . . 0.0 110.212 -179.924 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -63.53 -18.9 61.85 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.375 -1.49 . . . . 0.0 109.375 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 12.3 tttt -70.27 -31.54 68.95 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.179 -1.189 . . . . 0.0 110.193 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.474 ' HB3' ' HB3' ' A' ' 59' ' ' CYS . . . -105.19 159.53 15.79 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.302 -0.873 . . . . 0.0 110.123 -179.952 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.408 ' HG2' ' C ' ' A' ' 64' ' ' ALA . 73.9 mmtt -142.9 147.9 36.07 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.246 -0.909 . . . . 0.0 110.18 179.968 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' CYS . . . . . 0.498 ' HA ' ' O ' ' A' ' 43' ' ' GLN . 71.7 m -77.55 148.47 35.2 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.268 -0.895 . . . . 0.0 110.1 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' CYS . . . . . 0.891 ' SG ' HD12 ' A' ' 45' ' ' LEU . 92.6 m -145.7 131.15 18.69 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.13 -0.981 . . . . 0.0 110.256 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.419 ' HA ' ' HA2' ' A' ' 42' ' ' GLY . 82.0 tttt . . . . . 0 N--CA 1.491 1.604 0 CA-C-O 118.096 -0.954 . . . . 0.0 110.27 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.566 ' CE2' ' SG ' ' A' ' 37' ' ' CYS . 3.3 t80 . . . . . 0 N--CA 1.491 1.6 0 CA-C-O 121.201 0.524 . . . . 0.0 110.218 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' ASN . . . . . 0.52 ' ND2' ' HB3' ' A' ' 39' ' ' SER . 27.2 p-10 -94.22 85.12 4.56 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.266 -0.896 . . . . 0.0 110.234 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.566 ' SG ' ' CE2' ' A' ' 35' ' ' TYR . 87.6 m -65.02 -42.66 94.2 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.271 -0.893 . . . . 0.0 110.284 179.951 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 86.4 t -52.41 -40.86 33.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.301 -0.875 . . . . 0.0 110.196 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' SER . . . . . 0.52 ' HB3' ' ND2' ' A' ' 36' ' ' ASN . 24.6 t -62.67 -26.76 68.81 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.269 -0.895 . . . . 0.0 110.251 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.514 ' O ' ' CE ' ' A' ' 68' ' ' LYS . 2.2 t -79.95 -16.65 54.81 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.319 -0.863 . . . . 0.0 110.163 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 116.33 -12.53 16.37 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.468 -1.453 . . . . 0.0 109.468 -179.937 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.44 ' HA2' ' HA ' ' A' ' 68' ' ' LYS . . . -83.55 -175.36 50.9 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 -179.988 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' GLN . . . . . 0.529 ' NE2' HD21 ' A' ' 45' ' ' LEU . 42.5 tt0 -133.73 152.25 51.83 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.25 -1.147 . . . . 0.0 110.206 179.926 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' CYS . . . . . 0.571 ' O ' HD23 ' A' ' 45' ' ' LEU . 49.2 t -100.1 127.16 46.38 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.265 -0.897 . . . . 0.0 110.219 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.615 ' O ' ' HB1' ' A' ' 64' ' ' ALA . 28.9 mt -121.12 176.57 5.52 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.225 -0.922 . . . . 0.0 110.227 179.938 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 85.1 m-85 -104.19 -0.78 28.07 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.21 -0.931 . . . . 0.0 110.206 180.0 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 85.7 p -116.18 171.95 7.48 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.243 -0.911 . . . . 0.0 110.205 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -46.92 153.33 0.43 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.291 -0.881 . . . . 0.0 110.147 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 42.3 t -55.67 128.38 69.03 Favored Pre-proline 0 N--CA 1.492 1.641 0 O-C-N 121.325 -0.86 . . . . 0.0 110.165 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -72.64 153.69 54.43 Favored 'Trans proline' 0 C--N 1.305 -1.718 0 O-C-N 123.943 1.496 . . . . 0.0 110.485 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 28.1 pt -77.08 -6.45 9.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.26 -0.9 . . . . 0.0 110.105 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 46.6 m-85 -73.0 -22.94 60.59 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.248 -0.908 . . . . 0.0 110.14 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 69.9 p -137.62 161.81 35.47 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.317 -0.865 . . . . 0.0 110.204 179.946 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.497 ' O ' ' N ' ' A' ' 68' ' ' LYS . 64.3 mttt -90.32 169.54 11.01 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.289 -0.882 . . . . 0.0 110.15 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.726 HG23 ' O ' ' A' ' 55' ' ' ILE . 20.6 tt -95.48 111.27 25.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.262 -0.899 . . . . 0.0 110.133 -179.914 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' GLN . . . . . 0.531 ' CG ' ' HB3' ' A' ' 68' ' ' LYS . 56.6 mm-40 -90.32 -12.85 36.52 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.211 -0.931 . . . . 0.0 110.188 179.962 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' GLY . . . . . 0.517 ' HA3' ' CE2' ' A' ' 35' ' ' TYR . . . 170.79 -144.77 8.53 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.474 -1.451 . . . . 0.0 109.474 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 16.5 p -115.73 168.37 10.09 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.221 -1.164 . . . . 0.0 110.186 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' CYS . . . . . 0.47 ' SG ' ' N ' ' A' ' 66' ' ' CYS . 1.1 m -91.19 -161.6 0.83 Allowed 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.296 -0.877 . . . . 0.0 110.212 -179.92 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 94.2 m-85 -57.24 -40.82 78.37 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.31 -0.868 . . . . 0.0 110.317 179.861 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 93.8 mtt180 -132.44 178.26 6.96 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.222 -0.924 . . . . 0.0 110.214 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -76.25 -6.02 82.54 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.589 -1.404 . . . . 0.0 109.589 -179.947 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 40.6 mtpt -81.59 -23.75 36.9 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.197 -1.178 . . . . 0.0 110.184 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.615 ' HB1' ' O ' ' A' ' 45' ' ' LEU . . . -117.27 162.61 17.61 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.291 -0.88 . . . . 0.0 110.1 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 16.4 tppt? -141.16 123.02 15.37 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.244 -0.91 . . . . 0.0 110.16 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' CYS . . . . . 0.491 ' HA ' ' O ' ' A' ' 43' ' ' GLN . 28.9 p -87.84 151.3 22.96 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.173 -0.954 . . . . 0.0 110.188 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' CYS . . . . . 0.466 ' CA ' ' O ' ' A' ' 54' ' ' LYS . 73.1 m -148.77 143.47 26.4 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.222 -0.924 . . . . 0.0 110.192 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.531 ' HB3' ' CG ' ' A' ' 56' ' ' GLN . 78.3 tttt . . . . . 0 N--CA 1.492 1.633 0 CA-C-O 117.999 -1.0 . . . . 0.0 110.259 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.562 ' CD1' ' SG ' ' A' ' 37' ' ' CYS . 6.4 t80 . . . . . 0 N--CA 1.491 1.612 0 CA-C-O 121.263 0.554 . . . . 0.0 110.276 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' ASN . . . . . 0.568 ' ND2' ' CB ' ' A' ' 39' ' ' SER . 49.7 t30 65.95 54.55 1.01 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.277 -0.889 . . . . 0.0 110.168 -179.924 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.562 ' SG ' ' CD1' ' A' ' 35' ' ' TYR . 31.0 m -65.14 -52.95 52.08 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.304 -0.872 . . . . 0.0 110.146 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 38.0 t -47.91 -50.01 10.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.31 -0.869 . . . . 0.0 110.224 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' SER . . . . . 0.568 ' CB ' ' ND2' ' A' ' 36' ' ' ASN . 66.0 m -56.68 -32.33 65.33 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.249 -0.907 . . . . 0.0 110.115 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.472 ' O ' ' NZ ' ' A' ' 68' ' ' LYS . 24.0 m -72.87 -11.5 60.62 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.288 -0.883 . . . . 0.0 110.09 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 103.95 -12.35 52.78 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.389 -1.484 . . . . 0.0 109.389 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.476 ' HA3' ' HB2' ' A' ' 68' ' ' LYS . . . -81.52 -175.14 49.98 Favored Glycine 0 N--CA 1.489 2.217 0 N-CA-C 109.469 -1.452 . . . . 0.0 109.469 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' GLN . . . . . 0.56 ' NE2' HD21 ' A' ' 45' ' ' LEU . 47.7 tt0 -126.44 147.77 49.75 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.304 -1.115 . . . . 0.0 110.221 179.95 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 20.2 t -100.51 109.11 21.2 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.203 -0.936 . . . . 0.0 110.221 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.724 ' O ' ' HB1' ' A' ' 64' ' ' ALA . 59.0 mt -104.67 175.22 5.56 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.184 -0.947 . . . . 0.0 110.155 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 89.4 m-85 -107.84 -8.31 16.03 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.287 -0.883 . . . . 0.0 110.256 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.408 ' O ' ' C ' ' A' ' 48' ' ' ALA . 34.1 t -114.22 164.43 13.9 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.182 -0.949 . . . . 0.0 110.203 -179.984 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.418 ' O ' ' C ' ' A' ' 49' ' ' CYS . . . -42.62 132.45 3.68 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.309 -0.869 . . . . 0.0 110.159 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' CYS . . . . . 0.45 ' HB2' HD12 ' A' ' 55' ' ' ILE . 4.7 t -43.16 129.83 3.4 Favored Pre-proline 0 N--CA 1.492 1.642 0 O-C-N 121.254 -0.904 . . . . 0.0 110.15 179.997 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -72.99 146.27 41.35 Favored 'Trans proline' 0 C--N 1.305 -1.712 0 O-C-N 123.921 1.485 . . . . 0.0 110.397 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 34.0 pt -59.54 -20.05 17.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.289 -0.882 . . . . 0.0 110.119 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' PHE . . . . . 0.402 ' C ' HG23 ' A' ' 53' ' ' THR . 67.1 m-85 -61.82 -21.54 64.71 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.318 -0.864 . . . . 0.0 110.273 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.437 ' OG1' ' HB3' ' A' ' 67' ' ' CYS . 68.3 p -144.83 152.83 40.89 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.219 -0.925 . . . . 0.0 110.219 179.895 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.489 ' O ' ' HA ' ' A' ' 67' ' ' CYS . 62.2 mttm -78.01 173.5 12.12 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.32 -0.862 . . . . 0.0 110.174 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.642 HG23 ' O ' ' A' ' 55' ' ' ILE . 20.8 tt -110.78 121.24 63.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.25 -0.906 . . . . 0.0 110.169 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' GLN . . . . . 0.517 ' NE2' ' HB3' ' A' ' 68' ' ' LYS . 86.4 mm-40 -78.21 -27.02 47.71 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.253 -0.904 . . . . 0.0 110.225 -179.933 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 156.9 -155.96 26.8 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.478 -1.449 . . . . 0.0 109.478 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.421 ' O ' ' SG ' ' A' ' 66' ' ' CYS . 17.1 p -74.63 175.24 8.06 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.286 -1.126 . . . . 0.0 110.245 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' CYS . . . . . 1.204 ' SG ' ' SG ' ' A' ' 66' ' ' CYS . 0.1 OUTLIER -125.54 142.03 51.72 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.322 -0.861 . . . . 0.0 110.179 179.981 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 83.0 m-85 45.33 -92.53 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.295 -0.878 . . . . 0.0 110.23 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' ARG . . . . . 0.517 ' N ' ' O ' ' A' ' 59' ' ' CYS . 66.1 mtp180 -118.11 -8.21 10.71 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.194 -0.941 . . . . 0.0 110.151 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 127.3 -14.52 6.51 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.507 -1.437 . . . . 0.0 109.507 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 52.5 mtmt -61.12 -22.18 64.42 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.226 -1.161 . . . . 0.0 110.277 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.724 ' HB1' ' O ' ' A' ' 45' ' ' LEU . . . -127.97 173.83 9.7 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.226 -0.921 . . . . 0.0 110.166 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.463 ' HD3' ' O ' ' A' ' 64' ' ' ALA . 46.2 mmtt -124.16 122.76 38.7 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.248 -0.908 . . . . 0.0 110.215 -179.977 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' CYS . . . . . 1.204 ' SG ' ' SG ' ' A' ' 59' ' ' CYS . 75.9 m -75.09 149.36 39.15 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.271 -0.893 . . . . 0.0 110.135 -179.945 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' CYS . . . . . 0.489 ' HA ' ' O ' ' A' ' 54' ' ' LYS . 89.5 m -146.11 136.36 23.8 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.315 -0.866 . . . . 0.0 110.241 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.517 ' HB3' ' NE2' ' A' ' 56' ' ' GLN . 80.6 tttt . . . . . 0 N--CA 1.493 1.695 0 CA-C-O 118.093 -0.956 . . . . 0.0 110.209 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.502 ' CD1' ' N ' ' A' ' 36' ' ' ASN . 6.3 t80 . . . . . 0 N--CA 1.491 1.6 0 CA-C-O 121.258 0.551 . . . . 0.0 110.119 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' ASN . . . . . 0.502 ' N ' ' CD1' ' A' ' 35' ' ' TYR . 28.5 p-10 -84.99 57.43 4.44 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.199 -0.938 . . . . 0.0 110.293 -179.937 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 26.1 m -67.09 -56.26 10.8 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.252 -0.905 . . . . 0.0 110.058 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 60.1 t -53.47 -29.25 16.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.265 -0.897 . . . . 0.0 110.112 179.935 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 39.6 t -70.91 -30.06 66.3 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.298 -0.876 . . . . 0.0 110.121 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.491 ' O ' ' NZ ' ' A' ' 68' ' ' LYS . 0.4 OUTLIER -78.94 -21.48 47.16 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.287 -0.883 . . . . 0.0 110.118 179.969 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 117.29 3.57 16.95 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.611 -1.396 . . . . 0.0 109.611 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.435 ' HA2' ' HA ' ' A' ' 68' ' ' LYS . . . -100.5 172.31 23.89 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 -179.974 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 36.4 tt0 -118.14 153.41 33.84 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.25 -1.147 . . . . 0.0 110.187 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 30.5 t -98.03 97.99 9.38 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.253 -0.904 . . . . 0.0 110.205 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.658 HD12 ' CD ' ' A' ' 50' ' ' PRO . 79.7 mt -82.59 174.34 11.13 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.287 -0.883 . . . . 0.0 110.197 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 98.2 m-85 -107.25 0.66 23.36 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.29 -0.881 . . . . 0.0 110.276 -179.892 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.414 ' O ' ' C ' ' A' ' 48' ' ' ALA . 92.3 p -125.9 172.22 10.08 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.128 -0.982 . . . . 0.0 110.194 179.929 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.414 ' C ' ' O ' ' A' ' 47' ' ' SER . . . -42.93 124.2 3.05 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.316 -0.865 . . . . 0.0 110.169 179.948 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 16.4 t -42.87 130.41 3.13 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.29 -0.881 . . . . 0.0 110.215 -179.951 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.658 ' CD ' HD12 ' A' ' 45' ' ' LEU . 46.9 Cg_endo -72.72 140.73 32.86 Favored 'Trans proline' 0 C--N 1.306 -1.692 0 O-C-N 123.965 1.508 . . . . 0.0 110.391 -179.955 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 43.8 pt -62.2 -22.17 28.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.285 -0.884 . . . . 0.0 110.213 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 69.0 m-85 -55.92 -17.46 6.59 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.239 -0.913 . . . . 0.0 110.207 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.441 ' OG1' ' HB3' ' A' ' 67' ' ' CYS . 35.4 p -135.93 168.09 19.99 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.257 -0.902 . . . . 0.0 110.176 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.443 ' O ' ' HA ' ' A' ' 67' ' ' CYS . 22.1 mttp -96.12 152.98 18.04 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.274 -0.891 . . . . 0.0 110.241 179.977 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.699 HG23 ' O ' ' A' ' 55' ' ' ILE . 13.0 tt -94.54 113.57 29.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.247 -0.908 . . . . 0.0 110.316 -179.955 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' GLN . . . . . 0.505 ' NE2' ' HB3' ' A' ' 68' ' ' LYS . 90.4 mm-40 -76.13 -26.48 56.37 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.239 -0.913 . . . . 0.0 110.097 -179.977 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 167.5 -151.85 19.81 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.467 -1.453 . . . . 0.0 109.467 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 16.5 p -94.22 165.48 12.58 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.271 -1.135 . . . . 0.0 110.205 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' CYS . . . . . 0.97 ' SG ' ' SG ' ' A' ' 66' ' ' CYS . 0.5 OUTLIER -103.28 -158.02 0.64 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.202 -0.936 . . . . 0.0 110.207 -179.952 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 61.8 m-85 -56.64 -54.95 40.18 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.307 -0.871 . . . . 0.0 110.227 179.923 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' ARG . . . . . 0.519 ' CZ ' ' CD ' ' A' ' 63' ' ' LYS . 52.8 ttt180 -118.12 159.66 22.89 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.272 -0.893 . . . . 0.0 110.255 -179.979 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -63.16 -16.1 57.35 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.385 -1.486 . . . . 0.0 109.385 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.519 ' CD ' ' CZ ' ' A' ' 61' ' ' ARG . 41.9 mtpt -70.2 -27.84 64.81 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.257 -1.143 . . . . 0.0 110.172 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -110.48 166.41 11.01 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.379 -0.826 . . . . 0.0 110.192 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt -141.43 150.38 42.24 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.283 -0.885 . . . . 0.0 110.202 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' CYS . . . . . 0.97 ' SG ' ' SG ' ' A' ' 59' ' ' CYS . 94.7 m -92.46 144.14 25.66 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.282 -0.886 . . . . 0.0 110.185 179.939 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' CYS . . . . . 0.449 ' SG ' ' HD2' ' A' ' 50' ' ' PRO . 65.5 m -144.15 121.39 11.55 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.206 -0.934 . . . . 0.0 110.219 -179.995 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.505 ' HB3' ' NE2' ' A' ' 56' ' ' GLN . 80.4 tttt . . . . . 0 N--CA 1.491 1.606 0 CA-C-O 118.02 -0.99 . . . . 0.0 110.216 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.564 ' CZ ' ' SG ' ' A' ' 37' ' ' CYS . 26.2 p90 . . . . . 0 N--CA 1.492 1.638 0 CA-C-O 121.249 0.547 . . . . 0.0 110.112 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' ASN . . . . . 0.454 HD22 ' HB ' ' A' ' 38' ' ' VAL . 4.3 t-20 -85.63 109.92 18.9 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.34 -0.85 . . . . 0.0 110.28 -179.974 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.564 ' SG ' ' CZ ' ' A' ' 35' ' ' TYR . 98.0 m -66.04 -42.74 89.17 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.278 -0.889 . . . . 0.0 110.089 179.919 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.454 ' HB ' HD22 ' A' ' 36' ' ' ASN . 97.5 t -48.18 -42.76 11.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.233 -0.917 . . . . 0.0 110.161 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 2.8 m -64.79 -24.97 67.72 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.301 -0.874 . . . . 0.0 110.206 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 69.2 m -82.61 -9.62 59.31 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.272 -0.892 . . . . 0.0 110.229 179.923 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 107.97 -4.78 34.06 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.496 ' CA ' ' O ' ' A' ' 67' ' ' CYS . . . -90.71 -172.94 44.16 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.507 -1.437 . . . . 0.0 109.507 179.94 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' GLN . . . . . 0.553 ' NE2' HD21 ' A' ' 45' ' ' LEU . 44.8 tt0 -127.05 168.41 14.62 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.211 -1.17 . . . . 0.0 110.213 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' CYS . . . . . 0.657 ' O ' HD23 ' A' ' 45' ' ' LEU . 15.7 t -115.82 136.61 52.89 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.193 -0.942 . . . . 0.0 110.242 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.657 HD23 ' O ' ' A' ' 44' ' ' CYS . 81.6 mt -136.9 174.53 10.51 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.195 -0.941 . . . . 0.0 110.218 179.935 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 96.1 m-85 -109.44 0.55 19.39 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.185 -0.947 . . . . 0.0 110.254 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.419 ' O ' ' C ' ' A' ' 48' ' ' ALA . 41.4 m -122.79 164.79 17.72 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.271 -0.893 . . . . 0.0 110.237 180.0 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.419 ' C ' ' O ' ' A' ' 47' ' ' SER . . . -42.82 138.49 1.96 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.272 -0.892 . . . . 0.0 110.254 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' CYS . . . . . 0.505 ' HB2' HD12 ' A' ' 55' ' ' ILE . 11.6 t -44.5 131.38 4.83 Favored Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 121.201 -0.937 . . . . 0.0 110.182 -179.924 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.401 ' HD2' ' SG ' ' A' ' 67' ' ' CYS . 46.9 Cg_endo -72.71 161.13 44.73 Favored 'Trans proline' 0 C--N 1.306 -1.691 0 O-C-N 123.976 1.514 . . . . 0.0 110.47 179.94 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 47.1 pt -75.89 -10.69 13.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.212 -0.93 . . . . 0.0 110.274 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 77.0 m-85 -70.7 -25.38 62.93 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.21 -0.931 . . . . 0.0 110.212 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 81.3 p -137.55 159.82 40.88 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.261 -0.899 . . . . 0.0 110.304 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.44 ' HB2' ' O ' ' A' ' 68' ' ' LYS . 86.3 mttt -78.96 155.9 28.74 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.256 -0.902 . . . . 0.0 110.254 179.927 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.744 HG23 ' O ' ' A' ' 55' ' ' ILE . 17.3 tt -97.07 102.15 13.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.211 -0.93 . . . . 0.0 110.199 179.992 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' GLN . . . . . 0.521 ' CG ' ' HB3' ' A' ' 68' ' ' LYS . 64.9 mm-40 -70.4 -27.55 64.39 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.179 -0.951 . . . . 0.0 109.926 179.824 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 156.54 -158.85 29.05 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.401 -1.48 . . . . 0.0 109.401 179.961 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.651 HG22 ' HE3' ' A' ' 65' ' ' LYS . 19.3 p -81.87 164.84 21.32 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.254 -1.145 . . . . 0.0 110.19 179.947 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' CYS . . . . . 0.466 ' SG ' ' HB3' ' A' ' 66' ' ' CYS . 0.5 OUTLIER -92.64 -142.41 0.21 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.23 -0.918 . . . . 0.0 110.252 179.972 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 91.9 m-85 -50.52 -46.2 57.17 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.335 -0.853 . . . . 0.0 110.223 179.886 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -132.85 174.15 10.63 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.265 -0.897 . . . . 0.0 110.171 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -69.85 -16.21 72.2 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 48.9 mtpt -67.96 -25.85 65.64 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.234 -1.156 . . . . 0.0 110.257 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -124.63 161.29 26.57 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.301 -0.874 . . . . 0.0 110.212 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.651 ' HE3' HG22 ' A' ' 58' ' ' THR . 40.1 mmtm -133.62 143.26 48.51 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.309 -0.87 . . . . 0.0 110.213 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' CYS . . . . . 0.471 ' HA ' ' O ' ' A' ' 43' ' ' GLN . 19.5 p -109.93 162.78 14.18 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.318 -0.864 . . . . 0.0 110.226 179.97 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' CYS . . . . . 0.496 ' O ' ' CA ' ' A' ' 42' ' ' GLY . 75.7 m -142.41 165.29 27.82 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.302 -0.874 . . . . 0.0 110.264 179.968 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.521 ' HB3' ' CG ' ' A' ' 56' ' ' GLN . 39.6 ttpt . . . . . 0 N--CA 1.491 1.611 0 CA-C-O 117.984 -1.008 . . . . 0.0 110.152 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.485 ' CD1' ' SG ' ' A' ' 37' ' ' CYS . 6.3 t80 . . . . . 0 N--CA 1.491 1.598 0 CA-C-O 121.226 0.536 . . . . 0.0 110.149 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' ASN . . . . . 0.467 ' N ' ' CD1' ' A' ' 35' ' ' TYR . 11.0 t-20 -121.73 83.51 2.1 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.281 -0.887 . . . . 0.0 110.293 -179.959 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.485 ' SG ' ' CD1' ' A' ' 35' ' ' TYR . 28.9 m -68.71 -52.89 25.95 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.294 -0.879 . . . . 0.0 110.128 179.954 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 60.7 t -46.02 -48.52 5.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.205 -0.935 . . . . 0.0 110.164 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 58.9 p -58.63 -24.27 60.74 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.192 -0.943 . . . . 0.0 110.207 179.948 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.446 ' HB2' ' O ' ' A' ' 37' ' ' CYS . 66.7 m -82.08 -11.59 58.7 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.252 -0.905 . . . . 0.0 110.127 -179.964 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 106.31 -20.43 35.17 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 -179.921 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.519 ' CA ' ' O ' ' A' ' 67' ' ' CYS . . . -75.17 -177.66 40.64 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.452 -1.459 . . . . 0.0 109.452 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' GLN . . . . . 0.495 ' N ' ' O ' ' A' ' 67' ' ' CYS . 32.0 tt0 -129.83 160.12 34.46 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.276 -1.131 . . . . 0.0 110.204 -179.98 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' CYS . . . . . 0.47 ' SG ' ' CE2' ' A' ' 60' ' ' TYR . 13.5 t -114.97 107.63 15.63 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.259 -0.901 . . . . 0.0 110.182 179.972 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.736 HD12 ' HD3' ' A' ' 50' ' ' PRO . 16.7 mt -93.74 169.31 10.41 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.212 -0.93 . . . . 0.0 110.219 -179.931 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -86.53 -22.95 26.05 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.237 -0.915 . . . . 0.0 110.203 -179.907 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.417 ' O ' ' C ' ' A' ' 48' ' ' ALA . 40.2 t -103.51 163.64 12.17 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.284 -0.885 . . . . 0.0 110.251 -179.973 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.417 ' C ' ' O ' ' A' ' 47' ' ' SER . . . -43.45 138.01 2.58 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.231 -0.918 . . . . 0.0 110.194 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' CYS . . . . . 0.408 ' C ' ' O ' ' A' ' 48' ' ' ALA . 7.7 t -43.72 133.11 3.89 Favored Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.266 -0.896 . . . . 0.0 110.194 -179.958 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.736 ' HD3' HD12 ' A' ' 45' ' ' LEU . 46.4 Cg_endo -72.96 143.97 37.45 Favored 'Trans proline' 0 C--N 1.306 -1.691 0 O-C-N 123.954 1.502 . . . . 0.0 110.413 -179.935 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 40.3 pt -59.84 -24.18 28.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.213 -0.93 . . . . 0.0 110.163 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -55.72 -22.23 22.66 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.261 -0.9 . . . . 0.0 110.252 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.44 ' HB ' ' O ' ' A' ' 68' ' ' LYS . 67.2 p -139.35 153.83 47.76 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.261 -0.899 . . . . 0.0 110.239 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 72.0 mttt -79.6 172.07 14.29 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.262 -0.898 . . . . 0.0 110.166 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.721 HG23 ' O ' ' A' ' 55' ' ' ILE . 11.5 tt -106.9 110.62 32.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.276 -0.89 . . . . 0.0 110.116 179.965 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' GLN . . . . . 0.533 ' CG ' ' HB2' ' A' ' 68' ' ' LYS . 22.9 mm100 -62.02 -31.96 72.4 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.276 -0.89 . . . . 0.0 110.137 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 169.18 -144.57 8.77 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.443 -1.463 . . . . 0.0 109.443 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 17.5 p -97.91 164.97 12.15 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.184 -1.186 . . . . 0.0 110.196 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' CYS . . . . . 1.089 ' SG ' ' SG ' ' A' ' 66' ' ' CYS . 0.5 OUTLIER -106.49 -171.63 1.93 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.225 -0.922 . . . . 0.0 110.293 -179.976 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.527 ' CD1' ' N ' ' A' ' 61' ' ' ARG . 7.9 p90 -50.99 -31.68 18.76 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.309 -0.87 . . . . 0.0 110.263 179.862 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 61' ' ' ARG . . . . . 0.527 ' N ' ' CD1' ' A' ' 60' ' ' TYR . 91.9 mtt180 -140.89 173.35 11.57 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.308 -0.87 . . . . 0.0 110.258 179.939 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -81.76 -11.08 83.34 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.586 -1.405 . . . . 0.0 109.586 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.409 ' HE2' ' CD ' ' A' ' 61' ' ' ARG . 48.7 mtmt -68.04 -18.84 64.8 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.217 -1.167 . . . . 0.0 110.135 -179.949 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.697 ' HB1' ' O ' ' A' ' 45' ' ' LEU . . . -136.42 158.58 44.08 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.263 -0.898 . . . . 0.0 110.16 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 70.1 mmtt -126.55 140.55 52.36 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.279 -0.888 . . . . 0.0 110.231 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' CYS . . . . . 1.089 ' SG ' ' SG ' ' A' ' 59' ' ' CYS . 84.1 m -74.59 148.88 40.39 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.26 -0.9 . . . . 0.0 110.263 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' CYS . . . . . 0.519 ' O ' ' CA ' ' A' ' 42' ' ' GLY . 82.8 m -142.42 154.84 44.93 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.239 -0.913 . . . . 0.0 110.145 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.533 ' HB2' ' CG ' ' A' ' 56' ' ' GLN . 68.3 tttt . . . . . 0 N--CA 1.492 1.645 0 CA-C-O 118.04 -0.981 . . . . 0.0 110.191 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.566 ' CZ ' ' SG ' ' A' ' 37' ' ' CYS . 30.4 p90 . . . . . 0 N--CA 1.491 1.608 0 CA-C-O 121.327 0.584 . . . . 0.0 110.153 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' ASN . . . . . 0.507 ' ND2' ' OG ' ' A' ' 39' ' ' SER . 23.4 p-10 -88.15 100.45 12.97 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.198 -0.939 . . . . 0.0 110.243 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.566 ' SG ' ' CZ ' ' A' ' 35' ' ' TYR . 14.8 m -72.1 -22.2 61.38 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.287 -0.883 . . . . 0.0 110.086 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.585 HG23 ' N ' ' A' ' 39' ' ' SER . 35.8 m -60.98 -45.19 98.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.231 -0.918 . . . . 0.0 110.46 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' SER . . . . . 0.585 ' N ' HG23 ' A' ' 38' ' ' VAL . 95.0 p -60.6 -31.61 70.76 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.202 -0.936 . . . . 0.0 110.211 -179.928 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 72.8 m -73.64 -12.43 60.74 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.304 -0.872 . . . . 0.0 110.192 179.89 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 101.83 -11.27 57.59 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.431 -1.468 . . . . 0.0 109.431 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.511 ' CA ' ' O ' ' A' ' 67' ' ' CYS . . . -85.18 172.49 47.44 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.412 -1.475 . . . . 0.0 109.412 -179.912 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' GLN . . . . . 0.515 ' N ' ' O ' ' A' ' 67' ' ' CYS . 0.2 OUTLIER -123.28 -174.82 3.04 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.27 -1.135 . . . . 0.0 110.151 179.959 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 13.7 t -130.11 116.38 18.41 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.161 -0.962 . . . . 0.0 110.222 -179.947 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.505 HD12 ' HD3' ' A' ' 50' ' ' PRO . 93.5 mt -105.46 175.84 5.36 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.251 -0.905 . . . . 0.0 110.224 179.858 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 98.3 m-85 -102.45 -3.44 26.95 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.278 -0.889 . . . . 0.0 110.291 -179.877 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.407 ' O ' ' C ' ' A' ' 48' ' ' ALA . 69.3 m -122.76 166.49 14.86 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.272 -0.893 . . . . 0.0 110.246 179.967 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.422 ' O ' ' C ' ' A' ' 49' ' ' CYS . . . -42.97 131.64 4.15 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.243 -0.911 . . . . 0.0 110.19 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' CYS . . . . . 0.422 ' C ' ' O ' ' A' ' 48' ' ' ALA . 5.9 t -42.96 130.02 3.19 Favored Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 121.29 -0.881 . . . . 0.0 110.251 -179.981 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.505 ' HD3' HD12 ' A' ' 45' ' ' LEU . 47.4 Cg_endo -72.81 145.6 41.08 Favored 'Trans proline' 0 C--N 1.306 -1.689 0 O-C-N 123.945 1.497 . . . . 0.0 110.412 -179.993 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 45.1 pt -59.63 -18.48 14.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.254 -0.904 . . . . 0.0 110.192 179.918 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 91.8 m-85 -70.86 -4.49 24.54 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.293 -0.88 . . . . 0.0 110.256 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 69.5 p -137.69 170.76 15.51 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.286 -0.884 . . . . 0.0 110.248 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.477 ' O ' ' HA ' ' A' ' 67' ' ' CYS . 70.9 tttt -91.27 162.79 14.48 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.215 -0.928 . . . . 0.0 110.209 -179.953 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.771 HG23 ' O ' ' A' ' 55' ' ' ILE . 15.1 tt -93.47 100.65 11.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.268 -0.895 . . . . 0.0 110.145 -179.963 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' GLN . . . . . 0.545 ' HB2' ' CB ' ' A' ' 66' ' ' CYS . 23.7 mm100 -75.45 0.01 18.53 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.245 -0.909 . . . . 0.0 110.218 179.98 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 111.75 -127.49 8.15 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.497 -1.441 . . . . 0.0 109.497 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.454 ' HA ' ' HD3' ' A' ' 65' ' ' LYS . 71.0 p -105.23 168.62 8.95 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.213 -1.169 . . . . 0.0 110.203 -179.986 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 59' ' ' CYS . . . . . 0.933 ' SG ' ' SG ' ' A' ' 66' ' ' CYS . 0.1 OUTLIER -117.66 -149.23 0.44 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.222 -0.924 . . . . 0.0 110.179 179.968 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 98.0 m-85 -58.34 -46.47 86.18 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.298 -0.876 . . . . 0.0 110.199 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' ARG . . . . . 0.466 ' HD2' ' HD3' ' A' ' 63' ' ' LYS . 33.1 ttm180 -129.54 164.76 23.09 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.263 -0.898 . . . . 0.0 110.161 179.989 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 62' ' ' GLY . . . . . 0.431 ' N ' ' HG2' ' A' ' 61' ' ' ARG . . . -61.3 -23.2 61.95 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.466 ' HD3' ' HD2' ' A' ' 61' ' ' ARG . 44.1 mtpt -72.34 -28.53 63.11 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.21 -1.171 . . . . 0.0 110.228 -179.986 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.419 ' C ' ' HG2' ' A' ' 65' ' ' LYS . . . -107.31 160.44 15.61 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.225 -0.922 . . . . 0.0 110.284 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.511 ' CA ' ' HB2' ' A' ' 59' ' ' CYS . 34.0 mmtm -142.68 144.76 32.87 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.21 -0.931 . . . . 0.0 110.086 179.984 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 66' ' ' CYS . . . . . 0.933 ' SG ' ' SG ' ' A' ' 59' ' ' CYS . 79.9 m -83.56 132.24 34.93 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.173 -0.955 . . . . 0.0 110.163 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' CYS . . . . . 0.515 ' O ' ' N ' ' A' ' 43' ' ' GLN . 85.0 m -126.76 154.19 44.54 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.28 -0.888 . . . . 0.0 110.18 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.428 ' HB2' ' CD ' ' A' ' 56' ' ' GLN . 85.2 tttt . . . . . 0 N--CA 1.491 1.577 0 CA-C-O 117.951 -1.023 . . . . 0.0 110.271 179.999 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 3.6 t80 . . . . . 0 N--CA 1.491 1.619 0 CA-C-O 121.294 0.569 . . . . 0.0 110.252 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 36' ' ' ASN . . . . . 0.743 HD22 ' CG2' ' A' ' 38' ' ' VAL . 3.2 t-20 -100.79 117.27 34.54 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.236 -0.915 . . . . 0.0 110.157 179.931 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.45 ' O ' ' N ' ' A' ' 40' ' ' SER . 37.7 m -85.22 -51.07 6.86 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.332 -0.855 . . . . 0.0 110.311 -179.941 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.743 ' CG2' HD22 ' A' ' 36' ' ' ASN . 21.7 m -41.75 -46.26 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.248 -0.908 . . . . 0.0 110.33 -179.896 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 39' ' ' SER . . . . . 0.57 ' N ' HG23 ' A' ' 38' ' ' VAL . 0.8 OUTLIER -59.02 -32.18 69.49 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.177 -0.952 . . . . 0.0 110.14 179.98 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.483 ' O ' ' NZ ' ' A' ' 68' ' ' LYS . 50.2 m -75.43 -9.97 59.04 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.347 -0.846 . . . . 0.0 110.156 -179.991 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 41' ' ' GLY . . . . . 0.401 ' HA3' ' HE3' ' A' ' 68' ' ' LYS . . . 108.29 -20.54 30.31 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 179.931 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.444 ' O ' ' HA ' ' A' ' 38' ' ' VAL . . . -78.27 177.61 53.39 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.592 -1.403 . . . . 0.0 109.592 179.94 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 43' ' ' GLN . . . . . 0.517 ' O ' ' HA ' ' A' ' 66' ' ' CYS . 29.2 tt0 -125.38 155.93 39.58 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.206 -1.173 . . . . 0.0 110.192 179.921 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 15.7 t -104.5 104.09 13.88 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.257 -0.902 . . . . 0.0 110.281 -179.96 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.477 HD12 ' CD ' ' A' ' 50' ' ' PRO . 80.3 mt -88.7 174.63 7.91 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.217 -0.927 . . . . 0.0 110.238 179.966 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 88.8 m-85 -96.13 -19.48 19.35 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.21 -0.931 . . . . 0.0 110.185 -179.929 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.419 ' O ' ' C ' ' A' ' 48' ' ' ALA . 69.1 m -110.47 165.66 11.61 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.181 -0.949 . . . . 0.0 110.257 -179.934 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.419 ' C ' ' O ' ' A' ' 47' ' ' SER . . . -42.92 131.95 4.04 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.315 -0.866 . . . . 0.0 110.217 179.978 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 8.7 t -44.68 127.63 5.07 Favored Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.205 -0.934 . . . . 0.0 110.106 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.477 ' CD ' HD12 ' A' ' 45' ' ' LEU . 46.7 Cg_endo -72.4 149.46 50.51 Favored 'Trans proline' 0 C--N 1.306 -1.681 0 O-C-N 123.949 1.499 . . . . 0.0 110.402 -179.999 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.425 HG13 ' N ' ' A' ' 52' ' ' PHE . 27.8 pt -63.6 -22.28 30.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.244 -0.91 . . . . 0.0 110.211 179.933 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 52' ' ' PHE . . . . . 0.425 ' N ' HG13 ' A' ' 51' ' ' ILE . 91.0 m-85 -56.98 -20.28 22.93 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.215 -0.928 . . . . 0.0 110.211 -179.998 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 17.6 p -133.93 162.85 30.91 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.302 -0.874 . . . . 0.0 110.18 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 55.6 mttm -95.36 143.94 26.32 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.221 -0.924 . . . . 0.0 110.129 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.721 HG23 ' O ' ' A' ' 55' ' ' ILE . 18.2 tt -88.76 113.26 25.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.213 -0.929 . . . . 0.0 110.184 -179.979 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 56' ' ' GLN . . . . . 0.401 ' CD ' ' HB3' ' A' ' 68' ' ' LYS . 27.0 mm100 -72.41 -28.06 62.73 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.249 -0.907 . . . . 0.0 110.153 -179.975 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 176.88 -148.92 9.24 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.457 -1.457 . . . . 0.0 109.457 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 43.2 p -99.48 163.57 12.46 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.182 -1.187 . . . . 0.0 110.199 179.93 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' CYS . . . . . 0.864 ' SG ' ' SG ' ' A' ' 66' ' ' CYS . 0.8 OUTLIER -98.07 -160.41 0.8 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.277 -0.889 . . . . 0.0 110.318 -179.976 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 85.2 m-85 -57.51 -46.91 83.25 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.355 -0.84 . . . . 0.0 110.197 179.874 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 95.3 mtt180 -127.21 167.97 15.35 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.251 -0.906 . . . . 0.0 110.14 -179.978 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -68.52 -12.19 63.52 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.477 -1.449 . . . . 0.0 109.477 -179.947 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 53.9 mtmt -75.84 -23.66 55.74 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.291 -1.123 . . . . 0.0 110.244 179.999 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -113.26 163.09 15.24 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.255 -0.903 . . . . 0.0 110.249 -179.93 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -140.03 141.05 36.31 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.306 -0.871 . . . . 0.0 110.199 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' CYS . . . . . 0.864 ' SG ' ' SG ' ' A' ' 59' ' ' CYS . 58.6 m -84.99 148.05 26.38 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.248 -0.907 . . . . 0.0 110.154 -179.982 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 67' ' ' CYS . . . . . 0.436 ' SG ' ' HD2' ' A' ' 50' ' ' PRO . 80.5 m -143.64 128.08 17.93 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.276 -0.89 . . . . 0.0 110.195 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.483 ' NZ ' ' O ' ' A' ' 40' ' ' SER . 75.2 tttt . . . . . 0 N--CA 1.492 1.636 0 CA-C-O 118.058 -0.972 . . . . 0.0 110.194 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 43.2 t80 . . . . . 0 N--CA 1.492 1.645 0 CA-C-O 121.248 0.547 . . . . 0.0 110.161 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 17.4 p-10 -111.1 123.82 50.96 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.291 -0.881 . . . . 0.0 110.235 -179.949 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.65 ' SG ' ' SG ' ' A' ' 59' ' ' CYS . 22.3 m -68.62 -6.86 28.24 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.242 -0.912 . . . . 0.0 110.161 179.856 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 39.8 t -71.7 -41.52 70.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.236 -0.915 . . . . 0.0 110.157 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 3.1 m -51.4 -29.39 15.55 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.269 -0.894 . . . . 0.0 110.054 179.954 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.444 ' CB ' ' HB3' ' A' ' 56' ' ' GLN . 26.6 m -88.89 -17.36 29.76 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.236 -0.915 . . . . 0.0 110.058 179.898 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 41' ' ' GLY . . . . . 0.473 ' O ' ' HG3' ' A' ' 68' ' ' LYS . . . 108.06 8.75 29.11 Favored Glycine 0 N--CA 1.489 2.197 0 N-CA-C 109.488 -1.445 . . . . 0.0 109.488 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.511 ' CA ' ' O ' ' A' ' 67' ' ' CYS . . . -110.18 173.0 16.11 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.498 -1.441 . . . . 0.0 109.498 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 43' ' ' GLN . . . . . 0.485 ' N ' ' O ' ' A' ' 67' ' ' CYS . 2.0 pt20 -110.34 174.53 5.82 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.237 -1.155 . . . . 0.0 110.246 179.951 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 8.7 t -110.98 84.38 1.92 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.228 -0.92 . . . . 0.0 110.218 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.494 HD12 ' HA ' ' A' ' 45' ' ' LEU . 14.4 tp -69.26 167.09 17.06 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.357 -0.839 . . . . 0.0 110.191 -180.0 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 60.1 m-85 -91.77 -24.85 19.28 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.293 -0.88 . . . . 0.0 110.314 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.422 ' O ' ' C ' ' A' ' 48' ' ' ALA . 73.7 m -106.81 167.44 9.87 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.2 -0.937 . . . . 0.0 110.261 -179.928 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.422 ' C ' ' O ' ' A' ' 47' ' ' SER . . . -43.02 128.02 4.29 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.188 -0.945 . . . . 0.0 110.163 -179.965 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 8.2 t -46.12 130.4 7.39 Favored Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.277 -0.889 . . . . 0.0 110.3 -179.865 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.469 ' HD2' ' SG ' ' A' ' 67' ' ' CYS . 46.3 Cg_endo -72.74 151.1 51.3 Favored 'Trans proline' 0 C--N 1.307 -1.62 0 O-C-N 123.882 1.464 . . . . 0.0 110.302 179.843 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 37.0 pt -64.03 -21.23 28.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.196 -0.94 . . . . 0.0 110.305 179.982 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 82.1 m-85 -61.45 -19.9 62.51 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.206 -0.934 . . . . 0.0 110.174 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 38.8 p -118.57 168.64 10.5 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.25 -0.906 . . . . 0.0 110.192 -179.953 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.472 ' O ' ' HA ' ' A' ' 67' ' ' CYS . 30.1 tttt -96.83 162.38 13.44 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.223 -0.923 . . . . 0.0 110.142 179.983 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.686 HG23 ' O ' ' A' ' 55' ' ' ILE . 20.8 tt -97.6 116.43 40.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.247 -0.908 . . . . 0.0 110.171 179.961 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 56' ' ' GLN . . . . . 0.49 ' HB2' ' HB3' ' A' ' 66' ' ' CYS . 61.6 mm-40 -93.36 -1.46 55.87 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.244 -0.91 . . . . 0.0 110.177 -179.919 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 142.47 -131.61 4.75 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.423 -1.471 . . . . 0.0 109.423 -179.935 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.447 ' O ' ' SG ' ' A' ' 66' ' ' CYS . 18.5 p -120.88 164.91 15.95 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.227 -1.16 . . . . 0.0 110.189 179.988 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 59' ' ' CYS . . . . . 0.65 ' SG ' ' SG ' ' A' ' 37' ' ' CYS . 0.5 OUTLIER -105.86 -158.78 0.67 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.242 -0.911 . . . . 0.0 110.276 -179.902 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 99.6 m-85 -57.36 -50.6 72.43 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.257 -0.902 . . . . 0.0 110.133 179.922 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 74.2 mtm180 -123.55 165.25 17.46 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.284 -0.885 . . . . 0.0 110.128 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -61.51 -21.35 60.14 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.48 -1.448 . . . . 0.0 109.48 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 2.8 tptt -67.63 -31.35 71.31 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.26 -1.141 . . . . 0.0 110.215 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -102.6 158.56 16.14 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.384 -0.823 . . . . 0.0 110.145 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 70.3 mmtt -141.85 160.29 40.5 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.304 -0.872 . . . . 0.0 110.132 -179.954 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' CYS . . . . . 0.49 ' HB3' ' HB2' ' A' ' 56' ' ' GLN . 66.6 m -82.1 132.07 35.24 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.206 -0.934 . . . . 0.0 110.212 -179.983 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 67' ' ' CYS . . . . . 0.511 ' O ' ' CA ' ' A' ' 42' ' ' GLY . 78.6 m -129.32 124.35 34.11 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.251 -0.906 . . . . 0.0 110.151 -179.951 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.473 ' HG3' ' O ' ' A' ' 41' ' ' GLY . 47.2 tttt . . . . . 0 N--CA 1.491 1.614 0 CA-C-O 117.94 -1.029 . . . . 0.0 110.251 179.96 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.456 ' CD1' ' N ' ' A' ' 36' ' ' ASN . 11.2 t80 . . . . . 0 N--CA 1.492 1.629 0 CA-C-O 121.277 0.56 . . . . 0.0 110.181 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' ASN . . . . . 0.456 ' N ' ' CD1' ' A' ' 35' ' ' TYR . 28.2 p-10 -98.33 55.56 1.12 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.261 -0.899 . . . . 0.0 110.299 179.981 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.429 ' SG ' ' CD1' ' A' ' 35' ' ' TYR . 60.3 m -61.31 -22.51 64.95 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.24 -0.912 . . . . 0.0 110.171 -179.999 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 72.2 t -68.83 -39.94 80.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.22 -0.925 . . . . 0.0 110.211 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' SER . . . . . 0.45 ' OG ' ' ND2' ' A' ' 36' ' ' ASN . 87.4 p -64.13 -26.5 68.56 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.203 -0.935 . . . . 0.0 110.104 179.986 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 50.0 m -81.06 -20.56 41.34 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.237 -0.915 . . . . 0.0 110.198 179.973 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' GLY . . . . . 0.473 ' O ' ' HG3' ' A' ' 68' ' ' LYS . . . 112.14 14.89 10.36 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.511 -1.436 . . . . 0.0 109.511 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.435 ' HA2' ' HA ' ' A' ' 68' ' ' LYS . . . -110.3 171.82 15.09 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.504 -1.439 . . . . 0.0 109.504 179.962 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 43' ' ' GLN . . . . . 0.489 ' N ' ' O ' ' A' ' 67' ' ' CYS . 0.0 OUTLIER -129.24 175.16 8.95 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.25 -1.147 . . . . 0.0 110.301 -179.993 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 6.1 m -110.77 97.01 6.53 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.283 -0.886 . . . . 0.0 110.132 179.885 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.516 ' O ' ' HB1' ' A' ' 64' ' ' ALA . 23.0 tp -86.39 167.22 14.93 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.259 -0.901 . . . . 0.0 110.146 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 95.2 m-85 -92.13 -31.05 15.65 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.219 -0.926 . . . . 0.0 110.345 -179.916 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.422 ' O ' ' C ' ' A' ' 48' ' ' ALA . 76.8 p -92.02 160.61 15.15 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.386 -0.821 . . . . 0.0 110.231 -179.948 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.422 ' C ' ' O ' ' A' ' 47' ' ' SER . . . -42.7 129.28 4.18 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.33 -0.856 . . . . 0.0 110.194 179.937 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 4.1 t -43.15 128.44 3.42 Favored Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.182 -0.949 . . . . 0.0 110.203 -179.853 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.429 ' HD2' ' SG ' ' A' ' 67' ' ' CYS . 46.7 Cg_endo -72.34 146.07 44.46 Favored 'Trans proline' 0 C--N 1.305 -1.713 0 O-C-N 123.95 1.5 . . . . 0.0 110.452 -179.94 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 39.1 pt -60.39 -15.57 10.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.28 -0.887 . . . . 0.0 110.206 -179.951 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 76.1 m-85 -71.63 -10.26 59.5 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.26 -0.9 . . . . 0.0 110.208 179.924 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.463 ' HB ' ' N ' ' A' ' 68' ' ' LYS . 61.5 p -127.78 167.0 17.13 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.237 -0.914 . . . . 0.0 110.189 -179.995 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.466 ' O ' ' HA ' ' A' ' 67' ' ' CYS . 38.1 mttt -103.51 173.05 6.47 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.246 -0.909 . . . . 0.0 110.214 -179.98 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.672 HG23 ' O ' ' A' ' 55' ' ' ILE . 10.8 tp -99.65 119.33 47.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.357 -0.839 . . . . 0.0 110.209 179.961 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 16.1 mm100 -102.03 9.23 40.56 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.269 -0.894 . . . . 0.0 110.264 -179.928 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 129.17 -159.89 22.42 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.448 -1.461 . . . . 0.0 109.448 179.919 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.456 ' O ' ' SG ' ' A' ' 66' ' ' CYS . 19.1 p -92.48 164.28 13.52 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.217 -1.166 . . . . 0.0 110.214 -179.93 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 1.5 m -110.54 -163.14 0.83 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.227 -0.921 . . . . 0.0 110.147 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 67.0 m-85 -49.64 -59.95 3.32 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.391 -0.818 . . . . 0.0 110.151 179.761 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 30.0 mmt180 -120.22 166.3 13.65 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.169 -0.957 . . . . 0.0 110.103 -180.0 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -65.39 -23.63 70.28 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 52.4 mtmt -60.19 -25.42 65.56 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.209 -1.171 . . . . 0.0 110.164 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.516 ' HB1' ' O ' ' A' ' 45' ' ' LEU . . . -117.32 160.96 20.29 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.242 -0.911 . . . . 0.0 110.17 -179.868 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.406 ' HG2' ' C ' ' A' ' 64' ' ' ALA . 28.9 mmtp -137.94 154.64 49.38 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.23 -0.918 . . . . 0.0 110.307 179.946 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 66' ' ' CYS . . . . . 0.456 ' SG ' ' O ' ' A' ' 58' ' ' THR . 71.7 m -72.27 131.42 42.68 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.292 -0.88 . . . . 0.0 110.169 179.911 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 67' ' ' CYS . . . . . 0.489 ' O ' ' N ' ' A' ' 43' ' ' GLN . 94.7 m -129.8 131.24 46.12 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.228 -0.92 . . . . 0.0 110.247 -179.905 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.473 ' HG3' ' O ' ' A' ' 41' ' ' GLY . 84.4 tttt . . . . . 0 N--CA 1.49 1.547 0 CA-C-O 117.995 -1.002 . . . . 0.0 110.182 -179.951 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.568 ' CZ ' ' SG ' ' A' ' 37' ' ' CYS . 1.8 t80 . . . . . 0 N--CA 1.491 1.621 0 CA-C-O 121.275 0.559 . . . . 0.0 110.144 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 9.9 p-10 -121.7 114.66 21.44 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.225 -0.922 . . . . 0.0 110.213 -179.971 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.568 ' SG ' ' CZ ' ' A' ' 35' ' ' TYR . 46.7 m -74.26 -0.35 16.7 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.258 -0.901 . . . . 0.0 110.278 179.982 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 94.7 t -67.3 -33.95 65.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.208 -0.933 . . . . 0.0 110.116 -179.97 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 69.3 m -71.18 -27.81 63.79 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.24 -0.913 . . . . 0.0 110.149 179.912 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 63.7 m -82.42 -9.22 59.53 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.331 -0.855 . . . . 0.0 110.119 179.922 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' GLY . . . . . 0.428 ' C ' ' HG3' ' A' ' 68' ' ' LYS . . . 105.33 -24.61 27.17 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.341 -1.504 . . . . 0.0 109.341 -179.965 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.463 ' N ' ' HG3' ' A' ' 68' ' ' LYS . . . -67.74 -173.57 7.08 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.444 -1.462 . . . . 0.0 109.444 -179.979 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 43' ' ' GLN . . . . . 0.51 ' O ' ' HA ' ' A' ' 66' ' ' CYS . 36.1 tt0 -141.34 144.36 34.53 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.272 -1.134 . . . . 0.0 110.26 -179.941 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 44' ' ' CYS . . . . . 0.416 ' O ' HD23 ' A' ' 45' ' ' LEU . 76.4 m -94.96 137.11 34.46 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.268 -0.895 . . . . 0.0 110.144 179.998 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.678 ' O ' ' HB1' ' A' ' 64' ' ' ALA . 54.0 mt -130.01 178.8 6.27 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.276 -0.89 . . . . 0.0 110.239 -179.982 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 85.9 m-85 -109.46 -1.04 18.61 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.259 -0.901 . . . . 0.0 110.178 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.423 ' O ' ' C ' ' A' ' 48' ' ' ALA . 52.3 m -127.9 171.59 11.65 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.27 -0.894 . . . . 0.0 110.25 -179.984 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.423 ' C ' ' O ' ' A' ' 47' ' ' SER . . . -43.08 145.12 0.54 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.221 -0.924 . . . . 0.0 110.189 179.968 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 16.9 t -55.77 130.28 71.9 Favored Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 121.228 -0.92 . . . . 0.0 110.165 -179.974 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.47 ' HD2' ' SG ' ' A' ' 67' ' ' CYS . 47.5 Cg_endo -73.14 142.32 34.0 Favored 'Trans proline' 0 C--N 1.306 -1.685 0 O-C-N 123.991 1.521 . . . . 0.0 110.402 179.98 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 39.0 pt -63.68 -18.78 22.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.315 -0.866 . . . . 0.0 110.181 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 85.0 m-85 -59.45 -21.55 60.21 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.237 -0.914 . . . . 0.0 110.216 179.944 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.481 ' OG1' ' HB3' ' A' ' 67' ' ' CYS . 20.4 p -132.78 171.15 14.27 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.26 -0.9 . . . . 0.0 110.297 179.869 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.494 ' O ' ' HA ' ' A' ' 67' ' ' CYS . 45.5 tttp -83.68 165.04 19.27 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.24 -0.912 . . . . 0.0 110.21 179.943 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.737 HG23 ' O ' ' A' ' 55' ' ' ILE . 12.0 tt -91.28 108.67 20.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.268 -0.895 . . . . 0.0 110.162 179.895 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 56' ' ' GLN . . . . . 0.493 ' HB2' ' HB3' ' A' ' 66' ' ' CYS . 27.8 mm100 -85.31 -8.84 58.29 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.251 -0.906 . . . . 0.0 110.256 179.937 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 125.43 -124.44 5.28 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 179.941 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.457 ' HB ' ' HA2' ' A' ' 62' ' ' GLY . 16.6 p -117.98 169.49 9.61 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.31 -1.112 . . . . 0.0 110.157 -179.935 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 59' ' ' CYS . . . . . 0.646 ' HB3' ' HB3' ' A' ' 64' ' ' ALA . 0.9 OUTLIER -133.61 140.73 47.3 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.211 -0.931 . . . . 0.0 110.202 179.959 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.507 ' CB ' ' HB3' ' A' ' 63' ' ' LYS . 71.2 m-85 56.07 53.93 8.51 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.293 -0.879 . . . . 0.0 110.414 179.9 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 61' ' ' ARG . . . . . 0.451 ' HB2' ' O ' ' A' ' 60' ' ' TYR . 38.6 mmt180 57.38 39.95 27.87 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.25 -0.906 . . . . 0.0 110.609 179.696 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 62' ' ' GLY . . . . . 0.457 ' HA2' ' HB ' ' A' ' 58' ' ' THR . . . 85.86 -16.45 41.78 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.779 -1.328 . . . . 0.0 109.779 179.603 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.507 ' HB3' ' CB ' ' A' ' 60' ' ' TYR . 5.7 ttpt -55.44 -18.43 6.95 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.103 -1.234 . . . . 0.0 109.767 179.951 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.678 ' HB1' ' O ' ' A' ' 45' ' ' LEU . . . -149.56 172.09 15.57 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.405 -0.81 . . . . 0.0 109.961 179.757 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.405 ' HD2' ' HA ' ' A' ' 65' ' ' LYS . 53.2 tptt -111.15 122.33 47.6 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.147 -0.971 . . . . 0.0 110.275 -179.903 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 66' ' ' CYS . . . . . 0.51 ' HA ' ' O ' ' A' ' 43' ' ' GLN . 42.9 m -81.27 140.98 34.53 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.297 -0.877 . . . . 0.0 110.134 179.977 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 67' ' ' CYS . . . . . 0.494 ' HA ' ' O ' ' A' ' 54' ' ' LYS . 85.0 m -149.53 124.61 10.05 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.198 -0.939 . . . . 0.0 110.222 -179.969 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.463 ' HG3' ' N ' ' A' ' 42' ' ' GLY . 33.4 ttmt . . . . . 0 N--CA 1.491 1.618 0 CA-C-O 117.942 -1.028 . . . . 0.0 110.194 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 2.4 t80 . . . . . 0 N--CA 1.493 1.676 0 CA-C-O 121.271 0.557 . . . . 0.0 110.141 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 36.3 t30 -101.13 108.97 20.79 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.211 -0.931 . . . . 0.0 110.237 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 27.4 m -82.02 -3.78 55.29 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.183 -0.948 . . . . 0.0 110.191 179.948 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 91.9 t -70.18 -45.95 73.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.235 -0.915 . . . . 0.0 110.213 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 22.9 t -60.51 -26.39 66.81 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.258 -0.901 . . . . 0.0 110.175 179.996 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 42.5 m -83.59 -8.35 59.33 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.309 -0.869 . . . . 0.0 110.243 179.935 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' GLY . . . . . 0.435 ' C ' ' HG3' ' A' ' 68' ' ' LYS . . . 91.91 3.58 68.02 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.598 -1.401 . . . . 0.0 109.598 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -90.55 172.67 37.83 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' GLN . . . . . 0.514 ' O ' ' HA ' ' A' ' 66' ' ' CYS . 32.6 tt0 -127.58 137.2 52.52 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.345 -1.091 . . . . 0.0 110.217 -179.967 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 44' ' ' CYS . . . . . 0.57 ' SG ' ' HB3' ' A' ' 64' ' ' ALA . 24.7 t -83.68 113.17 20.67 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.234 -0.916 . . . . 0.0 110.242 179.934 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.659 HD12 ' SG ' ' A' ' 67' ' ' CYS . 47.3 mt -106.05 168.94 8.79 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.186 -0.946 . . . . 0.0 110.269 -179.936 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 91.1 m-85 -104.23 -1.47 27.07 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.286 -0.883 . . . . 0.0 110.231 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.417 ' O ' ' C ' ' A' ' 48' ' ' ALA . 89.5 p -126.99 168.36 14.65 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.211 -0.93 . . . . 0.0 110.257 -179.972 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.417 ' C ' ' O ' ' A' ' 47' ' ' SER . . . -42.86 128.66 4.27 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.251 -0.905 . . . . 0.0 110.136 179.991 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 6.0 t -44.44 132.09 4.72 Favored Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 121.238 -0.914 . . . . 0.0 110.174 179.904 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.443 ' HG2' ' OG1' ' A' ' 53' ' ' THR . 46.9 Cg_endo -73.19 148.58 44.42 Favored 'Trans proline' 0 C--N 1.306 -1.674 0 O-C-N 123.867 1.456 . . . . 0.0 110.406 -179.982 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 13.1 mt -62.96 -22.24 30.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.284 -0.885 . . . . 0.0 110.152 179.966 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -71.02 -3.94 22.27 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.313 -0.867 . . . . 0.0 110.218 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.504 ' CB ' ' HB3' ' A' ' 67' ' ' CYS . 54.6 p -133.27 162.55 31.5 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.241 -0.912 . . . . 0.0 110.276 179.978 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.484 ' O ' ' HA ' ' A' ' 67' ' ' CYS . 46.8 tttp -93.18 168.36 11.15 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.287 -0.883 . . . . 0.0 110.234 179.978 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.582 HG23 ' O ' ' A' ' 55' ' ' ILE . 18.5 tt -87.78 125.11 41.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.237 -0.914 . . . . 0.0 110.207 179.962 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 56' ' ' GLN . . . . . 0.523 ' HB2' ' CB ' ' A' ' 66' ' ' CYS . 26.7 mm100 -107.49 7.96 29.15 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.193 -0.942 . . . . 0.0 110.201 179.99 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 102.31 -140.1 14.71 Favored Glycine 0 N--CA 1.489 2.176 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 179.975 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.446 ' O ' ' SG ' ' A' ' 66' ' ' CYS . 38.7 p -98.75 -174.11 2.7 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.23 -1.159 . . . . 0.0 110.182 179.987 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 59' ' ' CYS . . . . . 0.773 ' SG ' ' SG ' ' A' ' 66' ' ' CYS . 1.2 m -112.48 -161.24 0.75 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.251 -0.905 . . . . 0.0 110.27 -179.957 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 74.4 m-85 -49.83 -65.62 0.53 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.238 -0.914 . . . . 0.0 110.411 179.952 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' ARG . . . . . 0.403 ' CD ' ' HE2' ' A' ' 63' ' ' LYS . 56.7 mtt180 -93.29 -14.49 26.9 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.241 -0.912 . . . . 0.0 110.446 -179.834 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 101.65 -21.02 44.04 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.366 -1.494 . . . . 0.0 109.366 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.403 ' HE2' ' CD ' ' A' ' 61' ' ' ARG . 37.0 mtmt -57.44 -30.2 64.8 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.278 -1.131 . . . . 0.0 109.98 179.77 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.57 ' HB3' ' SG ' ' A' ' 44' ' ' CYS . . . -106.54 159.41 16.2 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.498 -0.751 . . . . 0.0 110.268 -179.82 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.41 ' HD2' ' HA ' ' A' ' 65' ' ' LYS . 49.5 tptt -112.49 120.53 41.96 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.185 -0.947 . . . . 0.0 110.208 -179.902 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 66' ' ' CYS . . . . . 0.773 ' SG ' ' SG ' ' A' ' 59' ' ' CYS . 79.4 m -68.95 151.46 46.51 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.308 -0.87 . . . . 0.0 110.127 179.958 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 67' ' ' CYS . . . . . 0.659 ' SG ' HD12 ' A' ' 45' ' ' LEU . 90.4 m -149.0 125.32 10.86 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.146 -0.971 . . . . 0.0 110.219 179.994 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.435 ' HG3' ' C ' ' A' ' 41' ' ' GLY . 26.9 tttp . . . . . 0 N--CA 1.491 1.613 0 CA-C-O 118.013 -0.994 . . . . 0.0 110.212 179.952 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.473 ' CZ ' ' SG ' ' A' ' 37' ' ' CYS . 27.6 p90 . . . . . 0 N--CA 1.491 1.611 0 CA-C-O 121.221 0.534 . . . . 0.0 110.26 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 25.2 t30 -91.09 102.43 15.18 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.277 -0.889 . . . . 0.0 110.339 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.493 ' O ' ' N ' ' A' ' 40' ' ' SER . 57.5 m -59.49 -48.62 80.93 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.288 -0.882 . . . . 0.0 110.245 -179.97 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.438 ' C ' ' O ' ' A' ' 37' ' ' CYS . 39.5 t -40.45 -53.6 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.455 -0.778 . . . . 0.0 110.46 -179.862 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 5.1 t -53.16 -28.04 24.23 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.315 -0.866 . . . . 0.0 110.162 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.493 ' N ' ' O ' ' A' ' 37' ' ' CYS . 38.9 m -83.37 -8.0 59.48 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.272 -0.893 . . . . 0.0 110.252 179.957 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 106.03 -23.24 29.64 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.443 -1.463 . . . . 0.0 109.443 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.42 ' HA2' ' HA ' ' A' ' 68' ' ' LYS . . . -71.52 171.99 46.05 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 179.926 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 43' ' ' GLN . . . . . 0.626 ' OE1' HD21 ' A' ' 45' ' ' LEU . 10.9 tt0 -128.01 133.77 49.18 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.234 -1.156 . . . . 0.0 110.336 -179.975 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 44' ' ' CYS . . . . . 0.663 ' SG ' ' SG ' ' A' ' 66' ' ' CYS . 4.2 m -91.95 111.95 23.69 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.236 -0.915 . . . . 0.0 110.208 -179.996 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.626 HD21 ' OE1' ' A' ' 43' ' ' GLN . 75.1 mt -107.83 175.09 5.6 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.293 -0.879 . . . . 0.0 110.178 -179.88 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 72.9 m-85 -99.64 -11.24 21.1 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.328 -0.858 . . . . 0.0 110.3 179.985 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 41.2 t -111.98 166.46 11.21 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.213 -0.929 . . . . 0.0 110.229 -179.88 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -43.69 145.23 0.68 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.211 -0.931 . . . . 0.0 110.214 179.946 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 17.2 t -49.04 131.54 15.46 Favored Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.221 -0.924 . . . . 0.0 110.238 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.511 ' HD3' HD12 ' A' ' 45' ' ' LEU . 47.9 Cg_endo -73.23 164.37 35.49 Favored 'Trans proline' 0 C--N 1.306 -1.686 0 O-C-N 123.898 1.472 . . . . 0.0 110.471 -179.904 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 27.4 mt -74.89 -26.24 19.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.193 -0.942 . . . . 0.0 110.159 179.801 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 99.5 m-85 -66.62 -9.39 35.15 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.323 -0.86 . . . . 0.0 110.159 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.501 ' CB ' ' HB3' ' A' ' 67' ' ' CYS . 67.7 p -133.23 158.99 41.5 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.28 -0.887 . . . . 0.0 110.141 179.999 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.477 ' O ' ' HA ' ' A' ' 67' ' ' CYS . 63.1 mttt -100.58 172.42 7.11 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.206 -0.933 . . . . 0.0 110.247 -179.988 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.499 HG23 ' O ' ' A' ' 55' ' ' ILE . 21.0 tt -79.85 131.19 34.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.189 -0.944 . . . . 0.0 110.22 -179.957 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 90.2 mm-40 -119.04 -3.12 10.69 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.347 -0.846 . . . . 0.0 110.228 -179.945 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 131.7 -131.85 6.5 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.418 -1.473 . . . . 0.0 109.418 -179.996 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.45 ' O ' ' SG ' ' A' ' 66' ' ' CYS . 72.7 p -123.4 168.79 12.07 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.291 -1.123 . . . . 0.0 110.263 -179.984 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 59' ' ' CYS . . . . . 1.298 ' SG ' ' SG ' ' A' ' 66' ' ' CYS . 9.8 m -111.55 -163.31 0.84 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.217 -0.927 . . . . 0.0 110.29 179.924 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.427 ' C ' ' O ' ' A' ' 59' ' ' CYS . 68.9 m-85 -41.9 -46.85 4.15 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.312 -0.868 . . . . 0.0 110.317 179.859 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -124.42 171.62 9.8 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.198 -0.939 . . . . 0.0 110.117 179.898 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -72.5 -23.25 78.24 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.463 -1.455 . . . . 0.0 109.463 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 38.2 ttmt -65.41 -34.55 78.57 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.202 -1.176 . . . . 0.0 110.291 179.951 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -94.73 163.23 13.45 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.3 -0.875 . . . . 0.0 110.162 -179.923 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.447 ' HE3' HG13 ' A' ' 55' ' ' ILE . 50.4 tptt -140.05 135.98 33.18 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.253 -0.905 . . . . 0.0 110.118 -179.957 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 66' ' ' CYS . . . . . 1.298 ' SG ' ' SG ' ' A' ' 59' ' ' CYS . 73.8 m -85.17 136.61 33.46 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.279 -0.888 . . . . 0.0 110.257 179.969 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 67' ' ' CYS . . . . . 0.501 ' HB3' ' CB ' ' A' ' 53' ' ' THR . 76.4 m -141.51 129.78 22.31 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.266 -0.897 . . . . 0.0 110.144 -179.973 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.42 ' HA ' ' HA2' ' A' ' 42' ' ' GLY . 40.4 tttt . . . . . 0 N--CA 1.492 1.65 0 CA-C-O 118.065 -0.969 . . . . 0.0 110.169 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.548 ' CD1' ' SG ' ' A' ' 37' ' ' CYS . 2.3 t80 . . . . . 0 N--CA 1.491 1.615 0 CA-C-O 121.223 0.535 . . . . 0.0 110.17 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' ASN . . . . . 0.422 ' O ' ' CG ' ' A' ' 36' ' ' ASN . 22.0 p-10 -98.52 64.31 1.53 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.251 -0.906 . . . . 0.0 110.256 -179.918 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.548 ' SG ' ' CD1' ' A' ' 35' ' ' TYR . 34.4 m -62.89 -52.0 64.79 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.221 -0.924 . . . . 0.0 110.174 179.893 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.4 ' HA ' ' O ' ' A' ' 42' ' ' GLY . 68.8 t -54.04 -40.31 45.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.236 -0.915 . . . . 0.0 110.247 179.923 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 33.6 t -60.99 -30.57 70.36 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.146 -0.972 . . . . 0.0 110.255 179.945 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.44 ' O ' ' HE3' ' A' ' 68' ' ' LYS . 72.1 m -82.63 -7.96 59.62 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.358 -0.839 . . . . 0.0 110.165 179.97 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 104.17 5.47 43.5 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.514 ' CA ' ' O ' ' A' ' 67' ' ' CYS . . . -93.56 176.88 37.09 Favored Glycine 0 N--CA 1.489 2.198 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 -179.985 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 43' ' ' GLN . . . . . 0.504 ' N ' ' O ' ' A' ' 67' ' ' CYS . 16.1 tt0 -132.39 132.87 43.28 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.249 -1.147 . . . . 0.0 110.2 -179.926 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 22.6 m -95.78 116.66 29.22 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.336 -0.853 . . . . 0.0 110.298 179.977 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.696 HD12 ' HD3' ' A' ' 50' ' ' PRO . 92.5 mt -101.76 175.32 5.59 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.296 -0.877 . . . . 0.0 110.161 179.967 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 -91.37 -3.1 57.08 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.241 -0.912 . . . . 0.0 110.227 179.957 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.402 ' O ' ' C ' ' A' ' 48' ' ' ALA . 59.1 p -126.56 167.85 15.08 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.18 -0.95 . . . . 0.0 110.183 -179.976 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.48 ' HA ' ' HG3' ' A' ' 65' ' ' LYS . . . -42.62 148.19 0.24 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.271 -0.893 . . . . 0.0 110.192 179.952 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 17.1 t -52.86 130.37 47.94 Favored Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.24 -0.913 . . . . 0.0 110.077 179.986 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.696 ' HD3' HD12 ' A' ' 45' ' ' LEU . 47.5 Cg_endo -72.67 149.33 48.63 Favored 'Trans proline' 0 C--N 1.306 -1.68 0 O-C-N 123.88 1.463 . . . . 0.0 110.442 -179.924 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 44.9 pt -67.24 -11.26 13.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.26 -0.9 . . . . 0.0 110.128 179.961 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 55.5 m-85 -62.62 -25.56 68.17 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.255 -0.903 . . . . 0.0 110.157 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.484 ' OG1' ' HB3' ' A' ' 67' ' ' CYS . 69.1 p -143.01 158.86 43.2 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.348 -0.845 . . . . 0.0 110.218 -179.99 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.474 ' O ' ' HA ' ' A' ' 67' ' ' CYS . 84.7 mttt -77.52 176.81 8.56 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.21 -0.932 . . . . 0.0 110.161 -179.961 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.432 HG13 ' O ' ' A' ' 66' ' ' CYS . 19.7 tt -108.79 137.63 39.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.188 -0.945 . . . . 0.0 110.225 -179.982 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 56' ' ' GLN . . . . . 0.459 ' HG3' ' HB2' ' A' ' 68' ' ' LYS . 21.5 mm100 -98.83 -24.87 14.83 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.282 -0.886 . . . . 0.0 110.181 179.971 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 162.89 -152.39 22.54 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.444 -1.462 . . . . 0.0 109.444 179.997 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.445 ' O ' ' SG ' ' A' ' 66' ' ' CYS . 82.6 p -90.81 161.51 15.24 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.274 -1.133 . . . . 0.0 110.214 -179.921 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 59' ' ' CYS . . . . . 0.504 ' SG ' ' N ' ' A' ' 66' ' ' CYS . 16.8 m -110.19 -163.03 0.83 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.348 -0.845 . . . . 0.0 110.243 -179.966 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.428 ' C ' ' O ' ' A' ' 59' ' ' CYS . 80.1 m-85 -41.21 -48.38 3.49 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.422 -0.799 . . . . 0.0 110.402 179.92 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 88.8 mtm-85 -129.45 159.28 36.76 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.247 -0.908 . . . . 0.0 110.246 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -60.89 -24.65 62.91 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.436 -1.466 . . . . 0.0 109.436 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 47.4 mtpt -63.64 -32.55 74.07 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.272 -1.134 . . . . 0.0 110.203 179.891 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -96.68 164.41 12.6 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.421 -0.799 . . . . 0.0 110.16 -179.847 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.48 ' HG3' ' HA ' ' A' ' 48' ' ' ALA . 75.6 mmtt -134.54 140.74 46.37 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.244 -0.91 . . . . 0.0 110.169 -179.911 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 66' ' ' CYS . . . . . 0.504 ' N ' ' SG ' ' A' ' 59' ' ' CYS . 89.0 m -88.8 134.04 34.06 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.269 -0.895 . . . . 0.0 110.206 179.96 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 67' ' ' CYS . . . . . 0.514 ' O ' ' CA ' ' A' ' 42' ' ' GLY . 34.6 m -136.26 152.01 50.26 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.208 -0.932 . . . . 0.0 110.201 179.979 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.459 ' HB2' ' HG3' ' A' ' 56' ' ' GLN . 77.5 tttt . . . . . 0 N--CA 1.49 1.549 0 CA-C-O 118.005 -0.998 . . . . 0.0 110.22 -179.97 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.561 ' CD1' ' SG ' ' A' ' 37' ' ' CYS . 3.2 t80 . . . . . 0 N--CA 1.491 1.597 0 CA-C-O 121.26 0.553 . . . . 0.0 110.205 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' ASN . . . . . 0.553 ' ND2' ' CB ' ' A' ' 39' ' ' SER . 59.3 t30 -85.67 60.54 6.3 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.272 -0.893 . . . . 0.0 110.152 179.952 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.561 ' SG ' ' CD1' ' A' ' 35' ' ' TYR . 25.3 m -67.81 -53.22 28.73 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.307 -0.871 . . . . 0.0 110.24 179.991 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 75.4 t -43.92 -54.89 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.263 -0.898 . . . . 0.0 110.179 179.982 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' SER . . . . . 0.553 ' CB ' ' ND2' ' A' ' 36' ' ' ASN . 62.3 m -50.31 -35.19 26.46 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.192 -0.942 . . . . 0.0 110.218 -179.968 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.45 ' HB2' ' O ' ' A' ' 37' ' ' CYS . 72.5 m -70.73 -15.17 62.67 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.285 -0.884 . . . . 0.0 110.145 -179.976 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 41' ' ' GLY . . . . . 0.413 ' C ' ' HG3' ' A' ' 68' ' ' LYS . . . 108.53 -14.85 35.49 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.475 -1.45 . . . . 0.0 109.475 -179.992 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.473 ' CA ' ' O ' ' A' ' 67' ' ' CYS . . . -85.27 175.34 49.66 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.494 -1.442 . . . . 0.0 109.494 -179.984 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 43' ' ' GLN . . . . . 0.45 ' N ' ' O ' ' A' ' 67' ' ' CYS . 0.9 OUTLIER -115.14 179.76 3.86 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.2 -1.176 . . . . 0.0 110.164 -179.972 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 49.7 t -114.17 98.17 6.79 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.247 -0.908 . . . . 0.0 110.188 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.459 ' O ' ' HB1' ' A' ' 64' ' ' ALA . 71.4 mt -88.98 173.27 8.57 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.3 -0.875 . . . . 0.0 110.181 179.901 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 83.4 m-85 -109.6 -1.99 17.81 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.24 -0.912 . . . . 0.0 110.314 -179.962 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.414 ' O ' ' C ' ' A' ' 48' ' ' ALA . 74.7 m -125.42 166.17 17.09 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.191 -0.943 . . . . 0.0 110.173 179.925 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.414 ' C ' ' O ' ' A' ' 47' ' ' SER . . . -42.69 131.01 4.06 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.246 -0.909 . . . . 0.0 110.177 -179.91 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 49' ' ' CYS . . . . . 0.412 ' C ' ' O ' ' A' ' 48' ' ' ALA . 4.4 t -43.39 130.46 3.63 Favored Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 121.223 -0.923 . . . . 0.0 110.219 -179.988 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.491 ' HG2' ' CG2' ' A' ' 53' ' ' THR . 46.4 Cg_endo -72.74 156.57 53.06 Favored 'Trans proline' 0 C--N 1.306 -1.661 0 O-C-N 123.86 1.453 . . . . 0.0 110.446 179.978 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 21.5 mt -67.85 -28.62 42.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.224 -0.923 . . . . 0.0 110.243 -179.93 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 88.8 m-85 -67.69 -11.8 59.09 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.348 -0.845 . . . . 0.0 110.191 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.491 ' CG2' ' HG2' ' A' ' 50' ' ' PRO . 34.0 p -121.79 172.63 8.02 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.256 -0.903 . . . . 0.0 110.1 179.897 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.488 ' O ' ' HA ' ' A' ' 67' ' ' CYS . 80.4 mttt -111.34 127.54 55.68 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.309 -0.869 . . . . 0.0 110.296 -179.986 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 20.6 tt -67.35 138.73 22.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.246 -0.908 . . . . 0.0 110.216 179.956 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' GLN . . . . . 0.439 ' NE2' ' HB3' ' A' ' 54' ' ' LYS . 48.9 mm-40 -128.62 13.94 6.47 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.264 -0.898 . . . . 0.0 110.217 -179.941 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 57' ' ' GLY . . . . . 0.4 ' O ' ' HB2' ' A' ' 66' ' ' CYS . . . 119.52 179.81 16.62 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.451 -1.46 . . . . 0.0 109.451 179.956 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 17.0 p -75.79 168.99 19.01 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.307 -1.113 . . . . 0.0 110.266 179.969 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' CYS . . . . . 0.974 ' HB3' ' HB3' ' A' ' 64' ' ' ALA . 9.7 t -109.29 -65.36 1.15 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.198 -0.938 . . . . 0.0 110.27 179.89 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.536 ' HB3' ' CE ' ' A' ' 63' ' ' LYS . 78.2 m-85 -121.72 92.6 3.77 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.457 -0.777 . . . . 0.0 110.282 179.981 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 36.3 mmt180 51.52 25.39 2.69 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.269 -0.894 . . . . 0.0 110.296 179.994 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 89.97 -11.56 70.29 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.536 ' CE ' ' HB3' ' A' ' 60' ' ' TYR . 50.5 mtmt -58.58 -23.04 57.72 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.259 -1.142 . . . . 0.0 110.095 -179.99 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.974 ' HB3' ' HB3' ' A' ' 59' ' ' CYS . . . -138.37 161.86 35.88 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.261 -0.9 . . . . 0.0 110.148 179.936 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 65.1 mmtt -113.25 122.93 48.94 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.246 -0.909 . . . . 0.0 110.239 179.983 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' CYS . . . . . 0.415 ' HA ' ' O ' ' A' ' 43' ' ' GLN . 99.2 m -79.21 142.73 36.01 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.231 -0.918 . . . . 0.0 110.183 179.998 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 67' ' ' CYS . . . . . 0.488 ' HA ' ' O ' ' A' ' 54' ' ' LYS . 82.3 m -144.47 141.52 29.64 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.253 -0.904 . . . . 0.0 110.241 179.989 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.427 ' HA ' ' HA2' ' A' ' 42' ' ' GLY . 33.9 ttpt . . . . . 0 N--CA 1.491 1.585 0 CA-C-O 118.01 -0.995 . . . . 0.0 110.213 -179.921 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.523 ' CD1' ' SG ' ' A' ' 37' ' ' CYS . 2.4 t80 . . . . . 0 N--CA 1.491 1.612 0 CA-C-O 121.179 0.514 . . . . 0.0 110.254 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' ASN . . . . . 0.422 ' CG ' ' O ' ' A' ' 36' ' ' ASN . 35.9 p-10 -90.58 68.87 6.69 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.322 -0.861 . . . . 0.0 110.215 179.963 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.523 ' SG ' ' CD1' ' A' ' 35' ' ' TYR . 16.6 m -70.82 -39.88 72.79 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.33 -0.856 . . . . 0.0 110.108 -179.901 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.58 HG23 ' N ' ' A' ' 39' ' ' SER . 27.0 m -57.83 -44.73 86.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.334 -0.854 . . . . 0.0 110.328 179.988 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 39' ' ' SER . . . . . 0.58 ' N ' HG23 ' A' ' 38' ' ' VAL . 53.8 p -60.0 -32.52 70.94 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.272 -0.893 . . . . 0.0 110.278 179.958 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.427 ' O ' ' HE3' ' A' ' 68' ' ' LYS . 38.0 m -75.01 -10.3 59.34 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.306 -0.871 . . . . 0.0 110.091 179.996 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 98.63 -10.3 62.67 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.426 -1.47 . . . . 0.0 109.426 -179.889 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.533 ' CA ' ' O ' ' A' ' 67' ' ' CYS . . . -73.04 -171.65 21.13 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.426 -1.47 . . . . 0.0 109.426 -179.985 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 43' ' ' GLN . . . . . 0.486 ' N ' ' O ' ' A' ' 67' ' ' CYS . 6.4 tt0 -139.99 138.46 35.52 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.268 -1.137 . . . . 0.0 110.163 -179.975 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 12.5 t -95.37 108.3 20.48 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.248 -0.908 . . . . 0.0 110.064 179.894 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.471 HD12 ' HA ' ' A' ' 45' ' ' LEU . 9.5 tp -101.57 157.7 16.62 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.293 -0.879 . . . . 0.0 110.292 -179.937 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -82.64 -25.62 32.95 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.244 -0.91 . . . . 0.0 110.225 -179.954 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.417 ' O ' ' C ' ' A' ' 48' ' ' ALA . 39.1 t -93.13 159.37 15.32 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.234 -0.916 . . . . 0.0 110.194 179.996 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.417 ' C ' ' O ' ' A' ' 47' ' ' SER . . . -42.95 127.5 4.12 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.254 -0.903 . . . . 0.0 110.157 179.974 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 49' ' ' CYS . . . . . 0.403 ' C ' ' O ' ' A' ' 48' ' ' ALA . 8.3 t -42.76 129.73 3.07 Favored Pre-proline 0 N--CA 1.491 1.621 0 O-C-N 121.304 -0.872 . . . . 0.0 110.154 -179.927 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.486 ' HG2' HG23 ' A' ' 53' ' ' THR . 46.3 Cg_endo -72.65 141.64 34.64 Favored 'Trans proline' 0 C--N 1.305 -1.73 0 O-C-N 123.884 1.465 . . . . 0.0 110.411 -179.943 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 47.2 pt -57.53 -22.98 18.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.316 -0.865 . . . . 0.0 110.058 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 69.1 m-85 -65.13 -11.95 45.66 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.337 -0.852 . . . . 0.0 110.118 179.816 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.517 ' CB ' ' HB3' ' A' ' 67' ' ' CYS . 30.0 p -119.9 170.73 8.99 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.293 -0.879 . . . . 0.0 110.233 -179.919 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.467 ' O ' ' HA ' ' A' ' 67' ' ' CYS . 31.0 mttt -94.66 175.07 6.8 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.248 -0.908 . . . . 0.0 110.097 -179.991 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.718 HG23 ' O ' ' A' ' 55' ' ' ILE . 19.9 tt -106.01 111.41 34.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.203 -0.935 . . . . 0.0 110.245 -179.987 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 56' ' ' GLN . . . . . 0.599 ' NE2' ' HD2' ' A' ' 68' ' ' LYS . 17.8 mm100 -90.41 11.38 21.73 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.295 -0.878 . . . . 0.0 110.176 179.878 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 104.12 -127.88 9.28 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.371 -1.491 . . . . 0.0 109.371 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 28.1 p -111.55 171.93 7.19 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.226 -1.161 . . . . 0.0 110.144 -179.992 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' CYS . . . . . 1.193 ' SG ' ' SG ' ' A' ' 66' ' ' CYS . 0.1 OUTLIER -111.72 -166.73 1.1 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.167 -0.958 . . . . 0.0 110.215 -179.937 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.539 ' CD1' ' N ' ' A' ' 61' ' ' ARG . 7.2 p90 -57.27 -26.13 60.31 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.376 -0.828 . . . . 0.0 110.215 179.853 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 61' ' ' ARG . . . . . 0.539 ' N ' ' CD1' ' A' ' 60' ' ' TYR . 57.5 mtt85 -139.5 164.88 28.7 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.281 -0.887 . . . . 0.0 110.191 -179.999 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -80.97 -0.28 88.4 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.621 -1.392 . . . . 0.0 109.621 179.939 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 46.1 mtpt -81.56 -25.89 35.46 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.259 -1.142 . . . . 0.0 110.227 179.915 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -123.04 164.96 17.59 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.238 -0.914 . . . . 0.0 110.243 179.987 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 74.3 mmtt -128.28 145.17 51.13 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.244 -0.91 . . . . 0.0 110.196 179.971 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' CYS . . . . . 1.193 ' SG ' ' SG ' ' A' ' 59' ' ' CYS . 93.4 m -81.48 137.6 35.59 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.225 -0.922 . . . . 0.0 110.256 -179.949 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 67' ' ' CYS . . . . . 0.533 ' O ' ' CA ' ' A' ' 42' ' ' GLY . 73.2 m -128.24 172.42 11.05 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.366 -0.834 . . . . 0.0 110.031 179.92 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.599 ' HD2' ' NE2' ' A' ' 56' ' ' GLN . 77.6 tttt . . . . . 0 N--CA 1.491 1.617 0 CA-C-O 118.007 -0.997 . . . . 0.0 110.278 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 43.6 p90 . . . . . 0 N--CA 1.492 1.649 0 CA-C-O 121.256 0.55 . . . . 0.0 110.129 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 36' ' ' ASN . . . . . 0.442 ' ND2' ' OG ' ' A' ' 39' ' ' SER . 12.7 p-10 -87.68 120.85 29.4 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.276 -0.89 . . . . 0.0 110.211 179.996 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 84.6 m -75.57 0.7 16.48 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.297 -0.877 . . . . 0.0 110.248 -179.973 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 53.6 t -68.67 -34.2 63.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.268 -0.895 . . . . 0.0 110.209 179.919 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' SER . . . . . 0.442 ' OG ' ' ND2' ' A' ' 36' ' ' ASN . 65.3 m -71.36 -22.81 61.85 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.254 -0.904 . . . . 0.0 110.128 179.856 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 61.2 m -89.44 -5.43 57.38 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.325 -0.859 . . . . 0.0 110.128 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 101.64 -19.57 49.78 Favored Glycine 0 N--CA 1.489 2.196 0 N-CA-C 109.331 -1.507 . . . . 0.0 109.331 -179.859 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.45 ' HA2' ' HA ' ' A' ' 68' ' ' LYS . . . -73.08 171.35 51.05 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.509 -1.436 . . . . 0.0 109.509 -179.966 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 43' ' ' GLN . . . . . 0.503 ' O ' ' HA ' ' A' ' 66' ' ' CYS . 31.5 tt0 -130.53 164.04 25.74 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.341 -1.094 . . . . 0.0 110.207 -179.964 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 44' ' ' CYS . . . . . 0.422 ' N ' ' CG ' ' A' ' 43' ' ' GLN . 5.5 m -114.27 112.81 23.7 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.176 -0.952 . . . . 0.0 110.274 -179.964 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.648 HD12 ' HD3' ' A' ' 50' ' ' PRO . 27.7 mt -95.92 179.55 5.05 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.239 -0.913 . . . . 0.0 110.133 179.946 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 66.4 m-85 -92.59 -27.1 17.56 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.195 -0.94 . . . . 0.0 110.218 -179.97 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.431 ' O ' ' C ' ' A' ' 48' ' ' ALA . 64.2 m -107.55 166.92 10.31 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.344 -0.848 . . . . 0.0 110.084 179.964 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.494 ' HA ' ' HG3' ' A' ' 65' ' ' LYS . . . -43.01 132.55 3.98 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.269 -0.894 . . . . 0.0 110.118 179.942 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 49' ' ' CYS . . . . . 0.419 ' C ' ' O ' ' A' ' 48' ' ' ALA . 7.7 t -42.75 130.06 3.06 Favored Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 121.23 -0.919 . . . . 0.0 110.181 -179.997 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.648 ' HD3' HD12 ' A' ' 45' ' ' LEU . 45.5 Cg_endo -72.15 147.08 47.59 Favored 'Trans proline' 0 C--N 1.305 -1.73 0 O-C-N 123.909 1.479 . . . . 0.0 110.376 -179.977 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.4 ' H ' HG23 ' A' ' 51' ' ' ILE . 28.5 pt -58.0 -21.99 18.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.234 -0.917 . . . . 0.0 110.135 179.978 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 66.2 m-85 -57.09 -16.51 7.67 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.169 -0.957 . . . . 0.0 110.109 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 71.1 p -142.34 153.66 44.02 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.238 -0.914 . . . . 0.0 110.187 179.97 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.464 ' O ' ' HA ' ' A' ' 67' ' ' CYS . 58.2 tttt -74.16 164.66 26.34 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.199 -0.938 . . . . 0.0 110.193 -180.0 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.661 HG23 ' O ' ' A' ' 55' ' ' ILE . 20.1 tt -109.41 118.18 56.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.209 -0.932 . . . . 0.0 110.17 179.956 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 20.0 mm100 -69.61 -31.15 69.11 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.307 -0.871 . . . . 0.0 110.236 -179.972 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 149.24 -92.69 0.14 Allowed Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.471 -1.452 . . . . 0.0 109.471 179.956 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.401 ' O ' ' SG ' ' A' ' 66' ' ' CYS . 74.6 p -128.67 161.96 28.45 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.275 -1.132 . . . . 0.0 110.235 -179.937 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 59' ' ' CYS . . . . . 0.494 ' SG ' ' SG ' ' A' ' 66' ' ' CYS . 5.1 m -99.45 -68.86 0.79 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.281 -0.887 . . . . 0.0 110.145 179.883 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.439 ' CD2' ' HB3' ' A' ' 59' ' ' CYS . 89.4 m-85 -141.32 -68.9 0.38 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.345 -0.847 . . . . 0.0 110.178 -179.977 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 61' ' ' ARG . . . . . 0.419 ' HD2' ' CD ' ' A' ' 63' ' ' LYS . 38.7 ttm-85 -95.38 -37.8 10.79 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.256 -0.902 . . . . 0.0 110.177 -179.965 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 135.42 -15.84 4.14 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 -179.951 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.419 ' CD ' ' HD2' ' A' ' 61' ' ' ARG . 46.7 mtpt -65.55 -31.49 72.58 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.268 -1.137 . . . . 0.0 110.15 -179.979 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.553 ' HB1' ' O ' ' A' ' 45' ' ' LEU . . . -109.83 159.57 17.1 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.353 -0.842 . . . . 0.0 110.146 179.929 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.494 ' HG3' ' HA ' ' A' ' 48' ' ' ALA . 60.7 mmtt -124.02 124.74 43.22 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.211 -0.931 . . . . 0.0 110.269 179.999 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 66' ' ' CYS . . . . . 0.503 ' HA ' ' O ' ' A' ' 43' ' ' GLN . 60.9 m -55.11 155.13 4.92 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.229 -0.919 . . . . 0.0 110.139 179.939 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 67' ' ' CYS . . . . . 0.501 ' N ' ' O ' ' A' ' 43' ' ' GLN . 91.8 m -148.13 114.6 5.95 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.176 -0.952 . . . . 0.0 110.284 179.965 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.45 ' HA ' ' HA2' ' A' ' 42' ' ' GLY . 80.4 tttt . . . . . 0 N--CA 1.491 1.583 0 CA-C-O 118.019 -0.991 . . . . 0.0 110.215 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 62.0 t0 . . . . . 0 N--CA 1.491 1.619 0 CA-C-O 121.218 0.532 . . . . 0.0 110.193 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 42.1 p-80 -130.34 170.29 14.34 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.232 -0.917 . . . . 0.0 110.22 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.423 ' CE2' ' SG ' ' A' ' 37' ' ' CYS . 2.8 t80 -125.24 128.42 48.26 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.221 -0.924 . . . . 0.0 110.22 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 14.7 t-20 -107.71 105.26 15.02 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.272 -0.892 . . . . 0.0 110.275 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.423 ' SG ' ' CE2' ' A' ' 35' ' ' TYR . 31.1 m -80.69 2.54 25.5 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.258 -0.901 . . . . 0.0 110.241 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 69.2 t -83.22 -34.9 11.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.227 -0.921 . . . . 0.0 110.248 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 34.1 t -68.0 -29.43 68.44 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.256 -0.902 . . . . 0.0 110.162 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 5.1 m -76.23 -16.83 59.74 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.325 -0.859 . . . . 0.0 110.113 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 111.4 -14.53 27.78 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.421 -1.471 . . . . 0.0 109.421 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.522 ' CA ' ' O ' ' A' ' 67' ' ' CYS . . . -80.88 -177.67 51.73 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.496 -1.442 . . . . 0.0 109.496 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' GLN . . . . . 0.517 ' N ' ' O ' ' A' ' 67' ' ' CYS . 36.6 tt0 -133.82 160.14 38.51 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.29 -1.124 . . . . 0.0 110.211 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 38.6 t -114.92 107.43 15.38 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.245 -0.909 . . . . 0.0 110.173 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.591 HD12 ' CD ' ' A' ' 50' ' ' PRO . 82.8 mt -89.55 176.36 6.92 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.282 -0.886 . . . . 0.0 110.196 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 71.3 t80 -91.03 -24.03 20.18 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.242 -0.911 . . . . 0.0 110.232 -179.923 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.416 ' O ' ' C ' ' A' ' 48' ' ' ALA . 89.2 p -105.59 165.72 10.95 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.245 -0.91 . . . . 0.0 110.231 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.416 ' C ' ' O ' ' A' ' 47' ' ' SER . . . -43.01 130.8 4.37 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.207 -0.933 . . . . 0.0 110.202 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' CYS . . . . . 0.533 ' HB2' ' CG ' ' A' ' 65' ' ' LYS . 12.4 t -43.15 127.88 3.42 Favored Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 121.222 -0.924 . . . . 0.0 110.187 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.591 ' CD ' HD12 ' A' ' 45' ' ' LEU . 46.4 Cg_endo -72.31 147.03 46.58 Favored 'Trans proline' 0 C--N 1.306 -1.665 0 O-C-N 123.898 1.473 . . . . 0.0 110.423 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.416 ' H ' HG23 ' A' ' 51' ' ' ILE . 19.4 pt -58.69 -22.06 20.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.23 -0.919 . . . . 0.0 110.135 -179.918 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 82.5 m-85 -59.68 -14.77 15.35 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.207 -0.933 . . . . 0.0 110.142 179.901 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.529 ' CB ' ' HB3' ' A' ' 67' ' ' CYS . 72.7 p -127.45 172.85 10.31 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.254 -0.904 . . . . 0.0 110.139 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.496 ' O ' ' HA ' ' A' ' 67' ' ' CYS . 44.8 tttt -94.09 165.31 12.69 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.241 -0.912 . . . . 0.0 110.225 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.705 HG23 ' O ' ' A' ' 55' ' ' ILE . 16.6 tt -95.47 116.11 36.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.255 -0.903 . . . . 0.0 110.261 179.907 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' GLN . . . . . 0.521 ' NE2' ' HB3' ' A' ' 68' ' ' LYS . 64.9 mm-40 -93.77 15.8 15.6 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.263 -0.898 . . . . 0.0 110.2 -179.958 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 112.76 -114.64 3.51 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.489 -1.445 . . . . 0.0 109.489 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 16.9 p -131.4 174.02 10.49 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.26 -1.141 . . . . 0.0 110.181 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' CYS . . . . . 0.966 ' SG ' ' SG ' ' A' ' 66' ' ' CYS . 0.7 OUTLIER -114.09 -159.52 0.7 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.232 -0.918 . . . . 0.0 110.252 -179.972 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 90.9 m-85 -55.5 -43.77 75.94 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.309 -0.869 . . . . 0.0 110.192 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 80.4 mtm180 -133.43 168.95 17.68 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.242 -0.911 . . . . 0.0 110.202 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -67.7 -23.24 73.93 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 10.2 mmpt? -67.19 -24.84 65.9 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.253 -1.146 . . . . 0.0 110.186 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -112.77 162.82 15.32 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.224 -0.923 . . . . 0.0 110.191 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.533 ' CG ' ' HB2' ' A' ' 49' ' ' CYS . 48.1 tptt -141.77 144.18 33.85 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.276 -0.89 . . . . 0.0 110.226 -179.954 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' CYS . . . . . 0.966 ' SG ' ' SG ' ' A' ' 59' ' ' CYS . 99.7 m -82.96 153.54 24.96 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.192 -0.942 . . . . 0.0 110.155 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' CYS . . . . . 0.529 ' HB3' ' CB ' ' A' ' 53' ' ' THR . 75.1 m -142.51 156.22 45.12 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.258 -0.901 . . . . 0.0 110.205 -179.925 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.521 ' HB3' ' NE2' ' A' ' 56' ' ' GLN . 43.5 tttt . . . . . 0 N--CA 1.491 1.587 0 CA-C-O 117.978 -1.011 . . . . 0.0 110.24 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 50.3 p-10 . . . . . 0 N--CA 1.491 1.597 0 CA-C-O 121.308 0.575 . . . . 0.0 110.179 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 97.3 m-70 -109.62 122.84 48.36 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.207 -0.933 . . . . 0.0 110.225 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.412 ' CD1' ' N ' ' A' ' 36' ' ' ASN . 2.3 t80 -116.52 127.53 54.62 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.262 -0.899 . . . . 0.0 110.129 -179.969 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 0.44 ' ND2' ' HB3' ' A' ' 39' ' ' SER . 25.5 p-10 -92.22 91.86 7.93 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.3 -0.875 . . . . 0.0 110.164 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 18.8 m -73.54 -22.38 60.11 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.203 -0.936 . . . . 0.0 110.2 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.445 ' HA ' ' O ' ' A' ' 42' ' ' GLY . 70.6 t -63.62 -42.33 95.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.215 -0.928 . . . . 0.0 110.215 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.44 ' HB3' ' ND2' ' A' ' 36' ' ' ASN . 44.8 t -58.76 -26.59 64.15 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.198 -0.939 . . . . 0.0 110.216 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.437 ' O ' ' HE3' ' A' ' 68' ' ' LYS . 63.1 m -82.95 -18.34 40.35 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.267 -0.896 . . . . 0.0 110.203 179.977 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.467 ' O ' ' HG3' ' A' ' 68' ' ' LYS . . . 112.18 11.89 14.92 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.432 -1.467 . . . . 0.0 109.432 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.445 ' O ' ' HA ' ' A' ' 38' ' ' VAL . . . -113.17 178.78 18.83 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' GLN . . . . . 0.512 ' O ' ' HA ' ' A' ' 66' ' ' CYS . 0.3 OUTLIER -137.1 171.86 13.86 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.261 -1.14 . . . . 0.0 110.202 179.942 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 84.6 m -108.58 104.4 13.72 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.248 -0.908 . . . . 0.0 110.227 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.514 HD12 ' HD3' ' A' ' 50' ' ' PRO . 27.3 mt -85.82 179.61 7.01 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.163 -0.96 . . . . 0.0 110.137 179.988 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 98.1 m-85 -106.23 -7.91 17.59 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.272 -0.892 . . . . 0.0 110.192 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.414 ' O ' ' C ' ' A' ' 48' ' ' ALA . 84.0 p -121.41 166.92 13.4 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.267 -0.895 . . . . 0.0 110.201 179.959 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.414 ' C ' ' O ' ' A' ' 47' ' ' SER . . . -43.01 131.23 4.3 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.229 -0.92 . . . . 0.0 110.204 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' CYS . . . . . 0.461 ' HB2' ' HG2' ' A' ' 65' ' ' LYS . 3.9 t -42.76 128.53 3.1 Favored Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 121.284 -0.885 . . . . 0.0 110.226 -179.911 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.514 ' HD3' HD12 ' A' ' 45' ' ' LEU . 45.7 Cg_endo -72.83 150.42 49.63 Favored 'Trans proline' 0 C--N 1.306 -1.679 0 O-C-N 123.89 1.468 . . . . 0.0 110.427 -179.938 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 54.4 mt -63.19 -27.2 42.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.211 -0.93 . . . . 0.0 110.234 -179.931 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 99.4 m-85 -68.94 -9.22 50.86 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.319 -0.863 . . . . 0.0 110.12 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.509 ' CG2' ' HG2' ' A' ' 50' ' ' PRO . 46.2 p -123.79 144.57 49.62 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.208 -0.932 . . . . 0.0 110.171 179.961 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.484 ' O ' ' HA ' ' A' ' 67' ' ' CYS . 40.7 mtmt -81.0 167.9 19.3 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.193 -0.942 . . . . 0.0 110.275 -179.951 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.681 HG23 ' O ' ' A' ' 55' ' ' ILE . 18.8 tt -100.99 117.65 46.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.334 -0.854 . . . . 0.0 110.166 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' GLN . . . . . 0.503 ' CG ' ' HB2' ' A' ' 68' ' ' LYS . 71.8 mm-40 -96.64 3.11 52.7 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.201 -0.937 . . . . 0.0 110.206 179.966 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 125.52 -119.54 3.57 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.388 -1.485 . . . . 0.0 109.388 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.444 ' O ' ' SG ' ' A' ' 66' ' ' CYS . 24.4 p -133.05 164.24 27.44 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.26 -1.141 . . . . 0.0 110.18 179.938 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 1.8 m -114.13 -88.66 0.55 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.245 -0.91 . . . . 0.0 110.248 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 83.0 m-85 -116.97 98.94 6.75 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.283 -0.886 . . . . 0.0 110.287 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 27.7 mmm180 54.78 -145.69 0.61 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.316 -0.865 . . . . 0.0 110.141 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -102.83 18.33 50.32 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.559 -1.416 . . . . 0.0 109.559 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 48.0 mtpt -85.07 -24.38 28.13 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.277 -1.131 . . . . 0.0 110.194 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -145.34 164.07 32.61 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.308 -0.87 . . . . 0.0 110.261 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.461 ' HG2' ' HB2' ' A' ' 49' ' ' CYS . 54.5 tptt -127.68 132.92 49.61 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.29 -0.881 . . . . 0.0 110.19 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' CYS . . . . . 0.512 ' HA ' ' O ' ' A' ' 43' ' ' GLN . 59.2 m -72.35 132.42 43.95 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.261 -0.9 . . . . 0.0 110.201 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' CYS . . . . . 0.484 ' HA ' ' O ' ' A' ' 54' ' ' LYS . 90.9 m -135.56 144.29 46.14 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.287 -0.883 . . . . 0.0 110.243 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.503 ' HB2' ' CG ' ' A' ' 56' ' ' GLN . 81.5 tttt . . . . . 0 N--CA 1.492 1.644 0 CA-C-O 117.994 -1.003 . . . . 0.0 110.126 -179.923 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' ASP . . . . . 0.458 ' OD1' ' N ' ' A' ' 34' ' ' HIS . 63.4 t0 . . . . . 0 N--CA 1.491 1.598 0 CA-C-O 121.312 0.577 . . . . 0.0 110.144 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' HIS . . . . . 0.458 ' N ' ' OD1' ' A' ' 33' ' ' ASP . 98.5 m-70 -120.79 133.65 55.32 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.24 -0.913 . . . . 0.0 110.186 179.936 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 4.2 t80 -74.16 131.92 41.73 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.232 -0.917 . . . . 0.0 110.229 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 0.538 ' ND2' ' CB ' ' A' ' 39' ' ' SER . 54.0 t30 -74.28 65.9 1.24 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.246 -0.909 . . . . 0.0 110.168 -179.906 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.448 ' O ' ' HB2' ' A' ' 40' ' ' SER . 22.0 m -71.08 -53.66 13.86 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.235 -0.916 . . . . 0.0 110.305 179.97 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.466 ' HA ' ' O ' ' A' ' 42' ' ' GLY . 77.0 t -44.66 -55.09 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.178 -0.951 . . . . 0.0 110.243 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.538 ' CB ' ' ND2' ' A' ' 36' ' ' ASN . 53.4 m -53.62 -31.41 47.11 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.176 -0.952 . . . . 0.0 110.244 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.448 ' HB2' ' O ' ' A' ' 37' ' ' CYS . 50.8 m -71.5 -25.29 62.19 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.249 -0.907 . . . . 0.0 110.155 179.981 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 125.05 -16.76 7.21 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.458 -1.457 . . . . 0.0 109.458 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.475 ' CA ' ' O ' ' A' ' 67' ' ' CYS . . . -87.74 -177.45 48.07 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.485 -1.446 . . . . 0.0 109.485 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' GLN . . . . . 0.456 ' N ' ' O ' ' A' ' 67' ' ' CYS . 1.3 pt20 -133.66 175.73 9.18 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.313 -1.11 . . . . 0.0 110.31 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 11.1 t -107.21 89.39 2.98 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.215 -0.928 . . . . 0.0 110.18 179.939 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.451 HD12 ' HA ' ' A' ' 45' ' ' LEU . 13.7 tp -78.63 162.1 26.48 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.203 -0.935 . . . . 0.0 110.23 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 65.6 t80 -92.13 -24.6 19.06 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.227 -0.92 . . . . 0.0 110.182 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.423 ' O ' ' C ' ' A' ' 48' ' ' ALA . 44.8 m -95.94 157.85 15.71 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.265 -0.897 . . . . 0.0 110.192 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.425 ' O ' ' C ' ' A' ' 49' ' ' CYS . . . -42.74 133.15 3.6 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.256 -0.902 . . . . 0.0 110.219 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' CYS . . . . . 0.425 ' C ' ' O ' ' A' ' 48' ' ' ALA . 1.8 t -43.13 127.08 3.41 Favored Pre-proline 0 N--CA 1.491 1.609 0 O-C-N 121.248 -0.907 . . . . 0.0 110.084 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -72.45 159.64 48.68 Favored 'Trans proline' 0 C--N 1.306 -1.675 0 O-C-N 123.854 1.449 . . . . 0.0 110.436 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 7.5 mt -65.61 -25.92 37.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.167 -0.958 . . . . 0.0 110.114 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 94.2 m-85 -65.92 -12.14 52.45 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.305 -0.872 . . . . 0.0 110.117 179.871 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.465 ' OG1' ' HB3' ' A' ' 67' ' ' CYS . 67.3 p -136.09 147.35 47.78 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.272 -0.892 . . . . 0.0 110.165 179.941 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 36.8 tttt -97.41 165.23 12.11 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.211 -0.931 . . . . 0.0 110.228 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.689 HG23 ' O ' ' A' ' 55' ' ' ILE . 15.3 tt -86.94 115.21 27.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.276 -0.89 . . . . 0.0 110.19 -179.941 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' GLN . . . . . 0.503 ' HG3' ' HB2' ' A' ' 68' ' ' LYS . 54.4 mm-40 -97.14 18.96 13.76 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.239 -0.913 . . . . 0.0 110.224 179.957 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 139.91 -156.68 25.02 Favored Glycine 0 N--CA 1.488 2.144 0 N-CA-C 109.485 -1.446 . . . . 0.0 109.485 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.447 ' O ' ' SG ' ' A' ' 66' ' ' CYS . 24.5 p -109.26 165.04 11.92 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.188 -1.183 . . . . 0.0 110.174 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -107.65 -158.46 0.65 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.258 -0.902 . . . . 0.0 110.291 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 95.2 m-85 -58.58 -55.9 29.12 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.354 -0.841 . . . . 0.0 110.163 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -126.29 172.22 10.29 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.255 -0.903 . . . . 0.0 110.171 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -65.1 -20.25 66.82 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.424 -1.47 . . . . 0.0 109.424 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 48.8 mtmt -65.93 -24.1 66.76 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.231 -1.158 . . . . 0.0 110.215 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.412 ' C ' ' HG2' ' A' ' 65' ' ' LYS . . . -118.28 161.86 19.22 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.232 -0.917 . . . . 0.0 110.166 180.0 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.412 ' HG2' ' C ' ' A' ' 64' ' ' ALA . 73.8 mmtt -146.93 138.54 24.29 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.211 -0.931 . . . . 0.0 110.22 -179.942 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' CYS . . . . . 0.447 ' SG ' ' O ' ' A' ' 58' ' ' THR . 89.4 m -64.03 139.51 58.77 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.275 -0.891 . . . . 0.0 110.085 179.949 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' CYS . . . . . 0.475 ' O ' ' CA ' ' A' ' 42' ' ' GLY . 95.1 m -141.85 136.62 30.76 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.23 -0.919 . . . . 0.0 110.223 179.967 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.503 ' HB2' ' HG3' ' A' ' 56' ' ' GLN . 73.0 tttt . . . . . 0 N--CA 1.492 1.625 0 CA-C-O 118.03 -0.986 . . . . 0.0 110.157 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 82.2 m-20 . . . . . 0 N--CA 1.492 1.653 0 CA-C-O 121.236 0.541 . . . . 0.0 110.152 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 84.5 t60 -66.77 140.09 57.83 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.212 -0.93 . . . . 0.0 110.202 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 12.8 t80 -115.48 143.06 45.86 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.311 -0.868 . . . . 0.0 110.191 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 14.7 t-20 -91.43 67.92 5.71 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.203 -0.936 . . . . 0.0 110.223 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.409 ' O ' ' HB2' ' A' ' 40' ' ' SER . 55.8 m -64.63 -50.85 65.49 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.265 -0.897 . . . . 0.0 110.169 -179.923 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.432 HG23 ' H ' ' A' ' 38' ' ' VAL . 30.8 t -45.48 -47.32 4.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.137 -0.977 . . . . 0.0 110.193 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 32.2 t -59.01 -21.85 59.71 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.273 -0.892 . . . . 0.0 110.265 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.409 ' HB2' ' O ' ' A' ' 37' ' ' CYS . 74.7 m -86.31 -11.88 50.95 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.228 -0.92 . . . . 0.0 110.215 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 103.7 5.08 45.44 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.598 -1.401 . . . . 0.0 109.598 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.419 ' HA2' ' HA ' ' A' ' 68' ' ' LYS . . . -102.58 172.29 21.86 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.501 -1.439 . . . . 0.0 109.501 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' GLN . . . . . 0.498 ' O ' ' HA ' ' A' ' 66' ' ' CYS . 0.0 OUTLIER -123.35 175.11 6.91 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.204 -1.174 . . . . 0.0 110.219 179.939 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 22.4 t -107.93 94.16 4.93 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.23 -0.918 . . . . 0.0 110.197 -179.896 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.891 HD12 ' SG ' ' A' ' 67' ' ' CYS . 94.5 mt -73.24 177.9 4.83 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.206 -0.934 . . . . 0.0 110.216 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 80.3 m-85 -104.26 -11.54 17.14 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.267 -0.895 . . . . 0.0 110.278 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.401 ' O ' ' C ' ' A' ' 48' ' ' ALA . 60.1 p -125.74 173.23 9.18 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.307 -0.871 . . . . 0.0 110.258 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.401 ' C ' ' O ' ' A' ' 47' ' ' SER . . . -43.16 128.61 4.6 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.277 -0.89 . . . . 0.0 110.144 179.945 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 4.9 t -46.56 129.32 8.2 Favored Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.287 -0.883 . . . . 0.0 110.142 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.558 ' CD ' ' CD1' ' A' ' 45' ' ' LEU . 46.1 Cg_endo -72.84 149.76 48.38 Favored 'Trans proline' 0 C--N 1.306 -1.679 0 O-C-N 123.853 1.449 . . . . 0.0 110.406 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 46.1 pt -60.21 -24.75 31.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.299 -0.876 . . . . 0.0 110.177 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 58.4 m-85 -60.38 -13.91 15.85 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.156 -0.965 . . . . 0.0 110.202 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.455 ' OG1' ' HB3' ' A' ' 67' ' ' CYS . 77.4 p -135.87 154.72 51.07 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.15 -0.969 . . . . 0.0 110.237 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 95.7 mttt -98.11 152.55 19.22 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.294 -0.879 . . . . 0.0 110.259 179.941 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.59 HG23 ' O ' ' A' ' 55' ' ' ILE . 20.8 tt -89.36 124.39 42.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.329 -0.857 . . . . 0.0 110.244 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 67.1 mm-40 -97.37 -18.21 19.26 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.257 -0.902 . . . . 0.0 110.178 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -177.83 -149.59 8.05 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.453 -1.459 . . . . 0.0 109.453 -179.932 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.442 ' O ' ' SG ' ' A' ' 66' ' ' CYS . 33.2 p -111.32 163.33 14.08 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.288 -1.124 . . . . 0.0 110.131 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' CYS . . . . . 0.474 ' HB3' ' HB3' ' A' ' 64' ' ' ALA . 0.8 OUTLIER -96.75 -160.73 0.82 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.244 -0.91 . . . . 0.0 110.192 179.973 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 93.4 m-85 -60.8 -42.77 98.24 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.284 -0.885 . . . . 0.0 110.151 179.891 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 90.1 mtt-85 -135.41 170.87 15.27 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.214 -0.929 . . . . 0.0 110.212 -179.924 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -63.53 -18.9 61.85 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.375 -1.49 . . . . 0.0 109.375 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 12.3 tttt -70.27 -31.54 68.95 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.179 -1.189 . . . . 0.0 110.193 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.474 ' HB3' ' HB3' ' A' ' 59' ' ' CYS . . . -105.19 159.53 15.79 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.302 -0.873 . . . . 0.0 110.123 -179.952 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.408 ' HG2' ' C ' ' A' ' 64' ' ' ALA . 73.9 mmtt -142.9 147.9 36.07 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.246 -0.909 . . . . 0.0 110.18 179.968 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' CYS . . . . . 0.498 ' HA ' ' O ' ' A' ' 43' ' ' GLN . 71.7 m -77.55 148.47 35.2 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.268 -0.895 . . . . 0.0 110.1 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' CYS . . . . . 0.891 ' SG ' HD12 ' A' ' 45' ' ' LEU . 92.6 m -145.7 131.15 18.69 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.13 -0.981 . . . . 0.0 110.256 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.419 ' HA ' ' HA2' ' A' ' 42' ' ' GLY . 82.0 tttt . . . . . 0 N--CA 1.491 1.604 0 CA-C-O 118.096 -0.954 . . . . 0.0 110.27 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 56.1 p-10 . . . . . 0 N--CA 1.492 1.664 0 CA-C-O 121.311 0.577 . . . . 0.0 110.221 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 88.3 m-70 -104.23 128.33 51.95 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.217 -0.927 . . . . 0.0 110.214 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.566 ' CE2' ' SG ' ' A' ' 37' ' ' CYS . 3.3 t80 -114.49 127.4 55.79 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.253 -0.904 . . . . 0.0 110.218 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 0.52 ' ND2' ' HB3' ' A' ' 39' ' ' SER . 27.2 p-10 -94.22 85.12 4.56 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.266 -0.896 . . . . 0.0 110.234 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.566 ' SG ' ' CE2' ' A' ' 35' ' ' TYR . 87.6 m -65.02 -42.66 94.2 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.271 -0.893 . . . . 0.0 110.284 179.951 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 86.4 t -52.41 -40.86 33.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.301 -0.875 . . . . 0.0 110.196 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.52 ' HB3' ' ND2' ' A' ' 36' ' ' ASN . 24.6 t -62.67 -26.76 68.81 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.269 -0.895 . . . . 0.0 110.251 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.514 ' O ' ' CE ' ' A' ' 68' ' ' LYS . 2.2 t -79.95 -16.65 54.81 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.319 -0.863 . . . . 0.0 110.163 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 116.33 -12.53 16.37 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.468 -1.453 . . . . 0.0 109.468 -179.937 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.44 ' HA2' ' HA ' ' A' ' 68' ' ' LYS . . . -83.55 -175.36 50.9 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 -179.988 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' GLN . . . . . 0.529 ' NE2' HD21 ' A' ' 45' ' ' LEU . 42.5 tt0 -133.73 152.25 51.83 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.25 -1.147 . . . . 0.0 110.206 179.926 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' CYS . . . . . 0.571 ' O ' HD23 ' A' ' 45' ' ' LEU . 49.2 t -100.1 127.16 46.38 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.265 -0.897 . . . . 0.0 110.219 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.615 ' O ' ' HB1' ' A' ' 64' ' ' ALA . 28.9 mt -121.12 176.57 5.52 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.225 -0.922 . . . . 0.0 110.227 179.938 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 85.1 m-85 -104.19 -0.78 28.07 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.21 -0.931 . . . . 0.0 110.206 180.0 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 85.7 p -116.18 171.95 7.48 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.243 -0.911 . . . . 0.0 110.205 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -46.92 153.33 0.43 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.291 -0.881 . . . . 0.0 110.147 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 42.3 t -55.67 128.38 69.03 Favored Pre-proline 0 N--CA 1.492 1.641 0 O-C-N 121.325 -0.86 . . . . 0.0 110.165 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -72.64 153.69 54.43 Favored 'Trans proline' 0 C--N 1.305 -1.718 0 O-C-N 123.943 1.496 . . . . 0.0 110.485 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 28.1 pt -77.08 -6.45 9.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.26 -0.9 . . . . 0.0 110.105 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 46.6 m-85 -73.0 -22.94 60.59 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.248 -0.908 . . . . 0.0 110.14 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 69.9 p -137.62 161.81 35.47 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.317 -0.865 . . . . 0.0 110.204 179.946 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.497 ' O ' ' N ' ' A' ' 68' ' ' LYS . 64.3 mttt -90.32 169.54 11.01 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.289 -0.882 . . . . 0.0 110.15 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.726 HG23 ' O ' ' A' ' 55' ' ' ILE . 20.6 tt -95.48 111.27 25.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.262 -0.899 . . . . 0.0 110.133 -179.914 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' GLN . . . . . 0.531 ' CG ' ' HB3' ' A' ' 68' ' ' LYS . 56.6 mm-40 -90.32 -12.85 36.52 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.211 -0.931 . . . . 0.0 110.188 179.962 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' GLY . . . . . 0.517 ' HA3' ' CE2' ' A' ' 35' ' ' TYR . . . 170.79 -144.77 8.53 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.474 -1.451 . . . . 0.0 109.474 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 16.5 p -115.73 168.37 10.09 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.221 -1.164 . . . . 0.0 110.186 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' CYS . . . . . 0.47 ' SG ' ' N ' ' A' ' 66' ' ' CYS . 1.1 m -91.19 -161.6 0.83 Allowed 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.296 -0.877 . . . . 0.0 110.212 -179.92 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 94.2 m-85 -57.24 -40.82 78.37 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.31 -0.868 . . . . 0.0 110.317 179.861 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 93.8 mtt180 -132.44 178.26 6.96 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.222 -0.924 . . . . 0.0 110.214 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -76.25 -6.02 82.54 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.589 -1.404 . . . . 0.0 109.589 -179.947 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 40.6 mtpt -81.59 -23.75 36.9 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.197 -1.178 . . . . 0.0 110.184 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.615 ' HB1' ' O ' ' A' ' 45' ' ' LEU . . . -117.27 162.61 17.61 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.291 -0.88 . . . . 0.0 110.1 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 16.4 tppt? -141.16 123.02 15.37 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.244 -0.91 . . . . 0.0 110.16 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' CYS . . . . . 0.491 ' HA ' ' O ' ' A' ' 43' ' ' GLN . 28.9 p -87.84 151.3 22.96 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.173 -0.954 . . . . 0.0 110.188 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' CYS . . . . . 0.466 ' CA ' ' O ' ' A' ' 54' ' ' LYS . 73.1 m -148.77 143.47 26.4 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.222 -0.924 . . . . 0.0 110.192 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.531 ' HB3' ' CG ' ' A' ' 56' ' ' GLN . 78.3 tttt . . . . . 0 N--CA 1.492 1.633 0 CA-C-O 117.999 -1.0 . . . . 0.0 110.259 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 58.4 p-10 . . . . . 0 N--CA 1.491 1.598 0 CA-C-O 121.291 0.567 . . . . 0.0 110.205 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 93.6 m-70 -125.3 120.92 32.53 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.203 -0.936 . . . . 0.0 110.164 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.562 ' CD1' ' SG ' ' A' ' 37' ' ' CYS . 6.4 t80 -50.14 -37.23 33.36 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.24 -0.912 . . . . 0.0 110.276 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 0.568 ' ND2' ' CB ' ' A' ' 39' ' ' SER . 49.7 t30 65.95 54.55 1.01 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.277 -0.889 . . . . 0.0 110.168 -179.924 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.562 ' SG ' ' CD1' ' A' ' 35' ' ' TYR . 31.0 m -65.14 -52.95 52.08 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.304 -0.872 . . . . 0.0 110.146 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 38.0 t -47.91 -50.01 10.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.31 -0.869 . . . . 0.0 110.224 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.568 ' CB ' ' ND2' ' A' ' 36' ' ' ASN . 66.0 m -56.68 -32.33 65.33 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.249 -0.907 . . . . 0.0 110.115 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.472 ' O ' ' NZ ' ' A' ' 68' ' ' LYS . 24.0 m -72.87 -11.5 60.62 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.288 -0.883 . . . . 0.0 110.09 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 103.95 -12.35 52.78 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.389 -1.484 . . . . 0.0 109.389 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.476 ' HA3' ' HB2' ' A' ' 68' ' ' LYS . . . -81.52 -175.14 49.98 Favored Glycine 0 N--CA 1.489 2.217 0 N-CA-C 109.469 -1.452 . . . . 0.0 109.469 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' GLN . . . . . 0.56 ' NE2' HD21 ' A' ' 45' ' ' LEU . 47.7 tt0 -126.44 147.77 49.75 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.304 -1.115 . . . . 0.0 110.221 179.95 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 20.2 t -100.51 109.11 21.2 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.203 -0.936 . . . . 0.0 110.221 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.724 ' O ' ' HB1' ' A' ' 64' ' ' ALA . 59.0 mt -104.67 175.22 5.56 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.184 -0.947 . . . . 0.0 110.155 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 89.4 m-85 -107.84 -8.31 16.03 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.287 -0.883 . . . . 0.0 110.256 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.408 ' O ' ' C ' ' A' ' 48' ' ' ALA . 34.1 t -114.22 164.43 13.9 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.182 -0.949 . . . . 0.0 110.203 -179.984 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.418 ' O ' ' C ' ' A' ' 49' ' ' CYS . . . -42.62 132.45 3.68 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.309 -0.869 . . . . 0.0 110.159 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' CYS . . . . . 0.45 ' HB2' HD12 ' A' ' 55' ' ' ILE . 4.7 t -43.16 129.83 3.4 Favored Pre-proline 0 N--CA 1.492 1.642 0 O-C-N 121.254 -0.904 . . . . 0.0 110.15 179.997 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -72.99 146.27 41.35 Favored 'Trans proline' 0 C--N 1.305 -1.712 0 O-C-N 123.921 1.485 . . . . 0.0 110.397 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 34.0 pt -59.54 -20.05 17.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.289 -0.882 . . . . 0.0 110.119 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' PHE . . . . . 0.402 ' C ' HG23 ' A' ' 53' ' ' THR . 67.1 m-85 -61.82 -21.54 64.71 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.318 -0.864 . . . . 0.0 110.273 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.437 ' OG1' ' HB3' ' A' ' 67' ' ' CYS . 68.3 p -144.83 152.83 40.89 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.219 -0.925 . . . . 0.0 110.219 179.895 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.489 ' O ' ' HA ' ' A' ' 67' ' ' CYS . 62.2 mttm -78.01 173.5 12.12 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.32 -0.862 . . . . 0.0 110.174 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.642 HG23 ' O ' ' A' ' 55' ' ' ILE . 20.8 tt -110.78 121.24 63.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.25 -0.906 . . . . 0.0 110.169 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' GLN . . . . . 0.517 ' NE2' ' HB3' ' A' ' 68' ' ' LYS . 86.4 mm-40 -78.21 -27.02 47.71 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.253 -0.904 . . . . 0.0 110.225 -179.933 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 156.9 -155.96 26.8 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.478 -1.449 . . . . 0.0 109.478 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.421 ' O ' ' SG ' ' A' ' 66' ' ' CYS . 17.1 p -74.63 175.24 8.06 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.286 -1.126 . . . . 0.0 110.245 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' CYS . . . . . 1.204 ' SG ' ' SG ' ' A' ' 66' ' ' CYS . 0.1 OUTLIER -125.54 142.03 51.72 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.322 -0.861 . . . . 0.0 110.179 179.981 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 83.0 m-85 45.33 -92.53 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.295 -0.878 . . . . 0.0 110.23 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.517 ' N ' ' O ' ' A' ' 59' ' ' CYS . 66.1 mtp180 -118.11 -8.21 10.71 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.194 -0.941 . . . . 0.0 110.151 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 127.3 -14.52 6.51 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.507 -1.437 . . . . 0.0 109.507 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 52.5 mtmt -61.12 -22.18 64.42 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.226 -1.161 . . . . 0.0 110.277 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.724 ' HB1' ' O ' ' A' ' 45' ' ' LEU . . . -127.97 173.83 9.7 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.226 -0.921 . . . . 0.0 110.166 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.463 ' HD3' ' O ' ' A' ' 64' ' ' ALA . 46.2 mmtt -124.16 122.76 38.7 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.248 -0.908 . . . . 0.0 110.215 -179.977 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' CYS . . . . . 1.204 ' SG ' ' SG ' ' A' ' 59' ' ' CYS . 75.9 m -75.09 149.36 39.15 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.271 -0.893 . . . . 0.0 110.135 -179.945 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' CYS . . . . . 0.489 ' HA ' ' O ' ' A' ' 54' ' ' LYS . 89.5 m -146.11 136.36 23.8 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.315 -0.866 . . . . 0.0 110.241 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.517 ' HB3' ' NE2' ' A' ' 56' ' ' GLN . 80.6 tttt . . . . . 0 N--CA 1.493 1.695 0 CA-C-O 118.093 -0.956 . . . . 0.0 110.209 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 73.3 m-20 . . . . . 0 N--CA 1.492 1.637 0 CA-C-O 121.26 0.552 . . . . 0.0 110.195 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 44.0 p-80 -148.6 152.39 36.67 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.229 -0.919 . . . . 0.0 110.247 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.502 ' CD1' ' N ' ' A' ' 36' ' ' ASN . 6.3 t80 -121.45 147.72 45.37 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.281 -0.887 . . . . 0.0 110.119 179.995 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 0.502 ' N ' ' CD1' ' A' ' 35' ' ' TYR . 28.5 p-10 -84.99 57.43 4.44 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.199 -0.938 . . . . 0.0 110.293 -179.937 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 26.1 m -67.09 -56.26 10.8 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.252 -0.905 . . . . 0.0 110.058 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 60.1 t -53.47 -29.25 16.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.265 -0.897 . . . . 0.0 110.112 179.935 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 39.6 t -70.91 -30.06 66.3 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.298 -0.876 . . . . 0.0 110.121 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.491 ' O ' ' NZ ' ' A' ' 68' ' ' LYS . 0.4 OUTLIER -78.94 -21.48 47.16 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.287 -0.883 . . . . 0.0 110.118 179.969 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 117.29 3.57 16.95 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.611 -1.396 . . . . 0.0 109.611 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.435 ' HA2' ' HA ' ' A' ' 68' ' ' LYS . . . -100.5 172.31 23.89 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 -179.974 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 36.4 tt0 -118.14 153.41 33.84 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.25 -1.147 . . . . 0.0 110.187 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 30.5 t -98.03 97.99 9.38 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.253 -0.904 . . . . 0.0 110.205 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.658 HD12 ' CD ' ' A' ' 50' ' ' PRO . 79.7 mt -82.59 174.34 11.13 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.287 -0.883 . . . . 0.0 110.197 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 98.2 m-85 -107.25 0.66 23.36 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.29 -0.881 . . . . 0.0 110.276 -179.892 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.414 ' O ' ' C ' ' A' ' 48' ' ' ALA . 92.3 p -125.9 172.22 10.08 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.128 -0.982 . . . . 0.0 110.194 179.929 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.414 ' C ' ' O ' ' A' ' 47' ' ' SER . . . -42.93 124.2 3.05 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.316 -0.865 . . . . 0.0 110.169 179.948 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 16.4 t -42.87 130.41 3.13 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.29 -0.881 . . . . 0.0 110.215 -179.951 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.658 ' CD ' HD12 ' A' ' 45' ' ' LEU . 46.9 Cg_endo -72.72 140.73 32.86 Favored 'Trans proline' 0 C--N 1.306 -1.692 0 O-C-N 123.965 1.508 . . . . 0.0 110.391 -179.955 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 43.8 pt -62.2 -22.17 28.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.285 -0.884 . . . . 0.0 110.213 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 69.0 m-85 -55.92 -17.46 6.59 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.239 -0.913 . . . . 0.0 110.207 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.441 ' OG1' ' HB3' ' A' ' 67' ' ' CYS . 35.4 p -135.93 168.09 19.99 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.257 -0.902 . . . . 0.0 110.176 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.443 ' O ' ' HA ' ' A' ' 67' ' ' CYS . 22.1 mttp -96.12 152.98 18.04 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.274 -0.891 . . . . 0.0 110.241 179.977 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.699 HG23 ' O ' ' A' ' 55' ' ' ILE . 13.0 tt -94.54 113.57 29.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.247 -0.908 . . . . 0.0 110.316 -179.955 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' GLN . . . . . 0.505 ' NE2' ' HB3' ' A' ' 68' ' ' LYS . 90.4 mm-40 -76.13 -26.48 56.37 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.239 -0.913 . . . . 0.0 110.097 -179.977 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 167.5 -151.85 19.81 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.467 -1.453 . . . . 0.0 109.467 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 16.5 p -94.22 165.48 12.58 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.271 -1.135 . . . . 0.0 110.205 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' CYS . . . . . 0.97 ' SG ' ' SG ' ' A' ' 66' ' ' CYS . 0.5 OUTLIER -103.28 -158.02 0.64 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.202 -0.936 . . . . 0.0 110.207 -179.952 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 61.8 m-85 -56.64 -54.95 40.18 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.307 -0.871 . . . . 0.0 110.227 179.923 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.519 ' CZ ' ' CD ' ' A' ' 63' ' ' LYS . 52.8 ttt180 -118.12 159.66 22.89 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.272 -0.893 . . . . 0.0 110.255 -179.979 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -63.16 -16.1 57.35 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.385 -1.486 . . . . 0.0 109.385 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.519 ' CD ' ' CZ ' ' A' ' 61' ' ' ARG . 41.9 mtpt -70.2 -27.84 64.81 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.257 -1.143 . . . . 0.0 110.172 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -110.48 166.41 11.01 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.379 -0.826 . . . . 0.0 110.192 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt -141.43 150.38 42.24 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.283 -0.885 . . . . 0.0 110.202 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' CYS . . . . . 0.97 ' SG ' ' SG ' ' A' ' 59' ' ' CYS . 94.7 m -92.46 144.14 25.66 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.282 -0.886 . . . . 0.0 110.185 179.939 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' CYS . . . . . 0.449 ' SG ' ' HD2' ' A' ' 50' ' ' PRO . 65.5 m -144.15 121.39 11.55 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.206 -0.934 . . . . 0.0 110.219 -179.995 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.505 ' HB3' ' NE2' ' A' ' 56' ' ' GLN . 80.4 tttt . . . . . 0 N--CA 1.491 1.606 0 CA-C-O 118.02 -0.99 . . . . 0.0 110.216 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 85.9 m-20 . . . . . 0 N--CA 1.492 1.626 0 CA-C-O 121.168 0.509 . . . . 0.0 110.181 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 48.5 m80 -112.98 115.19 28.0 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.339 -0.85 . . . . 0.0 110.188 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.564 ' CZ ' ' SG ' ' A' ' 37' ' ' CYS . 26.2 p90 -125.38 156.99 37.91 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.23 -0.919 . . . . 0.0 110.112 -179.965 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 0.454 HD22 ' HB ' ' A' ' 38' ' ' VAL . 4.3 t-20 -85.63 109.92 18.9 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.34 -0.85 . . . . 0.0 110.28 -179.974 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.564 ' SG ' ' CZ ' ' A' ' 35' ' ' TYR . 98.0 m -66.04 -42.74 89.17 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.278 -0.889 . . . . 0.0 110.089 179.919 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.454 ' HB ' HD22 ' A' ' 36' ' ' ASN . 97.5 t -48.18 -42.76 11.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.233 -0.917 . . . . 0.0 110.161 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 2.8 m -64.79 -24.97 67.72 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.301 -0.874 . . . . 0.0 110.206 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 69.2 m -82.61 -9.62 59.31 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.272 -0.892 . . . . 0.0 110.229 179.923 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 107.97 -4.78 34.06 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.496 ' CA ' ' O ' ' A' ' 67' ' ' CYS . . . -90.71 -172.94 44.16 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.507 -1.437 . . . . 0.0 109.507 179.94 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' GLN . . . . . 0.553 ' NE2' HD21 ' A' ' 45' ' ' LEU . 44.8 tt0 -127.05 168.41 14.62 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.211 -1.17 . . . . 0.0 110.213 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' CYS . . . . . 0.657 ' O ' HD23 ' A' ' 45' ' ' LEU . 15.7 t -115.82 136.61 52.89 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.193 -0.942 . . . . 0.0 110.242 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.657 HD23 ' O ' ' A' ' 44' ' ' CYS . 81.6 mt -136.9 174.53 10.51 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.195 -0.941 . . . . 0.0 110.218 179.935 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 96.1 m-85 -109.44 0.55 19.39 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.185 -0.947 . . . . 0.0 110.254 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.419 ' O ' ' C ' ' A' ' 48' ' ' ALA . 41.4 m -122.79 164.79 17.72 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.271 -0.893 . . . . 0.0 110.237 180.0 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.419 ' C ' ' O ' ' A' ' 47' ' ' SER . . . -42.82 138.49 1.96 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.272 -0.892 . . . . 0.0 110.254 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' CYS . . . . . 0.505 ' HB2' HD12 ' A' ' 55' ' ' ILE . 11.6 t -44.5 131.38 4.83 Favored Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 121.201 -0.937 . . . . 0.0 110.182 -179.924 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.401 ' HD2' ' SG ' ' A' ' 67' ' ' CYS . 46.9 Cg_endo -72.71 161.13 44.73 Favored 'Trans proline' 0 C--N 1.306 -1.691 0 O-C-N 123.976 1.514 . . . . 0.0 110.47 179.94 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 47.1 pt -75.89 -10.69 13.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.212 -0.93 . . . . 0.0 110.274 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 77.0 m-85 -70.7 -25.38 62.93 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.21 -0.931 . . . . 0.0 110.212 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 81.3 p -137.55 159.82 40.88 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.261 -0.899 . . . . 0.0 110.304 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.44 ' HB2' ' O ' ' A' ' 68' ' ' LYS . 86.3 mttt -78.96 155.9 28.74 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.256 -0.902 . . . . 0.0 110.254 179.927 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.744 HG23 ' O ' ' A' ' 55' ' ' ILE . 17.3 tt -97.07 102.15 13.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.211 -0.93 . . . . 0.0 110.199 179.992 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' GLN . . . . . 0.521 ' CG ' ' HB3' ' A' ' 68' ' ' LYS . 64.9 mm-40 -70.4 -27.55 64.39 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.179 -0.951 . . . . 0.0 109.926 179.824 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 156.54 -158.85 29.05 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.401 -1.48 . . . . 0.0 109.401 179.961 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.651 HG22 ' HE3' ' A' ' 65' ' ' LYS . 19.3 p -81.87 164.84 21.32 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.254 -1.145 . . . . 0.0 110.19 179.947 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' CYS . . . . . 0.466 ' SG ' ' HB3' ' A' ' 66' ' ' CYS . 0.5 OUTLIER -92.64 -142.41 0.21 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.23 -0.918 . . . . 0.0 110.252 179.972 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 91.9 m-85 -50.52 -46.2 57.17 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.335 -0.853 . . . . 0.0 110.223 179.886 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -132.85 174.15 10.63 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.265 -0.897 . . . . 0.0 110.171 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -69.85 -16.21 72.2 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 48.9 mtpt -67.96 -25.85 65.64 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.234 -1.156 . . . . 0.0 110.257 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -124.63 161.29 26.57 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.301 -0.874 . . . . 0.0 110.212 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.651 ' HE3' HG22 ' A' ' 58' ' ' THR . 40.1 mmtm -133.62 143.26 48.51 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.309 -0.87 . . . . 0.0 110.213 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' CYS . . . . . 0.471 ' HA ' ' O ' ' A' ' 43' ' ' GLN . 19.5 p -109.93 162.78 14.18 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.318 -0.864 . . . . 0.0 110.226 179.97 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' CYS . . . . . 0.496 ' O ' ' CA ' ' A' ' 42' ' ' GLY . 75.7 m -142.41 165.29 27.82 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.302 -0.874 . . . . 0.0 110.264 179.968 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.521 ' HB3' ' CG ' ' A' ' 56' ' ' GLN . 39.6 ttpt . . . . . 0 N--CA 1.491 1.611 0 CA-C-O 117.984 -1.008 . . . . 0.0 110.152 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 44.0 t0 . . . . . 0 N--CA 1.49 1.571 0 CA-C-O 121.302 0.572 . . . . 0.0 110.182 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 91.3 m-70 -110.81 119.51 39.33 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.258 -0.901 . . . . 0.0 110.301 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.485 ' CD1' ' SG ' ' A' ' 37' ' ' CYS . 6.3 t80 -92.31 146.39 23.73 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.273 -0.892 . . . . 0.0 110.149 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 0.467 ' N ' ' CD1' ' A' ' 35' ' ' TYR . 11.0 t-20 -121.73 83.51 2.1 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.281 -0.887 . . . . 0.0 110.293 -179.959 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.485 ' SG ' ' CD1' ' A' ' 35' ' ' TYR . 28.9 m -68.71 -52.89 25.95 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.294 -0.879 . . . . 0.0 110.128 179.954 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 60.7 t -46.02 -48.52 5.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.205 -0.935 . . . . 0.0 110.164 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 58.9 p -58.63 -24.27 60.74 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.192 -0.943 . . . . 0.0 110.207 179.948 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.446 ' HB2' ' O ' ' A' ' 37' ' ' CYS . 66.7 m -82.08 -11.59 58.7 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.252 -0.905 . . . . 0.0 110.127 -179.964 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 106.31 -20.43 35.17 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 -179.921 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.519 ' CA ' ' O ' ' A' ' 67' ' ' CYS . . . -75.17 -177.66 40.64 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.452 -1.459 . . . . 0.0 109.452 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' GLN . . . . . 0.495 ' N ' ' O ' ' A' ' 67' ' ' CYS . 32.0 tt0 -129.83 160.12 34.46 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.276 -1.131 . . . . 0.0 110.204 -179.98 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' CYS . . . . . 0.47 ' SG ' ' CE2' ' A' ' 60' ' ' TYR . 13.5 t -114.97 107.63 15.63 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.259 -0.901 . . . . 0.0 110.182 179.972 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.736 HD12 ' HD3' ' A' ' 50' ' ' PRO . 16.7 mt -93.74 169.31 10.41 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.212 -0.93 . . . . 0.0 110.219 -179.931 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -86.53 -22.95 26.05 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.237 -0.915 . . . . 0.0 110.203 -179.907 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.417 ' O ' ' C ' ' A' ' 48' ' ' ALA . 40.2 t -103.51 163.64 12.17 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.284 -0.885 . . . . 0.0 110.251 -179.973 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.417 ' C ' ' O ' ' A' ' 47' ' ' SER . . . -43.45 138.01 2.58 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.231 -0.918 . . . . 0.0 110.194 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' CYS . . . . . 0.408 ' C ' ' O ' ' A' ' 48' ' ' ALA . 7.7 t -43.72 133.11 3.89 Favored Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.266 -0.896 . . . . 0.0 110.194 -179.958 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.736 ' HD3' HD12 ' A' ' 45' ' ' LEU . 46.4 Cg_endo -72.96 143.97 37.45 Favored 'Trans proline' 0 C--N 1.306 -1.691 0 O-C-N 123.954 1.502 . . . . 0.0 110.413 -179.935 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 40.3 pt -59.84 -24.18 28.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.213 -0.93 . . . . 0.0 110.163 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -55.72 -22.23 22.66 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.261 -0.9 . . . . 0.0 110.252 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.44 ' HB ' ' O ' ' A' ' 68' ' ' LYS . 67.2 p -139.35 153.83 47.76 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.261 -0.899 . . . . 0.0 110.239 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 72.0 mttt -79.6 172.07 14.29 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.262 -0.898 . . . . 0.0 110.166 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.721 HG23 ' O ' ' A' ' 55' ' ' ILE . 11.5 tt -106.9 110.62 32.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.276 -0.89 . . . . 0.0 110.116 179.965 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' GLN . . . . . 0.533 ' CG ' ' HB2' ' A' ' 68' ' ' LYS . 22.9 mm100 -62.02 -31.96 72.4 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.276 -0.89 . . . . 0.0 110.137 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 169.18 -144.57 8.77 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.443 -1.463 . . . . 0.0 109.443 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 17.5 p -97.91 164.97 12.15 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.184 -1.186 . . . . 0.0 110.196 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' CYS . . . . . 1.089 ' SG ' ' SG ' ' A' ' 66' ' ' CYS . 0.5 OUTLIER -106.49 -171.63 1.93 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.225 -0.922 . . . . 0.0 110.293 -179.976 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.527 ' CD1' ' N ' ' A' ' 61' ' ' ARG . 7.9 p90 -50.99 -31.68 18.76 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.309 -0.87 . . . . 0.0 110.263 179.862 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.527 ' N ' ' CD1' ' A' ' 60' ' ' TYR . 91.9 mtt180 -140.89 173.35 11.57 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.308 -0.87 . . . . 0.0 110.258 179.939 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -81.76 -11.08 83.34 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.586 -1.405 . . . . 0.0 109.586 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.409 ' HE2' ' CD ' ' A' ' 61' ' ' ARG . 48.7 mtmt -68.04 -18.84 64.8 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.217 -1.167 . . . . 0.0 110.135 -179.949 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.697 ' HB1' ' O ' ' A' ' 45' ' ' LEU . . . -136.42 158.58 44.08 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.263 -0.898 . . . . 0.0 110.16 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 70.1 mmtt -126.55 140.55 52.36 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.279 -0.888 . . . . 0.0 110.231 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' CYS . . . . . 1.089 ' SG ' ' SG ' ' A' ' 59' ' ' CYS . 84.1 m -74.59 148.88 40.39 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.26 -0.9 . . . . 0.0 110.263 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' CYS . . . . . 0.519 ' O ' ' CA ' ' A' ' 42' ' ' GLY . 82.8 m -142.42 154.84 44.93 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.239 -0.913 . . . . 0.0 110.145 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.533 ' HB2' ' CG ' ' A' ' 56' ' ' GLN . 68.3 tttt . . . . . 0 N--CA 1.492 1.645 0 CA-C-O 118.04 -0.981 . . . . 0.0 110.191 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 81.6 m-20 . . . . . 0 N--CA 1.492 1.655 0 CA-C-O 121.253 0.549 . . . . 0.0 110.196 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 21.6 t-80 -118.69 129.45 55.29 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.203 -0.936 . . . . 0.0 110.165 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.566 ' CZ ' ' SG ' ' A' ' 37' ' ' CYS . 30.4 p90 -130.81 173.35 11.03 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.236 -0.915 . . . . 0.0 110.153 -179.965 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 0.507 ' ND2' ' OG ' ' A' ' 39' ' ' SER . 23.4 p-10 -88.15 100.45 12.97 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.198 -0.939 . . . . 0.0 110.243 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.566 ' SG ' ' CZ ' ' A' ' 35' ' ' TYR . 14.8 m -72.1 -22.2 61.38 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.287 -0.883 . . . . 0.0 110.086 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.585 HG23 ' N ' ' A' ' 39' ' ' SER . 35.8 m -60.98 -45.19 98.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.231 -0.918 . . . . 0.0 110.46 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.585 ' N ' HG23 ' A' ' 38' ' ' VAL . 95.0 p -60.6 -31.61 70.76 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.202 -0.936 . . . . 0.0 110.211 -179.928 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 72.8 m -73.64 -12.43 60.74 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.304 -0.872 . . . . 0.0 110.192 179.89 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 101.83 -11.27 57.59 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.431 -1.468 . . . . 0.0 109.431 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.511 ' CA ' ' O ' ' A' ' 67' ' ' CYS . . . -85.18 172.49 47.44 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.412 -1.475 . . . . 0.0 109.412 -179.912 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' GLN . . . . . 0.515 ' N ' ' O ' ' A' ' 67' ' ' CYS . 0.2 OUTLIER -123.28 -174.82 3.04 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.27 -1.135 . . . . 0.0 110.151 179.959 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 13.7 t -130.11 116.38 18.41 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.161 -0.962 . . . . 0.0 110.222 -179.947 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.505 HD12 ' HD3' ' A' ' 50' ' ' PRO . 93.5 mt -105.46 175.84 5.36 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.251 -0.905 . . . . 0.0 110.224 179.858 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 98.3 m-85 -102.45 -3.44 26.95 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.278 -0.889 . . . . 0.0 110.291 -179.877 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.407 ' O ' ' C ' ' A' ' 48' ' ' ALA . 69.3 m -122.76 166.49 14.86 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.272 -0.893 . . . . 0.0 110.246 179.967 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.422 ' O ' ' C ' ' A' ' 49' ' ' CYS . . . -42.97 131.64 4.15 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.243 -0.911 . . . . 0.0 110.19 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' CYS . . . . . 0.422 ' C ' ' O ' ' A' ' 48' ' ' ALA . 5.9 t -42.96 130.02 3.19 Favored Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 121.29 -0.881 . . . . 0.0 110.251 -179.981 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.505 ' HD3' HD12 ' A' ' 45' ' ' LEU . 47.4 Cg_endo -72.81 145.6 41.08 Favored 'Trans proline' 0 C--N 1.306 -1.689 0 O-C-N 123.945 1.497 . . . . 0.0 110.412 -179.993 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 45.1 pt -59.63 -18.48 14.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.254 -0.904 . . . . 0.0 110.192 179.918 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 91.8 m-85 -70.86 -4.49 24.54 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.293 -0.88 . . . . 0.0 110.256 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 69.5 p -137.69 170.76 15.51 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.286 -0.884 . . . . 0.0 110.248 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.477 ' O ' ' HA ' ' A' ' 67' ' ' CYS . 70.9 tttt -91.27 162.79 14.48 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.215 -0.928 . . . . 0.0 110.209 -179.953 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.771 HG23 ' O ' ' A' ' 55' ' ' ILE . 15.1 tt -93.47 100.65 11.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.268 -0.895 . . . . 0.0 110.145 -179.963 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' GLN . . . . . 0.545 ' HB2' ' CB ' ' A' ' 66' ' ' CYS . 23.7 mm100 -75.45 0.01 18.53 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.245 -0.909 . . . . 0.0 110.218 179.98 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 111.75 -127.49 8.15 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.497 -1.441 . . . . 0.0 109.497 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.454 ' HA ' ' HD3' ' A' ' 65' ' ' LYS . 71.0 p -105.23 168.62 8.95 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.213 -1.169 . . . . 0.0 110.203 -179.986 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' CYS . . . . . 0.933 ' SG ' ' SG ' ' A' ' 66' ' ' CYS . 0.1 OUTLIER -117.66 -149.23 0.44 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.222 -0.924 . . . . 0.0 110.179 179.968 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 98.0 m-85 -58.34 -46.47 86.18 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.298 -0.876 . . . . 0.0 110.199 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.466 ' HD2' ' HD3' ' A' ' 63' ' ' LYS . 33.1 ttm180 -129.54 164.76 23.09 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.263 -0.898 . . . . 0.0 110.161 179.989 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.431 ' N ' ' HG2' ' A' ' 61' ' ' ARG . . . -61.3 -23.2 61.95 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.466 ' HD3' ' HD2' ' A' ' 61' ' ' ARG . 44.1 mtpt -72.34 -28.53 63.11 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.21 -1.171 . . . . 0.0 110.228 -179.986 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.419 ' C ' ' HG2' ' A' ' 65' ' ' LYS . . . -107.31 160.44 15.61 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.225 -0.922 . . . . 0.0 110.284 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.511 ' CA ' ' HB2' ' A' ' 59' ' ' CYS . 34.0 mmtm -142.68 144.76 32.87 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.21 -0.931 . . . . 0.0 110.086 179.984 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' CYS . . . . . 0.933 ' SG ' ' SG ' ' A' ' 59' ' ' CYS . 79.9 m -83.56 132.24 34.93 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.173 -0.955 . . . . 0.0 110.163 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' CYS . . . . . 0.515 ' O ' ' N ' ' A' ' 43' ' ' GLN . 85.0 m -126.76 154.19 44.54 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.28 -0.888 . . . . 0.0 110.18 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.428 ' HB2' ' CD ' ' A' ' 56' ' ' GLN . 85.2 tttt . . . . . 0 N--CA 1.491 1.577 0 CA-C-O 117.951 -1.023 . . . . 0.0 110.271 179.999 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 63.5 t0 . . . . . 0 N--CA 1.491 1.618 0 CA-C-O 121.159 0.504 . . . . 0.0 110.246 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 75.5 t60 -124.52 123.54 40.33 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.325 -0.859 . . . . 0.0 110.205 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 3.6 t80 -119.89 128.73 53.92 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.204 -0.935 . . . . 0.0 110.252 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 0.743 HD22 ' CG2' ' A' ' 38' ' ' VAL . 3.2 t-20 -100.79 117.27 34.54 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.236 -0.915 . . . . 0.0 110.157 179.931 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.45 ' O ' ' N ' ' A' ' 40' ' ' SER . 37.7 m -85.22 -51.07 6.86 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.332 -0.855 . . . . 0.0 110.311 -179.941 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.743 ' CG2' HD22 ' A' ' 36' ' ' ASN . 21.7 m -41.75 -46.26 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.248 -0.908 . . . . 0.0 110.33 -179.896 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.57 ' N ' HG23 ' A' ' 38' ' ' VAL . 0.8 OUTLIER -59.02 -32.18 69.49 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.177 -0.952 . . . . 0.0 110.14 179.98 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.483 ' O ' ' NZ ' ' A' ' 68' ' ' LYS . 50.2 m -75.43 -9.97 59.04 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.347 -0.846 . . . . 0.0 110.156 -179.991 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.401 ' HA3' ' HE3' ' A' ' 68' ' ' LYS . . . 108.29 -20.54 30.31 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 179.931 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.444 ' O ' ' HA ' ' A' ' 38' ' ' VAL . . . -78.27 177.61 53.39 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.592 -1.403 . . . . 0.0 109.592 179.94 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' GLN . . . . . 0.517 ' O ' ' HA ' ' A' ' 66' ' ' CYS . 29.2 tt0 -125.38 155.93 39.58 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.206 -1.173 . . . . 0.0 110.192 179.921 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 15.7 t -104.5 104.09 13.88 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.257 -0.902 . . . . 0.0 110.281 -179.96 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.477 HD12 ' CD ' ' A' ' 50' ' ' PRO . 80.3 mt -88.7 174.63 7.91 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.217 -0.927 . . . . 0.0 110.238 179.966 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 88.8 m-85 -96.13 -19.48 19.35 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.21 -0.931 . . . . 0.0 110.185 -179.929 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.419 ' O ' ' C ' ' A' ' 48' ' ' ALA . 69.1 m -110.47 165.66 11.61 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.181 -0.949 . . . . 0.0 110.257 -179.934 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.419 ' C ' ' O ' ' A' ' 47' ' ' SER . . . -42.92 131.95 4.04 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.315 -0.866 . . . . 0.0 110.217 179.978 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 8.7 t -44.68 127.63 5.07 Favored Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.205 -0.934 . . . . 0.0 110.106 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.477 ' CD ' HD12 ' A' ' 45' ' ' LEU . 46.7 Cg_endo -72.4 149.46 50.51 Favored 'Trans proline' 0 C--N 1.306 -1.681 0 O-C-N 123.949 1.499 . . . . 0.0 110.402 -179.999 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.425 HG13 ' N ' ' A' ' 52' ' ' PHE . 27.8 pt -63.6 -22.28 30.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.244 -0.91 . . . . 0.0 110.211 179.933 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' PHE . . . . . 0.425 ' N ' HG13 ' A' ' 51' ' ' ILE . 91.0 m-85 -56.98 -20.28 22.93 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.215 -0.928 . . . . 0.0 110.211 -179.998 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 17.6 p -133.93 162.85 30.91 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.302 -0.874 . . . . 0.0 110.18 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 55.6 mttm -95.36 143.94 26.32 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.221 -0.924 . . . . 0.0 110.129 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.721 HG23 ' O ' ' A' ' 55' ' ' ILE . 18.2 tt -88.76 113.26 25.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.213 -0.929 . . . . 0.0 110.184 -179.979 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' GLN . . . . . 0.401 ' CD ' ' HB3' ' A' ' 68' ' ' LYS . 27.0 mm100 -72.41 -28.06 62.73 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.249 -0.907 . . . . 0.0 110.153 -179.975 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 176.88 -148.92 9.24 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.457 -1.457 . . . . 0.0 109.457 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 43.2 p -99.48 163.57 12.46 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.182 -1.187 . . . . 0.0 110.199 179.93 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' CYS . . . . . 0.864 ' SG ' ' SG ' ' A' ' 66' ' ' CYS . 0.8 OUTLIER -98.07 -160.41 0.8 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.277 -0.889 . . . . 0.0 110.318 -179.976 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 85.2 m-85 -57.51 -46.91 83.25 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.355 -0.84 . . . . 0.0 110.197 179.874 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 95.3 mtt180 -127.21 167.97 15.35 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.251 -0.906 . . . . 0.0 110.14 -179.978 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -68.52 -12.19 63.52 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.477 -1.449 . . . . 0.0 109.477 -179.947 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 53.9 mtmt -75.84 -23.66 55.74 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.291 -1.123 . . . . 0.0 110.244 179.999 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -113.26 163.09 15.24 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.255 -0.903 . . . . 0.0 110.249 -179.93 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -140.03 141.05 36.31 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.306 -0.871 . . . . 0.0 110.199 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' CYS . . . . . 0.864 ' SG ' ' SG ' ' A' ' 59' ' ' CYS . 58.6 m -84.99 148.05 26.38 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.248 -0.907 . . . . 0.0 110.154 -179.982 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 67' ' ' CYS . . . . . 0.436 ' SG ' ' HD2' ' A' ' 50' ' ' PRO . 80.5 m -143.64 128.08 17.93 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.276 -0.89 . . . . 0.0 110.195 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.483 ' NZ ' ' O ' ' A' ' 40' ' ' SER . 75.2 tttt . . . . . 0 N--CA 1.492 1.636 0 CA-C-O 118.058 -0.972 . . . . 0.0 110.194 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 55.1 t0 . . . . . 0 N--CA 1.492 1.627 0 CA-C-O 121.247 0.546 . . . . 0.0 110.212 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 94.8 m-70 -117.96 134.36 55.03 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.206 -0.934 . . . . 0.0 110.238 -179.902 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 43.2 t80 -129.09 142.39 50.91 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.255 -0.903 . . . . 0.0 110.161 179.905 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 17.4 p-10 -111.1 123.82 50.96 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.291 -0.881 . . . . 0.0 110.235 -179.949 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.65 ' SG ' ' SG ' ' A' ' 59' ' ' CYS . 22.3 m -68.62 -6.86 28.24 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.242 -0.912 . . . . 0.0 110.161 179.856 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 39.8 t -71.7 -41.52 70.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.236 -0.915 . . . . 0.0 110.157 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 3.1 m -51.4 -29.39 15.55 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.269 -0.894 . . . . 0.0 110.054 179.954 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.444 ' CB ' ' HB3' ' A' ' 56' ' ' GLN . 26.6 m -88.89 -17.36 29.76 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.236 -0.915 . . . . 0.0 110.058 179.898 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.473 ' O ' ' HG3' ' A' ' 68' ' ' LYS . . . 108.06 8.75 29.11 Favored Glycine 0 N--CA 1.489 2.197 0 N-CA-C 109.488 -1.445 . . . . 0.0 109.488 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.511 ' CA ' ' O ' ' A' ' 67' ' ' CYS . . . -110.18 173.0 16.11 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.498 -1.441 . . . . 0.0 109.498 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' GLN . . . . . 0.485 ' N ' ' O ' ' A' ' 67' ' ' CYS . 2.0 pt20 -110.34 174.53 5.82 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.237 -1.155 . . . . 0.0 110.246 179.951 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 8.7 t -110.98 84.38 1.92 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.228 -0.92 . . . . 0.0 110.218 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.494 HD12 ' HA ' ' A' ' 45' ' ' LEU . 14.4 tp -69.26 167.09 17.06 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.357 -0.839 . . . . 0.0 110.191 -180.0 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 60.1 m-85 -91.77 -24.85 19.28 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.293 -0.88 . . . . 0.0 110.314 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.422 ' O ' ' C ' ' A' ' 48' ' ' ALA . 73.7 m -106.81 167.44 9.87 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.2 -0.937 . . . . 0.0 110.261 -179.928 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.422 ' C ' ' O ' ' A' ' 47' ' ' SER . . . -43.02 128.02 4.29 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.188 -0.945 . . . . 0.0 110.163 -179.965 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 8.2 t -46.12 130.4 7.39 Favored Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.277 -0.889 . . . . 0.0 110.3 -179.865 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.469 ' HD2' ' SG ' ' A' ' 67' ' ' CYS . 46.3 Cg_endo -72.74 151.1 51.3 Favored 'Trans proline' 0 C--N 1.307 -1.62 0 O-C-N 123.882 1.464 . . . . 0.0 110.302 179.843 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 37.0 pt -64.03 -21.23 28.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.196 -0.94 . . . . 0.0 110.305 179.982 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 82.1 m-85 -61.45 -19.9 62.51 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.206 -0.934 . . . . 0.0 110.174 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 38.8 p -118.57 168.64 10.5 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.25 -0.906 . . . . 0.0 110.192 -179.953 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.472 ' O ' ' HA ' ' A' ' 67' ' ' CYS . 30.1 tttt -96.83 162.38 13.44 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.223 -0.923 . . . . 0.0 110.142 179.983 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.686 HG23 ' O ' ' A' ' 55' ' ' ILE . 20.8 tt -97.6 116.43 40.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.247 -0.908 . . . . 0.0 110.171 179.961 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' GLN . . . . . 0.49 ' HB2' ' HB3' ' A' ' 66' ' ' CYS . 61.6 mm-40 -93.36 -1.46 55.87 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.244 -0.91 . . . . 0.0 110.177 -179.919 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 142.47 -131.61 4.75 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.423 -1.471 . . . . 0.0 109.423 -179.935 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.447 ' O ' ' SG ' ' A' ' 66' ' ' CYS . 18.5 p -120.88 164.91 15.95 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.227 -1.16 . . . . 0.0 110.189 179.988 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' CYS . . . . . 0.65 ' SG ' ' SG ' ' A' ' 37' ' ' CYS . 0.5 OUTLIER -105.86 -158.78 0.67 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.242 -0.911 . . . . 0.0 110.276 -179.902 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 99.6 m-85 -57.36 -50.6 72.43 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.257 -0.902 . . . . 0.0 110.133 179.922 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 74.2 mtm180 -123.55 165.25 17.46 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.284 -0.885 . . . . 0.0 110.128 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -61.51 -21.35 60.14 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.48 -1.448 . . . . 0.0 109.48 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 2.8 tptt -67.63 -31.35 71.31 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.26 -1.141 . . . . 0.0 110.215 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -102.6 158.56 16.14 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.384 -0.823 . . . . 0.0 110.145 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 70.3 mmtt -141.85 160.29 40.5 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.304 -0.872 . . . . 0.0 110.132 -179.954 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' CYS . . . . . 0.49 ' HB3' ' HB2' ' A' ' 56' ' ' GLN . 66.6 m -82.1 132.07 35.24 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.206 -0.934 . . . . 0.0 110.212 -179.983 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 67' ' ' CYS . . . . . 0.511 ' O ' ' CA ' ' A' ' 42' ' ' GLY . 78.6 m -129.32 124.35 34.11 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.251 -0.906 . . . . 0.0 110.151 -179.951 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.473 ' HG3' ' O ' ' A' ' 41' ' ' GLY . 47.2 tttt . . . . . 0 N--CA 1.491 1.614 0 CA-C-O 117.94 -1.029 . . . . 0.0 110.251 179.96 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 80.7 m-20 . . . . . 0 N--CA 1.491 1.616 0 CA-C-O 121.239 0.542 . . . . 0.0 110.21 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 69.6 t60 -98.87 109.43 22.19 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.179 -0.95 . . . . 0.0 110.173 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.456 ' CD1' ' N ' ' A' ' 36' ' ' ASN . 11.2 t80 -108.35 154.3 22.02 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.203 -0.935 . . . . 0.0 110.181 179.945 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 0.456 ' N ' ' CD1' ' A' ' 35' ' ' TYR . 28.2 p-10 -98.33 55.56 1.12 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.261 -0.899 . . . . 0.0 110.299 179.981 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.429 ' SG ' ' CD1' ' A' ' 35' ' ' TYR . 60.3 m -61.31 -22.51 64.95 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.24 -0.912 . . . . 0.0 110.171 -179.999 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 72.2 t -68.83 -39.94 80.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.22 -0.925 . . . . 0.0 110.211 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.45 ' OG ' ' ND2' ' A' ' 36' ' ' ASN . 87.4 p -64.13 -26.5 68.56 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.203 -0.935 . . . . 0.0 110.104 179.986 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 50.0 m -81.06 -20.56 41.34 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.237 -0.915 . . . . 0.0 110.198 179.973 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.473 ' O ' ' HG3' ' A' ' 68' ' ' LYS . . . 112.14 14.89 10.36 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.511 -1.436 . . . . 0.0 109.511 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.435 ' HA2' ' HA ' ' A' ' 68' ' ' LYS . . . -110.3 171.82 15.09 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.504 -1.439 . . . . 0.0 109.504 179.962 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' GLN . . . . . 0.489 ' N ' ' O ' ' A' ' 67' ' ' CYS . 0.0 OUTLIER -129.24 175.16 8.95 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.25 -1.147 . . . . 0.0 110.301 -179.993 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 6.1 m -110.77 97.01 6.53 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.283 -0.886 . . . . 0.0 110.132 179.885 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.516 ' O ' ' HB1' ' A' ' 64' ' ' ALA . 23.0 tp -86.39 167.22 14.93 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.259 -0.901 . . . . 0.0 110.146 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 95.2 m-85 -92.13 -31.05 15.65 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.219 -0.926 . . . . 0.0 110.345 -179.916 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.422 ' O ' ' C ' ' A' ' 48' ' ' ALA . 76.8 p -92.02 160.61 15.15 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.386 -0.821 . . . . 0.0 110.231 -179.948 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.422 ' C ' ' O ' ' A' ' 47' ' ' SER . . . -42.7 129.28 4.18 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.33 -0.856 . . . . 0.0 110.194 179.937 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 4.1 t -43.15 128.44 3.42 Favored Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.182 -0.949 . . . . 0.0 110.203 -179.853 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.429 ' HD2' ' SG ' ' A' ' 67' ' ' CYS . 46.7 Cg_endo -72.34 146.07 44.46 Favored 'Trans proline' 0 C--N 1.305 -1.713 0 O-C-N 123.95 1.5 . . . . 0.0 110.452 -179.94 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 39.1 pt -60.39 -15.57 10.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.28 -0.887 . . . . 0.0 110.206 -179.951 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 76.1 m-85 -71.63 -10.26 59.5 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.26 -0.9 . . . . 0.0 110.208 179.924 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.463 ' HB ' ' N ' ' A' ' 68' ' ' LYS . 61.5 p -127.78 167.0 17.13 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.237 -0.914 . . . . 0.0 110.189 -179.995 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.466 ' O ' ' HA ' ' A' ' 67' ' ' CYS . 38.1 mttt -103.51 173.05 6.47 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.246 -0.909 . . . . 0.0 110.214 -179.98 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.672 HG23 ' O ' ' A' ' 55' ' ' ILE . 10.8 tp -99.65 119.33 47.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.357 -0.839 . . . . 0.0 110.209 179.961 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 16.1 mm100 -102.03 9.23 40.56 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.269 -0.894 . . . . 0.0 110.264 -179.928 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 129.17 -159.89 22.42 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.448 -1.461 . . . . 0.0 109.448 179.919 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.456 ' O ' ' SG ' ' A' ' 66' ' ' CYS . 19.1 p -92.48 164.28 13.52 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.217 -1.166 . . . . 0.0 110.214 -179.93 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 1.5 m -110.54 -163.14 0.83 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.227 -0.921 . . . . 0.0 110.147 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 67.0 m-85 -49.64 -59.95 3.32 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.391 -0.818 . . . . 0.0 110.151 179.761 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 30.0 mmt180 -120.22 166.3 13.65 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.169 -0.957 . . . . 0.0 110.103 -180.0 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -65.39 -23.63 70.28 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 52.4 mtmt -60.19 -25.42 65.56 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.209 -1.171 . . . . 0.0 110.164 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.516 ' HB1' ' O ' ' A' ' 45' ' ' LEU . . . -117.32 160.96 20.29 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.242 -0.911 . . . . 0.0 110.17 -179.868 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.406 ' HG2' ' C ' ' A' ' 64' ' ' ALA . 28.9 mmtp -137.94 154.64 49.38 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.23 -0.918 . . . . 0.0 110.307 179.946 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 66' ' ' CYS . . . . . 0.456 ' SG ' ' O ' ' A' ' 58' ' ' THR . 71.7 m -72.27 131.42 42.68 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.292 -0.88 . . . . 0.0 110.169 179.911 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' CYS . . . . . 0.489 ' O ' ' N ' ' A' ' 43' ' ' GLN . 94.7 m -129.8 131.24 46.12 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.228 -0.92 . . . . 0.0 110.247 -179.905 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.473 ' HG3' ' O ' ' A' ' 41' ' ' GLY . 84.4 tttt . . . . . 0 N--CA 1.49 1.547 0 CA-C-O 117.995 -1.002 . . . . 0.0 110.182 -179.951 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 72.2 m-20 . . . . . 0 N--CA 1.491 1.621 0 CA-C-O 121.3 0.571 . . . . 0.0 110.221 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 69.1 m80 -69.21 149.76 48.21 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.223 -0.923 . . . . 0.0 110.205 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.568 ' CZ ' ' SG ' ' A' ' 37' ' ' CYS . 1.8 t80 -126.77 122.25 34.27 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.264 -0.898 . . . . 0.0 110.144 179.927 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 9.9 p-10 -121.7 114.66 21.44 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.225 -0.922 . . . . 0.0 110.213 -179.971 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.568 ' SG ' ' CZ ' ' A' ' 35' ' ' TYR . 46.7 m -74.26 -0.35 16.7 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.258 -0.901 . . . . 0.0 110.278 179.982 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 94.7 t -67.3 -33.95 65.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.208 -0.933 . . . . 0.0 110.116 -179.97 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 69.3 m -71.18 -27.81 63.79 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.24 -0.913 . . . . 0.0 110.149 179.912 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 63.7 m -82.42 -9.22 59.53 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.331 -0.855 . . . . 0.0 110.119 179.922 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.428 ' C ' ' HG3' ' A' ' 68' ' ' LYS . . . 105.33 -24.61 27.17 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.341 -1.504 . . . . 0.0 109.341 -179.965 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.463 ' N ' ' HG3' ' A' ' 68' ' ' LYS . . . -67.74 -173.57 7.08 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.444 -1.462 . . . . 0.0 109.444 -179.979 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 43' ' ' GLN . . . . . 0.51 ' O ' ' HA ' ' A' ' 66' ' ' CYS . 36.1 tt0 -141.34 144.36 34.53 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.272 -1.134 . . . . 0.0 110.26 -179.941 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' CYS . . . . . 0.416 ' O ' HD23 ' A' ' 45' ' ' LEU . 76.4 m -94.96 137.11 34.46 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.268 -0.895 . . . . 0.0 110.144 179.998 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.678 ' O ' ' HB1' ' A' ' 64' ' ' ALA . 54.0 mt -130.01 178.8 6.27 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.276 -0.89 . . . . 0.0 110.239 -179.982 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 85.9 m-85 -109.46 -1.04 18.61 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.259 -0.901 . . . . 0.0 110.178 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.423 ' O ' ' C ' ' A' ' 48' ' ' ALA . 52.3 m -127.9 171.59 11.65 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.27 -0.894 . . . . 0.0 110.25 -179.984 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.423 ' C ' ' O ' ' A' ' 47' ' ' SER . . . -43.08 145.12 0.54 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.221 -0.924 . . . . 0.0 110.189 179.968 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 16.9 t -55.77 130.28 71.9 Favored Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 121.228 -0.92 . . . . 0.0 110.165 -179.974 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.47 ' HD2' ' SG ' ' A' ' 67' ' ' CYS . 47.5 Cg_endo -73.14 142.32 34.0 Favored 'Trans proline' 0 C--N 1.306 -1.685 0 O-C-N 123.991 1.521 . . . . 0.0 110.402 179.98 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 39.0 pt -63.68 -18.78 22.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.315 -0.866 . . . . 0.0 110.181 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 85.0 m-85 -59.45 -21.55 60.21 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.237 -0.914 . . . . 0.0 110.216 179.944 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.481 ' OG1' ' HB3' ' A' ' 67' ' ' CYS . 20.4 p -132.78 171.15 14.27 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.26 -0.9 . . . . 0.0 110.297 179.869 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.494 ' O ' ' HA ' ' A' ' 67' ' ' CYS . 45.5 tttp -83.68 165.04 19.27 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.24 -0.912 . . . . 0.0 110.21 179.943 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.737 HG23 ' O ' ' A' ' 55' ' ' ILE . 12.0 tt -91.28 108.67 20.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.268 -0.895 . . . . 0.0 110.162 179.895 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' GLN . . . . . 0.493 ' HB2' ' HB3' ' A' ' 66' ' ' CYS . 27.8 mm100 -85.31 -8.84 58.29 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.251 -0.906 . . . . 0.0 110.256 179.937 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 125.43 -124.44 5.28 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 179.941 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.457 ' HB ' ' HA2' ' A' ' 62' ' ' GLY . 16.6 p -117.98 169.49 9.61 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.31 -1.112 . . . . 0.0 110.157 -179.935 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 59' ' ' CYS . . . . . 0.646 ' HB3' ' HB3' ' A' ' 64' ' ' ALA . 0.9 OUTLIER -133.61 140.73 47.3 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.211 -0.931 . . . . 0.0 110.202 179.959 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.507 ' CB ' ' HB3' ' A' ' 63' ' ' LYS . 71.2 m-85 56.07 53.93 8.51 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.293 -0.879 . . . . 0.0 110.414 179.9 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.451 ' HB2' ' O ' ' A' ' 60' ' ' TYR . 38.6 mmt180 57.38 39.95 27.87 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.25 -0.906 . . . . 0.0 110.609 179.696 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.457 ' HA2' ' HB ' ' A' ' 58' ' ' THR . . . 85.86 -16.45 41.78 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.779 -1.328 . . . . 0.0 109.779 179.603 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.507 ' HB3' ' CB ' ' A' ' 60' ' ' TYR . 5.7 ttpt -55.44 -18.43 6.95 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.103 -1.234 . . . . 0.0 109.767 179.951 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.678 ' HB1' ' O ' ' A' ' 45' ' ' LEU . . . -149.56 172.09 15.57 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.405 -0.81 . . . . 0.0 109.961 179.757 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.405 ' HD2' ' HA ' ' A' ' 65' ' ' LYS . 53.2 tptt -111.15 122.33 47.6 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.147 -0.971 . . . . 0.0 110.275 -179.903 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 66' ' ' CYS . . . . . 0.51 ' HA ' ' O ' ' A' ' 43' ' ' GLN . 42.9 m -81.27 140.98 34.53 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.297 -0.877 . . . . 0.0 110.134 179.977 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 67' ' ' CYS . . . . . 0.494 ' HA ' ' O ' ' A' ' 54' ' ' LYS . 85.0 m -149.53 124.61 10.05 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.198 -0.939 . . . . 0.0 110.222 -179.969 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.463 ' HG3' ' N ' ' A' ' 42' ' ' GLY . 33.4 ttmt . . . . . 0 N--CA 1.491 1.618 0 CA-C-O 117.942 -1.028 . . . . 0.0 110.194 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 46.5 m-20 . . . . . 0 N--CA 1.491 1.602 0 CA-C-O 121.234 0.54 . . . . 0.0 110.236 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 91.8 m-70 -111.3 143.16 42.53 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.248 -0.907 . . . . 0.0 110.186 -179.965 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 2.4 t80 -128.01 123.02 33.69 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.245 -0.909 . . . . 0.0 110.141 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 36.3 t30 -101.13 108.97 20.79 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.211 -0.931 . . . . 0.0 110.237 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 27.4 m -82.02 -3.78 55.29 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.183 -0.948 . . . . 0.0 110.191 179.948 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 91.9 t -70.18 -45.95 73.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.235 -0.915 . . . . 0.0 110.213 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 22.9 t -60.51 -26.39 66.81 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.258 -0.901 . . . . 0.0 110.175 179.996 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 42.5 m -83.59 -8.35 59.33 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.309 -0.869 . . . . 0.0 110.243 179.935 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.435 ' C ' ' HG3' ' A' ' 68' ' ' LYS . . . 91.91 3.58 68.02 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.598 -1.401 . . . . 0.0 109.598 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -90.55 172.67 37.83 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' GLN . . . . . 0.514 ' O ' ' HA ' ' A' ' 66' ' ' CYS . 32.6 tt0 -127.58 137.2 52.52 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.345 -1.091 . . . . 0.0 110.217 -179.967 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' CYS . . . . . 0.57 ' SG ' ' HB3' ' A' ' 64' ' ' ALA . 24.7 t -83.68 113.17 20.67 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.234 -0.916 . . . . 0.0 110.242 179.934 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.659 HD12 ' SG ' ' A' ' 67' ' ' CYS . 47.3 mt -106.05 168.94 8.79 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.186 -0.946 . . . . 0.0 110.269 -179.936 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 91.1 m-85 -104.23 -1.47 27.07 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.286 -0.883 . . . . 0.0 110.231 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.417 ' O ' ' C ' ' A' ' 48' ' ' ALA . 89.5 p -126.99 168.36 14.65 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.211 -0.93 . . . . 0.0 110.257 -179.972 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.417 ' C ' ' O ' ' A' ' 47' ' ' SER . . . -42.86 128.66 4.27 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.251 -0.905 . . . . 0.0 110.136 179.991 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 6.0 t -44.44 132.09 4.72 Favored Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 121.238 -0.914 . . . . 0.0 110.174 179.904 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.443 ' HG2' ' OG1' ' A' ' 53' ' ' THR . 46.9 Cg_endo -73.19 148.58 44.42 Favored 'Trans proline' 0 C--N 1.306 -1.674 0 O-C-N 123.867 1.456 . . . . 0.0 110.406 -179.982 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 13.1 mt -62.96 -22.24 30.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.284 -0.885 . . . . 0.0 110.152 179.966 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -71.02 -3.94 22.27 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.313 -0.867 . . . . 0.0 110.218 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.504 ' CB ' ' HB3' ' A' ' 67' ' ' CYS . 54.6 p -133.27 162.55 31.5 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.241 -0.912 . . . . 0.0 110.276 179.978 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.484 ' O ' ' HA ' ' A' ' 67' ' ' CYS . 46.8 tttp -93.18 168.36 11.15 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.287 -0.883 . . . . 0.0 110.234 179.978 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.582 HG23 ' O ' ' A' ' 55' ' ' ILE . 18.5 tt -87.78 125.11 41.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.237 -0.914 . . . . 0.0 110.207 179.962 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' GLN . . . . . 0.523 ' HB2' ' CB ' ' A' ' 66' ' ' CYS . 26.7 mm100 -107.49 7.96 29.15 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.193 -0.942 . . . . 0.0 110.201 179.99 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 102.31 -140.1 14.71 Favored Glycine 0 N--CA 1.489 2.176 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 179.975 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.446 ' O ' ' SG ' ' A' ' 66' ' ' CYS . 38.7 p -98.75 -174.11 2.7 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.23 -1.159 . . . . 0.0 110.182 179.987 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 59' ' ' CYS . . . . . 0.773 ' SG ' ' SG ' ' A' ' 66' ' ' CYS . 1.2 m -112.48 -161.24 0.75 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.251 -0.905 . . . . 0.0 110.27 -179.957 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 74.4 m-85 -49.83 -65.62 0.53 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.238 -0.914 . . . . 0.0 110.411 179.952 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.403 ' CD ' ' HE2' ' A' ' 63' ' ' LYS . 56.7 mtt180 -93.29 -14.49 26.9 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.241 -0.912 . . . . 0.0 110.446 -179.834 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 101.65 -21.02 44.04 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.366 -1.494 . . . . 0.0 109.366 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.403 ' HE2' ' CD ' ' A' ' 61' ' ' ARG . 37.0 mtmt -57.44 -30.2 64.8 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.278 -1.131 . . . . 0.0 109.98 179.77 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.57 ' HB3' ' SG ' ' A' ' 44' ' ' CYS . . . -106.54 159.41 16.2 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.498 -0.751 . . . . 0.0 110.268 -179.82 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.41 ' HD2' ' HA ' ' A' ' 65' ' ' LYS . 49.5 tptt -112.49 120.53 41.96 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.185 -0.947 . . . . 0.0 110.208 -179.902 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 66' ' ' CYS . . . . . 0.773 ' SG ' ' SG ' ' A' ' 59' ' ' CYS . 79.4 m -68.95 151.46 46.51 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.308 -0.87 . . . . 0.0 110.127 179.958 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 67' ' ' CYS . . . . . 0.659 ' SG ' HD12 ' A' ' 45' ' ' LEU . 90.4 m -149.0 125.32 10.86 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.146 -0.971 . . . . 0.0 110.219 179.994 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.435 ' HG3' ' C ' ' A' ' 41' ' ' GLY . 26.9 tttp . . . . . 0 N--CA 1.491 1.613 0 CA-C-O 118.013 -0.994 . . . . 0.0 110.212 179.952 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 95.4 m-20 . . . . . 0 N--CA 1.491 1.607 0 CA-C-O 121.21 0.529 . . . . 0.0 110.222 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 64.6 m170 -113.99 131.6 56.28 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.259 -0.9 . . . . 0.0 110.104 179.966 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.473 ' CZ ' ' SG ' ' A' ' 37' ' ' CYS . 27.6 p90 -139.55 165.36 27.45 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.308 -0.87 . . . . 0.0 110.26 -179.959 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 25.2 t30 -91.09 102.43 15.18 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.277 -0.889 . . . . 0.0 110.339 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.493 ' O ' ' N ' ' A' ' 40' ' ' SER . 57.5 m -59.49 -48.62 80.93 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.288 -0.882 . . . . 0.0 110.245 -179.97 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.438 ' C ' ' O ' ' A' ' 37' ' ' CYS . 39.5 t -40.45 -53.6 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.455 -0.778 . . . . 0.0 110.46 -179.862 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 5.1 t -53.16 -28.04 24.23 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.315 -0.866 . . . . 0.0 110.162 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.493 ' N ' ' O ' ' A' ' 37' ' ' CYS . 38.9 m -83.37 -8.0 59.48 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.272 -0.893 . . . . 0.0 110.252 179.957 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 106.03 -23.24 29.64 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.443 -1.463 . . . . 0.0 109.443 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.42 ' HA2' ' HA ' ' A' ' 68' ' ' LYS . . . -71.52 171.99 46.05 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 179.926 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 43' ' ' GLN . . . . . 0.626 ' OE1' HD21 ' A' ' 45' ' ' LEU . 10.9 tt0 -128.01 133.77 49.18 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.234 -1.156 . . . . 0.0 110.336 -179.975 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 44' ' ' CYS . . . . . 0.663 ' SG ' ' SG ' ' A' ' 66' ' ' CYS . 4.2 m -91.95 111.95 23.69 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.236 -0.915 . . . . 0.0 110.208 -179.996 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.626 HD21 ' OE1' ' A' ' 43' ' ' GLN . 75.1 mt -107.83 175.09 5.6 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.293 -0.879 . . . . 0.0 110.178 -179.88 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 72.9 m-85 -99.64 -11.24 21.1 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.328 -0.858 . . . . 0.0 110.3 179.985 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 41.2 t -111.98 166.46 11.21 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.213 -0.929 . . . . 0.0 110.229 -179.88 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -43.69 145.23 0.68 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.211 -0.931 . . . . 0.0 110.214 179.946 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 17.2 t -49.04 131.54 15.46 Favored Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.221 -0.924 . . . . 0.0 110.238 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.511 ' HD3' HD12 ' A' ' 45' ' ' LEU . 47.9 Cg_endo -73.23 164.37 35.49 Favored 'Trans proline' 0 C--N 1.306 -1.686 0 O-C-N 123.898 1.472 . . . . 0.0 110.471 -179.904 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 27.4 mt -74.89 -26.24 19.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.193 -0.942 . . . . 0.0 110.159 179.801 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 99.5 m-85 -66.62 -9.39 35.15 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.323 -0.86 . . . . 0.0 110.159 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.501 ' CB ' ' HB3' ' A' ' 67' ' ' CYS . 67.7 p -133.23 158.99 41.5 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.28 -0.887 . . . . 0.0 110.141 179.999 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.477 ' O ' ' HA ' ' A' ' 67' ' ' CYS . 63.1 mttt -100.58 172.42 7.11 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.206 -0.933 . . . . 0.0 110.247 -179.988 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.499 HG23 ' O ' ' A' ' 55' ' ' ILE . 21.0 tt -79.85 131.19 34.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.189 -0.944 . . . . 0.0 110.22 -179.957 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 90.2 mm-40 -119.04 -3.12 10.69 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.347 -0.846 . . . . 0.0 110.228 -179.945 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 131.7 -131.85 6.5 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.418 -1.473 . . . . 0.0 109.418 -179.996 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.45 ' O ' ' SG ' ' A' ' 66' ' ' CYS . 72.7 p -123.4 168.79 12.07 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.291 -1.123 . . . . 0.0 110.263 -179.984 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 59' ' ' CYS . . . . . 1.298 ' SG ' ' SG ' ' A' ' 66' ' ' CYS . 9.8 m -111.55 -163.31 0.84 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.217 -0.927 . . . . 0.0 110.29 179.924 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.427 ' C ' ' O ' ' A' ' 59' ' ' CYS . 68.9 m-85 -41.9 -46.85 4.15 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.312 -0.868 . . . . 0.0 110.317 179.859 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -124.42 171.62 9.8 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.198 -0.939 . . . . 0.0 110.117 179.898 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -72.5 -23.25 78.24 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.463 -1.455 . . . . 0.0 109.463 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 38.2 ttmt -65.41 -34.55 78.57 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.202 -1.176 . . . . 0.0 110.291 179.951 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -94.73 163.23 13.45 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.3 -0.875 . . . . 0.0 110.162 -179.923 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.447 ' HE3' HG13 ' A' ' 55' ' ' ILE . 50.4 tptt -140.05 135.98 33.18 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.253 -0.905 . . . . 0.0 110.118 -179.957 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 66' ' ' CYS . . . . . 1.298 ' SG ' ' SG ' ' A' ' 59' ' ' CYS . 73.8 m -85.17 136.61 33.46 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.279 -0.888 . . . . 0.0 110.257 179.969 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 67' ' ' CYS . . . . . 0.501 ' HB3' ' CB ' ' A' ' 53' ' ' THR . 76.4 m -141.51 129.78 22.31 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.266 -0.897 . . . . 0.0 110.144 -179.973 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.42 ' HA ' ' HA2' ' A' ' 42' ' ' GLY . 40.4 tttt . . . . . 0 N--CA 1.492 1.65 0 CA-C-O 118.065 -0.969 . . . . 0.0 110.169 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 56.9 t0 . . . . . 0 N--CA 1.491 1.586 0 CA-C-O 121.306 0.574 . . . . 0.0 110.207 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 97.2 m-70 -110.61 116.43 31.32 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.221 -0.924 . . . . 0.0 110.235 -179.986 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.548 ' CD1' ' SG ' ' A' ' 37' ' ' CYS . 2.3 t80 -54.23 138.63 38.19 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.202 -0.937 . . . . 0.0 110.17 179.913 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 0.422 ' O ' ' CG ' ' A' ' 36' ' ' ASN . 22.0 p-10 -98.52 64.31 1.53 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.251 -0.906 . . . . 0.0 110.256 -179.918 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.548 ' SG ' ' CD1' ' A' ' 35' ' ' TYR . 34.4 m -62.89 -52.0 64.79 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.221 -0.924 . . . . 0.0 110.174 179.893 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.4 ' HA ' ' O ' ' A' ' 42' ' ' GLY . 68.8 t -54.04 -40.31 45.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.236 -0.915 . . . . 0.0 110.247 179.923 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 33.6 t -60.99 -30.57 70.36 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.146 -0.972 . . . . 0.0 110.255 179.945 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.44 ' O ' ' HE3' ' A' ' 68' ' ' LYS . 72.1 m -82.63 -7.96 59.62 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.358 -0.839 . . . . 0.0 110.165 179.97 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 104.17 5.47 43.5 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.514 ' CA ' ' O ' ' A' ' 67' ' ' CYS . . . -93.56 176.88 37.09 Favored Glycine 0 N--CA 1.489 2.198 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 -179.985 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 43' ' ' GLN . . . . . 0.504 ' N ' ' O ' ' A' ' 67' ' ' CYS . 16.1 tt0 -132.39 132.87 43.28 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.249 -1.147 . . . . 0.0 110.2 -179.926 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 22.6 m -95.78 116.66 29.22 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.336 -0.853 . . . . 0.0 110.298 179.977 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.696 HD12 ' HD3' ' A' ' 50' ' ' PRO . 92.5 mt -101.76 175.32 5.59 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.296 -0.877 . . . . 0.0 110.161 179.967 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 -91.37 -3.1 57.08 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.241 -0.912 . . . . 0.0 110.227 179.957 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.402 ' O ' ' C ' ' A' ' 48' ' ' ALA . 59.1 p -126.56 167.85 15.08 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.18 -0.95 . . . . 0.0 110.183 -179.976 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.48 ' HA ' ' HG3' ' A' ' 65' ' ' LYS . . . -42.62 148.19 0.24 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.271 -0.893 . . . . 0.0 110.192 179.952 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 17.1 t -52.86 130.37 47.94 Favored Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.24 -0.913 . . . . 0.0 110.077 179.986 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.696 ' HD3' HD12 ' A' ' 45' ' ' LEU . 47.5 Cg_endo -72.67 149.33 48.63 Favored 'Trans proline' 0 C--N 1.306 -1.68 0 O-C-N 123.88 1.463 . . . . 0.0 110.442 -179.924 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 44.9 pt -67.24 -11.26 13.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.26 -0.9 . . . . 0.0 110.128 179.961 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 55.5 m-85 -62.62 -25.56 68.17 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.255 -0.903 . . . . 0.0 110.157 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.484 ' OG1' ' HB3' ' A' ' 67' ' ' CYS . 69.1 p -143.01 158.86 43.2 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.348 -0.845 . . . . 0.0 110.218 -179.99 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.474 ' O ' ' HA ' ' A' ' 67' ' ' CYS . 84.7 mttt -77.52 176.81 8.56 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.21 -0.932 . . . . 0.0 110.161 -179.961 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.432 HG13 ' O ' ' A' ' 66' ' ' CYS . 19.7 tt -108.79 137.63 39.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.188 -0.945 . . . . 0.0 110.225 -179.982 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 56' ' ' GLN . . . . . 0.459 ' HG3' ' HB2' ' A' ' 68' ' ' LYS . 21.5 mm100 -98.83 -24.87 14.83 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.282 -0.886 . . . . 0.0 110.181 179.971 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 162.89 -152.39 22.54 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.444 -1.462 . . . . 0.0 109.444 179.997 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.445 ' O ' ' SG ' ' A' ' 66' ' ' CYS . 82.6 p -90.81 161.51 15.24 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.274 -1.133 . . . . 0.0 110.214 -179.921 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 59' ' ' CYS . . . . . 0.504 ' SG ' ' N ' ' A' ' 66' ' ' CYS . 16.8 m -110.19 -163.03 0.83 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.348 -0.845 . . . . 0.0 110.243 -179.966 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.428 ' C ' ' O ' ' A' ' 59' ' ' CYS . 80.1 m-85 -41.21 -48.38 3.49 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.422 -0.799 . . . . 0.0 110.402 179.92 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 88.8 mtm-85 -129.45 159.28 36.76 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.247 -0.908 . . . . 0.0 110.246 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -60.89 -24.65 62.91 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.436 -1.466 . . . . 0.0 109.436 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 47.4 mtpt -63.64 -32.55 74.07 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.272 -1.134 . . . . 0.0 110.203 179.891 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -96.68 164.41 12.6 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.421 -0.799 . . . . 0.0 110.16 -179.847 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.48 ' HG3' ' HA ' ' A' ' 48' ' ' ALA . 75.6 mmtt -134.54 140.74 46.37 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.244 -0.91 . . . . 0.0 110.169 -179.911 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 66' ' ' CYS . . . . . 0.504 ' N ' ' SG ' ' A' ' 59' ' ' CYS . 89.0 m -88.8 134.04 34.06 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.269 -0.895 . . . . 0.0 110.206 179.96 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 67' ' ' CYS . . . . . 0.514 ' O ' ' CA ' ' A' ' 42' ' ' GLY . 34.6 m -136.26 152.01 50.26 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.208 -0.932 . . . . 0.0 110.201 179.979 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.459 ' HB2' ' HG3' ' A' ' 56' ' ' GLN . 77.5 tttt . . . . . 0 N--CA 1.49 1.549 0 CA-C-O 118.005 -0.998 . . . . 0.0 110.22 -179.97 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 49.2 t0 . . . . . 0 N--CA 1.491 1.597 0 CA-C-O 121.215 0.531 . . . . 0.0 110.174 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 34.8 p80 -142.97 162.75 34.64 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.302 -0.874 . . . . 0.0 110.22 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.561 ' CD1' ' SG ' ' A' ' 37' ' ' CYS . 3.2 t80 -71.42 140.19 50.0 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.222 -0.924 . . . . 0.0 110.205 179.986 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 0.553 ' ND2' ' CB ' ' A' ' 39' ' ' SER . 59.3 t30 -85.67 60.54 6.3 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.272 -0.893 . . . . 0.0 110.152 179.952 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.561 ' SG ' ' CD1' ' A' ' 35' ' ' TYR . 25.3 m -67.81 -53.22 28.73 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.307 -0.871 . . . . 0.0 110.24 179.991 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 75.4 t -43.92 -54.89 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.263 -0.898 . . . . 0.0 110.179 179.982 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.553 ' CB ' ' ND2' ' A' ' 36' ' ' ASN . 62.3 m -50.31 -35.19 26.46 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.192 -0.942 . . . . 0.0 110.218 -179.968 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.45 ' HB2' ' O ' ' A' ' 37' ' ' CYS . 72.5 m -70.73 -15.17 62.67 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.285 -0.884 . . . . 0.0 110.145 -179.976 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.413 ' C ' ' HG3' ' A' ' 68' ' ' LYS . . . 108.53 -14.85 35.49 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.475 -1.45 . . . . 0.0 109.475 -179.992 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.473 ' CA ' ' O ' ' A' ' 67' ' ' CYS . . . -85.27 175.34 49.66 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.494 -1.442 . . . . 0.0 109.494 -179.984 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 43' ' ' GLN . . . . . 0.45 ' N ' ' O ' ' A' ' 67' ' ' CYS . 0.9 OUTLIER -115.14 179.76 3.86 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.2 -1.176 . . . . 0.0 110.164 -179.972 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 49.7 t -114.17 98.17 6.79 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.247 -0.908 . . . . 0.0 110.188 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.459 ' O ' ' HB1' ' A' ' 64' ' ' ALA . 71.4 mt -88.98 173.27 8.57 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.3 -0.875 . . . . 0.0 110.181 179.901 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 83.4 m-85 -109.6 -1.99 17.81 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.24 -0.912 . . . . 0.0 110.314 -179.962 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.414 ' O ' ' C ' ' A' ' 48' ' ' ALA . 74.7 m -125.42 166.17 17.09 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.191 -0.943 . . . . 0.0 110.173 179.925 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.414 ' C ' ' O ' ' A' ' 47' ' ' SER . . . -42.69 131.01 4.06 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.246 -0.909 . . . . 0.0 110.177 -179.91 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 49' ' ' CYS . . . . . 0.412 ' C ' ' O ' ' A' ' 48' ' ' ALA . 4.4 t -43.39 130.46 3.63 Favored Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 121.223 -0.923 . . . . 0.0 110.219 -179.988 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.491 ' HG2' ' CG2' ' A' ' 53' ' ' THR . 46.4 Cg_endo -72.74 156.57 53.06 Favored 'Trans proline' 0 C--N 1.306 -1.661 0 O-C-N 123.86 1.453 . . . . 0.0 110.446 179.978 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 21.5 mt -67.85 -28.62 42.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.224 -0.923 . . . . 0.0 110.243 -179.93 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 88.8 m-85 -67.69 -11.8 59.09 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.348 -0.845 . . . . 0.0 110.191 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.491 ' CG2' ' HG2' ' A' ' 50' ' ' PRO . 34.0 p -121.79 172.63 8.02 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.256 -0.903 . . . . 0.0 110.1 179.897 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.488 ' O ' ' HA ' ' A' ' 67' ' ' CYS . 80.4 mttt -111.34 127.54 55.68 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.309 -0.869 . . . . 0.0 110.296 -179.986 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 20.6 tt -67.35 138.73 22.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.246 -0.908 . . . . 0.0 110.216 179.956 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' GLN . . . . . 0.439 ' NE2' ' HB3' ' A' ' 54' ' ' LYS . 48.9 mm-40 -128.62 13.94 6.47 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.264 -0.898 . . . . 0.0 110.217 -179.941 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 57' ' ' GLY . . . . . 0.4 ' O ' ' HB2' ' A' ' 66' ' ' CYS . . . 119.52 179.81 16.62 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.451 -1.46 . . . . 0.0 109.451 179.956 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 17.0 p -75.79 168.99 19.01 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.307 -1.113 . . . . 0.0 110.266 179.969 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' CYS . . . . . 0.974 ' HB3' ' HB3' ' A' ' 64' ' ' ALA . 9.7 t -109.29 -65.36 1.15 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.198 -0.938 . . . . 0.0 110.27 179.89 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.536 ' HB3' ' CE ' ' A' ' 63' ' ' LYS . 78.2 m-85 -121.72 92.6 3.77 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.457 -0.777 . . . . 0.0 110.282 179.981 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 36.3 mmt180 51.52 25.39 2.69 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.269 -0.894 . . . . 0.0 110.296 179.994 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 89.97 -11.56 70.29 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.536 ' CE ' ' HB3' ' A' ' 60' ' ' TYR . 50.5 mtmt -58.58 -23.04 57.72 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.259 -1.142 . . . . 0.0 110.095 -179.99 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.974 ' HB3' ' HB3' ' A' ' 59' ' ' CYS . . . -138.37 161.86 35.88 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.261 -0.9 . . . . 0.0 110.148 179.936 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 65.1 mmtt -113.25 122.93 48.94 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.246 -0.909 . . . . 0.0 110.239 179.983 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' CYS . . . . . 0.415 ' HA ' ' O ' ' A' ' 43' ' ' GLN . 99.2 m -79.21 142.73 36.01 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.231 -0.918 . . . . 0.0 110.183 179.998 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 67' ' ' CYS . . . . . 0.488 ' HA ' ' O ' ' A' ' 54' ' ' LYS . 82.3 m -144.47 141.52 29.64 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.253 -0.904 . . . . 0.0 110.241 179.989 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.427 ' HA ' ' HA2' ' A' ' 42' ' ' GLY . 33.9 ttpt . . . . . 0 N--CA 1.491 1.585 0 CA-C-O 118.01 -0.995 . . . . 0.0 110.213 -179.921 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 77.5 m-20 . . . . . 0 N--CA 1.492 1.626 0 CA-C-O 121.269 0.557 . . . . 0.0 110.198 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 70.8 m80 -112.98 129.24 56.56 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.255 -0.903 . . . . 0.0 110.17 179.991 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.523 ' CD1' ' SG ' ' A' ' 37' ' ' CYS . 2.4 t80 -55.08 135.67 48.87 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.25 -0.906 . . . . 0.0 110.254 -179.917 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 0.422 ' CG ' ' O ' ' A' ' 36' ' ' ASN . 35.9 p-10 -90.58 68.87 6.69 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.322 -0.861 . . . . 0.0 110.215 179.963 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.523 ' SG ' ' CD1' ' A' ' 35' ' ' TYR . 16.6 m -70.82 -39.88 72.79 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.33 -0.856 . . . . 0.0 110.108 -179.901 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.58 HG23 ' N ' ' A' ' 39' ' ' SER . 27.0 m -57.83 -44.73 86.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.334 -0.854 . . . . 0.0 110.328 179.988 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.58 ' N ' HG23 ' A' ' 38' ' ' VAL . 53.8 p -60.0 -32.52 70.94 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.272 -0.893 . . . . 0.0 110.278 179.958 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.427 ' O ' ' HE3' ' A' ' 68' ' ' LYS . 38.0 m -75.01 -10.3 59.34 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.306 -0.871 . . . . 0.0 110.091 179.996 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 98.63 -10.3 62.67 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.426 -1.47 . . . . 0.0 109.426 -179.889 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.533 ' CA ' ' O ' ' A' ' 67' ' ' CYS . . . -73.04 -171.65 21.13 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.426 -1.47 . . . . 0.0 109.426 -179.985 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 43' ' ' GLN . . . . . 0.486 ' N ' ' O ' ' A' ' 67' ' ' CYS . 6.4 tt0 -139.99 138.46 35.52 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.268 -1.137 . . . . 0.0 110.163 -179.975 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 12.5 t -95.37 108.3 20.48 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.248 -0.908 . . . . 0.0 110.064 179.894 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.471 HD12 ' HA ' ' A' ' 45' ' ' LEU . 9.5 tp -101.57 157.7 16.62 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.293 -0.879 . . . . 0.0 110.292 -179.937 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -82.64 -25.62 32.95 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.244 -0.91 . . . . 0.0 110.225 -179.954 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.417 ' O ' ' C ' ' A' ' 48' ' ' ALA . 39.1 t -93.13 159.37 15.32 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.234 -0.916 . . . . 0.0 110.194 179.996 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.417 ' C ' ' O ' ' A' ' 47' ' ' SER . . . -42.95 127.5 4.12 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.254 -0.903 . . . . 0.0 110.157 179.974 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 49' ' ' CYS . . . . . 0.403 ' C ' ' O ' ' A' ' 48' ' ' ALA . 8.3 t -42.76 129.73 3.07 Favored Pre-proline 0 N--CA 1.491 1.621 0 O-C-N 121.304 -0.872 . . . . 0.0 110.154 -179.927 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.486 ' HG2' HG23 ' A' ' 53' ' ' THR . 46.3 Cg_endo -72.65 141.64 34.64 Favored 'Trans proline' 0 C--N 1.305 -1.73 0 O-C-N 123.884 1.465 . . . . 0.0 110.411 -179.943 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 47.2 pt -57.53 -22.98 18.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.316 -0.865 . . . . 0.0 110.058 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 69.1 m-85 -65.13 -11.95 45.66 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.337 -0.852 . . . . 0.0 110.118 179.816 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.517 ' CB ' ' HB3' ' A' ' 67' ' ' CYS . 30.0 p -119.9 170.73 8.99 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.293 -0.879 . . . . 0.0 110.233 -179.919 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.467 ' O ' ' HA ' ' A' ' 67' ' ' CYS . 31.0 mttt -94.66 175.07 6.8 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.248 -0.908 . . . . 0.0 110.097 -179.991 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.718 HG23 ' O ' ' A' ' 55' ' ' ILE . 19.9 tt -106.01 111.41 34.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.203 -0.935 . . . . 0.0 110.245 -179.987 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 56' ' ' GLN . . . . . 0.599 ' NE2' ' HD2' ' A' ' 68' ' ' LYS . 17.8 mm100 -90.41 11.38 21.73 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.295 -0.878 . . . . 0.0 110.176 179.878 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 104.12 -127.88 9.28 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.371 -1.491 . . . . 0.0 109.371 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 28.1 p -111.55 171.93 7.19 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.226 -1.161 . . . . 0.0 110.144 -179.992 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' CYS . . . . . 1.193 ' SG ' ' SG ' ' A' ' 66' ' ' CYS . 0.1 OUTLIER -111.72 -166.73 1.1 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.167 -0.958 . . . . 0.0 110.215 -179.937 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.539 ' CD1' ' N ' ' A' ' 61' ' ' ARG . 7.2 p90 -57.27 -26.13 60.31 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.376 -0.828 . . . . 0.0 110.215 179.853 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.539 ' N ' ' CD1' ' A' ' 60' ' ' TYR . 57.5 mtt85 -139.5 164.88 28.7 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.281 -0.887 . . . . 0.0 110.191 -179.999 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -80.97 -0.28 88.4 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.621 -1.392 . . . . 0.0 109.621 179.939 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 46.1 mtpt -81.56 -25.89 35.46 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.259 -1.142 . . . . 0.0 110.227 179.915 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -123.04 164.96 17.59 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.238 -0.914 . . . . 0.0 110.243 179.987 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 74.3 mmtt -128.28 145.17 51.13 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.244 -0.91 . . . . 0.0 110.196 179.971 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' CYS . . . . . 1.193 ' SG ' ' SG ' ' A' ' 59' ' ' CYS . 93.4 m -81.48 137.6 35.59 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.225 -0.922 . . . . 0.0 110.256 -179.949 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 67' ' ' CYS . . . . . 0.533 ' O ' ' CA ' ' A' ' 42' ' ' GLY . 73.2 m -128.24 172.42 11.05 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.366 -0.834 . . . . 0.0 110.031 179.92 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.599 ' HD2' ' NE2' ' A' ' 56' ' ' GLN . 77.6 tttt . . . . . 0 N--CA 1.491 1.617 0 CA-C-O 118.007 -0.997 . . . . 0.0 110.278 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 26.6 p30 . . . . . 0 N--CA 1.491 1.602 0 CA-C-O 121.238 0.542 . . . . 0.0 110.229 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 83.4 m-70 -116.08 136.14 53.3 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.21 -0.931 . . . . 0.0 110.235 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 43.6 p90 -135.08 164.1 28.42 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.263 -0.898 . . . . 0.0 110.129 179.939 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 0.442 ' ND2' ' OG ' ' A' ' 39' ' ' SER . 12.7 p-10 -87.68 120.85 29.4 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.276 -0.89 . . . . 0.0 110.211 179.996 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 84.6 m -75.57 0.7 16.48 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.297 -0.877 . . . . 0.0 110.248 -179.973 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 53.6 t -68.67 -34.2 63.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.268 -0.895 . . . . 0.0 110.209 179.919 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.442 ' OG ' ' ND2' ' A' ' 36' ' ' ASN . 65.3 m -71.36 -22.81 61.85 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.254 -0.904 . . . . 0.0 110.128 179.856 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 61.2 m -89.44 -5.43 57.38 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.325 -0.859 . . . . 0.0 110.128 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 101.64 -19.57 49.78 Favored Glycine 0 N--CA 1.489 2.196 0 N-CA-C 109.331 -1.507 . . . . 0.0 109.331 -179.859 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.45 ' HA2' ' HA ' ' A' ' 68' ' ' LYS . . . -73.08 171.35 51.05 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.509 -1.436 . . . . 0.0 109.509 -179.966 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 43' ' ' GLN . . . . . 0.503 ' O ' ' HA ' ' A' ' 66' ' ' CYS . 31.5 tt0 -130.53 164.04 25.74 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.341 -1.094 . . . . 0.0 110.207 -179.964 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 44' ' ' CYS . . . . . 0.422 ' N ' ' CG ' ' A' ' 43' ' ' GLN . 5.5 m -114.27 112.81 23.7 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.176 -0.952 . . . . 0.0 110.274 -179.964 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.648 HD12 ' HD3' ' A' ' 50' ' ' PRO . 27.7 mt -95.92 179.55 5.05 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.239 -0.913 . . . . 0.0 110.133 179.946 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 66.4 m-85 -92.59 -27.1 17.56 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.195 -0.94 . . . . 0.0 110.218 -179.97 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.431 ' O ' ' C ' ' A' ' 48' ' ' ALA . 64.2 m -107.55 166.92 10.31 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.344 -0.848 . . . . 0.0 110.084 179.964 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.494 ' HA ' ' HG3' ' A' ' 65' ' ' LYS . . . -43.01 132.55 3.98 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.269 -0.894 . . . . 0.0 110.118 179.942 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 49' ' ' CYS . . . . . 0.419 ' C ' ' O ' ' A' ' 48' ' ' ALA . 7.7 t -42.75 130.06 3.06 Favored Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 121.23 -0.919 . . . . 0.0 110.181 -179.997 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.648 ' HD3' HD12 ' A' ' 45' ' ' LEU . 45.5 Cg_endo -72.15 147.08 47.59 Favored 'Trans proline' 0 C--N 1.305 -1.73 0 O-C-N 123.909 1.479 . . . . 0.0 110.376 -179.977 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.4 ' H ' HG23 ' A' ' 51' ' ' ILE . 28.5 pt -58.0 -21.99 18.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.234 -0.917 . . . . 0.0 110.135 179.978 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 66.2 m-85 -57.09 -16.51 7.67 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.169 -0.957 . . . . 0.0 110.109 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 71.1 p -142.34 153.66 44.02 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.238 -0.914 . . . . 0.0 110.187 179.97 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.464 ' O ' ' HA ' ' A' ' 67' ' ' CYS . 58.2 tttt -74.16 164.66 26.34 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.199 -0.938 . . . . 0.0 110.193 -180.0 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.661 HG23 ' O ' ' A' ' 55' ' ' ILE . 20.1 tt -109.41 118.18 56.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.209 -0.932 . . . . 0.0 110.17 179.956 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 20.0 mm100 -69.61 -31.15 69.11 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.307 -0.871 . . . . 0.0 110.236 -179.972 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 149.24 -92.69 0.14 Allowed Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.471 -1.452 . . . . 0.0 109.471 179.956 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.401 ' O ' ' SG ' ' A' ' 66' ' ' CYS . 74.6 p -128.67 161.96 28.45 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.275 -1.132 . . . . 0.0 110.235 -179.937 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 59' ' ' CYS . . . . . 0.494 ' SG ' ' SG ' ' A' ' 66' ' ' CYS . 5.1 m -99.45 -68.86 0.79 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.281 -0.887 . . . . 0.0 110.145 179.883 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.439 ' CD2' ' HB3' ' A' ' 59' ' ' CYS . 89.4 m-85 -141.32 -68.9 0.38 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.345 -0.847 . . . . 0.0 110.178 -179.977 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.419 ' HD2' ' CD ' ' A' ' 63' ' ' LYS . 38.7 ttm-85 -95.38 -37.8 10.79 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.256 -0.902 . . . . 0.0 110.177 -179.965 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 135.42 -15.84 4.14 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 -179.951 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.419 ' CD ' ' HD2' ' A' ' 61' ' ' ARG . 46.7 mtpt -65.55 -31.49 72.58 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.268 -1.137 . . . . 0.0 110.15 -179.979 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.553 ' HB1' ' O ' ' A' ' 45' ' ' LEU . . . -109.83 159.57 17.1 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.353 -0.842 . . . . 0.0 110.146 179.929 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.494 ' HG3' ' HA ' ' A' ' 48' ' ' ALA . 60.7 mmtt -124.02 124.74 43.22 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.211 -0.931 . . . . 0.0 110.269 179.999 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 66' ' ' CYS . . . . . 0.503 ' HA ' ' O ' ' A' ' 43' ' ' GLN . 60.9 m -55.11 155.13 4.92 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.229 -0.919 . . . . 0.0 110.139 179.939 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 67' ' ' CYS . . . . . 0.501 ' N ' ' O ' ' A' ' 43' ' ' GLN . 91.8 m -148.13 114.6 5.95 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.176 -0.952 . . . . 0.0 110.284 179.965 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.45 ' HA ' ' HA2' ' A' ' 42' ' ' GLY . 80.4 tttt . . . . . 0 N--CA 1.491 1.583 0 CA-C-O 118.019 -0.991 . . . . 0.0 110.215 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.423 ' CE2' ' SG ' ' A' ' 37' ' ' CYS . 2.8 t80 . . . . . 0 N--CA 1.491 1.598 0 CA-C-O 121.266 0.555 . . . . 0.0 110.22 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 52.5 t30 -107.71 105.26 15.02 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.272 -0.892 . . . . 0.0 110.275 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.423 ' SG ' ' CE2' ' A' ' 35' ' ' TYR . 31.1 m -80.69 2.54 25.5 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.258 -0.901 . . . . 0.0 110.241 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 69.2 t -83.22 -34.9 11.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.227 -0.921 . . . . 0.0 110.248 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 34.1 t -68.0 -29.43 68.44 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.256 -0.902 . . . . 0.0 110.162 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 5.1 m -76.23 -16.83 59.74 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.325 -0.859 . . . . 0.0 110.113 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 111.4 -14.53 27.78 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.421 -1.471 . . . . 0.0 109.421 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.522 ' CA ' ' O ' ' A' ' 67' ' ' CYS . . . -80.88 -177.67 51.73 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.496 -1.442 . . . . 0.0 109.496 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . 0.517 ' N ' ' O ' ' A' ' 67' ' ' CYS . 36.6 tt0 -133.82 160.14 38.51 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.29 -1.124 . . . . 0.0 110.211 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 38.6 t -114.92 107.43 15.38 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.245 -0.909 . . . . 0.0 110.173 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.591 HD12 ' CD ' ' A' ' 50' ' ' PRO . 82.8 mt -89.55 176.36 6.92 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.282 -0.886 . . . . 0.0 110.196 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 71.3 t80 -91.03 -24.03 20.18 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.242 -0.911 . . . . 0.0 110.232 -179.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.416 ' O ' ' C ' ' A' ' 48' ' ' ALA . 89.2 p -105.59 165.72 10.95 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.245 -0.91 . . . . 0.0 110.231 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.416 ' C ' ' O ' ' A' ' 47' ' ' SER . . . -43.01 130.8 4.37 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.207 -0.933 . . . . 0.0 110.202 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . 0.533 ' HB2' ' CG ' ' A' ' 65' ' ' LYS . 12.4 t -43.15 127.88 3.42 Favored Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 121.222 -0.924 . . . . 0.0 110.187 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.591 ' CD ' HD12 ' A' ' 45' ' ' LEU . 46.4 Cg_endo -72.31 147.03 46.58 Favored 'Trans proline' 0 C--N 1.306 -1.665 0 O-C-N 123.898 1.473 . . . . 0.0 110.423 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.416 ' H ' HG23 ' A' ' 51' ' ' ILE . 19.4 pt -58.69 -22.06 20.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.23 -0.919 . . . . 0.0 110.135 -179.918 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 82.5 m-85 -59.68 -14.77 15.35 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.207 -0.933 . . . . 0.0 110.142 179.901 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.529 ' CB ' ' HB3' ' A' ' 67' ' ' CYS . 72.7 p -127.45 172.85 10.31 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.254 -0.904 . . . . 0.0 110.139 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.496 ' O ' ' HA ' ' A' ' 67' ' ' CYS . 44.8 tttt -94.09 165.31 12.69 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.241 -0.912 . . . . 0.0 110.225 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.705 HG23 ' O ' ' A' ' 55' ' ' ILE . 16.6 tt -95.47 116.11 36.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.255 -0.903 . . . . 0.0 110.261 179.907 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . 0.521 ' NE2' ' HB3' ' A' ' 68' ' ' LYS . 64.9 mm-40 -93.77 15.8 15.6 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.263 -0.898 . . . . 0.0 110.2 -179.958 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 112.76 -114.64 3.51 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.489 -1.445 . . . . 0.0 109.489 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 16.9 p -131.4 174.02 10.49 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.26 -1.141 . . . . 0.0 110.181 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . 0.966 ' SG ' ' SG ' ' A' ' 66' ' ' CYS . 0.7 OUTLIER -114.09 -159.52 0.7 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.232 -0.918 . . . . 0.0 110.252 -179.972 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 90.9 m-85 -55.5 -43.77 75.94 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.309 -0.869 . . . . 0.0 110.192 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 80.4 mtm180 -133.43 168.95 17.68 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.242 -0.911 . . . . 0.0 110.202 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -67.7 -23.24 73.93 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 10.2 mmpt? -67.19 -24.84 65.9 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.253 -1.146 . . . . 0.0 110.186 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -112.77 162.82 15.32 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.224 -0.923 . . . . 0.0 110.191 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.533 ' CG ' ' HB2' ' A' ' 49' ' ' CYS . 48.1 tptt -141.77 144.18 33.85 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.276 -0.89 . . . . 0.0 110.226 -179.954 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' CYS . . . . . 0.966 ' SG ' ' SG ' ' A' ' 59' ' ' CYS . 99.7 m -82.96 153.54 24.96 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.192 -0.942 . . . . 0.0 110.155 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' CYS . . . . . 0.529 ' HB3' ' CB ' ' A' ' 53' ' ' THR . 75.1 m -142.51 156.22 45.12 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.258 -0.901 . . . . 0.0 110.205 -179.925 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.521 ' HB3' ' NE2' ' A' ' 56' ' ' GLN . 43.5 tttt . . . . . 0 N--CA 1.491 1.587 0 CA-C-O 117.978 -1.011 . . . . 0.0 110.24 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.412 ' CD1' ' N ' ' A' ' 36' ' ' ASN . 2.3 t80 . . . . . 0 N--CA 1.492 1.638 0 CA-C-O 121.272 0.558 . . . . 0.0 110.129 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . 0.44 ' ND2' ' HB3' ' A' ' 39' ' ' SER . 25.5 p-10 -92.22 91.86 7.93 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.3 -0.875 . . . . 0.0 110.164 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 18.8 m -73.54 -22.38 60.11 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.203 -0.936 . . . . 0.0 110.2 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.445 ' HA ' ' O ' ' A' ' 42' ' ' GLY . 70.6 t -63.62 -42.33 95.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.215 -0.928 . . . . 0.0 110.215 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . 0.44 ' HB3' ' ND2' ' A' ' 36' ' ' ASN . 44.8 t -58.76 -26.59 64.15 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.198 -0.939 . . . . 0.0 110.216 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.437 ' O ' ' HE3' ' A' ' 68' ' ' LYS . 63.1 m -82.95 -18.34 40.35 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.267 -0.896 . . . . 0.0 110.203 179.977 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . 0.467 ' O ' ' HG3' ' A' ' 68' ' ' LYS . . . 112.18 11.89 14.92 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.432 -1.467 . . . . 0.0 109.432 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.445 ' O ' ' HA ' ' A' ' 38' ' ' VAL . . . -113.17 178.78 18.83 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . 0.512 ' O ' ' HA ' ' A' ' 66' ' ' CYS . 0.3 OUTLIER -137.1 171.86 13.86 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.261 -1.14 . . . . 0.0 110.202 179.942 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 84.6 m -108.58 104.4 13.72 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.248 -0.908 . . . . 0.0 110.227 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.514 HD12 ' HD3' ' A' ' 50' ' ' PRO . 27.3 mt -85.82 179.61 7.01 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.163 -0.96 . . . . 0.0 110.137 179.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 98.1 m-85 -106.23 -7.91 17.59 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.272 -0.892 . . . . 0.0 110.192 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.414 ' O ' ' C ' ' A' ' 48' ' ' ALA . 84.0 p -121.41 166.92 13.4 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.267 -0.895 . . . . 0.0 110.201 179.959 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.414 ' C ' ' O ' ' A' ' 47' ' ' SER . . . -43.01 131.23 4.3 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.229 -0.92 . . . . 0.0 110.204 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . 0.461 ' HB2' ' HG2' ' A' ' 65' ' ' LYS . 3.9 t -42.76 128.53 3.1 Favored Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 121.284 -0.885 . . . . 0.0 110.226 -179.911 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.514 ' HD3' HD12 ' A' ' 45' ' ' LEU . 45.7 Cg_endo -72.83 150.42 49.63 Favored 'Trans proline' 0 C--N 1.306 -1.679 0 O-C-N 123.89 1.468 . . . . 0.0 110.427 -179.938 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 54.4 mt -63.19 -27.2 42.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.211 -0.93 . . . . 0.0 110.234 -179.931 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 99.4 m-85 -68.94 -9.22 50.86 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.319 -0.863 . . . . 0.0 110.12 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.509 ' CG2' ' HG2' ' A' ' 50' ' ' PRO . 46.2 p -123.79 144.57 49.62 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.208 -0.932 . . . . 0.0 110.171 179.961 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.484 ' O ' ' HA ' ' A' ' 67' ' ' CYS . 40.7 mtmt -81.0 167.9 19.3 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.193 -0.942 . . . . 0.0 110.275 -179.951 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.681 HG23 ' O ' ' A' ' 55' ' ' ILE . 18.8 tt -100.99 117.65 46.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.334 -0.854 . . . . 0.0 110.166 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . 0.503 ' CG ' ' HB2' ' A' ' 68' ' ' LYS . 71.8 mm-40 -96.64 3.11 52.7 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.201 -0.937 . . . . 0.0 110.206 179.966 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 125.52 -119.54 3.57 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.388 -1.485 . . . . 0.0 109.388 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.444 ' O ' ' SG ' ' A' ' 66' ' ' CYS . 24.4 p -133.05 164.24 27.44 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.26 -1.141 . . . . 0.0 110.18 179.938 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 1.8 m -114.13 -88.66 0.55 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.245 -0.91 . . . . 0.0 110.248 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 83.0 m-85 -116.97 98.94 6.75 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.283 -0.886 . . . . 0.0 110.287 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 27.7 mmm180 54.78 -145.69 0.61 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.316 -0.865 . . . . 0.0 110.141 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -102.83 18.33 50.32 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.559 -1.416 . . . . 0.0 109.559 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 48.0 mtpt -85.07 -24.38 28.13 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.277 -1.131 . . . . 0.0 110.194 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -145.34 164.07 32.61 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.308 -0.87 . . . . 0.0 110.261 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.461 ' HG2' ' HB2' ' A' ' 49' ' ' CYS . 54.5 tptt -127.68 132.92 49.61 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.29 -0.881 . . . . 0.0 110.19 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' CYS . . . . . 0.512 ' HA ' ' O ' ' A' ' 43' ' ' GLN . 59.2 m -72.35 132.42 43.95 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.261 -0.9 . . . . 0.0 110.201 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' CYS . . . . . 0.484 ' HA ' ' O ' ' A' ' 54' ' ' LYS . 90.9 m -135.56 144.29 46.14 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.287 -0.883 . . . . 0.0 110.243 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.503 ' HB2' ' CG ' ' A' ' 56' ' ' GLN . 81.5 tttt . . . . . 0 N--CA 1.492 1.644 0 CA-C-O 117.994 -1.003 . . . . 0.0 110.126 -179.923 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 4.2 t80 . . . . . 0 N--CA 1.49 1.575 0 CA-C-O 121.243 0.544 . . . . 0.0 110.229 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . 0.538 ' ND2' ' CB ' ' A' ' 39' ' ' SER . 54.0 t30 -74.28 65.9 1.24 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.246 -0.909 . . . . 0.0 110.168 -179.906 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.448 ' O ' ' HB2' ' A' ' 40' ' ' SER . 22.0 m -71.08 -53.66 13.86 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.235 -0.916 . . . . 0.0 110.305 179.97 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.466 ' HA ' ' O ' ' A' ' 42' ' ' GLY . 77.0 t -44.66 -55.09 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.178 -0.951 . . . . 0.0 110.243 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . 0.538 ' CB ' ' ND2' ' A' ' 36' ' ' ASN . 53.4 m -53.62 -31.41 47.11 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.176 -0.952 . . . . 0.0 110.244 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.448 ' HB2' ' O ' ' A' ' 37' ' ' CYS . 50.8 m -71.5 -25.29 62.19 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.249 -0.907 . . . . 0.0 110.155 179.981 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 125.05 -16.76 7.21 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.458 -1.457 . . . . 0.0 109.458 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.475 ' CA ' ' O ' ' A' ' 67' ' ' CYS . . . -87.74 -177.45 48.07 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.485 -1.446 . . . . 0.0 109.485 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . 0.456 ' N ' ' O ' ' A' ' 67' ' ' CYS . 1.3 pt20 -133.66 175.73 9.18 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.313 -1.11 . . . . 0.0 110.31 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 11.1 t -107.21 89.39 2.98 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.215 -0.928 . . . . 0.0 110.18 179.939 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.451 HD12 ' HA ' ' A' ' 45' ' ' LEU . 13.7 tp -78.63 162.1 26.48 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.203 -0.935 . . . . 0.0 110.23 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 65.6 t80 -92.13 -24.6 19.06 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.227 -0.92 . . . . 0.0 110.182 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.423 ' O ' ' C ' ' A' ' 48' ' ' ALA . 44.8 m -95.94 157.85 15.71 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.265 -0.897 . . . . 0.0 110.192 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.425 ' O ' ' C ' ' A' ' 49' ' ' CYS . . . -42.74 133.15 3.6 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.256 -0.902 . . . . 0.0 110.219 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . 0.425 ' C ' ' O ' ' A' ' 48' ' ' ALA . 1.8 t -43.13 127.08 3.41 Favored Pre-proline 0 N--CA 1.491 1.609 0 O-C-N 121.248 -0.907 . . . . 0.0 110.084 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -72.45 159.64 48.68 Favored 'Trans proline' 0 C--N 1.306 -1.675 0 O-C-N 123.854 1.449 . . . . 0.0 110.436 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 7.5 mt -65.61 -25.92 37.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.167 -0.958 . . . . 0.0 110.114 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 94.2 m-85 -65.92 -12.14 52.45 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.305 -0.872 . . . . 0.0 110.117 179.871 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.465 ' OG1' ' HB3' ' A' ' 67' ' ' CYS . 67.3 p -136.09 147.35 47.78 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.272 -0.892 . . . . 0.0 110.165 179.941 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 36.8 tttt -97.41 165.23 12.11 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.211 -0.931 . . . . 0.0 110.228 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.689 HG23 ' O ' ' A' ' 55' ' ' ILE . 15.3 tt -86.94 115.21 27.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.276 -0.89 . . . . 0.0 110.19 -179.941 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . 0.503 ' HG3' ' HB2' ' A' ' 68' ' ' LYS . 54.4 mm-40 -97.14 18.96 13.76 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.239 -0.913 . . . . 0.0 110.224 179.957 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 139.91 -156.68 25.02 Favored Glycine 0 N--CA 1.488 2.144 0 N-CA-C 109.485 -1.446 . . . . 0.0 109.485 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.447 ' O ' ' SG ' ' A' ' 66' ' ' CYS . 24.5 p -109.26 165.04 11.92 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.188 -1.183 . . . . 0.0 110.174 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -107.65 -158.46 0.65 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.258 -0.902 . . . . 0.0 110.291 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 95.2 m-85 -58.58 -55.9 29.12 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.354 -0.841 . . . . 0.0 110.163 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -126.29 172.22 10.29 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.255 -0.903 . . . . 0.0 110.171 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -65.1 -20.25 66.82 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.424 -1.47 . . . . 0.0 109.424 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 48.8 mtmt -65.93 -24.1 66.76 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.231 -1.158 . . . . 0.0 110.215 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.412 ' C ' ' HG2' ' A' ' 65' ' ' LYS . . . -118.28 161.86 19.22 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.232 -0.917 . . . . 0.0 110.166 180.0 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.412 ' HG2' ' C ' ' A' ' 64' ' ' ALA . 73.8 mmtt -146.93 138.54 24.29 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.211 -0.931 . . . . 0.0 110.22 -179.942 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' CYS . . . . . 0.447 ' SG ' ' O ' ' A' ' 58' ' ' THR . 89.4 m -64.03 139.51 58.77 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.275 -0.891 . . . . 0.0 110.085 179.949 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' CYS . . . . . 0.475 ' O ' ' CA ' ' A' ' 42' ' ' GLY . 95.1 m -141.85 136.62 30.76 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.23 -0.919 . . . . 0.0 110.223 179.967 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.503 ' HB2' ' HG3' ' A' ' 56' ' ' GLN . 73.0 tttt . . . . . 0 N--CA 1.492 1.625 0 CA-C-O 118.03 -0.986 . . . . 0.0 110.157 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 12.8 t80 . . . . . 0 N--CA 1.492 1.66 0 CA-C-O 121.281 0.562 . . . . 0.0 110.191 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . 0.521 ' ND2' ' HB2' ' A' ' 39' ' ' SER . 0.2 OUTLIER -91.43 67.92 5.71 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.203 -0.936 . . . . 0.0 110.223 179.981 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.409 ' O ' ' HB2' ' A' ' 40' ' ' SER . 55.8 m -64.63 -50.85 65.49 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.265 -0.897 . . . . 0.0 110.169 -179.923 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.432 HG23 ' H ' ' A' ' 38' ' ' VAL . 30.8 t -45.48 -47.32 4.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.137 -0.977 . . . . 0.0 110.193 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . 0.521 ' HB2' ' ND2' ' A' ' 36' ' ' ASN . 32.2 t -59.01 -21.85 59.71 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.273 -0.892 . . . . 0.0 110.265 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.409 ' HB2' ' O ' ' A' ' 37' ' ' CYS . 74.7 m -86.31 -11.88 50.95 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.228 -0.92 . . . . 0.0 110.215 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 103.7 5.08 45.44 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.598 -1.401 . . . . 0.0 109.598 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.419 ' HA2' ' HA ' ' A' ' 68' ' ' LYS . . . -102.58 172.29 21.86 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.501 -1.439 . . . . 0.0 109.501 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . 0.498 ' O ' ' HA ' ' A' ' 66' ' ' CYS . 1.1 pt20 -123.35 175.11 6.91 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.204 -1.174 . . . . 0.0 110.219 179.939 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 22.4 t -107.93 94.16 4.93 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.23 -0.918 . . . . 0.0 110.197 -179.896 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.891 HD12 ' SG ' ' A' ' 67' ' ' CYS . 94.5 mt -73.24 177.9 4.83 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.206 -0.934 . . . . 0.0 110.216 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 80.3 m-85 -104.26 -11.54 17.14 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.267 -0.895 . . . . 0.0 110.278 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.401 ' O ' ' C ' ' A' ' 48' ' ' ALA . 60.1 p -125.74 173.23 9.18 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.307 -0.871 . . . . 0.0 110.258 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.401 ' C ' ' O ' ' A' ' 47' ' ' SER . . . -43.16 128.61 4.6 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.277 -0.89 . . . . 0.0 110.144 179.945 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 4.9 t -46.56 129.32 8.2 Favored Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.287 -0.883 . . . . 0.0 110.142 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.558 ' CD ' ' CD1' ' A' ' 45' ' ' LEU . 46.1 Cg_endo -72.84 149.76 48.38 Favored 'Trans proline' 0 C--N 1.306 -1.679 0 O-C-N 123.853 1.449 . . . . 0.0 110.406 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 46.1 pt -60.21 -24.75 31.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.299 -0.876 . . . . 0.0 110.177 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 58.4 m-85 -60.38 -13.91 15.85 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.156 -0.965 . . . . 0.0 110.202 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.455 ' OG1' ' HB3' ' A' ' 67' ' ' CYS . 77.4 p -135.87 154.72 51.07 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.15 -0.969 . . . . 0.0 110.237 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 95.7 mttt -98.11 152.55 19.22 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.294 -0.879 . . . . 0.0 110.259 179.941 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.59 HG23 ' O ' ' A' ' 55' ' ' ILE . 20.8 tt -89.36 124.39 42.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.329 -0.857 . . . . 0.0 110.244 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 67.1 mm-40 -97.37 -18.21 19.26 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.257 -0.902 . . . . 0.0 110.178 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -177.83 -149.59 8.05 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.453 -1.459 . . . . 0.0 109.453 -179.932 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.442 ' O ' ' SG ' ' A' ' 66' ' ' CYS . 33.2 p -111.32 163.33 14.08 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.288 -1.124 . . . . 0.0 110.131 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . 0.474 ' HB3' ' HB3' ' A' ' 64' ' ' ALA . 0.8 OUTLIER -96.75 -160.73 0.82 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.244 -0.91 . . . . 0.0 110.192 179.973 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 93.4 m-85 -60.8 -42.77 98.24 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.284 -0.885 . . . . 0.0 110.151 179.891 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 90.1 mtt-85 -135.41 170.87 15.27 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.214 -0.929 . . . . 0.0 110.212 -179.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -63.53 -18.9 61.85 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.375 -1.49 . . . . 0.0 109.375 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 12.3 tttt -70.27 -31.54 68.95 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.179 -1.189 . . . . 0.0 110.193 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.474 ' HB3' ' HB3' ' A' ' 59' ' ' CYS . . . -105.19 159.53 15.79 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.302 -0.873 . . . . 0.0 110.123 -179.952 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.408 ' HG2' ' C ' ' A' ' 64' ' ' ALA . 73.9 mmtt -142.9 147.9 36.07 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.246 -0.909 . . . . 0.0 110.18 179.968 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' CYS . . . . . 0.498 ' HA ' ' O ' ' A' ' 43' ' ' GLN . 71.7 m -77.55 148.47 35.2 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.268 -0.895 . . . . 0.0 110.1 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' CYS . . . . . 0.891 ' SG ' HD12 ' A' ' 45' ' ' LEU . 92.6 m -145.7 131.15 18.69 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.13 -0.981 . . . . 0.0 110.256 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.419 ' HA ' ' HA2' ' A' ' 42' ' ' GLY . 82.0 tttt . . . . . 0 N--CA 1.491 1.604 0 CA-C-O 118.096 -0.954 . . . . 0.0 110.27 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.566 ' CE2' ' SG ' ' A' ' 37' ' ' CYS . 3.3 t80 . . . . . 0 N--CA 1.491 1.6 0 CA-C-O 121.201 0.524 . . . . 0.0 110.218 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . 0.52 ' ND2' ' HB3' ' A' ' 39' ' ' SER . 27.2 p-10 -94.22 85.12 4.56 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.266 -0.896 . . . . 0.0 110.234 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.566 ' SG ' ' CE2' ' A' ' 35' ' ' TYR . 87.6 m -65.02 -42.66 94.2 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.271 -0.893 . . . . 0.0 110.284 179.951 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 86.4 t -52.41 -40.86 33.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.301 -0.875 . . . . 0.0 110.196 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . 0.52 ' HB3' ' ND2' ' A' ' 36' ' ' ASN . 24.6 t -62.67 -26.76 68.81 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.269 -0.895 . . . . 0.0 110.251 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.514 ' O ' ' CE ' ' A' ' 68' ' ' LYS . 2.2 t -79.95 -16.65 54.81 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.319 -0.863 . . . . 0.0 110.163 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 116.33 -12.53 16.37 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.468 -1.453 . . . . 0.0 109.468 -179.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.44 ' HA2' ' HA ' ' A' ' 68' ' ' LYS . . . -83.55 -175.36 50.9 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 -179.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . 0.529 ' NE2' HD21 ' A' ' 45' ' ' LEU . 42.5 tt0 -133.73 152.25 51.83 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.25 -1.147 . . . . 0.0 110.206 179.926 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . 0.571 ' O ' HD23 ' A' ' 45' ' ' LEU . 49.2 t -100.1 127.16 46.38 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.265 -0.897 . . . . 0.0 110.219 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.615 ' O ' ' HB1' ' A' ' 64' ' ' ALA . 28.9 mt -121.12 176.57 5.52 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.225 -0.922 . . . . 0.0 110.227 179.938 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 85.1 m-85 -104.19 -0.78 28.07 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.21 -0.931 . . . . 0.0 110.206 180.0 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 85.7 p -116.18 171.95 7.48 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.243 -0.911 . . . . 0.0 110.205 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -46.92 153.33 0.43 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.291 -0.881 . . . . 0.0 110.147 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 42.3 t -55.67 128.38 69.03 Favored Pre-proline 0 N--CA 1.492 1.641 0 O-C-N 121.325 -0.86 . . . . 0.0 110.165 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -72.64 153.69 54.43 Favored 'Trans proline' 0 C--N 1.305 -1.718 0 O-C-N 123.943 1.496 . . . . 0.0 110.485 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 28.1 pt -77.08 -6.45 9.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.26 -0.9 . . . . 0.0 110.105 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 46.6 m-85 -73.0 -22.94 60.59 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.248 -0.908 . . . . 0.0 110.14 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 69.9 p -137.62 161.81 35.47 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.317 -0.865 . . . . 0.0 110.204 179.946 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.497 ' O ' ' N ' ' A' ' 68' ' ' LYS . 64.3 mttt -90.32 169.54 11.01 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.289 -0.882 . . . . 0.0 110.15 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.726 HG23 ' O ' ' A' ' 55' ' ' ILE . 20.6 tt -95.48 111.27 25.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.262 -0.899 . . . . 0.0 110.133 -179.914 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . 0.531 ' CG ' ' HB3' ' A' ' 68' ' ' LYS . 56.6 mm-40 -90.32 -12.85 36.52 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.211 -0.931 . . . . 0.0 110.188 179.962 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . 0.517 ' HA3' ' CE2' ' A' ' 35' ' ' TYR . . . 170.79 -144.77 8.53 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.474 -1.451 . . . . 0.0 109.474 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 16.5 p -115.73 168.37 10.09 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.221 -1.164 . . . . 0.0 110.186 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . 0.47 ' SG ' ' N ' ' A' ' 66' ' ' CYS . 1.1 m -91.19 -161.6 0.83 Allowed 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.296 -0.877 . . . . 0.0 110.212 -179.92 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 94.2 m-85 -57.24 -40.82 78.37 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.31 -0.868 . . . . 0.0 110.317 179.861 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 93.8 mtt180 -132.44 178.26 6.96 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.222 -0.924 . . . . 0.0 110.214 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -76.25 -6.02 82.54 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.589 -1.404 . . . . 0.0 109.589 -179.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 40.6 mtpt -81.59 -23.75 36.9 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.197 -1.178 . . . . 0.0 110.184 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.615 ' HB1' ' O ' ' A' ' 45' ' ' LEU . . . -117.27 162.61 17.61 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.291 -0.88 . . . . 0.0 110.1 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 16.4 tppt? -141.16 123.02 15.37 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.244 -0.91 . . . . 0.0 110.16 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' CYS . . . . . 0.491 ' HA ' ' O ' ' A' ' 43' ' ' GLN . 28.9 p -87.84 151.3 22.96 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.173 -0.954 . . . . 0.0 110.188 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' CYS . . . . . 0.466 ' CA ' ' O ' ' A' ' 54' ' ' LYS . 73.1 m -148.77 143.47 26.4 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.222 -0.924 . . . . 0.0 110.192 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.531 ' HB3' ' CG ' ' A' ' 56' ' ' GLN . 78.3 tttt . . . . . 0 N--CA 1.492 1.633 0 CA-C-O 117.999 -1.0 . . . . 0.0 110.259 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.562 ' CD1' ' SG ' ' A' ' 37' ' ' CYS . 6.4 t80 . . . . . 0 N--CA 1.491 1.612 0 CA-C-O 121.263 0.554 . . . . 0.0 110.276 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . 0.568 ' ND2' ' CB ' ' A' ' 39' ' ' SER . 49.7 t30 65.95 54.55 1.01 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.277 -0.889 . . . . 0.0 110.168 -179.924 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.562 ' SG ' ' CD1' ' A' ' 35' ' ' TYR . 31.0 m -65.14 -52.95 52.08 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.304 -0.872 . . . . 0.0 110.146 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 38.0 t -47.91 -50.01 10.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.31 -0.869 . . . . 0.0 110.224 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . 0.568 ' CB ' ' ND2' ' A' ' 36' ' ' ASN . 66.0 m -56.68 -32.33 65.33 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.249 -0.907 . . . . 0.0 110.115 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.472 ' O ' ' NZ ' ' A' ' 68' ' ' LYS . 24.0 m -72.87 -11.5 60.62 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.288 -0.883 . . . . 0.0 110.09 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 103.95 -12.35 52.78 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.389 -1.484 . . . . 0.0 109.389 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.476 ' HA3' ' HB2' ' A' ' 68' ' ' LYS . . . -81.52 -175.14 49.98 Favored Glycine 0 N--CA 1.489 2.217 0 N-CA-C 109.469 -1.452 . . . . 0.0 109.469 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . 0.56 ' NE2' HD21 ' A' ' 45' ' ' LEU . 47.7 tt0 -126.44 147.77 49.75 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.304 -1.115 . . . . 0.0 110.221 179.95 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 20.2 t -100.51 109.11 21.2 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.203 -0.936 . . . . 0.0 110.221 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.724 ' O ' ' HB1' ' A' ' 64' ' ' ALA . 59.0 mt -104.67 175.22 5.56 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.184 -0.947 . . . . 0.0 110.155 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 89.4 m-85 -107.84 -8.31 16.03 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.287 -0.883 . . . . 0.0 110.256 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.408 ' O ' ' C ' ' A' ' 48' ' ' ALA . 34.1 t -114.22 164.43 13.9 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.182 -0.949 . . . . 0.0 110.203 -179.984 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.418 ' O ' ' C ' ' A' ' 49' ' ' CYS . . . -42.62 132.45 3.68 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.309 -0.869 . . . . 0.0 110.159 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . 0.45 ' HB2' HD12 ' A' ' 55' ' ' ILE . 4.7 t -43.16 129.83 3.4 Favored Pre-proline 0 N--CA 1.492 1.642 0 O-C-N 121.254 -0.904 . . . . 0.0 110.15 179.997 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -72.99 146.27 41.35 Favored 'Trans proline' 0 C--N 1.305 -1.712 0 O-C-N 123.921 1.485 . . . . 0.0 110.397 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 34.0 pt -59.54 -20.05 17.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.289 -0.882 . . . . 0.0 110.119 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . 0.402 ' C ' HG23 ' A' ' 53' ' ' THR . 67.1 m-85 -61.82 -21.54 64.71 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.318 -0.864 . . . . 0.0 110.273 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.437 ' OG1' ' HB3' ' A' ' 67' ' ' CYS . 68.3 p -144.83 152.83 40.89 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.219 -0.925 . . . . 0.0 110.219 179.895 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.489 ' O ' ' HA ' ' A' ' 67' ' ' CYS . 62.2 mttm -78.01 173.5 12.12 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.32 -0.862 . . . . 0.0 110.174 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.642 HG23 ' O ' ' A' ' 55' ' ' ILE . 20.8 tt -110.78 121.24 63.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.25 -0.906 . . . . 0.0 110.169 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . 0.517 ' NE2' ' HB3' ' A' ' 68' ' ' LYS . 86.4 mm-40 -78.21 -27.02 47.71 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.253 -0.904 . . . . 0.0 110.225 -179.933 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 156.9 -155.96 26.8 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.478 -1.449 . . . . 0.0 109.478 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.421 ' O ' ' SG ' ' A' ' 66' ' ' CYS . 17.1 p -74.63 175.24 8.06 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.286 -1.126 . . . . 0.0 110.245 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . 1.204 ' SG ' ' SG ' ' A' ' 66' ' ' CYS . 0.1 OUTLIER -125.54 142.03 51.72 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.322 -0.861 . . . . 0.0 110.179 179.981 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 83.0 m-85 45.33 -92.53 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.295 -0.878 . . . . 0.0 110.23 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . 0.517 ' N ' ' O ' ' A' ' 59' ' ' CYS . 66.1 mtp180 -118.11 -8.21 10.71 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.194 -0.941 . . . . 0.0 110.151 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 127.3 -14.52 6.51 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.507 -1.437 . . . . 0.0 109.507 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 52.5 mtmt -61.12 -22.18 64.42 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.226 -1.161 . . . . 0.0 110.277 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.724 ' HB1' ' O ' ' A' ' 45' ' ' LEU . . . -127.97 173.83 9.7 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.226 -0.921 . . . . 0.0 110.166 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.463 ' HD3' ' O ' ' A' ' 64' ' ' ALA . 46.2 mmtt -124.16 122.76 38.7 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.248 -0.908 . . . . 0.0 110.215 -179.977 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' CYS . . . . . 1.204 ' SG ' ' SG ' ' A' ' 59' ' ' CYS . 75.9 m -75.09 149.36 39.15 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.271 -0.893 . . . . 0.0 110.135 -179.945 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' CYS . . . . . 0.489 ' HA ' ' O ' ' A' ' 54' ' ' LYS . 89.5 m -146.11 136.36 23.8 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.315 -0.866 . . . . 0.0 110.241 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.517 ' HB3' ' NE2' ' A' ' 56' ' ' GLN . 80.6 tttt . . . . . 0 N--CA 1.493 1.695 0 CA-C-O 118.093 -0.956 . . . . 0.0 110.209 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.502 ' CD1' ' N ' ' A' ' 36' ' ' ASN . 6.3 t80 . . . . . 0 N--CA 1.491 1.6 0 CA-C-O 121.258 0.551 . . . . 0.0 110.119 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . 0.502 ' N ' ' CD1' ' A' ' 35' ' ' TYR . 28.5 p-10 -84.99 57.43 4.44 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.199 -0.938 . . . . 0.0 110.293 -179.937 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 26.1 m -67.09 -56.26 10.8 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.252 -0.905 . . . . 0.0 110.058 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 60.1 t -53.47 -29.25 16.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.265 -0.897 . . . . 0.0 110.112 179.935 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 39.6 t -70.91 -30.06 66.3 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.298 -0.876 . . . . 0.0 110.121 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.491 ' O ' ' NZ ' ' A' ' 68' ' ' LYS . 0.4 OUTLIER -78.94 -21.48 47.16 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.287 -0.883 . . . . 0.0 110.118 179.969 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 117.29 3.57 16.95 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.611 -1.396 . . . . 0.0 109.611 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.435 ' HA2' ' HA ' ' A' ' 68' ' ' LYS . . . -100.5 172.31 23.89 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 -179.974 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 36.4 tt0 -118.14 153.41 33.84 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.25 -1.147 . . . . 0.0 110.187 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 30.5 t -98.03 97.99 9.38 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.253 -0.904 . . . . 0.0 110.205 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.658 HD12 ' CD ' ' A' ' 50' ' ' PRO . 79.7 mt -82.59 174.34 11.13 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.287 -0.883 . . . . 0.0 110.197 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 98.2 m-85 -107.25 0.66 23.36 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.29 -0.881 . . . . 0.0 110.276 -179.892 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.414 ' O ' ' C ' ' A' ' 48' ' ' ALA . 92.3 p -125.9 172.22 10.08 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.128 -0.982 . . . . 0.0 110.194 179.929 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.414 ' C ' ' O ' ' A' ' 47' ' ' SER . . . -42.93 124.2 3.05 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.316 -0.865 . . . . 0.0 110.169 179.948 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 16.4 t -42.87 130.41 3.13 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.29 -0.881 . . . . 0.0 110.215 -179.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.658 ' CD ' HD12 ' A' ' 45' ' ' LEU . 46.9 Cg_endo -72.72 140.73 32.86 Favored 'Trans proline' 0 C--N 1.306 -1.692 0 O-C-N 123.965 1.508 . . . . 0.0 110.391 -179.955 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 43.8 pt -62.2 -22.17 28.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.285 -0.884 . . . . 0.0 110.213 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 69.0 m-85 -55.92 -17.46 6.59 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.239 -0.913 . . . . 0.0 110.207 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.441 ' OG1' ' HB3' ' A' ' 67' ' ' CYS . 35.4 p -135.93 168.09 19.99 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.257 -0.902 . . . . 0.0 110.176 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.443 ' O ' ' HA ' ' A' ' 67' ' ' CYS . 22.1 mttp -96.12 152.98 18.04 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.274 -0.891 . . . . 0.0 110.241 179.977 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.699 HG23 ' O ' ' A' ' 55' ' ' ILE . 13.0 tt -94.54 113.57 29.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.247 -0.908 . . . . 0.0 110.316 -179.955 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . 0.505 ' NE2' ' HB3' ' A' ' 68' ' ' LYS . 90.4 mm-40 -76.13 -26.48 56.37 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.239 -0.913 . . . . 0.0 110.097 -179.977 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 167.5 -151.85 19.81 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.467 -1.453 . . . . 0.0 109.467 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 16.5 p -94.22 165.48 12.58 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.271 -1.135 . . . . 0.0 110.205 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . 0.97 ' SG ' ' SG ' ' A' ' 66' ' ' CYS . 0.5 OUTLIER -103.28 -158.02 0.64 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.202 -0.936 . . . . 0.0 110.207 -179.952 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 61.8 m-85 -56.64 -54.95 40.18 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.307 -0.871 . . . . 0.0 110.227 179.923 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . 0.519 ' CZ ' ' CD ' ' A' ' 63' ' ' LYS . 52.8 ttt180 -118.12 159.66 22.89 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.272 -0.893 . . . . 0.0 110.255 -179.979 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -63.16 -16.1 57.35 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.385 -1.486 . . . . 0.0 109.385 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.519 ' CD ' ' CZ ' ' A' ' 61' ' ' ARG . 41.9 mtpt -70.2 -27.84 64.81 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.257 -1.143 . . . . 0.0 110.172 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -110.48 166.41 11.01 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.379 -0.826 . . . . 0.0 110.192 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt -141.43 150.38 42.24 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.283 -0.885 . . . . 0.0 110.202 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' CYS . . . . . 0.97 ' SG ' ' SG ' ' A' ' 59' ' ' CYS . 94.7 m -92.46 144.14 25.66 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.282 -0.886 . . . . 0.0 110.185 179.939 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' CYS . . . . . 0.449 ' SG ' ' HD2' ' A' ' 50' ' ' PRO . 65.5 m -144.15 121.39 11.55 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.206 -0.934 . . . . 0.0 110.219 -179.995 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.505 ' HB3' ' NE2' ' A' ' 56' ' ' GLN . 80.4 tttt . . . . . 0 N--CA 1.491 1.606 0 CA-C-O 118.02 -0.99 . . . . 0.0 110.216 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.564 ' CZ ' ' SG ' ' A' ' 37' ' ' CYS . 26.2 p90 . . . . . 0 N--CA 1.492 1.638 0 CA-C-O 121.249 0.547 . . . . 0.0 110.112 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . 0.439 ' ND2' ' OG ' ' A' ' 39' ' ' SER . 32.1 t30 -85.63 109.92 18.9 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.34 -0.85 . . . . 0.0 110.28 -179.974 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.564 ' SG ' ' CZ ' ' A' ' 35' ' ' TYR . 98.0 m -66.04 -42.74 89.17 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.278 -0.889 . . . . 0.0 110.089 179.919 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 97.5 t -48.18 -42.76 11.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.233 -0.917 . . . . 0.0 110.161 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . 0.439 ' OG ' ' ND2' ' A' ' 36' ' ' ASN . 2.8 m -64.79 -24.97 67.72 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.301 -0.874 . . . . 0.0 110.206 179.959 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 69.2 m -82.61 -9.62 59.31 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.272 -0.892 . . . . 0.0 110.229 179.923 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 107.97 -4.78 34.06 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.496 ' CA ' ' O ' ' A' ' 67' ' ' CYS . . . -90.71 -172.94 44.16 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.507 -1.437 . . . . 0.0 109.507 179.94 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . 0.553 ' NE2' HD21 ' A' ' 45' ' ' LEU . 44.8 tt0 -127.05 168.41 14.62 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.211 -1.17 . . . . 0.0 110.213 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . 0.657 ' O ' HD23 ' A' ' 45' ' ' LEU . 15.7 t -115.82 136.61 52.89 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.193 -0.942 . . . . 0.0 110.242 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.657 HD23 ' O ' ' A' ' 44' ' ' CYS . 81.6 mt -136.9 174.53 10.51 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.195 -0.941 . . . . 0.0 110.218 179.935 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 96.1 m-85 -109.44 0.55 19.39 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.185 -0.947 . . . . 0.0 110.254 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.419 ' O ' ' C ' ' A' ' 48' ' ' ALA . 41.4 m -122.79 164.79 17.72 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.271 -0.893 . . . . 0.0 110.237 180.0 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.419 ' C ' ' O ' ' A' ' 47' ' ' SER . . . -42.82 138.49 1.96 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.272 -0.892 . . . . 0.0 110.254 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . 0.505 ' HB2' HD12 ' A' ' 55' ' ' ILE . 11.6 t -44.5 131.38 4.83 Favored Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 121.201 -0.937 . . . . 0.0 110.182 -179.924 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.401 ' HD2' ' SG ' ' A' ' 67' ' ' CYS . 46.9 Cg_endo -72.71 161.13 44.73 Favored 'Trans proline' 0 C--N 1.306 -1.691 0 O-C-N 123.976 1.514 . . . . 0.0 110.47 179.94 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 47.1 pt -75.89 -10.69 13.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.212 -0.93 . . . . 0.0 110.274 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 77.0 m-85 -70.7 -25.38 62.93 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.21 -0.931 . . . . 0.0 110.212 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 81.3 p -137.55 159.82 40.88 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.261 -0.899 . . . . 0.0 110.304 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.44 ' HB2' ' O ' ' A' ' 68' ' ' LYS . 86.3 mttt -78.96 155.9 28.74 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.256 -0.902 . . . . 0.0 110.254 179.927 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.744 HG23 ' O ' ' A' ' 55' ' ' ILE . 17.3 tt -97.07 102.15 13.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.211 -0.93 . . . . 0.0 110.199 179.992 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . 0.521 ' CG ' ' HB3' ' A' ' 68' ' ' LYS . 64.9 mm-40 -70.4 -27.55 64.39 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.179 -0.951 . . . . 0.0 109.926 179.824 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 156.54 -158.85 29.05 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.401 -1.48 . . . . 0.0 109.401 179.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.651 HG22 ' HE3' ' A' ' 65' ' ' LYS . 19.3 p -81.87 164.84 21.32 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.254 -1.145 . . . . 0.0 110.19 179.947 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . 0.466 ' SG ' ' HB3' ' A' ' 66' ' ' CYS . 0.5 OUTLIER -92.64 -142.41 0.21 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.23 -0.918 . . . . 0.0 110.252 179.972 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 91.9 m-85 -50.52 -46.2 57.17 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.335 -0.853 . . . . 0.0 110.223 179.886 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -132.85 174.15 10.63 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.265 -0.897 . . . . 0.0 110.171 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -69.85 -16.21 72.2 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 48.9 mtpt -67.96 -25.85 65.64 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.234 -1.156 . . . . 0.0 110.257 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -124.63 161.29 26.57 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.301 -0.874 . . . . 0.0 110.212 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.651 ' HE3' HG22 ' A' ' 58' ' ' THR . 40.1 mmtm -133.62 143.26 48.51 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.309 -0.87 . . . . 0.0 110.213 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' CYS . . . . . 0.471 ' HA ' ' O ' ' A' ' 43' ' ' GLN . 19.5 p -109.93 162.78 14.18 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.318 -0.864 . . . . 0.0 110.226 179.97 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' CYS . . . . . 0.496 ' O ' ' CA ' ' A' ' 42' ' ' GLY . 75.7 m -142.41 165.29 27.82 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.302 -0.874 . . . . 0.0 110.264 179.968 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.521 ' HB3' ' CG ' ' A' ' 56' ' ' GLN . 39.6 ttpt . . . . . 0 N--CA 1.491 1.611 0 CA-C-O 117.984 -1.008 . . . . 0.0 110.152 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.485 ' CD1' ' SG ' ' A' ' 37' ' ' CYS . 6.3 t80 . . . . . 0 N--CA 1.491 1.598 0 CA-C-O 121.226 0.536 . . . . 0.0 110.149 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . 0.467 ' N ' ' CD1' ' A' ' 35' ' ' TYR . 0.2 OUTLIER -121.73 83.51 2.1 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.281 -0.887 . . . . 0.0 110.293 -179.959 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.485 ' SG ' ' CD1' ' A' ' 35' ' ' TYR . 28.9 m -68.71 -52.89 25.95 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.294 -0.879 . . . . 0.0 110.128 179.954 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 60.7 t -46.02 -48.52 5.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.205 -0.935 . . . . 0.0 110.164 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 58.9 p -58.63 -24.27 60.74 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.192 -0.943 . . . . 0.0 110.207 179.948 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.446 ' HB2' ' O ' ' A' ' 37' ' ' CYS . 66.7 m -82.08 -11.59 58.7 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.252 -0.905 . . . . 0.0 110.127 -179.964 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 106.31 -20.43 35.17 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 -179.921 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.519 ' CA ' ' O ' ' A' ' 67' ' ' CYS . . . -75.17 -177.66 40.64 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.452 -1.459 . . . . 0.0 109.452 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . 0.495 ' N ' ' O ' ' A' ' 67' ' ' CYS . 32.0 tt0 -129.83 160.12 34.46 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.276 -1.131 . . . . 0.0 110.204 -179.98 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . 0.47 ' SG ' ' CE2' ' A' ' 60' ' ' TYR . 13.5 t -114.97 107.63 15.63 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.259 -0.901 . . . . 0.0 110.182 179.972 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.736 HD12 ' HD3' ' A' ' 50' ' ' PRO . 16.7 mt -93.74 169.31 10.41 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.212 -0.93 . . . . 0.0 110.219 -179.931 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -86.53 -22.95 26.05 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.237 -0.915 . . . . 0.0 110.203 -179.907 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.417 ' O ' ' C ' ' A' ' 48' ' ' ALA . 40.2 t -103.51 163.64 12.17 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.284 -0.885 . . . . 0.0 110.251 -179.973 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.417 ' C ' ' O ' ' A' ' 47' ' ' SER . . . -43.45 138.01 2.58 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.231 -0.918 . . . . 0.0 110.194 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . 0.408 ' C ' ' O ' ' A' ' 48' ' ' ALA . 7.7 t -43.72 133.11 3.89 Favored Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.266 -0.896 . . . . 0.0 110.194 -179.958 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.736 ' HD3' HD12 ' A' ' 45' ' ' LEU . 46.4 Cg_endo -72.96 143.97 37.45 Favored 'Trans proline' 0 C--N 1.306 -1.691 0 O-C-N 123.954 1.502 . . . . 0.0 110.413 -179.935 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 40.3 pt -59.84 -24.18 28.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.213 -0.93 . . . . 0.0 110.163 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -55.72 -22.23 22.66 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.261 -0.9 . . . . 0.0 110.252 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.44 ' HB ' ' O ' ' A' ' 68' ' ' LYS . 67.2 p -139.35 153.83 47.76 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.261 -0.899 . . . . 0.0 110.239 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 72.0 mttt -79.6 172.07 14.29 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.262 -0.898 . . . . 0.0 110.166 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.721 HG23 ' O ' ' A' ' 55' ' ' ILE . 11.5 tt -106.9 110.62 32.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.276 -0.89 . . . . 0.0 110.116 179.965 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . 0.533 ' CG ' ' HB2' ' A' ' 68' ' ' LYS . 72.1 mm-40 -62.02 -31.96 72.4 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.276 -0.89 . . . . 0.0 110.137 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 169.18 -144.57 8.77 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.443 -1.463 . . . . 0.0 109.443 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 17.5 p -97.91 164.97 12.15 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.184 -1.186 . . . . 0.0 110.196 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . 1.089 ' SG ' ' SG ' ' A' ' 66' ' ' CYS . 0.5 OUTLIER -106.49 -171.63 1.93 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.225 -0.922 . . . . 0.0 110.293 -179.976 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.527 ' CD1' ' N ' ' A' ' 61' ' ' ARG . 7.9 p90 -50.99 -31.68 18.76 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.309 -0.87 . . . . 0.0 110.263 179.862 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . 0.527 ' N ' ' CD1' ' A' ' 60' ' ' TYR . 91.9 mtt180 -140.89 173.35 11.57 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.308 -0.87 . . . . 0.0 110.258 179.939 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -81.76 -11.08 83.34 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.586 -1.405 . . . . 0.0 109.586 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.409 ' HE2' ' CD ' ' A' ' 61' ' ' ARG . 48.7 mtmt -68.04 -18.84 64.8 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.217 -1.167 . . . . 0.0 110.135 -179.949 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.697 ' HB1' ' O ' ' A' ' 45' ' ' LEU . . . -136.42 158.58 44.08 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.263 -0.898 . . . . 0.0 110.16 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 70.1 mmtt -126.55 140.55 52.36 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.279 -0.888 . . . . 0.0 110.231 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' CYS . . . . . 1.089 ' SG ' ' SG ' ' A' ' 59' ' ' CYS . 84.1 m -74.59 148.88 40.39 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.26 -0.9 . . . . 0.0 110.263 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' CYS . . . . . 0.519 ' O ' ' CA ' ' A' ' 42' ' ' GLY . 82.8 m -142.42 154.84 44.93 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.239 -0.913 . . . . 0.0 110.145 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.533 ' HB2' ' CG ' ' A' ' 56' ' ' GLN . 68.3 tttt . . . . . 0 N--CA 1.492 1.645 0 CA-C-O 118.04 -0.981 . . . . 0.0 110.191 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.566 ' CZ ' ' SG ' ' A' ' 37' ' ' CYS . 30.4 p90 . . . . . 0 N--CA 1.491 1.608 0 CA-C-O 121.327 0.584 . . . . 0.0 110.153 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . 0.507 ' ND2' ' OG ' ' A' ' 39' ' ' SER . 23.4 p-10 -88.15 100.45 12.97 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.198 -0.939 . . . . 0.0 110.243 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.566 ' SG ' ' CZ ' ' A' ' 35' ' ' TYR . 14.8 m -72.1 -22.2 61.38 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.287 -0.883 . . . . 0.0 110.086 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.585 HG23 ' N ' ' A' ' 39' ' ' SER . 35.8 m -60.98 -45.19 98.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.231 -0.918 . . . . 0.0 110.46 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . 0.585 ' N ' HG23 ' A' ' 38' ' ' VAL . 95.0 p -60.6 -31.61 70.76 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.202 -0.936 . . . . 0.0 110.211 -179.928 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 72.8 m -73.64 -12.43 60.74 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.304 -0.872 . . . . 0.0 110.192 179.89 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 101.83 -11.27 57.59 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.431 -1.468 . . . . 0.0 109.431 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.511 ' CA ' ' O ' ' A' ' 67' ' ' CYS . . . -85.18 172.49 47.44 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.412 -1.475 . . . . 0.0 109.412 -179.912 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . 0.515 ' N ' ' O ' ' A' ' 67' ' ' CYS . 0.4 OUTLIER -123.28 -174.82 3.04 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.27 -1.135 . . . . 0.0 110.151 179.959 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 13.7 t -130.11 116.38 18.41 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.161 -0.962 . . . . 0.0 110.222 -179.947 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.505 HD12 ' HD3' ' A' ' 50' ' ' PRO . 93.5 mt -105.46 175.84 5.36 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.251 -0.905 . . . . 0.0 110.224 179.858 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 98.3 m-85 -102.45 -3.44 26.95 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.278 -0.889 . . . . 0.0 110.291 -179.877 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.407 ' O ' ' C ' ' A' ' 48' ' ' ALA . 69.3 m -122.76 166.49 14.86 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.272 -0.893 . . . . 0.0 110.246 179.967 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.422 ' O ' ' C ' ' A' ' 49' ' ' CYS . . . -42.97 131.64 4.15 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.243 -0.911 . . . . 0.0 110.19 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . 0.422 ' C ' ' O ' ' A' ' 48' ' ' ALA . 5.9 t -42.96 130.02 3.19 Favored Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 121.29 -0.881 . . . . 0.0 110.251 -179.981 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.505 ' HD3' HD12 ' A' ' 45' ' ' LEU . 47.4 Cg_endo -72.81 145.6 41.08 Favored 'Trans proline' 0 C--N 1.306 -1.689 0 O-C-N 123.945 1.497 . . . . 0.0 110.412 -179.993 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 45.1 pt -59.63 -18.48 14.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.254 -0.904 . . . . 0.0 110.192 179.918 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 91.8 m-85 -70.86 -4.49 24.54 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.293 -0.88 . . . . 0.0 110.256 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 69.5 p -137.69 170.76 15.51 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.286 -0.884 . . . . 0.0 110.248 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.477 ' O ' ' HA ' ' A' ' 67' ' ' CYS . 70.9 tttt -91.27 162.79 14.48 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.215 -0.928 . . . . 0.0 110.209 -179.953 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.771 HG23 ' O ' ' A' ' 55' ' ' ILE . 15.1 tt -93.47 100.65 11.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.268 -0.895 . . . . 0.0 110.145 -179.963 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . 0.545 ' HB2' ' CB ' ' A' ' 66' ' ' CYS . 79.2 mm-40 -75.45 0.01 18.53 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.245 -0.909 . . . . 0.0 110.218 179.98 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 111.75 -127.49 8.15 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.497 -1.441 . . . . 0.0 109.497 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.454 ' HA ' ' HD3' ' A' ' 65' ' ' LYS . 71.0 p -105.23 168.62 8.95 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.213 -1.169 . . . . 0.0 110.203 -179.986 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . 0.933 ' SG ' ' SG ' ' A' ' 66' ' ' CYS . 0.1 OUTLIER -117.66 -149.23 0.44 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.222 -0.924 . . . . 0.0 110.179 179.968 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 98.0 m-85 -58.34 -46.47 86.18 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.298 -0.876 . . . . 0.0 110.199 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . 0.466 ' HD2' ' HD3' ' A' ' 63' ' ' LYS . 33.1 ttm180 -129.54 164.76 23.09 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.263 -0.898 . . . . 0.0 110.161 179.989 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . 0.431 ' N ' ' HG2' ' A' ' 61' ' ' ARG . . . -61.3 -23.2 61.95 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.466 ' HD3' ' HD2' ' A' ' 61' ' ' ARG . 44.1 mtpt -72.34 -28.53 63.11 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.21 -1.171 . . . . 0.0 110.228 -179.986 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.419 ' C ' ' HG2' ' A' ' 65' ' ' LYS . . . -107.31 160.44 15.61 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.225 -0.922 . . . . 0.0 110.284 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.511 ' CA ' ' HB2' ' A' ' 59' ' ' CYS . 34.0 mmtm -142.68 144.76 32.87 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.21 -0.931 . . . . 0.0 110.086 179.984 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' CYS . . . . . 0.933 ' SG ' ' SG ' ' A' ' 59' ' ' CYS . 79.9 m -83.56 132.24 34.93 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.173 -0.955 . . . . 0.0 110.163 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' CYS . . . . . 0.515 ' O ' ' N ' ' A' ' 43' ' ' GLN . 85.0 m -126.76 154.19 44.54 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.28 -0.888 . . . . 0.0 110.18 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.514 ' HB3' ' NE2' ' A' ' 56' ' ' GLN . 85.2 tttt . . . . . 0 N--CA 1.491 1.577 0 CA-C-O 117.951 -1.023 . . . . 0.0 110.271 179.999 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 3.6 t80 . . . . . 0 N--CA 1.491 1.619 0 CA-C-O 121.294 0.569 . . . . 0.0 110.252 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . 0.513 ' ND2' ' OG ' ' A' ' 39' ' ' SER . 64.2 t30 -100.79 117.27 34.54 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.236 -0.915 . . . . 0.0 110.157 179.931 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.45 ' O ' ' N ' ' A' ' 40' ' ' SER . 37.7 m -85.22 -51.07 6.86 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.332 -0.855 . . . . 0.0 110.311 -179.941 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.57 HG23 ' N ' ' A' ' 39' ' ' SER . 21.7 m -41.75 -46.26 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.248 -0.908 . . . . 0.0 110.33 -179.896 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . 0.57 ' N ' HG23 ' A' ' 38' ' ' VAL . 0.8 OUTLIER -59.02 -32.18 69.49 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.177 -0.952 . . . . 0.0 110.14 179.98 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.483 ' O ' ' NZ ' ' A' ' 68' ' ' LYS . 50.2 m -75.43 -9.97 59.04 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.347 -0.846 . . . . 0.0 110.156 -179.991 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . 0.401 ' HA3' ' HE3' ' A' ' 68' ' ' LYS . . . 108.29 -20.54 30.31 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 179.931 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.444 ' O ' ' HA ' ' A' ' 38' ' ' VAL . . . -78.27 177.61 53.39 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.592 -1.403 . . . . 0.0 109.592 179.94 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . 0.517 ' O ' ' HA ' ' A' ' 66' ' ' CYS . 14.4 tt0 -125.38 155.93 39.58 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.206 -1.173 . . . . 0.0 110.192 179.921 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 15.7 t -104.5 104.09 13.88 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.257 -0.902 . . . . 0.0 110.281 -179.96 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.477 HD12 ' CD ' ' A' ' 50' ' ' PRO . 80.3 mt -88.7 174.63 7.91 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.217 -0.927 . . . . 0.0 110.238 179.966 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 88.8 m-85 -96.13 -19.48 19.35 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.21 -0.931 . . . . 0.0 110.185 -179.929 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.419 ' O ' ' C ' ' A' ' 48' ' ' ALA . 69.1 m -110.47 165.66 11.61 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.181 -0.949 . . . . 0.0 110.257 -179.934 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.419 ' C ' ' O ' ' A' ' 47' ' ' SER . . . -42.92 131.95 4.04 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.315 -0.866 . . . . 0.0 110.217 179.978 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 8.7 t -44.68 127.63 5.07 Favored Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.205 -0.934 . . . . 0.0 110.106 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.477 ' CD ' HD12 ' A' ' 45' ' ' LEU . 46.7 Cg_endo -72.4 149.46 50.51 Favored 'Trans proline' 0 C--N 1.306 -1.681 0 O-C-N 123.949 1.499 . . . . 0.0 110.402 -179.999 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.425 HG13 ' N ' ' A' ' 52' ' ' PHE . 27.8 pt -63.6 -22.28 30.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.244 -0.91 . . . . 0.0 110.211 179.933 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . 0.425 ' N ' HG13 ' A' ' 51' ' ' ILE . 91.0 m-85 -56.98 -20.28 22.93 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.215 -0.928 . . . . 0.0 110.211 -179.998 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 17.6 p -133.93 162.85 30.91 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.302 -0.874 . . . . 0.0 110.18 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 55.6 mttm -95.36 143.94 26.32 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.221 -0.924 . . . . 0.0 110.129 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.721 HG23 ' O ' ' A' ' 55' ' ' ILE . 18.2 tt -88.76 113.26 25.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.213 -0.929 . . . . 0.0 110.184 -179.979 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . 0.471 ' NE2' ' HB3' ' A' ' 68' ' ' LYS . 88.2 mm-40 -72.41 -28.06 62.73 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.249 -0.907 . . . . 0.0 110.153 -179.975 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 176.88 -148.92 9.24 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.457 -1.457 . . . . 0.0 109.457 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 43.2 p -99.48 163.57 12.46 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.182 -1.187 . . . . 0.0 110.199 179.93 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . 0.864 ' SG ' ' SG ' ' A' ' 66' ' ' CYS . 0.8 OUTLIER -98.07 -160.41 0.8 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.277 -0.889 . . . . 0.0 110.318 -179.976 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 85.2 m-85 -57.51 -46.91 83.25 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.355 -0.84 . . . . 0.0 110.197 179.874 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 95.3 mtt180 -127.21 167.97 15.35 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.251 -0.906 . . . . 0.0 110.14 -179.978 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -68.52 -12.19 63.52 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.477 -1.449 . . . . 0.0 109.477 -179.947 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 53.9 mtmt -75.84 -23.66 55.74 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.291 -1.123 . . . . 0.0 110.244 179.999 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -113.26 163.09 15.24 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.255 -0.903 . . . . 0.0 110.249 -179.93 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -140.03 141.05 36.31 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.306 -0.871 . . . . 0.0 110.199 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' CYS . . . . . 0.864 ' SG ' ' SG ' ' A' ' 59' ' ' CYS . 58.6 m -84.99 148.05 26.38 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.248 -0.907 . . . . 0.0 110.154 -179.982 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' CYS . . . . . 0.436 ' SG ' ' HD2' ' A' ' 50' ' ' PRO . 80.5 m -143.64 128.08 17.93 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.276 -0.89 . . . . 0.0 110.195 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.483 ' NZ ' ' O ' ' A' ' 40' ' ' SER . 75.2 tttt . . . . . 0 N--CA 1.492 1.636 0 CA-C-O 118.058 -0.972 . . . . 0.0 110.194 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 43.2 t80 . . . . . 0 N--CA 1.492 1.645 0 CA-C-O 121.248 0.547 . . . . 0.0 110.161 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 17.4 p-10 -111.1 123.82 50.96 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.291 -0.881 . . . . 0.0 110.235 -179.949 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.65 ' SG ' ' SG ' ' A' ' 59' ' ' CYS . 22.3 m -68.62 -6.86 28.24 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.242 -0.912 . . . . 0.0 110.161 179.856 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 39.8 t -71.7 -41.52 70.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.236 -0.915 . . . . 0.0 110.157 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 3.1 m -51.4 -29.39 15.55 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.269 -0.894 . . . . 0.0 110.054 179.954 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.444 ' CB ' ' HB3' ' A' ' 56' ' ' GLN . 26.6 m -88.89 -17.36 29.76 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.236 -0.915 . . . . 0.0 110.058 179.898 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . 0.473 ' O ' ' HG3' ' A' ' 68' ' ' LYS . . . 108.06 8.75 29.11 Favored Glycine 0 N--CA 1.489 2.197 0 N-CA-C 109.488 -1.445 . . . . 0.0 109.488 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.511 ' CA ' ' O ' ' A' ' 67' ' ' CYS . . . -110.18 173.0 16.11 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.498 -1.441 . . . . 0.0 109.498 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . 0.485 ' N ' ' O ' ' A' ' 67' ' ' CYS . 2.0 pt20 -110.34 174.53 5.82 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.237 -1.155 . . . . 0.0 110.246 179.951 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 8.7 t -110.98 84.38 1.92 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.228 -0.92 . . . . 0.0 110.218 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.494 HD12 ' HA ' ' A' ' 45' ' ' LEU . 14.4 tp -69.26 167.09 17.06 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.357 -0.839 . . . . 0.0 110.191 -180.0 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 60.1 m-85 -91.77 -24.85 19.28 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.293 -0.88 . . . . 0.0 110.314 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.422 ' O ' ' C ' ' A' ' 48' ' ' ALA . 73.7 m -106.81 167.44 9.87 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.2 -0.937 . . . . 0.0 110.261 -179.928 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.422 ' C ' ' O ' ' A' ' 47' ' ' SER . . . -43.02 128.02 4.29 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.188 -0.945 . . . . 0.0 110.163 -179.965 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 8.2 t -46.12 130.4 7.39 Favored Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.277 -0.889 . . . . 0.0 110.3 -179.865 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.469 ' HD2' ' SG ' ' A' ' 67' ' ' CYS . 46.3 Cg_endo -72.74 151.1 51.3 Favored 'Trans proline' 0 C--N 1.307 -1.62 0 O-C-N 123.882 1.464 . . . . 0.0 110.302 179.843 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 37.0 pt -64.03 -21.23 28.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.196 -0.94 . . . . 0.0 110.305 179.982 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 82.1 m-85 -61.45 -19.9 62.51 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.206 -0.934 . . . . 0.0 110.174 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 38.8 p -118.57 168.64 10.5 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.25 -0.906 . . . . 0.0 110.192 -179.953 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.472 ' O ' ' HA ' ' A' ' 67' ' ' CYS . 30.1 tttt -96.83 162.38 13.44 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.223 -0.923 . . . . 0.0 110.142 179.983 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.686 HG23 ' O ' ' A' ' 55' ' ' ILE . 20.8 tt -97.6 116.43 40.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.247 -0.908 . . . . 0.0 110.171 179.961 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . 0.49 ' HB2' ' HB3' ' A' ' 66' ' ' CYS . 61.6 mm-40 -93.36 -1.46 55.87 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.244 -0.91 . . . . 0.0 110.177 -179.919 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 142.47 -131.61 4.75 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.423 -1.471 . . . . 0.0 109.423 -179.935 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.447 ' O ' ' SG ' ' A' ' 66' ' ' CYS . 18.5 p -120.88 164.91 15.95 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.227 -1.16 . . . . 0.0 110.189 179.988 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . 0.65 ' SG ' ' SG ' ' A' ' 37' ' ' CYS . 0.5 OUTLIER -105.86 -158.78 0.67 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.242 -0.911 . . . . 0.0 110.276 -179.902 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 99.6 m-85 -57.36 -50.6 72.43 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.257 -0.902 . . . . 0.0 110.133 179.922 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 74.2 mtm180 -123.55 165.25 17.46 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.284 -0.885 . . . . 0.0 110.128 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -61.51 -21.35 60.14 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.48 -1.448 . . . . 0.0 109.48 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 2.8 tptt -67.63 -31.35 71.31 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.26 -1.141 . . . . 0.0 110.215 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -102.6 158.56 16.14 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.384 -0.823 . . . . 0.0 110.145 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 70.3 mmtt -141.85 160.29 40.5 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.304 -0.872 . . . . 0.0 110.132 -179.954 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' CYS . . . . . 0.49 ' HB3' ' HB2' ' A' ' 56' ' ' GLN . 66.6 m -82.1 132.07 35.24 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.206 -0.934 . . . . 0.0 110.212 -179.983 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' CYS . . . . . 0.511 ' O ' ' CA ' ' A' ' 42' ' ' GLY . 78.6 m -129.32 124.35 34.11 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.251 -0.906 . . . . 0.0 110.151 -179.951 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.473 ' HG3' ' O ' ' A' ' 41' ' ' GLY . 47.2 tttt . . . . . 0 N--CA 1.491 1.614 0 CA-C-O 117.94 -1.029 . . . . 0.0 110.251 179.96 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.456 ' CD1' ' N ' ' A' ' 36' ' ' ASN . 11.2 t80 . . . . . 0 N--CA 1.492 1.629 0 CA-C-O 121.277 0.56 . . . . 0.0 110.181 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . 0.456 ' N ' ' CD1' ' A' ' 35' ' ' TYR . 28.2 p-10 -98.33 55.56 1.12 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.261 -0.899 . . . . 0.0 110.299 179.981 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.429 ' SG ' ' CD1' ' A' ' 35' ' ' TYR . 60.3 m -61.31 -22.51 64.95 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.24 -0.912 . . . . 0.0 110.171 -179.999 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 72.2 t -68.83 -39.94 80.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.22 -0.925 . . . . 0.0 110.211 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . 0.45 ' OG ' ' ND2' ' A' ' 36' ' ' ASN . 87.4 p -64.13 -26.5 68.56 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.203 -0.935 . . . . 0.0 110.104 179.986 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 50.0 m -81.06 -20.56 41.34 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.237 -0.915 . . . . 0.0 110.198 179.973 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . 0.473 ' O ' ' HG3' ' A' ' 68' ' ' LYS . . . 112.14 14.89 10.36 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.511 -1.436 . . . . 0.0 109.511 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.435 ' HA2' ' HA ' ' A' ' 68' ' ' LYS . . . -110.3 171.82 15.09 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.504 -1.439 . . . . 0.0 109.504 179.962 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . 0.489 ' N ' ' O ' ' A' ' 67' ' ' CYS . 0.3 OUTLIER -129.24 175.16 8.95 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.25 -1.147 . . . . 0.0 110.301 -179.993 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 6.1 m -110.77 97.01 6.53 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.283 -0.886 . . . . 0.0 110.132 179.885 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.516 ' O ' ' HB1' ' A' ' 64' ' ' ALA . 23.0 tp -86.39 167.22 14.93 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.259 -0.901 . . . . 0.0 110.146 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 95.2 m-85 -92.13 -31.05 15.65 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.219 -0.926 . . . . 0.0 110.345 -179.916 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.422 ' O ' ' C ' ' A' ' 48' ' ' ALA . 76.8 p -92.02 160.61 15.15 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.386 -0.821 . . . . 0.0 110.231 -179.948 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.422 ' C ' ' O ' ' A' ' 47' ' ' SER . . . -42.7 129.28 4.18 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.33 -0.856 . . . . 0.0 110.194 179.937 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 4.1 t -43.15 128.44 3.42 Favored Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.182 -0.949 . . . . 0.0 110.203 -179.853 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.429 ' HD2' ' SG ' ' A' ' 67' ' ' CYS . 46.7 Cg_endo -72.34 146.07 44.46 Favored 'Trans proline' 0 C--N 1.305 -1.713 0 O-C-N 123.95 1.5 . . . . 0.0 110.452 -179.94 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 39.1 pt -60.39 -15.57 10.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.28 -0.887 . . . . 0.0 110.206 -179.951 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 76.1 m-85 -71.63 -10.26 59.5 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.26 -0.9 . . . . 0.0 110.208 179.924 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.463 ' HB ' ' N ' ' A' ' 68' ' ' LYS . 61.5 p -127.78 167.0 17.13 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.237 -0.914 . . . . 0.0 110.189 -179.995 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.466 ' O ' ' HA ' ' A' ' 67' ' ' CYS . 38.1 mttt -103.51 173.05 6.47 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.246 -0.909 . . . . 0.0 110.214 -179.98 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.672 HG23 ' O ' ' A' ' 55' ' ' ILE . 10.8 tp -99.65 119.33 47.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.357 -0.839 . . . . 0.0 110.209 179.961 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 68.2 mm-40 -102.03 9.23 40.56 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.269 -0.894 . . . . 0.0 110.264 -179.928 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 129.17 -159.89 22.42 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.448 -1.461 . . . . 0.0 109.448 179.919 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.456 ' O ' ' SG ' ' A' ' 66' ' ' CYS . 19.1 p -92.48 164.28 13.52 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.217 -1.166 . . . . 0.0 110.214 -179.93 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 1.5 m -110.54 -163.14 0.83 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.227 -0.921 . . . . 0.0 110.147 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 67.0 m-85 -49.64 -59.95 3.32 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.391 -0.818 . . . . 0.0 110.151 179.761 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 30.0 mmt180 -120.22 166.3 13.65 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.169 -0.957 . . . . 0.0 110.103 -180.0 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -65.39 -23.63 70.28 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 52.4 mtmt -60.19 -25.42 65.56 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.209 -1.171 . . . . 0.0 110.164 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.516 ' HB1' ' O ' ' A' ' 45' ' ' LEU . . . -117.32 160.96 20.29 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.242 -0.911 . . . . 0.0 110.17 -179.868 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.406 ' HG2' ' C ' ' A' ' 64' ' ' ALA . 28.9 mmtp -137.94 154.64 49.38 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.23 -0.918 . . . . 0.0 110.307 179.946 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' CYS . . . . . 0.456 ' SG ' ' O ' ' A' ' 58' ' ' THR . 71.7 m -72.27 131.42 42.68 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.292 -0.88 . . . . 0.0 110.169 179.911 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' CYS . . . . . 0.489 ' O ' ' N ' ' A' ' 43' ' ' GLN . 94.7 m -129.8 131.24 46.12 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.228 -0.92 . . . . 0.0 110.247 -179.905 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.473 ' HG3' ' O ' ' A' ' 41' ' ' GLY . 84.4 tttt . . . . . 0 N--CA 1.49 1.547 0 CA-C-O 117.995 -1.002 . . . . 0.0 110.182 -179.951 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.568 ' CZ ' ' SG ' ' A' ' 37' ' ' CYS . 1.8 t80 . . . . . 0 N--CA 1.491 1.621 0 CA-C-O 121.275 0.559 . . . . 0.0 110.144 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 9.9 p-10 -121.7 114.66 21.44 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.225 -0.922 . . . . 0.0 110.213 -179.971 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.568 ' SG ' ' CZ ' ' A' ' 35' ' ' TYR . 46.7 m -74.26 -0.35 16.7 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.258 -0.901 . . . . 0.0 110.278 179.982 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 94.7 t -67.3 -33.95 65.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.208 -0.933 . . . . 0.0 110.116 -179.97 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 69.3 m -71.18 -27.81 63.79 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.24 -0.913 . . . . 0.0 110.149 179.912 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 63.7 m -82.42 -9.22 59.53 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.331 -0.855 . . . . 0.0 110.119 179.922 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . 0.428 ' C ' ' HG3' ' A' ' 68' ' ' LYS . . . 105.33 -24.61 27.17 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.341 -1.504 . . . . 0.0 109.341 -179.965 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.463 ' N ' ' HG3' ' A' ' 68' ' ' LYS . . . -67.74 -173.57 7.08 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.444 -1.462 . . . . 0.0 109.444 -179.979 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . 0.51 ' O ' ' HA ' ' A' ' 66' ' ' CYS . 36.1 tt0 -141.34 144.36 34.53 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.272 -1.134 . . . . 0.0 110.26 -179.941 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . 0.416 ' O ' HD23 ' A' ' 45' ' ' LEU . 76.4 m -94.96 137.11 34.46 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.268 -0.895 . . . . 0.0 110.144 179.998 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.678 ' O ' ' HB1' ' A' ' 64' ' ' ALA . 54.0 mt -130.01 178.8 6.27 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.276 -0.89 . . . . 0.0 110.239 -179.982 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 85.9 m-85 -109.46 -1.04 18.61 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.259 -0.901 . . . . 0.0 110.178 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.423 ' O ' ' C ' ' A' ' 48' ' ' ALA . 52.3 m -127.9 171.59 11.65 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.27 -0.894 . . . . 0.0 110.25 -179.984 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.423 ' C ' ' O ' ' A' ' 47' ' ' SER . . . -43.08 145.12 0.54 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.221 -0.924 . . . . 0.0 110.189 179.968 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 16.9 t -55.77 130.28 71.9 Favored Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 121.228 -0.92 . . . . 0.0 110.165 -179.974 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.47 ' HD2' ' SG ' ' A' ' 67' ' ' CYS . 47.5 Cg_endo -73.14 142.32 34.0 Favored 'Trans proline' 0 C--N 1.306 -1.685 0 O-C-N 123.991 1.521 . . . . 0.0 110.402 179.98 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 39.0 pt -63.68 -18.78 22.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.315 -0.866 . . . . 0.0 110.181 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 85.0 m-85 -59.45 -21.55 60.21 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.237 -0.914 . . . . 0.0 110.216 179.944 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.481 ' OG1' ' HB3' ' A' ' 67' ' ' CYS . 20.4 p -132.78 171.15 14.27 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.26 -0.9 . . . . 0.0 110.297 179.869 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.494 ' O ' ' HA ' ' A' ' 67' ' ' CYS . 45.5 tttp -83.68 165.04 19.27 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.24 -0.912 . . . . 0.0 110.21 179.943 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.737 HG23 ' O ' ' A' ' 55' ' ' ILE . 12.0 tt -91.28 108.67 20.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.268 -0.895 . . . . 0.0 110.162 179.895 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . 0.493 ' HB2' ' HB3' ' A' ' 66' ' ' CYS . 94.0 mm-40 -85.31 -8.84 58.29 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.251 -0.906 . . . . 0.0 110.256 179.937 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 125.43 -124.44 5.28 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 179.941 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.457 ' HB ' ' HA2' ' A' ' 62' ' ' GLY . 16.6 p -117.98 169.49 9.61 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.31 -1.112 . . . . 0.0 110.157 -179.935 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . 0.646 ' HB3' ' HB3' ' A' ' 64' ' ' ALA . 0.9 OUTLIER -133.61 140.73 47.3 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.211 -0.931 . . . . 0.0 110.202 179.959 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.507 ' CB ' ' HB3' ' A' ' 63' ' ' LYS . 71.2 m-85 56.07 53.93 8.51 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.293 -0.879 . . . . 0.0 110.414 179.9 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . 0.451 ' HB2' ' O ' ' A' ' 60' ' ' TYR . 38.6 mmt180 57.38 39.95 27.87 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.25 -0.906 . . . . 0.0 110.609 179.696 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . 0.457 ' HA2' ' HB ' ' A' ' 58' ' ' THR . . . 85.86 -16.45 41.78 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.779 -1.328 . . . . 0.0 109.779 179.603 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.507 ' HB3' ' CB ' ' A' ' 60' ' ' TYR . 5.7 ttpt -55.44 -18.43 6.95 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.103 -1.234 . . . . 0.0 109.767 179.951 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.678 ' HB1' ' O ' ' A' ' 45' ' ' LEU . . . -149.56 172.09 15.57 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.405 -0.81 . . . . 0.0 109.961 179.757 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.405 ' HD2' ' HA ' ' A' ' 65' ' ' LYS . 53.2 tptt -111.15 122.33 47.6 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.147 -0.971 . . . . 0.0 110.275 -179.903 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' CYS . . . . . 0.51 ' HA ' ' O ' ' A' ' 43' ' ' GLN . 42.9 m -81.27 140.98 34.53 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.297 -0.877 . . . . 0.0 110.134 179.977 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' CYS . . . . . 0.494 ' HA ' ' O ' ' A' ' 54' ' ' LYS . 85.0 m -149.53 124.61 10.05 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.198 -0.939 . . . . 0.0 110.222 -179.969 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.481 ' HB3' ' NE2' ' A' ' 56' ' ' GLN . 33.4 ttmt . . . . . 0 N--CA 1.491 1.618 0 CA-C-O 117.942 -1.028 . . . . 0.0 110.194 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 2.4 t80 . . . . . 0 N--CA 1.493 1.676 0 CA-C-O 121.271 0.557 . . . . 0.0 110.141 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 36.3 t30 -101.13 108.97 20.79 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.211 -0.931 . . . . 0.0 110.237 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 27.4 m -82.02 -3.78 55.29 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.183 -0.948 . . . . 0.0 110.191 179.948 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 91.9 t -70.18 -45.95 73.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.235 -0.915 . . . . 0.0 110.213 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 22.9 t -60.51 -26.39 66.81 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.258 -0.901 . . . . 0.0 110.175 179.996 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 42.5 m -83.59 -8.35 59.33 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.309 -0.869 . . . . 0.0 110.243 179.935 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . 0.435 ' C ' ' HG3' ' A' ' 68' ' ' LYS . . . 91.91 3.58 68.02 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.598 -1.401 . . . . 0.0 109.598 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -90.55 172.67 37.83 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . 0.514 ' O ' ' HA ' ' A' ' 66' ' ' CYS . 32.6 tt0 -127.58 137.2 52.52 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.345 -1.091 . . . . 0.0 110.217 -179.967 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . 0.57 ' SG ' ' HB3' ' A' ' 64' ' ' ALA . 24.7 t -83.68 113.17 20.67 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.234 -0.916 . . . . 0.0 110.242 179.934 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.659 HD12 ' SG ' ' A' ' 67' ' ' CYS . 47.3 mt -106.05 168.94 8.79 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.186 -0.946 . . . . 0.0 110.269 -179.936 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 91.1 m-85 -104.23 -1.47 27.07 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.286 -0.883 . . . . 0.0 110.231 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.417 ' O ' ' C ' ' A' ' 48' ' ' ALA . 89.5 p -126.99 168.36 14.65 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.211 -0.93 . . . . 0.0 110.257 -179.972 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.417 ' C ' ' O ' ' A' ' 47' ' ' SER . . . -42.86 128.66 4.27 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.251 -0.905 . . . . 0.0 110.136 179.991 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 6.0 t -44.44 132.09 4.72 Favored Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 121.238 -0.914 . . . . 0.0 110.174 179.904 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.443 ' HG2' ' OG1' ' A' ' 53' ' ' THR . 46.9 Cg_endo -73.19 148.58 44.42 Favored 'Trans proline' 0 C--N 1.306 -1.674 0 O-C-N 123.867 1.456 . . . . 0.0 110.406 -179.982 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 13.1 mt -62.96 -22.24 30.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.284 -0.885 . . . . 0.0 110.152 179.966 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -71.02 -3.94 22.27 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.313 -0.867 . . . . 0.0 110.218 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.504 ' CB ' ' HB3' ' A' ' 67' ' ' CYS . 54.6 p -133.27 162.55 31.5 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.241 -0.912 . . . . 0.0 110.276 179.978 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.484 ' O ' ' HA ' ' A' ' 67' ' ' CYS . 46.8 tttp -93.18 168.36 11.15 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.287 -0.883 . . . . 0.0 110.234 179.978 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.582 HG23 ' O ' ' A' ' 55' ' ' ILE . 18.5 tt -87.78 125.11 41.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.237 -0.914 . . . . 0.0 110.207 179.962 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . 0.523 ' HB2' ' CB ' ' A' ' 66' ' ' CYS . 86.3 mm-40 -107.49 7.96 29.15 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.193 -0.942 . . . . 0.0 110.201 179.99 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 102.31 -140.1 14.71 Favored Glycine 0 N--CA 1.489 2.176 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 179.975 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.446 ' O ' ' SG ' ' A' ' 66' ' ' CYS . 38.7 p -98.75 -174.11 2.7 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.23 -1.159 . . . . 0.0 110.182 179.987 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . 0.773 ' SG ' ' SG ' ' A' ' 66' ' ' CYS . 1.2 m -112.48 -161.24 0.75 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.251 -0.905 . . . . 0.0 110.27 -179.957 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 74.4 m-85 -49.83 -65.62 0.53 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.238 -0.914 . . . . 0.0 110.411 179.952 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . 0.403 ' CD ' ' HE2' ' A' ' 63' ' ' LYS . 56.7 mtt180 -93.29 -14.49 26.9 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.241 -0.912 . . . . 0.0 110.446 -179.834 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 101.65 -21.02 44.04 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.366 -1.494 . . . . 0.0 109.366 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.403 ' HE2' ' CD ' ' A' ' 61' ' ' ARG . 37.0 mtmt -57.44 -30.2 64.8 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.278 -1.131 . . . . 0.0 109.98 179.77 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.57 ' HB3' ' SG ' ' A' ' 44' ' ' CYS . . . -106.54 159.41 16.2 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.498 -0.751 . . . . 0.0 110.268 -179.82 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.41 ' HD2' ' HA ' ' A' ' 65' ' ' LYS . 49.5 tptt -112.49 120.53 41.96 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.185 -0.947 . . . . 0.0 110.208 -179.902 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' CYS . . . . . 0.773 ' SG ' ' SG ' ' A' ' 59' ' ' CYS . 79.4 m -68.95 151.46 46.51 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.308 -0.87 . . . . 0.0 110.127 179.958 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' CYS . . . . . 0.659 ' SG ' HD12 ' A' ' 45' ' ' LEU . 90.4 m -149.0 125.32 10.86 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.146 -0.971 . . . . 0.0 110.219 179.994 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.509 ' HB3' ' NE2' ' A' ' 56' ' ' GLN . 26.9 tttp . . . . . 0 N--CA 1.491 1.613 0 CA-C-O 118.013 -0.994 . . . . 0.0 110.212 179.952 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.473 ' CZ ' ' SG ' ' A' ' 37' ' ' CYS . 27.6 p90 . . . . . 0 N--CA 1.491 1.611 0 CA-C-O 121.221 0.534 . . . . 0.0 110.26 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 25.2 t30 -91.09 102.43 15.18 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.277 -0.889 . . . . 0.0 110.339 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.493 ' O ' ' N ' ' A' ' 40' ' ' SER . 57.5 m -59.49 -48.62 80.93 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.288 -0.882 . . . . 0.0 110.245 -179.97 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.438 ' C ' ' O ' ' A' ' 37' ' ' CYS . 39.5 t -40.45 -53.6 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.455 -0.778 . . . . 0.0 110.46 -179.862 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 5.1 t -53.16 -28.04 24.23 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.315 -0.866 . . . . 0.0 110.162 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.493 ' N ' ' O ' ' A' ' 37' ' ' CYS . 38.9 m -83.37 -8.0 59.48 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.272 -0.893 . . . . 0.0 110.252 179.957 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 106.03 -23.24 29.64 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.443 -1.463 . . . . 0.0 109.443 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.42 ' HA2' ' HA ' ' A' ' 68' ' ' LYS . . . -71.52 171.99 46.05 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 179.926 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . 0.626 ' OE1' HD21 ' A' ' 45' ' ' LEU . 10.9 tt0 -128.01 133.77 49.18 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.234 -1.156 . . . . 0.0 110.336 -179.975 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . 0.663 ' SG ' ' SG ' ' A' ' 66' ' ' CYS . 4.2 m -91.95 111.95 23.69 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.236 -0.915 . . . . 0.0 110.208 -179.996 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.626 HD21 ' OE1' ' A' ' 43' ' ' GLN . 75.1 mt -107.83 175.09 5.6 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.293 -0.879 . . . . 0.0 110.178 -179.88 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 72.9 m-85 -99.64 -11.24 21.1 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.328 -0.858 . . . . 0.0 110.3 179.985 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 41.2 t -111.98 166.46 11.21 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.213 -0.929 . . . . 0.0 110.229 -179.88 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -43.69 145.23 0.68 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.211 -0.931 . . . . 0.0 110.214 179.946 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 17.2 t -49.04 131.54 15.46 Favored Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.221 -0.924 . . . . 0.0 110.238 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.511 ' HD3' HD12 ' A' ' 45' ' ' LEU . 47.9 Cg_endo -73.23 164.37 35.49 Favored 'Trans proline' 0 C--N 1.306 -1.686 0 O-C-N 123.898 1.472 . . . . 0.0 110.471 -179.904 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 27.4 mt -74.89 -26.24 19.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.193 -0.942 . . . . 0.0 110.159 179.801 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 99.5 m-85 -66.62 -9.39 35.15 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.323 -0.86 . . . . 0.0 110.159 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.501 ' CB ' ' HB3' ' A' ' 67' ' ' CYS . 67.7 p -133.23 158.99 41.5 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.28 -0.887 . . . . 0.0 110.141 179.999 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.477 ' O ' ' HA ' ' A' ' 67' ' ' CYS . 63.1 mttt -100.58 172.42 7.11 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.206 -0.933 . . . . 0.0 110.247 -179.988 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.499 HG23 ' O ' ' A' ' 55' ' ' ILE . 21.0 tt -79.85 131.19 34.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.189 -0.944 . . . . 0.0 110.22 -179.957 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 90.2 mm-40 -119.04 -3.12 10.69 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.347 -0.846 . . . . 0.0 110.228 -179.945 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 131.7 -131.85 6.5 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.418 -1.473 . . . . 0.0 109.418 -179.996 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.45 ' O ' ' SG ' ' A' ' 66' ' ' CYS . 72.7 p -123.4 168.79 12.07 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.291 -1.123 . . . . 0.0 110.263 -179.984 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . 1.298 ' SG ' ' SG ' ' A' ' 66' ' ' CYS . 9.8 m -111.55 -163.31 0.84 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.217 -0.927 . . . . 0.0 110.29 179.924 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.427 ' C ' ' O ' ' A' ' 59' ' ' CYS . 68.9 m-85 -41.9 -46.85 4.15 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.312 -0.868 . . . . 0.0 110.317 179.859 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -124.42 171.62 9.8 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.198 -0.939 . . . . 0.0 110.117 179.898 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -72.5 -23.25 78.24 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.463 -1.455 . . . . 0.0 109.463 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 38.2 ttmt -65.41 -34.55 78.57 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.202 -1.176 . . . . 0.0 110.291 179.951 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -94.73 163.23 13.45 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.3 -0.875 . . . . 0.0 110.162 -179.923 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.447 ' HE3' HG13 ' A' ' 55' ' ' ILE . 50.4 tptt -140.05 135.98 33.18 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.253 -0.905 . . . . 0.0 110.118 -179.957 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' CYS . . . . . 1.298 ' SG ' ' SG ' ' A' ' 59' ' ' CYS . 73.8 m -85.17 136.61 33.46 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.279 -0.888 . . . . 0.0 110.257 179.969 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' CYS . . . . . 0.501 ' HB3' ' CB ' ' A' ' 53' ' ' THR . 76.4 m -141.51 129.78 22.31 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.266 -0.897 . . . . 0.0 110.144 -179.973 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.42 ' HA ' ' HA2' ' A' ' 42' ' ' GLY . 40.4 tttt . . . . . 0 N--CA 1.492 1.65 0 CA-C-O 118.065 -0.969 . . . . 0.0 110.169 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.548 ' CD1' ' SG ' ' A' ' 37' ' ' CYS . 2.3 t80 . . . . . 0 N--CA 1.491 1.615 0 CA-C-O 121.223 0.535 . . . . 0.0 110.17 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . 0.422 ' O ' ' CG ' ' A' ' 36' ' ' ASN . 22.0 p-10 -98.52 64.31 1.53 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.251 -0.906 . . . . 0.0 110.256 -179.918 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.548 ' SG ' ' CD1' ' A' ' 35' ' ' TYR . 34.4 m -62.89 -52.0 64.79 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.221 -0.924 . . . . 0.0 110.174 179.893 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.4 ' HA ' ' O ' ' A' ' 42' ' ' GLY . 68.8 t -54.04 -40.31 45.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.236 -0.915 . . . . 0.0 110.247 179.923 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 33.6 t -60.99 -30.57 70.36 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.146 -0.972 . . . . 0.0 110.255 179.945 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.44 ' O ' ' HE3' ' A' ' 68' ' ' LYS . 72.1 m -82.63 -7.96 59.62 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.358 -0.839 . . . . 0.0 110.165 179.97 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 104.17 5.47 43.5 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.514 ' CA ' ' O ' ' A' ' 67' ' ' CYS . . . -93.56 176.88 37.09 Favored Glycine 0 N--CA 1.489 2.198 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 -179.985 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . 0.504 ' N ' ' O ' ' A' ' 67' ' ' CYS . 16.1 tt0 -132.39 132.87 43.28 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.249 -1.147 . . . . 0.0 110.2 -179.926 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 22.6 m -95.78 116.66 29.22 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.336 -0.853 . . . . 0.0 110.298 179.977 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.696 HD12 ' HD3' ' A' ' 50' ' ' PRO . 92.5 mt -101.76 175.32 5.59 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.296 -0.877 . . . . 0.0 110.161 179.967 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 -91.37 -3.1 57.08 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.241 -0.912 . . . . 0.0 110.227 179.957 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.402 ' O ' ' C ' ' A' ' 48' ' ' ALA . 59.1 p -126.56 167.85 15.08 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.18 -0.95 . . . . 0.0 110.183 -179.976 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.48 ' HA ' ' HG3' ' A' ' 65' ' ' LYS . . . -42.62 148.19 0.24 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.271 -0.893 . . . . 0.0 110.192 179.952 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 17.1 t -52.86 130.37 47.94 Favored Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.24 -0.913 . . . . 0.0 110.077 179.986 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.696 ' HD3' HD12 ' A' ' 45' ' ' LEU . 47.5 Cg_endo -72.67 149.33 48.63 Favored 'Trans proline' 0 C--N 1.306 -1.68 0 O-C-N 123.88 1.463 . . . . 0.0 110.442 -179.924 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 44.9 pt -67.24 -11.26 13.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.26 -0.9 . . . . 0.0 110.128 179.961 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 55.5 m-85 -62.62 -25.56 68.17 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.255 -0.903 . . . . 0.0 110.157 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.484 ' OG1' ' HB3' ' A' ' 67' ' ' CYS . 69.1 p -143.01 158.86 43.2 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.348 -0.845 . . . . 0.0 110.218 -179.99 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.474 ' O ' ' HA ' ' A' ' 67' ' ' CYS . 84.7 mttt -77.52 176.81 8.56 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.21 -0.932 . . . . 0.0 110.161 -179.961 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.432 HG13 ' O ' ' A' ' 66' ' ' CYS . 19.7 tt -108.79 137.63 39.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.188 -0.945 . . . . 0.0 110.225 -179.982 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . 0.459 ' HG3' ' HB2' ' A' ' 68' ' ' LYS . 76.6 mm-40 -98.83 -24.87 14.83 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.282 -0.886 . . . . 0.0 110.181 179.971 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 162.89 -152.39 22.54 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.444 -1.462 . . . . 0.0 109.444 179.997 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.445 ' O ' ' SG ' ' A' ' 66' ' ' CYS . 82.6 p -90.81 161.51 15.24 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.274 -1.133 . . . . 0.0 110.214 -179.921 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . 0.504 ' SG ' ' N ' ' A' ' 66' ' ' CYS . 16.8 m -110.19 -163.03 0.83 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.348 -0.845 . . . . 0.0 110.243 -179.966 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.428 ' C ' ' O ' ' A' ' 59' ' ' CYS . 80.1 m-85 -41.21 -48.38 3.49 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.422 -0.799 . . . . 0.0 110.402 179.92 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 88.8 mtm-85 -129.45 159.28 36.76 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.247 -0.908 . . . . 0.0 110.246 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -60.89 -24.65 62.91 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.436 -1.466 . . . . 0.0 109.436 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 47.4 mtpt -63.64 -32.55 74.07 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.272 -1.134 . . . . 0.0 110.203 179.891 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -96.68 164.41 12.6 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.421 -0.799 . . . . 0.0 110.16 -179.847 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.48 ' HG3' ' HA ' ' A' ' 48' ' ' ALA . 75.6 mmtt -134.54 140.74 46.37 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.244 -0.91 . . . . 0.0 110.169 -179.911 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' CYS . . . . . 0.504 ' N ' ' SG ' ' A' ' 59' ' ' CYS . 89.0 m -88.8 134.04 34.06 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.269 -0.895 . . . . 0.0 110.206 179.96 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' CYS . . . . . 0.514 ' O ' ' CA ' ' A' ' 42' ' ' GLY . 34.6 m -136.26 152.01 50.26 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.208 -0.932 . . . . 0.0 110.201 179.979 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.459 ' HB2' ' HG3' ' A' ' 56' ' ' GLN . 77.5 tttt . . . . . 0 N--CA 1.49 1.549 0 CA-C-O 118.005 -0.998 . . . . 0.0 110.22 -179.97 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.561 ' CD1' ' SG ' ' A' ' 37' ' ' CYS . 3.2 t80 . . . . . 0 N--CA 1.491 1.597 0 CA-C-O 121.26 0.553 . . . . 0.0 110.205 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . 0.553 ' ND2' ' CB ' ' A' ' 39' ' ' SER . 59.3 t30 -85.67 60.54 6.3 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.272 -0.893 . . . . 0.0 110.152 179.952 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.561 ' SG ' ' CD1' ' A' ' 35' ' ' TYR . 25.3 m -67.81 -53.22 28.73 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.307 -0.871 . . . . 0.0 110.24 179.991 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 75.4 t -43.92 -54.89 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.263 -0.898 . . . . 0.0 110.179 179.982 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . 0.553 ' CB ' ' ND2' ' A' ' 36' ' ' ASN . 62.3 m -50.31 -35.19 26.46 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.192 -0.942 . . . . 0.0 110.218 -179.968 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.45 ' HB2' ' O ' ' A' ' 37' ' ' CYS . 72.5 m -70.73 -15.17 62.67 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.285 -0.884 . . . . 0.0 110.145 -179.976 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . 0.413 ' C ' ' HG3' ' A' ' 68' ' ' LYS . . . 108.53 -14.85 35.49 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.475 -1.45 . . . . 0.0 109.475 -179.992 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.473 ' CA ' ' O ' ' A' ' 67' ' ' CYS . . . -85.27 175.34 49.66 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.494 -1.442 . . . . 0.0 109.494 -179.984 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . 0.45 ' N ' ' O ' ' A' ' 67' ' ' CYS . 0.9 OUTLIER -115.14 179.76 3.86 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.2 -1.176 . . . . 0.0 110.164 -179.972 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 49.7 t -114.17 98.17 6.79 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.247 -0.908 . . . . 0.0 110.188 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.459 ' O ' ' HB1' ' A' ' 64' ' ' ALA . 71.4 mt -88.98 173.27 8.57 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.3 -0.875 . . . . 0.0 110.181 179.901 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 83.4 m-85 -109.6 -1.99 17.81 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.24 -0.912 . . . . 0.0 110.314 -179.962 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.414 ' O ' ' C ' ' A' ' 48' ' ' ALA . 74.7 m -125.42 166.17 17.09 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.191 -0.943 . . . . 0.0 110.173 179.925 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.414 ' C ' ' O ' ' A' ' 47' ' ' SER . . . -42.69 131.01 4.06 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.246 -0.909 . . . . 0.0 110.177 -179.91 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . 0.412 ' C ' ' O ' ' A' ' 48' ' ' ALA . 4.4 t -43.39 130.46 3.63 Favored Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 121.223 -0.923 . . . . 0.0 110.219 -179.988 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.491 ' HG2' ' CG2' ' A' ' 53' ' ' THR . 46.4 Cg_endo -72.74 156.57 53.06 Favored 'Trans proline' 0 C--N 1.306 -1.661 0 O-C-N 123.86 1.453 . . . . 0.0 110.446 179.978 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 21.5 mt -67.85 -28.62 42.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.224 -0.923 . . . . 0.0 110.243 -179.93 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 88.8 m-85 -67.69 -11.8 59.09 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.348 -0.845 . . . . 0.0 110.191 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.491 ' CG2' ' HG2' ' A' ' 50' ' ' PRO . 34.0 p -121.79 172.63 8.02 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.256 -0.903 . . . . 0.0 110.1 179.897 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.488 ' O ' ' HA ' ' A' ' 67' ' ' CYS . 80.4 mttt -111.34 127.54 55.68 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.309 -0.869 . . . . 0.0 110.296 -179.986 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 20.6 tt -67.35 138.73 22.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.246 -0.908 . . . . 0.0 110.216 179.956 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . 0.439 ' NE2' ' HB3' ' A' ' 54' ' ' LYS . 48.9 mm-40 -128.62 13.94 6.47 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.264 -0.898 . . . . 0.0 110.217 -179.941 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . 0.4 ' O ' ' HB2' ' A' ' 66' ' ' CYS . . . 119.52 179.81 16.62 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.451 -1.46 . . . . 0.0 109.451 179.956 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 17.0 p -75.79 168.99 19.01 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.307 -1.113 . . . . 0.0 110.266 179.969 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . 0.974 ' HB3' ' HB3' ' A' ' 64' ' ' ALA . 9.7 t -109.29 -65.36 1.15 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.198 -0.938 . . . . 0.0 110.27 179.89 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.536 ' HB3' ' CE ' ' A' ' 63' ' ' LYS . 78.2 m-85 -121.72 92.6 3.77 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.457 -0.777 . . . . 0.0 110.282 179.981 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 36.3 mmt180 51.52 25.39 2.69 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.269 -0.894 . . . . 0.0 110.296 179.994 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 89.97 -11.56 70.29 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.536 ' CE ' ' HB3' ' A' ' 60' ' ' TYR . 50.5 mtmt -58.58 -23.04 57.72 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.259 -1.142 . . . . 0.0 110.095 -179.99 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.974 ' HB3' ' HB3' ' A' ' 59' ' ' CYS . . . -138.37 161.86 35.88 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.261 -0.9 . . . . 0.0 110.148 179.936 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 65.1 mmtt -113.25 122.93 48.94 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.246 -0.909 . . . . 0.0 110.239 179.983 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' CYS . . . . . 0.415 ' HA ' ' O ' ' A' ' 43' ' ' GLN . 99.2 m -79.21 142.73 36.01 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.231 -0.918 . . . . 0.0 110.183 179.998 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' CYS . . . . . 0.488 ' HA ' ' O ' ' A' ' 54' ' ' LYS . 82.3 m -144.47 141.52 29.64 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.253 -0.904 . . . . 0.0 110.241 179.989 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.427 ' HA ' ' HA2' ' A' ' 42' ' ' GLY . 33.9 ttpt . . . . . 0 N--CA 1.491 1.585 0 CA-C-O 118.01 -0.995 . . . . 0.0 110.213 -179.921 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.523 ' CD1' ' SG ' ' A' ' 37' ' ' CYS . 2.4 t80 . . . . . 0 N--CA 1.491 1.612 0 CA-C-O 121.179 0.514 . . . . 0.0 110.254 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . 0.422 ' CG ' ' O ' ' A' ' 36' ' ' ASN . 35.9 p-10 -90.58 68.87 6.69 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.322 -0.861 . . . . 0.0 110.215 179.963 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.523 ' SG ' ' CD1' ' A' ' 35' ' ' TYR . 16.6 m -70.82 -39.88 72.79 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.33 -0.856 . . . . 0.0 110.108 -179.901 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.58 HG23 ' N ' ' A' ' 39' ' ' SER . 27.0 m -57.83 -44.73 86.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.334 -0.854 . . . . 0.0 110.328 179.988 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . 0.58 ' N ' HG23 ' A' ' 38' ' ' VAL . 53.8 p -60.0 -32.52 70.94 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.272 -0.893 . . . . 0.0 110.278 179.958 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.427 ' O ' ' HE3' ' A' ' 68' ' ' LYS . 38.0 m -75.01 -10.3 59.34 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.306 -0.871 . . . . 0.0 110.091 179.996 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 98.63 -10.3 62.67 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.426 -1.47 . . . . 0.0 109.426 -179.889 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.533 ' CA ' ' O ' ' A' ' 67' ' ' CYS . . . -73.04 -171.65 21.13 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.426 -1.47 . . . . 0.0 109.426 -179.985 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . 0.486 ' N ' ' O ' ' A' ' 67' ' ' CYS . 6.4 tt0 -139.99 138.46 35.52 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.268 -1.137 . . . . 0.0 110.163 -179.975 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 12.5 t -95.37 108.3 20.48 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.248 -0.908 . . . . 0.0 110.064 179.894 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.471 HD12 ' HA ' ' A' ' 45' ' ' LEU . 9.5 tp -101.57 157.7 16.62 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.293 -0.879 . . . . 0.0 110.292 -179.937 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -82.64 -25.62 32.95 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.244 -0.91 . . . . 0.0 110.225 -179.954 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.417 ' O ' ' C ' ' A' ' 48' ' ' ALA . 39.1 t -93.13 159.37 15.32 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.234 -0.916 . . . . 0.0 110.194 179.996 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.417 ' C ' ' O ' ' A' ' 47' ' ' SER . . . -42.95 127.5 4.12 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.254 -0.903 . . . . 0.0 110.157 179.974 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . 0.403 ' C ' ' O ' ' A' ' 48' ' ' ALA . 8.3 t -42.76 129.73 3.07 Favored Pre-proline 0 N--CA 1.491 1.621 0 O-C-N 121.304 -0.872 . . . . 0.0 110.154 -179.927 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.486 ' HG2' HG23 ' A' ' 53' ' ' THR . 46.3 Cg_endo -72.65 141.64 34.64 Favored 'Trans proline' 0 C--N 1.305 -1.73 0 O-C-N 123.884 1.465 . . . . 0.0 110.411 -179.943 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 47.2 pt -57.53 -22.98 18.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.316 -0.865 . . . . 0.0 110.058 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 69.1 m-85 -65.13 -11.95 45.66 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.337 -0.852 . . . . 0.0 110.118 179.816 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.517 ' CB ' ' HB3' ' A' ' 67' ' ' CYS . 30.0 p -119.9 170.73 8.99 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.293 -0.879 . . . . 0.0 110.233 -179.919 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.467 ' O ' ' HA ' ' A' ' 67' ' ' CYS . 31.0 mttt -94.66 175.07 6.8 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.248 -0.908 . . . . 0.0 110.097 -179.991 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.718 HG23 ' O ' ' A' ' 55' ' ' ILE . 19.9 tt -106.01 111.41 34.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.203 -0.935 . . . . 0.0 110.245 -179.987 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . 0.552 ' NE2' ' CB ' ' A' ' 68' ' ' LYS . 69.9 mm-40 -90.41 11.38 21.73 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.295 -0.878 . . . . 0.0 110.176 179.878 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 104.12 -127.88 9.28 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.371 -1.491 . . . . 0.0 109.371 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 28.1 p -111.55 171.93 7.19 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.226 -1.161 . . . . 0.0 110.144 -179.992 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . 1.193 ' SG ' ' SG ' ' A' ' 66' ' ' CYS . 0.1 OUTLIER -111.72 -166.73 1.1 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.167 -0.958 . . . . 0.0 110.215 -179.937 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.539 ' CD1' ' N ' ' A' ' 61' ' ' ARG . 7.2 p90 -57.27 -26.13 60.31 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.376 -0.828 . . . . 0.0 110.215 179.853 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . 0.539 ' N ' ' CD1' ' A' ' 60' ' ' TYR . 57.5 mtt85 -139.5 164.88 28.7 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.281 -0.887 . . . . 0.0 110.191 -179.999 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -80.97 -0.28 88.4 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.621 -1.392 . . . . 0.0 109.621 179.939 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 46.1 mtpt -81.56 -25.89 35.46 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.259 -1.142 . . . . 0.0 110.227 179.915 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -123.04 164.96 17.59 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.238 -0.914 . . . . 0.0 110.243 179.987 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 74.3 mmtt -128.28 145.17 51.13 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.244 -0.91 . . . . 0.0 110.196 179.971 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' CYS . . . . . 1.193 ' SG ' ' SG ' ' A' ' 59' ' ' CYS . 93.4 m -81.48 137.6 35.59 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.225 -0.922 . . . . 0.0 110.256 -179.949 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' CYS . . . . . 0.533 ' O ' ' CA ' ' A' ' 42' ' ' GLY . 73.2 m -128.24 172.42 11.05 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.366 -0.834 . . . . 0.0 110.031 179.92 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.552 ' CB ' ' NE2' ' A' ' 56' ' ' GLN . 77.6 tttt . . . . . 0 N--CA 1.491 1.617 0 CA-C-O 118.007 -0.997 . . . . 0.0 110.278 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 43.6 p90 . . . . . 0 N--CA 1.492 1.649 0 CA-C-O 121.256 0.55 . . . . 0.0 110.129 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . 0.442 ' ND2' ' OG ' ' A' ' 39' ' ' SER . 12.7 p-10 -87.68 120.85 29.4 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.276 -0.89 . . . . 0.0 110.211 179.996 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 84.6 m -75.57 0.7 16.48 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.297 -0.877 . . . . 0.0 110.248 -179.973 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 53.6 t -68.67 -34.2 63.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.268 -0.895 . . . . 0.0 110.209 179.919 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . 0.442 ' OG ' ' ND2' ' A' ' 36' ' ' ASN . 65.3 m -71.36 -22.81 61.85 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.254 -0.904 . . . . 0.0 110.128 179.856 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 61.2 m -89.44 -5.43 57.38 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.325 -0.859 . . . . 0.0 110.128 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 101.64 -19.57 49.78 Favored Glycine 0 N--CA 1.489 2.196 0 N-CA-C 109.331 -1.507 . . . . 0.0 109.331 -179.859 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.45 ' HA2' ' HA ' ' A' ' 68' ' ' LYS . . . -73.08 171.35 51.05 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.509 -1.436 . . . . 0.0 109.509 -179.966 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . 0.503 ' O ' ' HA ' ' A' ' 66' ' ' CYS . 15.0 tt0 -130.53 164.04 25.74 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.341 -1.094 . . . . 0.0 110.207 -179.964 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . 0.422 ' N ' ' CG ' ' A' ' 43' ' ' GLN . 5.5 m -114.27 112.81 23.7 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.176 -0.952 . . . . 0.0 110.274 -179.964 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.648 HD12 ' HD3' ' A' ' 50' ' ' PRO . 27.7 mt -95.92 179.55 5.05 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.239 -0.913 . . . . 0.0 110.133 179.946 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 66.4 m-85 -92.59 -27.1 17.56 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.195 -0.94 . . . . 0.0 110.218 -179.97 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.431 ' O ' ' C ' ' A' ' 48' ' ' ALA . 64.2 m -107.55 166.92 10.31 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.344 -0.848 . . . . 0.0 110.084 179.964 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.494 ' HA ' ' HG3' ' A' ' 65' ' ' LYS . . . -43.01 132.55 3.98 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.269 -0.894 . . . . 0.0 110.118 179.942 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . 0.419 ' C ' ' O ' ' A' ' 48' ' ' ALA . 7.7 t -42.75 130.06 3.06 Favored Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 121.23 -0.919 . . . . 0.0 110.181 -179.997 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.648 ' HD3' HD12 ' A' ' 45' ' ' LEU . 45.5 Cg_endo -72.15 147.08 47.59 Favored 'Trans proline' 0 C--N 1.305 -1.73 0 O-C-N 123.909 1.479 . . . . 0.0 110.376 -179.977 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.4 ' H ' HG23 ' A' ' 51' ' ' ILE . 28.5 pt -58.0 -21.99 18.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.234 -0.917 . . . . 0.0 110.135 179.978 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 66.2 m-85 -57.09 -16.51 7.67 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.169 -0.957 . . . . 0.0 110.109 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 71.1 p -142.34 153.66 44.02 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.238 -0.914 . . . . 0.0 110.187 179.97 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.464 ' O ' ' HA ' ' A' ' 67' ' ' CYS . 58.2 tttt -74.16 164.66 26.34 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.199 -0.938 . . . . 0.0 110.193 -180.0 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.661 HG23 ' O ' ' A' ' 55' ' ' ILE . 20.1 tt -109.41 118.18 56.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.209 -0.932 . . . . 0.0 110.17 179.956 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . 0.473 ' NE2' ' HB3' ' A' ' 68' ' ' LYS . 70.4 mm-40 -69.61 -31.15 69.11 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.307 -0.871 . . . . 0.0 110.236 -179.972 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 149.24 -92.69 0.14 Allowed Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.471 -1.452 . . . . 0.0 109.471 179.956 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.401 ' O ' ' SG ' ' A' ' 66' ' ' CYS . 74.6 p -128.67 161.96 28.45 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.275 -1.132 . . . . 0.0 110.235 -179.937 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . 0.494 ' SG ' ' SG ' ' A' ' 66' ' ' CYS . 5.1 m -99.45 -68.86 0.79 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.281 -0.887 . . . . 0.0 110.145 179.883 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.439 ' CD2' ' HB3' ' A' ' 59' ' ' CYS . 89.4 m-85 -141.32 -68.9 0.38 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.345 -0.847 . . . . 0.0 110.178 -179.977 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . 0.419 ' HD2' ' CD ' ' A' ' 63' ' ' LYS . 38.7 ttm-85 -95.38 -37.8 10.79 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.256 -0.902 . . . . 0.0 110.177 -179.965 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 135.42 -15.84 4.14 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 -179.951 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.419 ' CD ' ' HD2' ' A' ' 61' ' ' ARG . 46.7 mtpt -65.55 -31.49 72.58 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.268 -1.137 . . . . 0.0 110.15 -179.979 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.553 ' HB1' ' O ' ' A' ' 45' ' ' LEU . . . -109.83 159.57 17.1 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.353 -0.842 . . . . 0.0 110.146 179.929 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.494 ' HG3' ' HA ' ' A' ' 48' ' ' ALA . 60.7 mmtt -124.02 124.74 43.22 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.211 -0.931 . . . . 0.0 110.269 179.999 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' CYS . . . . . 0.503 ' HA ' ' O ' ' A' ' 43' ' ' GLN . 60.9 m -55.11 155.13 4.92 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.229 -0.919 . . . . 0.0 110.139 179.939 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' CYS . . . . . 0.501 ' N ' ' O ' ' A' ' 43' ' ' GLN . 91.8 m -148.13 114.6 5.95 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.176 -0.952 . . . . 0.0 110.284 179.965 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.473 ' HB3' ' NE2' ' A' ' 56' ' ' GLN . 80.4 tttt . . . . . 0 N--CA 1.491 1.583 0 CA-C-O 118.019 -0.991 . . . . 0.0 110.215 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 62.0 t0 . . . . . 0 N--CA 1.491 1.619 0 CA-C-O 121.218 0.532 . . . . 0.0 110.193 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 42.1 p-80 -130.34 170.29 14.34 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.232 -0.917 . . . . 0.0 110.22 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.423 ' CE2' ' SG ' ' A' ' 37' ' ' CYS . 2.8 t80 -125.24 128.42 48.26 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.221 -0.924 . . . . 0.0 110.22 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 52.5 t30 -107.71 105.26 15.02 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.272 -0.892 . . . . 0.0 110.275 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.423 ' SG ' ' CE2' ' A' ' 35' ' ' TYR . 31.1 m -80.69 2.54 25.5 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.258 -0.901 . . . . 0.0 110.241 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 69.2 t -83.22 -34.9 11.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.227 -0.921 . . . . 0.0 110.248 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 34.1 t -68.0 -29.43 68.44 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.256 -0.902 . . . . 0.0 110.162 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 5.1 m -76.23 -16.83 59.74 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.325 -0.859 . . . . 0.0 110.113 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 111.4 -14.53 27.78 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.421 -1.471 . . . . 0.0 109.421 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.522 ' CA ' ' O ' ' A' ' 67' ' ' CYS . . . -80.88 -177.67 51.73 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.496 -1.442 . . . . 0.0 109.496 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . 0.517 ' N ' ' O ' ' A' ' 67' ' ' CYS . 36.6 tt0 -133.82 160.14 38.51 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.29 -1.124 . . . . 0.0 110.211 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 38.6 t -114.92 107.43 15.38 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.245 -0.909 . . . . 0.0 110.173 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.591 HD12 ' CD ' ' A' ' 50' ' ' PRO . 82.8 mt -89.55 176.36 6.92 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.282 -0.886 . . . . 0.0 110.196 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 71.3 t80 -91.03 -24.03 20.18 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.242 -0.911 . . . . 0.0 110.232 -179.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.416 ' O ' ' C ' ' A' ' 48' ' ' ALA . 89.2 p -105.59 165.72 10.95 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.245 -0.91 . . . . 0.0 110.231 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.416 ' C ' ' O ' ' A' ' 47' ' ' SER . . . -43.01 130.8 4.37 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.207 -0.933 . . . . 0.0 110.202 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . 0.533 ' HB2' ' CG ' ' A' ' 65' ' ' LYS . 12.4 t -43.15 127.88 3.42 Favored Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 121.222 -0.924 . . . . 0.0 110.187 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.591 ' CD ' HD12 ' A' ' 45' ' ' LEU . 46.4 Cg_endo -72.31 147.03 46.58 Favored 'Trans proline' 0 C--N 1.306 -1.665 0 O-C-N 123.898 1.473 . . . . 0.0 110.423 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.416 ' H ' HG23 ' A' ' 51' ' ' ILE . 19.4 pt -58.69 -22.06 20.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.23 -0.919 . . . . 0.0 110.135 -179.918 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 82.5 m-85 -59.68 -14.77 15.35 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.207 -0.933 . . . . 0.0 110.142 179.901 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.529 ' CB ' ' HB3' ' A' ' 67' ' ' CYS . 72.7 p -127.45 172.85 10.31 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.254 -0.904 . . . . 0.0 110.139 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.496 ' O ' ' HA ' ' A' ' 67' ' ' CYS . 44.8 tttt -94.09 165.31 12.69 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.241 -0.912 . . . . 0.0 110.225 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.705 HG23 ' O ' ' A' ' 55' ' ' ILE . 16.6 tt -95.47 116.11 36.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.255 -0.903 . . . . 0.0 110.261 179.907 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . 0.521 ' NE2' ' HB3' ' A' ' 68' ' ' LYS . 64.9 mm-40 -93.77 15.8 15.6 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.263 -0.898 . . . . 0.0 110.2 -179.958 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 112.76 -114.64 3.51 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.489 -1.445 . . . . 0.0 109.489 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 16.9 p -131.4 174.02 10.49 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.26 -1.141 . . . . 0.0 110.181 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . 0.966 ' SG ' ' SG ' ' A' ' 66' ' ' CYS . 0.7 OUTLIER -114.09 -159.52 0.7 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.232 -0.918 . . . . 0.0 110.252 -179.972 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 90.9 m-85 -55.5 -43.77 75.94 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.309 -0.869 . . . . 0.0 110.192 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 80.4 mtm180 -133.43 168.95 17.68 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.242 -0.911 . . . . 0.0 110.202 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -67.7 -23.24 73.93 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 10.2 mmpt? -67.19 -24.84 65.9 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.253 -1.146 . . . . 0.0 110.186 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -112.77 162.82 15.32 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.224 -0.923 . . . . 0.0 110.191 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.533 ' CG ' ' HB2' ' A' ' 49' ' ' CYS . 48.1 tptt -141.77 144.18 33.85 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.276 -0.89 . . . . 0.0 110.226 -179.954 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' CYS . . . . . 0.966 ' SG ' ' SG ' ' A' ' 59' ' ' CYS . 99.7 m -82.96 153.54 24.96 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.192 -0.942 . . . . 0.0 110.155 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' CYS . . . . . 0.529 ' HB3' ' CB ' ' A' ' 53' ' ' THR . 75.1 m -142.51 156.22 45.12 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.258 -0.901 . . . . 0.0 110.205 -179.925 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.521 ' HB3' ' NE2' ' A' ' 56' ' ' GLN . 43.5 tttt . . . . . 0 N--CA 1.491 1.587 0 CA-C-O 117.978 -1.011 . . . . 0.0 110.24 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 50.3 p-10 . . . . . 0 N--CA 1.491 1.597 0 CA-C-O 121.308 0.575 . . . . 0.0 110.179 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 97.3 m-70 -109.62 122.84 48.36 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.207 -0.933 . . . . 0.0 110.225 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.412 ' CD1' ' N ' ' A' ' 36' ' ' ASN . 2.3 t80 -116.52 127.53 54.62 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.262 -0.899 . . . . 0.0 110.129 -179.969 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.44 ' ND2' ' HB3' ' A' ' 39' ' ' SER . 25.5 p-10 -92.22 91.86 7.93 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.3 -0.875 . . . . 0.0 110.164 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 18.8 m -73.54 -22.38 60.11 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.203 -0.936 . . . . 0.0 110.2 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.445 ' HA ' ' O ' ' A' ' 42' ' ' GLY . 70.6 t -63.62 -42.33 95.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.215 -0.928 . . . . 0.0 110.215 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.44 ' HB3' ' ND2' ' A' ' 36' ' ' ASN . 44.8 t -58.76 -26.59 64.15 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.198 -0.939 . . . . 0.0 110.216 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.437 ' O ' ' HE3' ' A' ' 68' ' ' LYS . 63.1 m -82.95 -18.34 40.35 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.267 -0.896 . . . . 0.0 110.203 179.977 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.467 ' O ' ' HG3' ' A' ' 68' ' ' LYS . . . 112.18 11.89 14.92 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.432 -1.467 . . . . 0.0 109.432 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.445 ' O ' ' HA ' ' A' ' 38' ' ' VAL . . . -113.17 178.78 18.83 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . 0.512 ' O ' ' HA ' ' A' ' 66' ' ' CYS . 0.3 OUTLIER -137.1 171.86 13.86 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.261 -1.14 . . . . 0.0 110.202 179.942 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 84.6 m -108.58 104.4 13.72 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.248 -0.908 . . . . 0.0 110.227 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.514 HD12 ' HD3' ' A' ' 50' ' ' PRO . 27.3 mt -85.82 179.61 7.01 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.163 -0.96 . . . . 0.0 110.137 179.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 98.1 m-85 -106.23 -7.91 17.59 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.272 -0.892 . . . . 0.0 110.192 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.414 ' O ' ' C ' ' A' ' 48' ' ' ALA . 84.0 p -121.41 166.92 13.4 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.267 -0.895 . . . . 0.0 110.201 179.959 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.414 ' C ' ' O ' ' A' ' 47' ' ' SER . . . -43.01 131.23 4.3 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.229 -0.92 . . . . 0.0 110.204 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . 0.461 ' HB2' ' HG2' ' A' ' 65' ' ' LYS . 3.9 t -42.76 128.53 3.1 Favored Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 121.284 -0.885 . . . . 0.0 110.226 -179.911 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.514 ' HD3' HD12 ' A' ' 45' ' ' LEU . 45.7 Cg_endo -72.83 150.42 49.63 Favored 'Trans proline' 0 C--N 1.306 -1.679 0 O-C-N 123.89 1.468 . . . . 0.0 110.427 -179.938 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 54.4 mt -63.19 -27.2 42.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.211 -0.93 . . . . 0.0 110.234 -179.931 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 99.4 m-85 -68.94 -9.22 50.86 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.319 -0.863 . . . . 0.0 110.12 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.509 ' CG2' ' HG2' ' A' ' 50' ' ' PRO . 46.2 p -123.79 144.57 49.62 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.208 -0.932 . . . . 0.0 110.171 179.961 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.484 ' O ' ' HA ' ' A' ' 67' ' ' CYS . 40.7 mtmt -81.0 167.9 19.3 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.193 -0.942 . . . . 0.0 110.275 -179.951 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.681 HG23 ' O ' ' A' ' 55' ' ' ILE . 18.8 tt -100.99 117.65 46.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.334 -0.854 . . . . 0.0 110.166 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . 0.503 ' CG ' ' HB2' ' A' ' 68' ' ' LYS . 71.8 mm-40 -96.64 3.11 52.7 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.201 -0.937 . . . . 0.0 110.206 179.966 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 125.52 -119.54 3.57 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.388 -1.485 . . . . 0.0 109.388 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.444 ' O ' ' SG ' ' A' ' 66' ' ' CYS . 24.4 p -133.05 164.24 27.44 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.26 -1.141 . . . . 0.0 110.18 179.938 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 1.8 m -114.13 -88.66 0.55 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.245 -0.91 . . . . 0.0 110.248 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 83.0 m-85 -116.97 98.94 6.75 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.283 -0.886 . . . . 0.0 110.287 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 27.7 mmm180 54.78 -145.69 0.61 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.316 -0.865 . . . . 0.0 110.141 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -102.83 18.33 50.32 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.559 -1.416 . . . . 0.0 109.559 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 48.0 mtpt -85.07 -24.38 28.13 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.277 -1.131 . . . . 0.0 110.194 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -145.34 164.07 32.61 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.308 -0.87 . . . . 0.0 110.261 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.461 ' HG2' ' HB2' ' A' ' 49' ' ' CYS . 54.5 tptt -127.68 132.92 49.61 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.29 -0.881 . . . . 0.0 110.19 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' CYS . . . . . 0.512 ' HA ' ' O ' ' A' ' 43' ' ' GLN . 59.2 m -72.35 132.42 43.95 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.261 -0.9 . . . . 0.0 110.201 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' CYS . . . . . 0.484 ' HA ' ' O ' ' A' ' 54' ' ' LYS . 90.9 m -135.56 144.29 46.14 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.287 -0.883 . . . . 0.0 110.243 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.503 ' HB2' ' CG ' ' A' ' 56' ' ' GLN . 81.5 tttt . . . . . 0 N--CA 1.492 1.644 0 CA-C-O 117.994 -1.003 . . . . 0.0 110.126 -179.923 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . 0.458 ' OD1' ' N ' ' A' ' 34' ' ' HIS . 63.4 t0 . . . . . 0 N--CA 1.491 1.598 0 CA-C-O 121.312 0.577 . . . . 0.0 110.144 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . 0.458 ' N ' ' OD1' ' A' ' 33' ' ' ASP . 98.5 m-70 -120.79 133.65 55.32 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.24 -0.913 . . . . 0.0 110.186 179.936 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 4.2 t80 -74.16 131.92 41.73 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.232 -0.917 . . . . 0.0 110.229 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.538 ' ND2' ' CB ' ' A' ' 39' ' ' SER . 54.0 t30 -74.28 65.9 1.24 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.246 -0.909 . . . . 0.0 110.168 -179.906 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.448 ' O ' ' HB2' ' A' ' 40' ' ' SER . 22.0 m -71.08 -53.66 13.86 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.235 -0.916 . . . . 0.0 110.305 179.97 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.466 ' HA ' ' O ' ' A' ' 42' ' ' GLY . 77.0 t -44.66 -55.09 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.178 -0.951 . . . . 0.0 110.243 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.538 ' CB ' ' ND2' ' A' ' 36' ' ' ASN . 53.4 m -53.62 -31.41 47.11 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.176 -0.952 . . . . 0.0 110.244 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.448 ' HB2' ' O ' ' A' ' 37' ' ' CYS . 50.8 m -71.5 -25.29 62.19 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.249 -0.907 . . . . 0.0 110.155 179.981 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 125.05 -16.76 7.21 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.458 -1.457 . . . . 0.0 109.458 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.475 ' CA ' ' O ' ' A' ' 67' ' ' CYS . . . -87.74 -177.45 48.07 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.485 -1.446 . . . . 0.0 109.485 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . 0.456 ' N ' ' O ' ' A' ' 67' ' ' CYS . 1.3 pt20 -133.66 175.73 9.18 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.313 -1.11 . . . . 0.0 110.31 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 11.1 t -107.21 89.39 2.98 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.215 -0.928 . . . . 0.0 110.18 179.939 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.451 HD12 ' HA ' ' A' ' 45' ' ' LEU . 13.7 tp -78.63 162.1 26.48 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.203 -0.935 . . . . 0.0 110.23 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 65.6 t80 -92.13 -24.6 19.06 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.227 -0.92 . . . . 0.0 110.182 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.423 ' O ' ' C ' ' A' ' 48' ' ' ALA . 44.8 m -95.94 157.85 15.71 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.265 -0.897 . . . . 0.0 110.192 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.425 ' O ' ' C ' ' A' ' 49' ' ' CYS . . . -42.74 133.15 3.6 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.256 -0.902 . . . . 0.0 110.219 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . 0.425 ' C ' ' O ' ' A' ' 48' ' ' ALA . 1.8 t -43.13 127.08 3.41 Favored Pre-proline 0 N--CA 1.491 1.609 0 O-C-N 121.248 -0.907 . . . . 0.0 110.084 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -72.45 159.64 48.68 Favored 'Trans proline' 0 C--N 1.306 -1.675 0 O-C-N 123.854 1.449 . . . . 0.0 110.436 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 7.5 mt -65.61 -25.92 37.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.167 -0.958 . . . . 0.0 110.114 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 94.2 m-85 -65.92 -12.14 52.45 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.305 -0.872 . . . . 0.0 110.117 179.871 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.465 ' OG1' ' HB3' ' A' ' 67' ' ' CYS . 67.3 p -136.09 147.35 47.78 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.272 -0.892 . . . . 0.0 110.165 179.941 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 36.8 tttt -97.41 165.23 12.11 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.211 -0.931 . . . . 0.0 110.228 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.689 HG23 ' O ' ' A' ' 55' ' ' ILE . 15.3 tt -86.94 115.21 27.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.276 -0.89 . . . . 0.0 110.19 -179.941 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . 0.503 ' HG3' ' HB2' ' A' ' 68' ' ' LYS . 54.4 mm-40 -97.14 18.96 13.76 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.239 -0.913 . . . . 0.0 110.224 179.957 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 139.91 -156.68 25.02 Favored Glycine 0 N--CA 1.488 2.144 0 N-CA-C 109.485 -1.446 . . . . 0.0 109.485 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.447 ' O ' ' SG ' ' A' ' 66' ' ' CYS . 24.5 p -109.26 165.04 11.92 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.188 -1.183 . . . . 0.0 110.174 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -107.65 -158.46 0.65 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.258 -0.902 . . . . 0.0 110.291 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 95.2 m-85 -58.58 -55.9 29.12 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.354 -0.841 . . . . 0.0 110.163 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -126.29 172.22 10.29 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.255 -0.903 . . . . 0.0 110.171 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -65.1 -20.25 66.82 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.424 -1.47 . . . . 0.0 109.424 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 48.8 mtmt -65.93 -24.1 66.76 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.231 -1.158 . . . . 0.0 110.215 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.412 ' C ' ' HG2' ' A' ' 65' ' ' LYS . . . -118.28 161.86 19.22 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.232 -0.917 . . . . 0.0 110.166 180.0 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.412 ' HG2' ' C ' ' A' ' 64' ' ' ALA . 73.8 mmtt -146.93 138.54 24.29 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.211 -0.931 . . . . 0.0 110.22 -179.942 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' CYS . . . . . 0.447 ' SG ' ' O ' ' A' ' 58' ' ' THR . 89.4 m -64.03 139.51 58.77 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.275 -0.891 . . . . 0.0 110.085 179.949 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' CYS . . . . . 0.475 ' O ' ' CA ' ' A' ' 42' ' ' GLY . 95.1 m -141.85 136.62 30.76 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.23 -0.919 . . . . 0.0 110.223 179.967 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.503 ' HB2' ' HG3' ' A' ' 56' ' ' GLN . 73.0 tttt . . . . . 0 N--CA 1.492 1.625 0 CA-C-O 118.03 -0.986 . . . . 0.0 110.157 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 82.2 m-20 . . . . . 0 N--CA 1.492 1.653 0 CA-C-O 121.236 0.541 . . . . 0.0 110.152 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 84.5 t60 -66.77 140.09 57.83 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.212 -0.93 . . . . 0.0 110.202 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 12.8 t80 -115.48 143.06 45.86 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.311 -0.868 . . . . 0.0 110.191 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.521 ' ND2' ' HB2' ' A' ' 39' ' ' SER . 0.2 OUTLIER -91.43 67.92 5.71 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.203 -0.936 . . . . 0.0 110.223 179.981 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.409 ' O ' ' HB2' ' A' ' 40' ' ' SER . 55.8 m -64.63 -50.85 65.49 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.265 -0.897 . . . . 0.0 110.169 -179.923 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.432 HG23 ' H ' ' A' ' 38' ' ' VAL . 30.8 t -45.48 -47.32 4.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.137 -0.977 . . . . 0.0 110.193 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.521 ' HB2' ' ND2' ' A' ' 36' ' ' ASN . 32.2 t -59.01 -21.85 59.71 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.273 -0.892 . . . . 0.0 110.265 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.409 ' HB2' ' O ' ' A' ' 37' ' ' CYS . 74.7 m -86.31 -11.88 50.95 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.228 -0.92 . . . . 0.0 110.215 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 103.7 5.08 45.44 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.598 -1.401 . . . . 0.0 109.598 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.419 ' HA2' ' HA ' ' A' ' 68' ' ' LYS . . . -102.58 172.29 21.86 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.501 -1.439 . . . . 0.0 109.501 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . 0.498 ' O ' ' HA ' ' A' ' 66' ' ' CYS . 1.1 pt20 -123.35 175.11 6.91 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.204 -1.174 . . . . 0.0 110.219 179.939 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 22.4 t -107.93 94.16 4.93 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.23 -0.918 . . . . 0.0 110.197 -179.896 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.891 HD12 ' SG ' ' A' ' 67' ' ' CYS . 94.5 mt -73.24 177.9 4.83 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.206 -0.934 . . . . 0.0 110.216 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 80.3 m-85 -104.26 -11.54 17.14 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.267 -0.895 . . . . 0.0 110.278 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.401 ' O ' ' C ' ' A' ' 48' ' ' ALA . 60.1 p -125.74 173.23 9.18 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.307 -0.871 . . . . 0.0 110.258 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.401 ' C ' ' O ' ' A' ' 47' ' ' SER . . . -43.16 128.61 4.6 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.277 -0.89 . . . . 0.0 110.144 179.945 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 4.9 t -46.56 129.32 8.2 Favored Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.287 -0.883 . . . . 0.0 110.142 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.558 ' CD ' ' CD1' ' A' ' 45' ' ' LEU . 46.1 Cg_endo -72.84 149.76 48.38 Favored 'Trans proline' 0 C--N 1.306 -1.679 0 O-C-N 123.853 1.449 . . . . 0.0 110.406 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 46.1 pt -60.21 -24.75 31.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.299 -0.876 . . . . 0.0 110.177 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 58.4 m-85 -60.38 -13.91 15.85 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.156 -0.965 . . . . 0.0 110.202 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.455 ' OG1' ' HB3' ' A' ' 67' ' ' CYS . 77.4 p -135.87 154.72 51.07 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.15 -0.969 . . . . 0.0 110.237 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 95.7 mttt -98.11 152.55 19.22 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.294 -0.879 . . . . 0.0 110.259 179.941 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.59 HG23 ' O ' ' A' ' 55' ' ' ILE . 20.8 tt -89.36 124.39 42.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.329 -0.857 . . . . 0.0 110.244 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 67.1 mm-40 -97.37 -18.21 19.26 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.257 -0.902 . . . . 0.0 110.178 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -177.83 -149.59 8.05 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.453 -1.459 . . . . 0.0 109.453 -179.932 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.442 ' O ' ' SG ' ' A' ' 66' ' ' CYS . 33.2 p -111.32 163.33 14.08 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.288 -1.124 . . . . 0.0 110.131 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . 0.474 ' HB3' ' HB3' ' A' ' 64' ' ' ALA . 0.8 OUTLIER -96.75 -160.73 0.82 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.244 -0.91 . . . . 0.0 110.192 179.973 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 93.4 m-85 -60.8 -42.77 98.24 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.284 -0.885 . . . . 0.0 110.151 179.891 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 90.1 mtt-85 -135.41 170.87 15.27 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.214 -0.929 . . . . 0.0 110.212 -179.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -63.53 -18.9 61.85 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.375 -1.49 . . . . 0.0 109.375 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 12.3 tttt -70.27 -31.54 68.95 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.179 -1.189 . . . . 0.0 110.193 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.474 ' HB3' ' HB3' ' A' ' 59' ' ' CYS . . . -105.19 159.53 15.79 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.302 -0.873 . . . . 0.0 110.123 -179.952 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.408 ' HG2' ' C ' ' A' ' 64' ' ' ALA . 73.9 mmtt -142.9 147.9 36.07 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.246 -0.909 . . . . 0.0 110.18 179.968 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' CYS . . . . . 0.498 ' HA ' ' O ' ' A' ' 43' ' ' GLN . 71.7 m -77.55 148.47 35.2 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.268 -0.895 . . . . 0.0 110.1 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' CYS . . . . . 0.891 ' SG ' HD12 ' A' ' 45' ' ' LEU . 92.6 m -145.7 131.15 18.69 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.13 -0.981 . . . . 0.0 110.256 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.419 ' HA ' ' HA2' ' A' ' 42' ' ' GLY . 82.0 tttt . . . . . 0 N--CA 1.491 1.604 0 CA-C-O 118.096 -0.954 . . . . 0.0 110.27 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 56.1 p-10 . . . . . 0 N--CA 1.492 1.664 0 CA-C-O 121.311 0.577 . . . . 0.0 110.221 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 88.3 m-70 -104.23 128.33 51.95 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.217 -0.927 . . . . 0.0 110.214 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.566 ' CE2' ' SG ' ' A' ' 37' ' ' CYS . 3.3 t80 -114.49 127.4 55.79 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.253 -0.904 . . . . 0.0 110.218 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.52 ' ND2' ' HB3' ' A' ' 39' ' ' SER . 27.2 p-10 -94.22 85.12 4.56 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.266 -0.896 . . . . 0.0 110.234 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.566 ' SG ' ' CE2' ' A' ' 35' ' ' TYR . 87.6 m -65.02 -42.66 94.2 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.271 -0.893 . . . . 0.0 110.284 179.951 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 86.4 t -52.41 -40.86 33.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.301 -0.875 . . . . 0.0 110.196 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.52 ' HB3' ' ND2' ' A' ' 36' ' ' ASN . 24.6 t -62.67 -26.76 68.81 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.269 -0.895 . . . . 0.0 110.251 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.514 ' O ' ' CE ' ' A' ' 68' ' ' LYS . 2.2 t -79.95 -16.65 54.81 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.319 -0.863 . . . . 0.0 110.163 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 116.33 -12.53 16.37 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.468 -1.453 . . . . 0.0 109.468 -179.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.44 ' HA2' ' HA ' ' A' ' 68' ' ' LYS . . . -83.55 -175.36 50.9 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 -179.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . 0.529 ' NE2' HD21 ' A' ' 45' ' ' LEU . 42.5 tt0 -133.73 152.25 51.83 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.25 -1.147 . . . . 0.0 110.206 179.926 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . 0.571 ' O ' HD23 ' A' ' 45' ' ' LEU . 49.2 t -100.1 127.16 46.38 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.265 -0.897 . . . . 0.0 110.219 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.615 ' O ' ' HB1' ' A' ' 64' ' ' ALA . 28.9 mt -121.12 176.57 5.52 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.225 -0.922 . . . . 0.0 110.227 179.938 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 85.1 m-85 -104.19 -0.78 28.07 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.21 -0.931 . . . . 0.0 110.206 180.0 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 85.7 p -116.18 171.95 7.48 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.243 -0.911 . . . . 0.0 110.205 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -46.92 153.33 0.43 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.291 -0.881 . . . . 0.0 110.147 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 42.3 t -55.67 128.38 69.03 Favored Pre-proline 0 N--CA 1.492 1.641 0 O-C-N 121.325 -0.86 . . . . 0.0 110.165 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -72.64 153.69 54.43 Favored 'Trans proline' 0 C--N 1.305 -1.718 0 O-C-N 123.943 1.496 . . . . 0.0 110.485 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 28.1 pt -77.08 -6.45 9.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.26 -0.9 . . . . 0.0 110.105 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 46.6 m-85 -73.0 -22.94 60.59 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.248 -0.908 . . . . 0.0 110.14 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 69.9 p -137.62 161.81 35.47 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.317 -0.865 . . . . 0.0 110.204 179.946 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.497 ' O ' ' N ' ' A' ' 68' ' ' LYS . 64.3 mttt -90.32 169.54 11.01 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.289 -0.882 . . . . 0.0 110.15 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.726 HG23 ' O ' ' A' ' 55' ' ' ILE . 20.6 tt -95.48 111.27 25.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.262 -0.899 . . . . 0.0 110.133 -179.914 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . 0.531 ' CG ' ' HB3' ' A' ' 68' ' ' LYS . 56.6 mm-40 -90.32 -12.85 36.52 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.211 -0.931 . . . . 0.0 110.188 179.962 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . 0.517 ' HA3' ' CE2' ' A' ' 35' ' ' TYR . . . 170.79 -144.77 8.53 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.474 -1.451 . . . . 0.0 109.474 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 16.5 p -115.73 168.37 10.09 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.221 -1.164 . . . . 0.0 110.186 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . 0.47 ' SG ' ' N ' ' A' ' 66' ' ' CYS . 1.1 m -91.19 -161.6 0.83 Allowed 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.296 -0.877 . . . . 0.0 110.212 -179.92 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 94.2 m-85 -57.24 -40.82 78.37 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.31 -0.868 . . . . 0.0 110.317 179.861 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 93.8 mtt180 -132.44 178.26 6.96 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.222 -0.924 . . . . 0.0 110.214 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -76.25 -6.02 82.54 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.589 -1.404 . . . . 0.0 109.589 -179.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 40.6 mtpt -81.59 -23.75 36.9 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.197 -1.178 . . . . 0.0 110.184 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.615 ' HB1' ' O ' ' A' ' 45' ' ' LEU . . . -117.27 162.61 17.61 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.291 -0.88 . . . . 0.0 110.1 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 16.4 tppt? -141.16 123.02 15.37 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.244 -0.91 . . . . 0.0 110.16 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' CYS . . . . . 0.491 ' HA ' ' O ' ' A' ' 43' ' ' GLN . 28.9 p -87.84 151.3 22.96 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.173 -0.954 . . . . 0.0 110.188 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' CYS . . . . . 0.466 ' CA ' ' O ' ' A' ' 54' ' ' LYS . 73.1 m -148.77 143.47 26.4 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.222 -0.924 . . . . 0.0 110.192 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.531 ' HB3' ' CG ' ' A' ' 56' ' ' GLN . 78.3 tttt . . . . . 0 N--CA 1.492 1.633 0 CA-C-O 117.999 -1.0 . . . . 0.0 110.259 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 58.4 p-10 . . . . . 0 N--CA 1.491 1.598 0 CA-C-O 121.291 0.567 . . . . 0.0 110.205 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 93.6 m-70 -125.3 120.92 32.53 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.203 -0.936 . . . . 0.0 110.164 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.562 ' CD1' ' SG ' ' A' ' 37' ' ' CYS . 6.4 t80 -50.14 -37.23 33.36 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.24 -0.912 . . . . 0.0 110.276 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.568 ' ND2' ' CB ' ' A' ' 39' ' ' SER . 49.7 t30 65.95 54.55 1.01 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.277 -0.889 . . . . 0.0 110.168 -179.924 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.562 ' SG ' ' CD1' ' A' ' 35' ' ' TYR . 31.0 m -65.14 -52.95 52.08 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.304 -0.872 . . . . 0.0 110.146 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 38.0 t -47.91 -50.01 10.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.31 -0.869 . . . . 0.0 110.224 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.568 ' CB ' ' ND2' ' A' ' 36' ' ' ASN . 66.0 m -56.68 -32.33 65.33 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.249 -0.907 . . . . 0.0 110.115 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.472 ' O ' ' NZ ' ' A' ' 68' ' ' LYS . 24.0 m -72.87 -11.5 60.62 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.288 -0.883 . . . . 0.0 110.09 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 103.95 -12.35 52.78 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.389 -1.484 . . . . 0.0 109.389 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.476 ' HA3' ' HB2' ' A' ' 68' ' ' LYS . . . -81.52 -175.14 49.98 Favored Glycine 0 N--CA 1.489 2.217 0 N-CA-C 109.469 -1.452 . . . . 0.0 109.469 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . 0.56 ' NE2' HD21 ' A' ' 45' ' ' LEU . 47.7 tt0 -126.44 147.77 49.75 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.304 -1.115 . . . . 0.0 110.221 179.95 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 20.2 t -100.51 109.11 21.2 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.203 -0.936 . . . . 0.0 110.221 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.724 ' O ' ' HB1' ' A' ' 64' ' ' ALA . 59.0 mt -104.67 175.22 5.56 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.184 -0.947 . . . . 0.0 110.155 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 89.4 m-85 -107.84 -8.31 16.03 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.287 -0.883 . . . . 0.0 110.256 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.408 ' O ' ' C ' ' A' ' 48' ' ' ALA . 34.1 t -114.22 164.43 13.9 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.182 -0.949 . . . . 0.0 110.203 -179.984 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.418 ' O ' ' C ' ' A' ' 49' ' ' CYS . . . -42.62 132.45 3.68 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.309 -0.869 . . . . 0.0 110.159 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . 0.45 ' HB2' HD12 ' A' ' 55' ' ' ILE . 4.7 t -43.16 129.83 3.4 Favored Pre-proline 0 N--CA 1.492 1.642 0 O-C-N 121.254 -0.904 . . . . 0.0 110.15 179.997 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -72.99 146.27 41.35 Favored 'Trans proline' 0 C--N 1.305 -1.712 0 O-C-N 123.921 1.485 . . . . 0.0 110.397 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 34.0 pt -59.54 -20.05 17.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.289 -0.882 . . . . 0.0 110.119 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . 0.402 ' C ' HG23 ' A' ' 53' ' ' THR . 67.1 m-85 -61.82 -21.54 64.71 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.318 -0.864 . . . . 0.0 110.273 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.437 ' OG1' ' HB3' ' A' ' 67' ' ' CYS . 68.3 p -144.83 152.83 40.89 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.219 -0.925 . . . . 0.0 110.219 179.895 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.489 ' O ' ' HA ' ' A' ' 67' ' ' CYS . 62.2 mttm -78.01 173.5 12.12 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.32 -0.862 . . . . 0.0 110.174 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.642 HG23 ' O ' ' A' ' 55' ' ' ILE . 20.8 tt -110.78 121.24 63.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.25 -0.906 . . . . 0.0 110.169 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . 0.517 ' NE2' ' HB3' ' A' ' 68' ' ' LYS . 86.4 mm-40 -78.21 -27.02 47.71 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.253 -0.904 . . . . 0.0 110.225 -179.933 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 156.9 -155.96 26.8 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.478 -1.449 . . . . 0.0 109.478 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.421 ' O ' ' SG ' ' A' ' 66' ' ' CYS . 17.1 p -74.63 175.24 8.06 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.286 -1.126 . . . . 0.0 110.245 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . 1.204 ' SG ' ' SG ' ' A' ' 66' ' ' CYS . 0.1 OUTLIER -125.54 142.03 51.72 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.322 -0.861 . . . . 0.0 110.179 179.981 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 83.0 m-85 45.33 -92.53 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.295 -0.878 . . . . 0.0 110.23 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.517 ' N ' ' O ' ' A' ' 59' ' ' CYS . 66.1 mtp180 -118.11 -8.21 10.71 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.194 -0.941 . . . . 0.0 110.151 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 127.3 -14.52 6.51 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.507 -1.437 . . . . 0.0 109.507 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 52.5 mtmt -61.12 -22.18 64.42 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.226 -1.161 . . . . 0.0 110.277 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.724 ' HB1' ' O ' ' A' ' 45' ' ' LEU . . . -127.97 173.83 9.7 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.226 -0.921 . . . . 0.0 110.166 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.463 ' HD3' ' O ' ' A' ' 64' ' ' ALA . 46.2 mmtt -124.16 122.76 38.7 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.248 -0.908 . . . . 0.0 110.215 -179.977 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' CYS . . . . . 1.204 ' SG ' ' SG ' ' A' ' 59' ' ' CYS . 75.9 m -75.09 149.36 39.15 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.271 -0.893 . . . . 0.0 110.135 -179.945 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' CYS . . . . . 0.489 ' HA ' ' O ' ' A' ' 54' ' ' LYS . 89.5 m -146.11 136.36 23.8 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.315 -0.866 . . . . 0.0 110.241 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.517 ' HB3' ' NE2' ' A' ' 56' ' ' GLN . 80.6 tttt . . . . . 0 N--CA 1.493 1.695 0 CA-C-O 118.093 -0.956 . . . . 0.0 110.209 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 73.3 m-20 . . . . . 0 N--CA 1.492 1.637 0 CA-C-O 121.26 0.552 . . . . 0.0 110.195 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 44.0 p-80 -148.6 152.39 36.67 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.229 -0.919 . . . . 0.0 110.247 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.502 ' CD1' ' N ' ' A' ' 36' ' ' ASN . 6.3 t80 -121.45 147.72 45.37 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.281 -0.887 . . . . 0.0 110.119 179.995 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.502 ' N ' ' CD1' ' A' ' 35' ' ' TYR . 28.5 p-10 -84.99 57.43 4.44 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.199 -0.938 . . . . 0.0 110.293 -179.937 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 26.1 m -67.09 -56.26 10.8 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.252 -0.905 . . . . 0.0 110.058 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 60.1 t -53.47 -29.25 16.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.265 -0.897 . . . . 0.0 110.112 179.935 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 39.6 t -70.91 -30.06 66.3 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.298 -0.876 . . . . 0.0 110.121 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.491 ' O ' ' NZ ' ' A' ' 68' ' ' LYS . 0.4 OUTLIER -78.94 -21.48 47.16 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.287 -0.883 . . . . 0.0 110.118 179.969 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 117.29 3.57 16.95 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.611 -1.396 . . . . 0.0 109.611 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.435 ' HA2' ' HA ' ' A' ' 68' ' ' LYS . . . -100.5 172.31 23.89 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 -179.974 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 36.4 tt0 -118.14 153.41 33.84 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.25 -1.147 . . . . 0.0 110.187 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 30.5 t -98.03 97.99 9.38 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.253 -0.904 . . . . 0.0 110.205 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.658 HD12 ' CD ' ' A' ' 50' ' ' PRO . 79.7 mt -82.59 174.34 11.13 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.287 -0.883 . . . . 0.0 110.197 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 98.2 m-85 -107.25 0.66 23.36 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.29 -0.881 . . . . 0.0 110.276 -179.892 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.414 ' O ' ' C ' ' A' ' 48' ' ' ALA . 92.3 p -125.9 172.22 10.08 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.128 -0.982 . . . . 0.0 110.194 179.929 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.414 ' C ' ' O ' ' A' ' 47' ' ' SER . . . -42.93 124.2 3.05 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.316 -0.865 . . . . 0.0 110.169 179.948 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 16.4 t -42.87 130.41 3.13 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.29 -0.881 . . . . 0.0 110.215 -179.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.658 ' CD ' HD12 ' A' ' 45' ' ' LEU . 46.9 Cg_endo -72.72 140.73 32.86 Favored 'Trans proline' 0 C--N 1.306 -1.692 0 O-C-N 123.965 1.508 . . . . 0.0 110.391 -179.955 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 43.8 pt -62.2 -22.17 28.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.285 -0.884 . . . . 0.0 110.213 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 69.0 m-85 -55.92 -17.46 6.59 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.239 -0.913 . . . . 0.0 110.207 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.441 ' OG1' ' HB3' ' A' ' 67' ' ' CYS . 35.4 p -135.93 168.09 19.99 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.257 -0.902 . . . . 0.0 110.176 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.443 ' O ' ' HA ' ' A' ' 67' ' ' CYS . 22.1 mttp -96.12 152.98 18.04 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.274 -0.891 . . . . 0.0 110.241 179.977 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.699 HG23 ' O ' ' A' ' 55' ' ' ILE . 13.0 tt -94.54 113.57 29.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.247 -0.908 . . . . 0.0 110.316 -179.955 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . 0.505 ' NE2' ' HB3' ' A' ' 68' ' ' LYS . 90.4 mm-40 -76.13 -26.48 56.37 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.239 -0.913 . . . . 0.0 110.097 -179.977 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 167.5 -151.85 19.81 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.467 -1.453 . . . . 0.0 109.467 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 16.5 p -94.22 165.48 12.58 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.271 -1.135 . . . . 0.0 110.205 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . 0.97 ' SG ' ' SG ' ' A' ' 66' ' ' CYS . 0.5 OUTLIER -103.28 -158.02 0.64 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.202 -0.936 . . . . 0.0 110.207 -179.952 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 61.8 m-85 -56.64 -54.95 40.18 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.307 -0.871 . . . . 0.0 110.227 179.923 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.519 ' CZ ' ' CD ' ' A' ' 63' ' ' LYS . 52.8 ttt180 -118.12 159.66 22.89 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.272 -0.893 . . . . 0.0 110.255 -179.979 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -63.16 -16.1 57.35 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.385 -1.486 . . . . 0.0 109.385 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.519 ' CD ' ' CZ ' ' A' ' 61' ' ' ARG . 41.9 mtpt -70.2 -27.84 64.81 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.257 -1.143 . . . . 0.0 110.172 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -110.48 166.41 11.01 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.379 -0.826 . . . . 0.0 110.192 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt -141.43 150.38 42.24 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.283 -0.885 . . . . 0.0 110.202 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' CYS . . . . . 0.97 ' SG ' ' SG ' ' A' ' 59' ' ' CYS . 94.7 m -92.46 144.14 25.66 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.282 -0.886 . . . . 0.0 110.185 179.939 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' CYS . . . . . 0.449 ' SG ' ' HD2' ' A' ' 50' ' ' PRO . 65.5 m -144.15 121.39 11.55 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.206 -0.934 . . . . 0.0 110.219 -179.995 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.505 ' HB3' ' NE2' ' A' ' 56' ' ' GLN . 80.4 tttt . . . . . 0 N--CA 1.491 1.606 0 CA-C-O 118.02 -0.99 . . . . 0.0 110.216 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 85.9 m-20 . . . . . 0 N--CA 1.492 1.626 0 CA-C-O 121.168 0.509 . . . . 0.0 110.181 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 48.5 m80 -112.98 115.19 28.0 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.339 -0.85 . . . . 0.0 110.188 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.564 ' CZ ' ' SG ' ' A' ' 37' ' ' CYS . 26.2 p90 -125.38 156.99 37.91 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.23 -0.919 . . . . 0.0 110.112 -179.965 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.439 ' ND2' ' OG ' ' A' ' 39' ' ' SER . 32.1 t30 -85.63 109.92 18.9 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.34 -0.85 . . . . 0.0 110.28 -179.974 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.564 ' SG ' ' CZ ' ' A' ' 35' ' ' TYR . 98.0 m -66.04 -42.74 89.17 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.278 -0.889 . . . . 0.0 110.089 179.919 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 97.5 t -48.18 -42.76 11.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.233 -0.917 . . . . 0.0 110.161 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.439 ' OG ' ' ND2' ' A' ' 36' ' ' ASN . 2.8 m -64.79 -24.97 67.72 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.301 -0.874 . . . . 0.0 110.206 179.959 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 69.2 m -82.61 -9.62 59.31 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.272 -0.892 . . . . 0.0 110.229 179.923 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 107.97 -4.78 34.06 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.496 ' CA ' ' O ' ' A' ' 67' ' ' CYS . . . -90.71 -172.94 44.16 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.507 -1.437 . . . . 0.0 109.507 179.94 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . 0.553 ' NE2' HD21 ' A' ' 45' ' ' LEU . 44.8 tt0 -127.05 168.41 14.62 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.211 -1.17 . . . . 0.0 110.213 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . 0.657 ' O ' HD23 ' A' ' 45' ' ' LEU . 15.7 t -115.82 136.61 52.89 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.193 -0.942 . . . . 0.0 110.242 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.657 HD23 ' O ' ' A' ' 44' ' ' CYS . 81.6 mt -136.9 174.53 10.51 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.195 -0.941 . . . . 0.0 110.218 179.935 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 96.1 m-85 -109.44 0.55 19.39 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.185 -0.947 . . . . 0.0 110.254 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.419 ' O ' ' C ' ' A' ' 48' ' ' ALA . 41.4 m -122.79 164.79 17.72 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.271 -0.893 . . . . 0.0 110.237 180.0 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.419 ' C ' ' O ' ' A' ' 47' ' ' SER . . . -42.82 138.49 1.96 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.272 -0.892 . . . . 0.0 110.254 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . 0.505 ' HB2' HD12 ' A' ' 55' ' ' ILE . 11.6 t -44.5 131.38 4.83 Favored Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 121.201 -0.937 . . . . 0.0 110.182 -179.924 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.401 ' HD2' ' SG ' ' A' ' 67' ' ' CYS . 46.9 Cg_endo -72.71 161.13 44.73 Favored 'Trans proline' 0 C--N 1.306 -1.691 0 O-C-N 123.976 1.514 . . . . 0.0 110.47 179.94 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 47.1 pt -75.89 -10.69 13.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.212 -0.93 . . . . 0.0 110.274 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 77.0 m-85 -70.7 -25.38 62.93 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.21 -0.931 . . . . 0.0 110.212 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 81.3 p -137.55 159.82 40.88 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.261 -0.899 . . . . 0.0 110.304 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.44 ' HB2' ' O ' ' A' ' 68' ' ' LYS . 86.3 mttt -78.96 155.9 28.74 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.256 -0.902 . . . . 0.0 110.254 179.927 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.744 HG23 ' O ' ' A' ' 55' ' ' ILE . 17.3 tt -97.07 102.15 13.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.211 -0.93 . . . . 0.0 110.199 179.992 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . 0.521 ' CG ' ' HB3' ' A' ' 68' ' ' LYS . 64.9 mm-40 -70.4 -27.55 64.39 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.179 -0.951 . . . . 0.0 109.926 179.824 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 156.54 -158.85 29.05 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.401 -1.48 . . . . 0.0 109.401 179.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.651 HG22 ' HE3' ' A' ' 65' ' ' LYS . 19.3 p -81.87 164.84 21.32 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.254 -1.145 . . . . 0.0 110.19 179.947 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . 0.466 ' SG ' ' HB3' ' A' ' 66' ' ' CYS . 0.5 OUTLIER -92.64 -142.41 0.21 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.23 -0.918 . . . . 0.0 110.252 179.972 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 91.9 m-85 -50.52 -46.2 57.17 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.335 -0.853 . . . . 0.0 110.223 179.886 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -132.85 174.15 10.63 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.265 -0.897 . . . . 0.0 110.171 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -69.85 -16.21 72.2 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 48.9 mtpt -67.96 -25.85 65.64 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.234 -1.156 . . . . 0.0 110.257 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -124.63 161.29 26.57 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.301 -0.874 . . . . 0.0 110.212 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.651 ' HE3' HG22 ' A' ' 58' ' ' THR . 40.1 mmtm -133.62 143.26 48.51 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.309 -0.87 . . . . 0.0 110.213 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' CYS . . . . . 0.471 ' HA ' ' O ' ' A' ' 43' ' ' GLN . 19.5 p -109.93 162.78 14.18 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.318 -0.864 . . . . 0.0 110.226 179.97 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' CYS . . . . . 0.496 ' O ' ' CA ' ' A' ' 42' ' ' GLY . 75.7 m -142.41 165.29 27.82 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.302 -0.874 . . . . 0.0 110.264 179.968 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.521 ' HB3' ' CG ' ' A' ' 56' ' ' GLN . 39.6 ttpt . . . . . 0 N--CA 1.491 1.611 0 CA-C-O 117.984 -1.008 . . . . 0.0 110.152 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 44.0 t0 . . . . . 0 N--CA 1.49 1.571 0 CA-C-O 121.302 0.572 . . . . 0.0 110.182 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 91.3 m-70 -110.81 119.51 39.33 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.258 -0.901 . . . . 0.0 110.301 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.485 ' CD1' ' SG ' ' A' ' 37' ' ' CYS . 6.3 t80 -92.31 146.39 23.73 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.273 -0.892 . . . . 0.0 110.149 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.467 ' N ' ' CD1' ' A' ' 35' ' ' TYR . 0.2 OUTLIER -121.73 83.51 2.1 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.281 -0.887 . . . . 0.0 110.293 -179.959 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.485 ' SG ' ' CD1' ' A' ' 35' ' ' TYR . 28.9 m -68.71 -52.89 25.95 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.294 -0.879 . . . . 0.0 110.128 179.954 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 60.7 t -46.02 -48.52 5.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.205 -0.935 . . . . 0.0 110.164 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 58.9 p -58.63 -24.27 60.74 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.192 -0.943 . . . . 0.0 110.207 179.948 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.446 ' HB2' ' O ' ' A' ' 37' ' ' CYS . 66.7 m -82.08 -11.59 58.7 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.252 -0.905 . . . . 0.0 110.127 -179.964 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 106.31 -20.43 35.17 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 -179.921 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.519 ' CA ' ' O ' ' A' ' 67' ' ' CYS . . . -75.17 -177.66 40.64 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.452 -1.459 . . . . 0.0 109.452 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . 0.495 ' N ' ' O ' ' A' ' 67' ' ' CYS . 32.0 tt0 -129.83 160.12 34.46 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.276 -1.131 . . . . 0.0 110.204 -179.98 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . 0.47 ' SG ' ' CE2' ' A' ' 60' ' ' TYR . 13.5 t -114.97 107.63 15.63 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.259 -0.901 . . . . 0.0 110.182 179.972 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.736 HD12 ' HD3' ' A' ' 50' ' ' PRO . 16.7 mt -93.74 169.31 10.41 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.212 -0.93 . . . . 0.0 110.219 -179.931 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -86.53 -22.95 26.05 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.237 -0.915 . . . . 0.0 110.203 -179.907 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.417 ' O ' ' C ' ' A' ' 48' ' ' ALA . 40.2 t -103.51 163.64 12.17 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.284 -0.885 . . . . 0.0 110.251 -179.973 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.417 ' C ' ' O ' ' A' ' 47' ' ' SER . . . -43.45 138.01 2.58 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.231 -0.918 . . . . 0.0 110.194 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . 0.408 ' C ' ' O ' ' A' ' 48' ' ' ALA . 7.7 t -43.72 133.11 3.89 Favored Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.266 -0.896 . . . . 0.0 110.194 -179.958 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.736 ' HD3' HD12 ' A' ' 45' ' ' LEU . 46.4 Cg_endo -72.96 143.97 37.45 Favored 'Trans proline' 0 C--N 1.306 -1.691 0 O-C-N 123.954 1.502 . . . . 0.0 110.413 -179.935 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 40.3 pt -59.84 -24.18 28.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.213 -0.93 . . . . 0.0 110.163 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -55.72 -22.23 22.66 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.261 -0.9 . . . . 0.0 110.252 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.44 ' HB ' ' O ' ' A' ' 68' ' ' LYS . 67.2 p -139.35 153.83 47.76 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.261 -0.899 . . . . 0.0 110.239 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 72.0 mttt -79.6 172.07 14.29 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.262 -0.898 . . . . 0.0 110.166 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.721 HG23 ' O ' ' A' ' 55' ' ' ILE . 11.5 tt -106.9 110.62 32.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.276 -0.89 . . . . 0.0 110.116 179.965 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . 0.533 ' CG ' ' HB2' ' A' ' 68' ' ' LYS . 72.1 mm-40 -62.02 -31.96 72.4 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.276 -0.89 . . . . 0.0 110.137 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 169.18 -144.57 8.77 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.443 -1.463 . . . . 0.0 109.443 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 17.5 p -97.91 164.97 12.15 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.184 -1.186 . . . . 0.0 110.196 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . 1.089 ' SG ' ' SG ' ' A' ' 66' ' ' CYS . 0.5 OUTLIER -106.49 -171.63 1.93 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.225 -0.922 . . . . 0.0 110.293 -179.976 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.527 ' CD1' ' N ' ' A' ' 61' ' ' ARG . 7.9 p90 -50.99 -31.68 18.76 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.309 -0.87 . . . . 0.0 110.263 179.862 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.527 ' N ' ' CD1' ' A' ' 60' ' ' TYR . 91.9 mtt180 -140.89 173.35 11.57 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.308 -0.87 . . . . 0.0 110.258 179.939 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -81.76 -11.08 83.34 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.586 -1.405 . . . . 0.0 109.586 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.409 ' HE2' ' CD ' ' A' ' 61' ' ' ARG . 48.7 mtmt -68.04 -18.84 64.8 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.217 -1.167 . . . . 0.0 110.135 -179.949 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.697 ' HB1' ' O ' ' A' ' 45' ' ' LEU . . . -136.42 158.58 44.08 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.263 -0.898 . . . . 0.0 110.16 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 70.1 mmtt -126.55 140.55 52.36 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.279 -0.888 . . . . 0.0 110.231 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' CYS . . . . . 1.089 ' SG ' ' SG ' ' A' ' 59' ' ' CYS . 84.1 m -74.59 148.88 40.39 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.26 -0.9 . . . . 0.0 110.263 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' CYS . . . . . 0.519 ' O ' ' CA ' ' A' ' 42' ' ' GLY . 82.8 m -142.42 154.84 44.93 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.239 -0.913 . . . . 0.0 110.145 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.533 ' HB2' ' CG ' ' A' ' 56' ' ' GLN . 68.3 tttt . . . . . 0 N--CA 1.492 1.645 0 CA-C-O 118.04 -0.981 . . . . 0.0 110.191 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 81.6 m-20 . . . . . 0 N--CA 1.492 1.655 0 CA-C-O 121.253 0.549 . . . . 0.0 110.196 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . 0.591 ' CE1' ' CD1' ' A' ' 60' ' ' TYR . 64.7 t60 -118.69 129.45 55.29 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.203 -0.936 . . . . 0.0 110.165 179.98 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.566 ' CZ ' ' SG ' ' A' ' 37' ' ' CYS . 30.4 p90 -130.81 173.35 11.03 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.236 -0.915 . . . . 0.0 110.153 -179.965 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.507 ' ND2' ' OG ' ' A' ' 39' ' ' SER . 23.4 p-10 -88.15 100.45 12.97 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.198 -0.939 . . . . 0.0 110.243 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.566 ' SG ' ' CZ ' ' A' ' 35' ' ' TYR . 14.8 m -72.1 -22.2 61.38 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.287 -0.883 . . . . 0.0 110.086 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.585 HG23 ' N ' ' A' ' 39' ' ' SER . 35.8 m -60.98 -45.19 98.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.231 -0.918 . . . . 0.0 110.46 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.585 ' N ' HG23 ' A' ' 38' ' ' VAL . 95.0 p -60.6 -31.61 70.76 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.202 -0.936 . . . . 0.0 110.211 -179.928 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 72.8 m -73.64 -12.43 60.74 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.304 -0.872 . . . . 0.0 110.192 179.89 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 101.83 -11.27 57.59 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.431 -1.468 . . . . 0.0 109.431 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.511 ' CA ' ' O ' ' A' ' 67' ' ' CYS . . . -85.18 172.49 47.44 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.412 -1.475 . . . . 0.0 109.412 -179.912 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . 0.515 ' N ' ' O ' ' A' ' 67' ' ' CYS . 0.4 OUTLIER -123.28 -174.82 3.04 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.27 -1.135 . . . . 0.0 110.151 179.959 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 13.7 t -130.11 116.38 18.41 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.161 -0.962 . . . . 0.0 110.222 -179.947 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.505 HD12 ' HD3' ' A' ' 50' ' ' PRO . 93.5 mt -105.46 175.84 5.36 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.251 -0.905 . . . . 0.0 110.224 179.858 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 98.3 m-85 -102.45 -3.44 26.95 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.278 -0.889 . . . . 0.0 110.291 -179.877 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.407 ' O ' ' C ' ' A' ' 48' ' ' ALA . 69.3 m -122.76 166.49 14.86 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.272 -0.893 . . . . 0.0 110.246 179.967 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.422 ' O ' ' C ' ' A' ' 49' ' ' CYS . . . -42.97 131.64 4.15 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.243 -0.911 . . . . 0.0 110.19 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . 0.422 ' C ' ' O ' ' A' ' 48' ' ' ALA . 5.9 t -42.96 130.02 3.19 Favored Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 121.29 -0.881 . . . . 0.0 110.251 -179.981 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.505 ' HD3' HD12 ' A' ' 45' ' ' LEU . 47.4 Cg_endo -72.81 145.6 41.08 Favored 'Trans proline' 0 C--N 1.306 -1.689 0 O-C-N 123.945 1.497 . . . . 0.0 110.412 -179.993 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 45.1 pt -59.63 -18.48 14.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.254 -0.904 . . . . 0.0 110.192 179.918 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 91.8 m-85 -70.86 -4.49 24.54 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.293 -0.88 . . . . 0.0 110.256 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 69.5 p -137.69 170.76 15.51 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.286 -0.884 . . . . 0.0 110.248 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.477 ' O ' ' HA ' ' A' ' 67' ' ' CYS . 70.9 tttt -91.27 162.79 14.48 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.215 -0.928 . . . . 0.0 110.209 -179.953 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.771 HG23 ' O ' ' A' ' 55' ' ' ILE . 15.1 tt -93.47 100.65 11.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.268 -0.895 . . . . 0.0 110.145 -179.963 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . 0.545 ' HB2' ' CB ' ' A' ' 66' ' ' CYS . 79.2 mm-40 -75.45 0.01 18.53 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.245 -0.909 . . . . 0.0 110.218 179.98 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 111.75 -127.49 8.15 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.497 -1.441 . . . . 0.0 109.497 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.454 ' HA ' ' HD3' ' A' ' 65' ' ' LYS . 71.0 p -105.23 168.62 8.95 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.213 -1.169 . . . . 0.0 110.203 -179.986 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . 0.933 ' SG ' ' SG ' ' A' ' 66' ' ' CYS . 0.1 OUTLIER -117.66 -149.23 0.44 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.222 -0.924 . . . . 0.0 110.179 179.968 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.591 ' CD1' ' CE1' ' A' ' 34' ' ' HIS . 98.0 m-85 -58.34 -46.47 86.18 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.298 -0.876 . . . . 0.0 110.199 179.947 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.466 ' HD2' ' HD3' ' A' ' 63' ' ' LYS . 33.1 ttm180 -129.54 164.76 23.09 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.263 -0.898 . . . . 0.0 110.161 179.989 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.431 ' N ' ' HG2' ' A' ' 61' ' ' ARG . . . -61.3 -23.2 61.95 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.466 ' HD3' ' HD2' ' A' ' 61' ' ' ARG . 44.1 mtpt -72.34 -28.53 63.11 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.21 -1.171 . . . . 0.0 110.228 -179.986 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.419 ' C ' ' HG2' ' A' ' 65' ' ' LYS . . . -107.31 160.44 15.61 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.225 -0.922 . . . . 0.0 110.284 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.511 ' CA ' ' HB2' ' A' ' 59' ' ' CYS . 34.0 mmtm -142.68 144.76 32.87 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.21 -0.931 . . . . 0.0 110.086 179.984 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' CYS . . . . . 0.933 ' SG ' ' SG ' ' A' ' 59' ' ' CYS . 79.9 m -83.56 132.24 34.93 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.173 -0.955 . . . . 0.0 110.163 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' CYS . . . . . 0.515 ' O ' ' N ' ' A' ' 43' ' ' GLN . 85.0 m -126.76 154.19 44.54 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.28 -0.888 . . . . 0.0 110.18 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.514 ' HB3' ' NE2' ' A' ' 56' ' ' GLN . 85.2 tttt . . . . . 0 N--CA 1.491 1.577 0 CA-C-O 117.951 -1.023 . . . . 0.0 110.271 179.999 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 63.5 t0 . . . . . 0 N--CA 1.491 1.618 0 CA-C-O 121.159 0.504 . . . . 0.0 110.246 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 75.5 t60 -124.52 123.54 40.33 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.325 -0.859 . . . . 0.0 110.205 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 3.6 t80 -119.89 128.73 53.92 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.204 -0.935 . . . . 0.0 110.252 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.513 ' ND2' ' OG ' ' A' ' 39' ' ' SER . 64.2 t30 -100.79 117.27 34.54 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.236 -0.915 . . . . 0.0 110.157 179.931 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.45 ' O ' ' N ' ' A' ' 40' ' ' SER . 37.7 m -85.22 -51.07 6.86 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.332 -0.855 . . . . 0.0 110.311 -179.941 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.57 HG23 ' N ' ' A' ' 39' ' ' SER . 21.7 m -41.75 -46.26 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.248 -0.908 . . . . 0.0 110.33 -179.896 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.57 ' N ' HG23 ' A' ' 38' ' ' VAL . 0.8 OUTLIER -59.02 -32.18 69.49 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.177 -0.952 . . . . 0.0 110.14 179.98 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.483 ' O ' ' NZ ' ' A' ' 68' ' ' LYS . 50.2 m -75.43 -9.97 59.04 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.347 -0.846 . . . . 0.0 110.156 -179.991 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.401 ' HA3' ' HE3' ' A' ' 68' ' ' LYS . . . 108.29 -20.54 30.31 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 179.931 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.444 ' O ' ' HA ' ' A' ' 38' ' ' VAL . . . -78.27 177.61 53.39 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.592 -1.403 . . . . 0.0 109.592 179.94 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . 0.517 ' O ' ' HA ' ' A' ' 66' ' ' CYS . 14.4 tt0 -125.38 155.93 39.58 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.206 -1.173 . . . . 0.0 110.192 179.921 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 15.7 t -104.5 104.09 13.88 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.257 -0.902 . . . . 0.0 110.281 -179.96 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.477 HD12 ' CD ' ' A' ' 50' ' ' PRO . 80.3 mt -88.7 174.63 7.91 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.217 -0.927 . . . . 0.0 110.238 179.966 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 88.8 m-85 -96.13 -19.48 19.35 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.21 -0.931 . . . . 0.0 110.185 -179.929 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.419 ' O ' ' C ' ' A' ' 48' ' ' ALA . 69.1 m -110.47 165.66 11.61 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.181 -0.949 . . . . 0.0 110.257 -179.934 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.419 ' C ' ' O ' ' A' ' 47' ' ' SER . . . -42.92 131.95 4.04 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.315 -0.866 . . . . 0.0 110.217 179.978 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 8.7 t -44.68 127.63 5.07 Favored Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.205 -0.934 . . . . 0.0 110.106 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.477 ' CD ' HD12 ' A' ' 45' ' ' LEU . 46.7 Cg_endo -72.4 149.46 50.51 Favored 'Trans proline' 0 C--N 1.306 -1.681 0 O-C-N 123.949 1.499 . . . . 0.0 110.402 -179.999 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.425 HG13 ' N ' ' A' ' 52' ' ' PHE . 27.8 pt -63.6 -22.28 30.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.244 -0.91 . . . . 0.0 110.211 179.933 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . 0.425 ' N ' HG13 ' A' ' 51' ' ' ILE . 91.0 m-85 -56.98 -20.28 22.93 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.215 -0.928 . . . . 0.0 110.211 -179.998 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 17.6 p -133.93 162.85 30.91 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.302 -0.874 . . . . 0.0 110.18 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 55.6 mttm -95.36 143.94 26.32 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.221 -0.924 . . . . 0.0 110.129 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.721 HG23 ' O ' ' A' ' 55' ' ' ILE . 18.2 tt -88.76 113.26 25.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.213 -0.929 . . . . 0.0 110.184 -179.979 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . 0.471 ' NE2' ' HB3' ' A' ' 68' ' ' LYS . 88.2 mm-40 -72.41 -28.06 62.73 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.249 -0.907 . . . . 0.0 110.153 -179.975 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 176.88 -148.92 9.24 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.457 -1.457 . . . . 0.0 109.457 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 43.2 p -99.48 163.57 12.46 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.182 -1.187 . . . . 0.0 110.199 179.93 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . 0.864 ' SG ' ' SG ' ' A' ' 66' ' ' CYS . 0.8 OUTLIER -98.07 -160.41 0.8 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.277 -0.889 . . . . 0.0 110.318 -179.976 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 85.2 m-85 -57.51 -46.91 83.25 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.355 -0.84 . . . . 0.0 110.197 179.874 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 95.3 mtt180 -127.21 167.97 15.35 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.251 -0.906 . . . . 0.0 110.14 -179.978 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -68.52 -12.19 63.52 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.477 -1.449 . . . . 0.0 109.477 -179.947 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 53.9 mtmt -75.84 -23.66 55.74 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.291 -1.123 . . . . 0.0 110.244 179.999 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -113.26 163.09 15.24 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.255 -0.903 . . . . 0.0 110.249 -179.93 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -140.03 141.05 36.31 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.306 -0.871 . . . . 0.0 110.199 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' CYS . . . . . 0.864 ' SG ' ' SG ' ' A' ' 59' ' ' CYS . 58.6 m -84.99 148.05 26.38 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.248 -0.907 . . . . 0.0 110.154 -179.982 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' CYS . . . . . 0.436 ' SG ' ' HD2' ' A' ' 50' ' ' PRO . 80.5 m -143.64 128.08 17.93 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.276 -0.89 . . . . 0.0 110.195 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.483 ' NZ ' ' O ' ' A' ' 40' ' ' SER . 75.2 tttt . . . . . 0 N--CA 1.492 1.636 0 CA-C-O 118.058 -0.972 . . . . 0.0 110.194 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 55.1 t0 . . . . . 0 N--CA 1.492 1.627 0 CA-C-O 121.247 0.546 . . . . 0.0 110.212 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 94.8 m-70 -117.96 134.36 55.03 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.206 -0.934 . . . . 0.0 110.238 -179.902 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 43.2 t80 -129.09 142.39 50.91 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.255 -0.903 . . . . 0.0 110.161 179.905 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 17.4 p-10 -111.1 123.82 50.96 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.291 -0.881 . . . . 0.0 110.235 -179.949 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.65 ' SG ' ' SG ' ' A' ' 59' ' ' CYS . 22.3 m -68.62 -6.86 28.24 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.242 -0.912 . . . . 0.0 110.161 179.856 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 39.8 t -71.7 -41.52 70.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.236 -0.915 . . . . 0.0 110.157 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 3.1 m -51.4 -29.39 15.55 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.269 -0.894 . . . . 0.0 110.054 179.954 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.444 ' CB ' ' HB3' ' A' ' 56' ' ' GLN . 26.6 m -88.89 -17.36 29.76 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.236 -0.915 . . . . 0.0 110.058 179.898 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.473 ' O ' ' HG3' ' A' ' 68' ' ' LYS . . . 108.06 8.75 29.11 Favored Glycine 0 N--CA 1.489 2.197 0 N-CA-C 109.488 -1.445 . . . . 0.0 109.488 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.511 ' CA ' ' O ' ' A' ' 67' ' ' CYS . . . -110.18 173.0 16.11 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.498 -1.441 . . . . 0.0 109.498 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . 0.485 ' N ' ' O ' ' A' ' 67' ' ' CYS . 2.0 pt20 -110.34 174.53 5.82 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.237 -1.155 . . . . 0.0 110.246 179.951 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 8.7 t -110.98 84.38 1.92 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.228 -0.92 . . . . 0.0 110.218 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.494 HD12 ' HA ' ' A' ' 45' ' ' LEU . 14.4 tp -69.26 167.09 17.06 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.357 -0.839 . . . . 0.0 110.191 -180.0 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 60.1 m-85 -91.77 -24.85 19.28 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.293 -0.88 . . . . 0.0 110.314 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.422 ' O ' ' C ' ' A' ' 48' ' ' ALA . 73.7 m -106.81 167.44 9.87 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.2 -0.937 . . . . 0.0 110.261 -179.928 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.422 ' C ' ' O ' ' A' ' 47' ' ' SER . . . -43.02 128.02 4.29 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.188 -0.945 . . . . 0.0 110.163 -179.965 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 8.2 t -46.12 130.4 7.39 Favored Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.277 -0.889 . . . . 0.0 110.3 -179.865 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.469 ' HD2' ' SG ' ' A' ' 67' ' ' CYS . 46.3 Cg_endo -72.74 151.1 51.3 Favored 'Trans proline' 0 C--N 1.307 -1.62 0 O-C-N 123.882 1.464 . . . . 0.0 110.302 179.843 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 37.0 pt -64.03 -21.23 28.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.196 -0.94 . . . . 0.0 110.305 179.982 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 82.1 m-85 -61.45 -19.9 62.51 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.206 -0.934 . . . . 0.0 110.174 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 38.8 p -118.57 168.64 10.5 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.25 -0.906 . . . . 0.0 110.192 -179.953 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.472 ' O ' ' HA ' ' A' ' 67' ' ' CYS . 30.1 tttt -96.83 162.38 13.44 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.223 -0.923 . . . . 0.0 110.142 179.983 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.686 HG23 ' O ' ' A' ' 55' ' ' ILE . 20.8 tt -97.6 116.43 40.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.247 -0.908 . . . . 0.0 110.171 179.961 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . 0.49 ' HB2' ' HB3' ' A' ' 66' ' ' CYS . 61.6 mm-40 -93.36 -1.46 55.87 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.244 -0.91 . . . . 0.0 110.177 -179.919 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 142.47 -131.61 4.75 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.423 -1.471 . . . . 0.0 109.423 -179.935 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.447 ' O ' ' SG ' ' A' ' 66' ' ' CYS . 18.5 p -120.88 164.91 15.95 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.227 -1.16 . . . . 0.0 110.189 179.988 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . 0.65 ' SG ' ' SG ' ' A' ' 37' ' ' CYS . 0.5 OUTLIER -105.86 -158.78 0.67 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.242 -0.911 . . . . 0.0 110.276 -179.902 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 99.6 m-85 -57.36 -50.6 72.43 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.257 -0.902 . . . . 0.0 110.133 179.922 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 74.2 mtm180 -123.55 165.25 17.46 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.284 -0.885 . . . . 0.0 110.128 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -61.51 -21.35 60.14 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.48 -1.448 . . . . 0.0 109.48 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 2.8 tptt -67.63 -31.35 71.31 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.26 -1.141 . . . . 0.0 110.215 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -102.6 158.56 16.14 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.384 -0.823 . . . . 0.0 110.145 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 70.3 mmtt -141.85 160.29 40.5 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.304 -0.872 . . . . 0.0 110.132 -179.954 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' CYS . . . . . 0.49 ' HB3' ' HB2' ' A' ' 56' ' ' GLN . 66.6 m -82.1 132.07 35.24 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.206 -0.934 . . . . 0.0 110.212 -179.983 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' CYS . . . . . 0.511 ' O ' ' CA ' ' A' ' 42' ' ' GLY . 78.6 m -129.32 124.35 34.11 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.251 -0.906 . . . . 0.0 110.151 -179.951 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.473 ' HG3' ' O ' ' A' ' 41' ' ' GLY . 47.2 tttt . . . . . 0 N--CA 1.491 1.614 0 CA-C-O 117.94 -1.029 . . . . 0.0 110.251 179.96 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 80.7 m-20 . . . . . 0 N--CA 1.491 1.616 0 CA-C-O 121.239 0.542 . . . . 0.0 110.21 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 69.6 t60 -98.87 109.43 22.19 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.179 -0.95 . . . . 0.0 110.173 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.456 ' CD1' ' N ' ' A' ' 36' ' ' ASN . 11.2 t80 -108.35 154.3 22.02 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.203 -0.935 . . . . 0.0 110.181 179.945 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.456 ' N ' ' CD1' ' A' ' 35' ' ' TYR . 28.2 p-10 -98.33 55.56 1.12 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.261 -0.899 . . . . 0.0 110.299 179.981 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.429 ' SG ' ' CD1' ' A' ' 35' ' ' TYR . 60.3 m -61.31 -22.51 64.95 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.24 -0.912 . . . . 0.0 110.171 -179.999 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 72.2 t -68.83 -39.94 80.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.22 -0.925 . . . . 0.0 110.211 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.45 ' OG ' ' ND2' ' A' ' 36' ' ' ASN . 87.4 p -64.13 -26.5 68.56 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.203 -0.935 . . . . 0.0 110.104 179.986 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 50.0 m -81.06 -20.56 41.34 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.237 -0.915 . . . . 0.0 110.198 179.973 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.473 ' O ' ' HG3' ' A' ' 68' ' ' LYS . . . 112.14 14.89 10.36 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.511 -1.436 . . . . 0.0 109.511 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.435 ' HA2' ' HA ' ' A' ' 68' ' ' LYS . . . -110.3 171.82 15.09 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.504 -1.439 . . . . 0.0 109.504 179.962 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . 0.489 ' N ' ' O ' ' A' ' 67' ' ' CYS . 0.3 OUTLIER -129.24 175.16 8.95 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.25 -1.147 . . . . 0.0 110.301 -179.993 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 6.1 m -110.77 97.01 6.53 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.283 -0.886 . . . . 0.0 110.132 179.885 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.516 ' O ' ' HB1' ' A' ' 64' ' ' ALA . 23.0 tp -86.39 167.22 14.93 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.259 -0.901 . . . . 0.0 110.146 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 95.2 m-85 -92.13 -31.05 15.65 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.219 -0.926 . . . . 0.0 110.345 -179.916 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.422 ' O ' ' C ' ' A' ' 48' ' ' ALA . 76.8 p -92.02 160.61 15.15 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.386 -0.821 . . . . 0.0 110.231 -179.948 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.422 ' C ' ' O ' ' A' ' 47' ' ' SER . . . -42.7 129.28 4.18 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.33 -0.856 . . . . 0.0 110.194 179.937 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 4.1 t -43.15 128.44 3.42 Favored Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.182 -0.949 . . . . 0.0 110.203 -179.853 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.429 ' HD2' ' SG ' ' A' ' 67' ' ' CYS . 46.7 Cg_endo -72.34 146.07 44.46 Favored 'Trans proline' 0 C--N 1.305 -1.713 0 O-C-N 123.95 1.5 . . . . 0.0 110.452 -179.94 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 39.1 pt -60.39 -15.57 10.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.28 -0.887 . . . . 0.0 110.206 -179.951 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 76.1 m-85 -71.63 -10.26 59.5 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.26 -0.9 . . . . 0.0 110.208 179.924 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.463 ' HB ' ' N ' ' A' ' 68' ' ' LYS . 61.5 p -127.78 167.0 17.13 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.237 -0.914 . . . . 0.0 110.189 -179.995 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.466 ' O ' ' HA ' ' A' ' 67' ' ' CYS . 38.1 mttt -103.51 173.05 6.47 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.246 -0.909 . . . . 0.0 110.214 -179.98 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.672 HG23 ' O ' ' A' ' 55' ' ' ILE . 10.8 tp -99.65 119.33 47.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.357 -0.839 . . . . 0.0 110.209 179.961 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 68.2 mm-40 -102.03 9.23 40.56 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.269 -0.894 . . . . 0.0 110.264 -179.928 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 129.17 -159.89 22.42 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.448 -1.461 . . . . 0.0 109.448 179.919 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.456 ' O ' ' SG ' ' A' ' 66' ' ' CYS . 19.1 p -92.48 164.28 13.52 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.217 -1.166 . . . . 0.0 110.214 -179.93 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 1.5 m -110.54 -163.14 0.83 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.227 -0.921 . . . . 0.0 110.147 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 67.0 m-85 -49.64 -59.95 3.32 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.391 -0.818 . . . . 0.0 110.151 179.761 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 30.0 mmt180 -120.22 166.3 13.65 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.169 -0.957 . . . . 0.0 110.103 -180.0 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -65.39 -23.63 70.28 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 52.4 mtmt -60.19 -25.42 65.56 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.209 -1.171 . . . . 0.0 110.164 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.516 ' HB1' ' O ' ' A' ' 45' ' ' LEU . . . -117.32 160.96 20.29 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.242 -0.911 . . . . 0.0 110.17 -179.868 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.406 ' HG2' ' C ' ' A' ' 64' ' ' ALA . 28.9 mmtp -137.94 154.64 49.38 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.23 -0.918 . . . . 0.0 110.307 179.946 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' CYS . . . . . 0.456 ' SG ' ' O ' ' A' ' 58' ' ' THR . 71.7 m -72.27 131.42 42.68 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.292 -0.88 . . . . 0.0 110.169 179.911 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' CYS . . . . . 0.489 ' O ' ' N ' ' A' ' 43' ' ' GLN . 94.7 m -129.8 131.24 46.12 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.228 -0.92 . . . . 0.0 110.247 -179.905 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.473 ' HG3' ' O ' ' A' ' 41' ' ' GLY . 84.4 tttt . . . . . 0 N--CA 1.49 1.547 0 CA-C-O 117.995 -1.002 . . . . 0.0 110.182 -179.951 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 72.2 m-20 . . . . . 0 N--CA 1.491 1.621 0 CA-C-O 121.3 0.571 . . . . 0.0 110.221 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 69.1 m80 -69.21 149.76 48.21 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.223 -0.923 . . . . 0.0 110.205 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.568 ' CZ ' ' SG ' ' A' ' 37' ' ' CYS . 1.8 t80 -126.77 122.25 34.27 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.264 -0.898 . . . . 0.0 110.144 179.927 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 9.9 p-10 -121.7 114.66 21.44 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.225 -0.922 . . . . 0.0 110.213 -179.971 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.568 ' SG ' ' CZ ' ' A' ' 35' ' ' TYR . 46.7 m -74.26 -0.35 16.7 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.258 -0.901 . . . . 0.0 110.278 179.982 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 94.7 t -67.3 -33.95 65.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.208 -0.933 . . . . 0.0 110.116 -179.97 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 69.3 m -71.18 -27.81 63.79 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.24 -0.913 . . . . 0.0 110.149 179.912 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 63.7 m -82.42 -9.22 59.53 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.331 -0.855 . . . . 0.0 110.119 179.922 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.428 ' C ' ' HG3' ' A' ' 68' ' ' LYS . . . 105.33 -24.61 27.17 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.341 -1.504 . . . . 0.0 109.341 -179.965 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.463 ' N ' ' HG3' ' A' ' 68' ' ' LYS . . . -67.74 -173.57 7.08 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.444 -1.462 . . . . 0.0 109.444 -179.979 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . 0.51 ' O ' ' HA ' ' A' ' 66' ' ' CYS . 36.1 tt0 -141.34 144.36 34.53 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.272 -1.134 . . . . 0.0 110.26 -179.941 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . 0.416 ' O ' HD23 ' A' ' 45' ' ' LEU . 76.4 m -94.96 137.11 34.46 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.268 -0.895 . . . . 0.0 110.144 179.998 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.678 ' O ' ' HB1' ' A' ' 64' ' ' ALA . 54.0 mt -130.01 178.8 6.27 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.276 -0.89 . . . . 0.0 110.239 -179.982 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 85.9 m-85 -109.46 -1.04 18.61 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.259 -0.901 . . . . 0.0 110.178 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.423 ' O ' ' C ' ' A' ' 48' ' ' ALA . 52.3 m -127.9 171.59 11.65 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.27 -0.894 . . . . 0.0 110.25 -179.984 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.423 ' C ' ' O ' ' A' ' 47' ' ' SER . . . -43.08 145.12 0.54 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.221 -0.924 . . . . 0.0 110.189 179.968 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 16.9 t -55.77 130.28 71.9 Favored Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 121.228 -0.92 . . . . 0.0 110.165 -179.974 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.47 ' HD2' ' SG ' ' A' ' 67' ' ' CYS . 47.5 Cg_endo -73.14 142.32 34.0 Favored 'Trans proline' 0 C--N 1.306 -1.685 0 O-C-N 123.991 1.521 . . . . 0.0 110.402 179.98 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 39.0 pt -63.68 -18.78 22.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.315 -0.866 . . . . 0.0 110.181 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 85.0 m-85 -59.45 -21.55 60.21 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.237 -0.914 . . . . 0.0 110.216 179.944 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.481 ' OG1' ' HB3' ' A' ' 67' ' ' CYS . 20.4 p -132.78 171.15 14.27 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.26 -0.9 . . . . 0.0 110.297 179.869 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.494 ' O ' ' HA ' ' A' ' 67' ' ' CYS . 45.5 tttp -83.68 165.04 19.27 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.24 -0.912 . . . . 0.0 110.21 179.943 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.737 HG23 ' O ' ' A' ' 55' ' ' ILE . 12.0 tt -91.28 108.67 20.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.268 -0.895 . . . . 0.0 110.162 179.895 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . 0.493 ' HB2' ' HB3' ' A' ' 66' ' ' CYS . 94.0 mm-40 -85.31 -8.84 58.29 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.251 -0.906 . . . . 0.0 110.256 179.937 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 125.43 -124.44 5.28 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 179.941 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.457 ' HB ' ' HA2' ' A' ' 62' ' ' GLY . 16.6 p -117.98 169.49 9.61 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.31 -1.112 . . . . 0.0 110.157 -179.935 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . 0.646 ' HB3' ' HB3' ' A' ' 64' ' ' ALA . 0.9 OUTLIER -133.61 140.73 47.3 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.211 -0.931 . . . . 0.0 110.202 179.959 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.507 ' CB ' ' HB3' ' A' ' 63' ' ' LYS . 71.2 m-85 56.07 53.93 8.51 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.293 -0.879 . . . . 0.0 110.414 179.9 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.451 ' HB2' ' O ' ' A' ' 60' ' ' TYR . 38.6 mmt180 57.38 39.95 27.87 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.25 -0.906 . . . . 0.0 110.609 179.696 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.457 ' HA2' ' HB ' ' A' ' 58' ' ' THR . . . 85.86 -16.45 41.78 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.779 -1.328 . . . . 0.0 109.779 179.603 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.507 ' HB3' ' CB ' ' A' ' 60' ' ' TYR . 5.7 ttpt -55.44 -18.43 6.95 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.103 -1.234 . . . . 0.0 109.767 179.951 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.678 ' HB1' ' O ' ' A' ' 45' ' ' LEU . . . -149.56 172.09 15.57 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.405 -0.81 . . . . 0.0 109.961 179.757 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.405 ' HD2' ' HA ' ' A' ' 65' ' ' LYS . 53.2 tptt -111.15 122.33 47.6 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.147 -0.971 . . . . 0.0 110.275 -179.903 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' CYS . . . . . 0.51 ' HA ' ' O ' ' A' ' 43' ' ' GLN . 42.9 m -81.27 140.98 34.53 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.297 -0.877 . . . . 0.0 110.134 179.977 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' CYS . . . . . 0.494 ' HA ' ' O ' ' A' ' 54' ' ' LYS . 85.0 m -149.53 124.61 10.05 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.198 -0.939 . . . . 0.0 110.222 -179.969 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.481 ' HB3' ' NE2' ' A' ' 56' ' ' GLN . 33.4 ttmt . . . . . 0 N--CA 1.491 1.618 0 CA-C-O 117.942 -1.028 . . . . 0.0 110.194 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 46.5 m-20 . . . . . 0 N--CA 1.491 1.602 0 CA-C-O 121.234 0.54 . . . . 0.0 110.236 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 91.8 m-70 -111.3 143.16 42.53 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.248 -0.907 . . . . 0.0 110.186 -179.965 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 2.4 t80 -128.01 123.02 33.69 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.245 -0.909 . . . . 0.0 110.141 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 36.3 t30 -101.13 108.97 20.79 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.211 -0.931 . . . . 0.0 110.237 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 27.4 m -82.02 -3.78 55.29 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.183 -0.948 . . . . 0.0 110.191 179.948 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 91.9 t -70.18 -45.95 73.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.235 -0.915 . . . . 0.0 110.213 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 22.9 t -60.51 -26.39 66.81 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.258 -0.901 . . . . 0.0 110.175 179.996 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 42.5 m -83.59 -8.35 59.33 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.309 -0.869 . . . . 0.0 110.243 179.935 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.435 ' C ' ' HG3' ' A' ' 68' ' ' LYS . . . 91.91 3.58 68.02 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.598 -1.401 . . . . 0.0 109.598 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -90.55 172.67 37.83 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . 0.514 ' O ' ' HA ' ' A' ' 66' ' ' CYS . 32.6 tt0 -127.58 137.2 52.52 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.345 -1.091 . . . . 0.0 110.217 -179.967 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . 0.57 ' SG ' ' HB3' ' A' ' 64' ' ' ALA . 24.7 t -83.68 113.17 20.67 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.234 -0.916 . . . . 0.0 110.242 179.934 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.659 HD12 ' SG ' ' A' ' 67' ' ' CYS . 47.3 mt -106.05 168.94 8.79 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.186 -0.946 . . . . 0.0 110.269 -179.936 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 91.1 m-85 -104.23 -1.47 27.07 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.286 -0.883 . . . . 0.0 110.231 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.417 ' O ' ' C ' ' A' ' 48' ' ' ALA . 89.5 p -126.99 168.36 14.65 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.211 -0.93 . . . . 0.0 110.257 -179.972 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.417 ' C ' ' O ' ' A' ' 47' ' ' SER . . . -42.86 128.66 4.27 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.251 -0.905 . . . . 0.0 110.136 179.991 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 6.0 t -44.44 132.09 4.72 Favored Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 121.238 -0.914 . . . . 0.0 110.174 179.904 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.443 ' HG2' ' OG1' ' A' ' 53' ' ' THR . 46.9 Cg_endo -73.19 148.58 44.42 Favored 'Trans proline' 0 C--N 1.306 -1.674 0 O-C-N 123.867 1.456 . . . . 0.0 110.406 -179.982 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 13.1 mt -62.96 -22.24 30.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.284 -0.885 . . . . 0.0 110.152 179.966 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -71.02 -3.94 22.27 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.313 -0.867 . . . . 0.0 110.218 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.504 ' CB ' ' HB3' ' A' ' 67' ' ' CYS . 54.6 p -133.27 162.55 31.5 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.241 -0.912 . . . . 0.0 110.276 179.978 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.484 ' O ' ' HA ' ' A' ' 67' ' ' CYS . 46.8 tttp -93.18 168.36 11.15 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.287 -0.883 . . . . 0.0 110.234 179.978 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.582 HG23 ' O ' ' A' ' 55' ' ' ILE . 18.5 tt -87.78 125.11 41.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.237 -0.914 . . . . 0.0 110.207 179.962 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . 0.523 ' HB2' ' CB ' ' A' ' 66' ' ' CYS . 86.3 mm-40 -107.49 7.96 29.15 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.193 -0.942 . . . . 0.0 110.201 179.99 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 102.31 -140.1 14.71 Favored Glycine 0 N--CA 1.489 2.176 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 179.975 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.446 ' O ' ' SG ' ' A' ' 66' ' ' CYS . 38.7 p -98.75 -174.11 2.7 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.23 -1.159 . . . . 0.0 110.182 179.987 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . 0.773 ' SG ' ' SG ' ' A' ' 66' ' ' CYS . 1.2 m -112.48 -161.24 0.75 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.251 -0.905 . . . . 0.0 110.27 -179.957 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 74.4 m-85 -49.83 -65.62 0.53 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.238 -0.914 . . . . 0.0 110.411 179.952 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.403 ' CD ' ' HE2' ' A' ' 63' ' ' LYS . 56.7 mtt180 -93.29 -14.49 26.9 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.241 -0.912 . . . . 0.0 110.446 -179.834 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 101.65 -21.02 44.04 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.366 -1.494 . . . . 0.0 109.366 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.403 ' HE2' ' CD ' ' A' ' 61' ' ' ARG . 37.0 mtmt -57.44 -30.2 64.8 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.278 -1.131 . . . . 0.0 109.98 179.77 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.57 ' HB3' ' SG ' ' A' ' 44' ' ' CYS . . . -106.54 159.41 16.2 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.498 -0.751 . . . . 0.0 110.268 -179.82 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.41 ' HD2' ' HA ' ' A' ' 65' ' ' LYS . 49.5 tptt -112.49 120.53 41.96 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.185 -0.947 . . . . 0.0 110.208 -179.902 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' CYS . . . . . 0.773 ' SG ' ' SG ' ' A' ' 59' ' ' CYS . 79.4 m -68.95 151.46 46.51 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.308 -0.87 . . . . 0.0 110.127 179.958 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' CYS . . . . . 0.659 ' SG ' HD12 ' A' ' 45' ' ' LEU . 90.4 m -149.0 125.32 10.86 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.146 -0.971 . . . . 0.0 110.219 179.994 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.509 ' HB3' ' NE2' ' A' ' 56' ' ' GLN . 26.9 tttp . . . . . 0 N--CA 1.491 1.613 0 CA-C-O 118.013 -0.994 . . . . 0.0 110.212 179.952 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 95.4 m-20 . . . . . 0 N--CA 1.491 1.607 0 CA-C-O 121.21 0.529 . . . . 0.0 110.222 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 64.6 m170 -113.99 131.6 56.28 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.259 -0.9 . . . . 0.0 110.104 179.966 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.473 ' CZ ' ' SG ' ' A' ' 37' ' ' CYS . 27.6 p90 -139.55 165.36 27.45 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.308 -0.87 . . . . 0.0 110.26 -179.959 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 25.2 t30 -91.09 102.43 15.18 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.277 -0.889 . . . . 0.0 110.339 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.493 ' O ' ' N ' ' A' ' 40' ' ' SER . 57.5 m -59.49 -48.62 80.93 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.288 -0.882 . . . . 0.0 110.245 -179.97 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.438 ' C ' ' O ' ' A' ' 37' ' ' CYS . 39.5 t -40.45 -53.6 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.455 -0.778 . . . . 0.0 110.46 -179.862 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 5.1 t -53.16 -28.04 24.23 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.315 -0.866 . . . . 0.0 110.162 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.493 ' N ' ' O ' ' A' ' 37' ' ' CYS . 38.9 m -83.37 -8.0 59.48 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.272 -0.893 . . . . 0.0 110.252 179.957 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 106.03 -23.24 29.64 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.443 -1.463 . . . . 0.0 109.443 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.42 ' HA2' ' HA ' ' A' ' 68' ' ' LYS . . . -71.52 171.99 46.05 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 179.926 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . 0.626 ' OE1' HD21 ' A' ' 45' ' ' LEU . 10.9 tt0 -128.01 133.77 49.18 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.234 -1.156 . . . . 0.0 110.336 -179.975 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . 0.663 ' SG ' ' SG ' ' A' ' 66' ' ' CYS . 4.2 m -91.95 111.95 23.69 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.236 -0.915 . . . . 0.0 110.208 -179.996 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.626 HD21 ' OE1' ' A' ' 43' ' ' GLN . 75.1 mt -107.83 175.09 5.6 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.293 -0.879 . . . . 0.0 110.178 -179.88 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 72.9 m-85 -99.64 -11.24 21.1 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.328 -0.858 . . . . 0.0 110.3 179.985 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 41.2 t -111.98 166.46 11.21 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.213 -0.929 . . . . 0.0 110.229 -179.88 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -43.69 145.23 0.68 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.211 -0.931 . . . . 0.0 110.214 179.946 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 17.2 t -49.04 131.54 15.46 Favored Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.221 -0.924 . . . . 0.0 110.238 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.511 ' HD3' HD12 ' A' ' 45' ' ' LEU . 47.9 Cg_endo -73.23 164.37 35.49 Favored 'Trans proline' 0 C--N 1.306 -1.686 0 O-C-N 123.898 1.472 . . . . 0.0 110.471 -179.904 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 27.4 mt -74.89 -26.24 19.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.193 -0.942 . . . . 0.0 110.159 179.801 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 99.5 m-85 -66.62 -9.39 35.15 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.323 -0.86 . . . . 0.0 110.159 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.501 ' CB ' ' HB3' ' A' ' 67' ' ' CYS . 67.7 p -133.23 158.99 41.5 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.28 -0.887 . . . . 0.0 110.141 179.999 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.477 ' O ' ' HA ' ' A' ' 67' ' ' CYS . 63.1 mttt -100.58 172.42 7.11 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.206 -0.933 . . . . 0.0 110.247 -179.988 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.499 HG23 ' O ' ' A' ' 55' ' ' ILE . 21.0 tt -79.85 131.19 34.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.189 -0.944 . . . . 0.0 110.22 -179.957 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 90.2 mm-40 -119.04 -3.12 10.69 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.347 -0.846 . . . . 0.0 110.228 -179.945 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 131.7 -131.85 6.5 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.418 -1.473 . . . . 0.0 109.418 -179.996 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.45 ' O ' ' SG ' ' A' ' 66' ' ' CYS . 72.7 p -123.4 168.79 12.07 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.291 -1.123 . . . . 0.0 110.263 -179.984 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . 1.298 ' SG ' ' SG ' ' A' ' 66' ' ' CYS . 9.8 m -111.55 -163.31 0.84 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.217 -0.927 . . . . 0.0 110.29 179.924 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.427 ' C ' ' O ' ' A' ' 59' ' ' CYS . 68.9 m-85 -41.9 -46.85 4.15 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.312 -0.868 . . . . 0.0 110.317 179.859 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -124.42 171.62 9.8 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.198 -0.939 . . . . 0.0 110.117 179.898 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -72.5 -23.25 78.24 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.463 -1.455 . . . . 0.0 109.463 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 38.2 ttmt -65.41 -34.55 78.57 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.202 -1.176 . . . . 0.0 110.291 179.951 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -94.73 163.23 13.45 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.3 -0.875 . . . . 0.0 110.162 -179.923 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.447 ' HE3' HG13 ' A' ' 55' ' ' ILE . 50.4 tptt -140.05 135.98 33.18 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.253 -0.905 . . . . 0.0 110.118 -179.957 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' CYS . . . . . 1.298 ' SG ' ' SG ' ' A' ' 59' ' ' CYS . 73.8 m -85.17 136.61 33.46 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.279 -0.888 . . . . 0.0 110.257 179.969 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' CYS . . . . . 0.501 ' HB3' ' CB ' ' A' ' 53' ' ' THR . 76.4 m -141.51 129.78 22.31 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.266 -0.897 . . . . 0.0 110.144 -179.973 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.42 ' HA ' ' HA2' ' A' ' 42' ' ' GLY . 40.4 tttt . . . . . 0 N--CA 1.492 1.65 0 CA-C-O 118.065 -0.969 . . . . 0.0 110.169 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . 0.416 ' OD2' ' CE1' ' A' ' 34' ' ' HIS . 56.9 t0 . . . . . 0 N--CA 1.491 1.586 0 CA-C-O 121.306 0.574 . . . . 0.0 110.207 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . 0.416 ' CE1' ' OD2' ' A' ' 33' ' ' ASP . 61.0 m80 -110.61 116.43 31.32 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.221 -0.924 . . . . 0.0 110.235 -179.986 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.548 ' CD1' ' SG ' ' A' ' 37' ' ' CYS . 2.3 t80 -54.23 138.63 38.19 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.202 -0.937 . . . . 0.0 110.17 179.913 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.422 ' O ' ' CG ' ' A' ' 36' ' ' ASN . 22.0 p-10 -98.52 64.31 1.53 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.251 -0.906 . . . . 0.0 110.256 -179.918 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.548 ' SG ' ' CD1' ' A' ' 35' ' ' TYR . 34.4 m -62.89 -52.0 64.79 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.221 -0.924 . . . . 0.0 110.174 179.893 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.4 ' HA ' ' O ' ' A' ' 42' ' ' GLY . 68.8 t -54.04 -40.31 45.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.236 -0.915 . . . . 0.0 110.247 179.923 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 33.6 t -60.99 -30.57 70.36 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.146 -0.972 . . . . 0.0 110.255 179.945 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.44 ' O ' ' HE3' ' A' ' 68' ' ' LYS . 72.1 m -82.63 -7.96 59.62 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.358 -0.839 . . . . 0.0 110.165 179.97 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 104.17 5.47 43.5 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.514 ' CA ' ' O ' ' A' ' 67' ' ' CYS . . . -93.56 176.88 37.09 Favored Glycine 0 N--CA 1.489 2.198 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 -179.985 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . 0.504 ' N ' ' O ' ' A' ' 67' ' ' CYS . 16.1 tt0 -132.39 132.87 43.28 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.249 -1.147 . . . . 0.0 110.2 -179.926 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 22.6 m -95.78 116.66 29.22 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.336 -0.853 . . . . 0.0 110.298 179.977 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.696 HD12 ' HD3' ' A' ' 50' ' ' PRO . 92.5 mt -101.76 175.32 5.59 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.296 -0.877 . . . . 0.0 110.161 179.967 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 -91.37 -3.1 57.08 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.241 -0.912 . . . . 0.0 110.227 179.957 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.402 ' O ' ' C ' ' A' ' 48' ' ' ALA . 59.1 p -126.56 167.85 15.08 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.18 -0.95 . . . . 0.0 110.183 -179.976 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.48 ' HA ' ' HG3' ' A' ' 65' ' ' LYS . . . -42.62 148.19 0.24 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.271 -0.893 . . . . 0.0 110.192 179.952 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 17.1 t -52.86 130.37 47.94 Favored Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.24 -0.913 . . . . 0.0 110.077 179.986 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.696 ' HD3' HD12 ' A' ' 45' ' ' LEU . 47.5 Cg_endo -72.67 149.33 48.63 Favored 'Trans proline' 0 C--N 1.306 -1.68 0 O-C-N 123.88 1.463 . . . . 0.0 110.442 -179.924 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 44.9 pt -67.24 -11.26 13.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.26 -0.9 . . . . 0.0 110.128 179.961 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 55.5 m-85 -62.62 -25.56 68.17 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.255 -0.903 . . . . 0.0 110.157 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.484 ' OG1' ' HB3' ' A' ' 67' ' ' CYS . 69.1 p -143.01 158.86 43.2 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.348 -0.845 . . . . 0.0 110.218 -179.99 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.474 ' O ' ' HA ' ' A' ' 67' ' ' CYS . 84.7 mttt -77.52 176.81 8.56 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.21 -0.932 . . . . 0.0 110.161 -179.961 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.432 HG13 ' O ' ' A' ' 66' ' ' CYS . 19.7 tt -108.79 137.63 39.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.188 -0.945 . . . . 0.0 110.225 -179.982 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . 0.459 ' HG3' ' HB2' ' A' ' 68' ' ' LYS . 76.6 mm-40 -98.83 -24.87 14.83 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.282 -0.886 . . . . 0.0 110.181 179.971 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 162.89 -152.39 22.54 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.444 -1.462 . . . . 0.0 109.444 179.997 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.445 ' O ' ' SG ' ' A' ' 66' ' ' CYS . 82.6 p -90.81 161.51 15.24 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.274 -1.133 . . . . 0.0 110.214 -179.921 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . 0.504 ' SG ' ' N ' ' A' ' 66' ' ' CYS . 16.8 m -110.19 -163.03 0.83 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.348 -0.845 . . . . 0.0 110.243 -179.966 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.428 ' C ' ' O ' ' A' ' 59' ' ' CYS . 80.1 m-85 -41.21 -48.38 3.49 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.422 -0.799 . . . . 0.0 110.402 179.92 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 88.8 mtm-85 -129.45 159.28 36.76 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.247 -0.908 . . . . 0.0 110.246 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -60.89 -24.65 62.91 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.436 -1.466 . . . . 0.0 109.436 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 47.4 mtpt -63.64 -32.55 74.07 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.272 -1.134 . . . . 0.0 110.203 179.891 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -96.68 164.41 12.6 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.421 -0.799 . . . . 0.0 110.16 -179.847 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.48 ' HG3' ' HA ' ' A' ' 48' ' ' ALA . 75.6 mmtt -134.54 140.74 46.37 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.244 -0.91 . . . . 0.0 110.169 -179.911 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' CYS . . . . . 0.504 ' N ' ' SG ' ' A' ' 59' ' ' CYS . 89.0 m -88.8 134.04 34.06 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.269 -0.895 . . . . 0.0 110.206 179.96 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' CYS . . . . . 0.514 ' O ' ' CA ' ' A' ' 42' ' ' GLY . 34.6 m -136.26 152.01 50.26 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.208 -0.932 . . . . 0.0 110.201 179.979 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.459 ' HB2' ' HG3' ' A' ' 56' ' ' GLN . 77.5 tttt . . . . . 0 N--CA 1.49 1.549 0 CA-C-O 118.005 -0.998 . . . . 0.0 110.22 -179.97 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 49.2 t0 . . . . . 0 N--CA 1.491 1.597 0 CA-C-O 121.215 0.531 . . . . 0.0 110.174 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 28.8 p-80 -142.97 162.75 34.64 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.302 -0.874 . . . . 0.0 110.22 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.561 ' CD1' ' SG ' ' A' ' 37' ' ' CYS . 3.2 t80 -71.42 140.19 50.0 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.222 -0.924 . . . . 0.0 110.205 179.986 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.553 ' ND2' ' CB ' ' A' ' 39' ' ' SER . 59.3 t30 -85.67 60.54 6.3 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.272 -0.893 . . . . 0.0 110.152 179.952 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.561 ' SG ' ' CD1' ' A' ' 35' ' ' TYR . 25.3 m -67.81 -53.22 28.73 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.307 -0.871 . . . . 0.0 110.24 179.991 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 75.4 t -43.92 -54.89 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.263 -0.898 . . . . 0.0 110.179 179.982 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.553 ' CB ' ' ND2' ' A' ' 36' ' ' ASN . 62.3 m -50.31 -35.19 26.46 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.192 -0.942 . . . . 0.0 110.218 -179.968 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.45 ' HB2' ' O ' ' A' ' 37' ' ' CYS . 72.5 m -70.73 -15.17 62.67 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.285 -0.884 . . . . 0.0 110.145 -179.976 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.413 ' C ' ' HG3' ' A' ' 68' ' ' LYS . . . 108.53 -14.85 35.49 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.475 -1.45 . . . . 0.0 109.475 -179.992 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.473 ' CA ' ' O ' ' A' ' 67' ' ' CYS . . . -85.27 175.34 49.66 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.494 -1.442 . . . . 0.0 109.494 -179.984 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . 0.45 ' N ' ' O ' ' A' ' 67' ' ' CYS . 0.9 OUTLIER -115.14 179.76 3.86 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.2 -1.176 . . . . 0.0 110.164 -179.972 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 49.7 t -114.17 98.17 6.79 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.247 -0.908 . . . . 0.0 110.188 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.459 ' O ' ' HB1' ' A' ' 64' ' ' ALA . 71.4 mt -88.98 173.27 8.57 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.3 -0.875 . . . . 0.0 110.181 179.901 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 83.4 m-85 -109.6 -1.99 17.81 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.24 -0.912 . . . . 0.0 110.314 -179.962 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.414 ' O ' ' C ' ' A' ' 48' ' ' ALA . 74.7 m -125.42 166.17 17.09 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.191 -0.943 . . . . 0.0 110.173 179.925 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.414 ' C ' ' O ' ' A' ' 47' ' ' SER . . . -42.69 131.01 4.06 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.246 -0.909 . . . . 0.0 110.177 -179.91 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . 0.412 ' C ' ' O ' ' A' ' 48' ' ' ALA . 4.4 t -43.39 130.46 3.63 Favored Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 121.223 -0.923 . . . . 0.0 110.219 -179.988 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.491 ' HG2' ' CG2' ' A' ' 53' ' ' THR . 46.4 Cg_endo -72.74 156.57 53.06 Favored 'Trans proline' 0 C--N 1.306 -1.661 0 O-C-N 123.86 1.453 . . . . 0.0 110.446 179.978 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 21.5 mt -67.85 -28.62 42.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.224 -0.923 . . . . 0.0 110.243 -179.93 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 88.8 m-85 -67.69 -11.8 59.09 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.348 -0.845 . . . . 0.0 110.191 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.491 ' CG2' ' HG2' ' A' ' 50' ' ' PRO . 34.0 p -121.79 172.63 8.02 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.256 -0.903 . . . . 0.0 110.1 179.897 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.488 ' O ' ' HA ' ' A' ' 67' ' ' CYS . 80.4 mttt -111.34 127.54 55.68 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.309 -0.869 . . . . 0.0 110.296 -179.986 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 20.6 tt -67.35 138.73 22.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.246 -0.908 . . . . 0.0 110.216 179.956 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . 0.439 ' NE2' ' HB3' ' A' ' 54' ' ' LYS . 48.9 mm-40 -128.62 13.94 6.47 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.264 -0.898 . . . . 0.0 110.217 -179.941 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . 0.4 ' O ' ' HB2' ' A' ' 66' ' ' CYS . . . 119.52 179.81 16.62 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.451 -1.46 . . . . 0.0 109.451 179.956 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 17.0 p -75.79 168.99 19.01 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.307 -1.113 . . . . 0.0 110.266 179.969 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . 0.974 ' HB3' ' HB3' ' A' ' 64' ' ' ALA . 9.7 t -109.29 -65.36 1.15 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.198 -0.938 . . . . 0.0 110.27 179.89 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.536 ' HB3' ' CE ' ' A' ' 63' ' ' LYS . 78.2 m-85 -121.72 92.6 3.77 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.457 -0.777 . . . . 0.0 110.282 179.981 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 36.3 mmt180 51.52 25.39 2.69 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.269 -0.894 . . . . 0.0 110.296 179.994 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 89.97 -11.56 70.29 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.536 ' CE ' ' HB3' ' A' ' 60' ' ' TYR . 50.5 mtmt -58.58 -23.04 57.72 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.259 -1.142 . . . . 0.0 110.095 -179.99 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.974 ' HB3' ' HB3' ' A' ' 59' ' ' CYS . . . -138.37 161.86 35.88 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.261 -0.9 . . . . 0.0 110.148 179.936 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 65.1 mmtt -113.25 122.93 48.94 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.246 -0.909 . . . . 0.0 110.239 179.983 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' CYS . . . . . 0.415 ' HA ' ' O ' ' A' ' 43' ' ' GLN . 99.2 m -79.21 142.73 36.01 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.231 -0.918 . . . . 0.0 110.183 179.998 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' CYS . . . . . 0.488 ' HA ' ' O ' ' A' ' 54' ' ' LYS . 82.3 m -144.47 141.52 29.64 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.253 -0.904 . . . . 0.0 110.241 179.989 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.427 ' HA ' ' HA2' ' A' ' 42' ' ' GLY . 33.9 ttpt . . . . . 0 N--CA 1.491 1.585 0 CA-C-O 118.01 -0.995 . . . . 0.0 110.213 -179.921 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 77.5 m-20 . . . . . 0 N--CA 1.492 1.626 0 CA-C-O 121.269 0.557 . . . . 0.0 110.198 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 70.8 m80 -112.98 129.24 56.56 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.255 -0.903 . . . . 0.0 110.17 179.991 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.523 ' CD1' ' SG ' ' A' ' 37' ' ' CYS . 2.4 t80 -55.08 135.67 48.87 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.25 -0.906 . . . . 0.0 110.254 -179.917 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.422 ' CG ' ' O ' ' A' ' 36' ' ' ASN . 35.9 p-10 -90.58 68.87 6.69 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.322 -0.861 . . . . 0.0 110.215 179.963 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.523 ' SG ' ' CD1' ' A' ' 35' ' ' TYR . 16.6 m -70.82 -39.88 72.79 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.33 -0.856 . . . . 0.0 110.108 -179.901 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.58 HG23 ' N ' ' A' ' 39' ' ' SER . 27.0 m -57.83 -44.73 86.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.334 -0.854 . . . . 0.0 110.328 179.988 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.58 ' N ' HG23 ' A' ' 38' ' ' VAL . 53.8 p -60.0 -32.52 70.94 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.272 -0.893 . . . . 0.0 110.278 179.958 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.427 ' O ' ' HE3' ' A' ' 68' ' ' LYS . 38.0 m -75.01 -10.3 59.34 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.306 -0.871 . . . . 0.0 110.091 179.996 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 98.63 -10.3 62.67 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.426 -1.47 . . . . 0.0 109.426 -179.889 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.533 ' CA ' ' O ' ' A' ' 67' ' ' CYS . . . -73.04 -171.65 21.13 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.426 -1.47 . . . . 0.0 109.426 -179.985 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . 0.486 ' N ' ' O ' ' A' ' 67' ' ' CYS . 6.4 tt0 -139.99 138.46 35.52 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.268 -1.137 . . . . 0.0 110.163 -179.975 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 12.5 t -95.37 108.3 20.48 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.248 -0.908 . . . . 0.0 110.064 179.894 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.471 HD12 ' HA ' ' A' ' 45' ' ' LEU . 9.5 tp -101.57 157.7 16.62 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.293 -0.879 . . . . 0.0 110.292 -179.937 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -82.64 -25.62 32.95 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.244 -0.91 . . . . 0.0 110.225 -179.954 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.417 ' O ' ' C ' ' A' ' 48' ' ' ALA . 39.1 t -93.13 159.37 15.32 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.234 -0.916 . . . . 0.0 110.194 179.996 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.417 ' C ' ' O ' ' A' ' 47' ' ' SER . . . -42.95 127.5 4.12 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.254 -0.903 . . . . 0.0 110.157 179.974 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . 0.403 ' C ' ' O ' ' A' ' 48' ' ' ALA . 8.3 t -42.76 129.73 3.07 Favored Pre-proline 0 N--CA 1.491 1.621 0 O-C-N 121.304 -0.872 . . . . 0.0 110.154 -179.927 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.486 ' HG2' HG23 ' A' ' 53' ' ' THR . 46.3 Cg_endo -72.65 141.64 34.64 Favored 'Trans proline' 0 C--N 1.305 -1.73 0 O-C-N 123.884 1.465 . . . . 0.0 110.411 -179.943 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 47.2 pt -57.53 -22.98 18.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.316 -0.865 . . . . 0.0 110.058 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 69.1 m-85 -65.13 -11.95 45.66 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.337 -0.852 . . . . 0.0 110.118 179.816 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.517 ' CB ' ' HB3' ' A' ' 67' ' ' CYS . 30.0 p -119.9 170.73 8.99 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.293 -0.879 . . . . 0.0 110.233 -179.919 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.467 ' O ' ' HA ' ' A' ' 67' ' ' CYS . 31.0 mttt -94.66 175.07 6.8 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.248 -0.908 . . . . 0.0 110.097 -179.991 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.718 HG23 ' O ' ' A' ' 55' ' ' ILE . 19.9 tt -106.01 111.41 34.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.203 -0.935 . . . . 0.0 110.245 -179.987 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . 0.552 ' NE2' ' CB ' ' A' ' 68' ' ' LYS . 69.9 mm-40 -90.41 11.38 21.73 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.295 -0.878 . . . . 0.0 110.176 179.878 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 104.12 -127.88 9.28 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.371 -1.491 . . . . 0.0 109.371 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 28.1 p -111.55 171.93 7.19 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.226 -1.161 . . . . 0.0 110.144 -179.992 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . 1.193 ' SG ' ' SG ' ' A' ' 66' ' ' CYS . 0.1 OUTLIER -111.72 -166.73 1.1 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.167 -0.958 . . . . 0.0 110.215 -179.937 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.539 ' CD1' ' N ' ' A' ' 61' ' ' ARG . 7.2 p90 -57.27 -26.13 60.31 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.376 -0.828 . . . . 0.0 110.215 179.853 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.539 ' N ' ' CD1' ' A' ' 60' ' ' TYR . 57.5 mtt85 -139.5 164.88 28.7 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.281 -0.887 . . . . 0.0 110.191 -179.999 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -80.97 -0.28 88.4 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.621 -1.392 . . . . 0.0 109.621 179.939 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 46.1 mtpt -81.56 -25.89 35.46 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.259 -1.142 . . . . 0.0 110.227 179.915 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -123.04 164.96 17.59 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.238 -0.914 . . . . 0.0 110.243 179.987 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 74.3 mmtt -128.28 145.17 51.13 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.244 -0.91 . . . . 0.0 110.196 179.971 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' CYS . . . . . 1.193 ' SG ' ' SG ' ' A' ' 59' ' ' CYS . 93.4 m -81.48 137.6 35.59 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.225 -0.922 . . . . 0.0 110.256 -179.949 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' CYS . . . . . 0.533 ' O ' ' CA ' ' A' ' 42' ' ' GLY . 73.2 m -128.24 172.42 11.05 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.366 -0.834 . . . . 0.0 110.031 179.92 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.552 ' CB ' ' NE2' ' A' ' 56' ' ' GLN . 77.6 tttt . . . . . 0 N--CA 1.491 1.617 0 CA-C-O 118.007 -0.997 . . . . 0.0 110.278 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 26.6 p30 . . . . . 0 N--CA 1.491 1.602 0 CA-C-O 121.238 0.542 . . . . 0.0 110.229 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 83.4 m-70 -116.08 136.14 53.3 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.21 -0.931 . . . . 0.0 110.235 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 43.6 p90 -135.08 164.1 28.42 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.263 -0.898 . . . . 0.0 110.129 179.939 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.442 ' ND2' ' OG ' ' A' ' 39' ' ' SER . 12.7 p-10 -87.68 120.85 29.4 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.276 -0.89 . . . . 0.0 110.211 179.996 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 84.6 m -75.57 0.7 16.48 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.297 -0.877 . . . . 0.0 110.248 -179.973 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 53.6 t -68.67 -34.2 63.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.268 -0.895 . . . . 0.0 110.209 179.919 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.442 ' OG ' ' ND2' ' A' ' 36' ' ' ASN . 65.3 m -71.36 -22.81 61.85 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.254 -0.904 . . . . 0.0 110.128 179.856 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 61.2 m -89.44 -5.43 57.38 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.325 -0.859 . . . . 0.0 110.128 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 101.64 -19.57 49.78 Favored Glycine 0 N--CA 1.489 2.196 0 N-CA-C 109.331 -1.507 . . . . 0.0 109.331 -179.859 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.45 ' HA2' ' HA ' ' A' ' 68' ' ' LYS . . . -73.08 171.35 51.05 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.509 -1.436 . . . . 0.0 109.509 -179.966 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . 0.503 ' O ' ' HA ' ' A' ' 66' ' ' CYS . 15.0 tt0 -130.53 164.04 25.74 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.341 -1.094 . . . . 0.0 110.207 -179.964 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . 0.422 ' N ' ' CG ' ' A' ' 43' ' ' GLN . 5.5 m -114.27 112.81 23.7 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.176 -0.952 . . . . 0.0 110.274 -179.964 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.648 HD12 ' HD3' ' A' ' 50' ' ' PRO . 27.7 mt -95.92 179.55 5.05 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.239 -0.913 . . . . 0.0 110.133 179.946 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 66.4 m-85 -92.59 -27.1 17.56 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.195 -0.94 . . . . 0.0 110.218 -179.97 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.431 ' O ' ' C ' ' A' ' 48' ' ' ALA . 64.2 m -107.55 166.92 10.31 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.344 -0.848 . . . . 0.0 110.084 179.964 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.494 ' HA ' ' HG3' ' A' ' 65' ' ' LYS . . . -43.01 132.55 3.98 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.269 -0.894 . . . . 0.0 110.118 179.942 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . 0.419 ' C ' ' O ' ' A' ' 48' ' ' ALA . 7.7 t -42.75 130.06 3.06 Favored Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 121.23 -0.919 . . . . 0.0 110.181 -179.997 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.648 ' HD3' HD12 ' A' ' 45' ' ' LEU . 45.5 Cg_endo -72.15 147.08 47.59 Favored 'Trans proline' 0 C--N 1.305 -1.73 0 O-C-N 123.909 1.479 . . . . 0.0 110.376 -179.977 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.4 ' H ' HG23 ' A' ' 51' ' ' ILE . 28.5 pt -58.0 -21.99 18.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.234 -0.917 . . . . 0.0 110.135 179.978 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 66.2 m-85 -57.09 -16.51 7.67 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.169 -0.957 . . . . 0.0 110.109 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 71.1 p -142.34 153.66 44.02 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.238 -0.914 . . . . 0.0 110.187 179.97 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.464 ' O ' ' HA ' ' A' ' 67' ' ' CYS . 58.2 tttt -74.16 164.66 26.34 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.199 -0.938 . . . . 0.0 110.193 -180.0 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.661 HG23 ' O ' ' A' ' 55' ' ' ILE . 20.1 tt -109.41 118.18 56.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.209 -0.932 . . . . 0.0 110.17 179.956 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . 0.473 ' NE2' ' HB3' ' A' ' 68' ' ' LYS . 70.4 mm-40 -69.61 -31.15 69.11 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.307 -0.871 . . . . 0.0 110.236 -179.972 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 149.24 -92.69 0.14 Allowed Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.471 -1.452 . . . . 0.0 109.471 179.956 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.401 ' O ' ' SG ' ' A' ' 66' ' ' CYS . 74.6 p -128.67 161.96 28.45 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.275 -1.132 . . . . 0.0 110.235 -179.937 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . 0.494 ' SG ' ' SG ' ' A' ' 66' ' ' CYS . 5.1 m -99.45 -68.86 0.79 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.281 -0.887 . . . . 0.0 110.145 179.883 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.439 ' CD2' ' HB3' ' A' ' 59' ' ' CYS . 89.4 m-85 -141.32 -68.9 0.38 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.345 -0.847 . . . . 0.0 110.178 -179.977 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.419 ' HD2' ' CD ' ' A' ' 63' ' ' LYS . 38.7 ttm-85 -95.38 -37.8 10.79 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.256 -0.902 . . . . 0.0 110.177 -179.965 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 135.42 -15.84 4.14 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 -179.951 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.419 ' CD ' ' HD2' ' A' ' 61' ' ' ARG . 46.7 mtpt -65.55 -31.49 72.58 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.268 -1.137 . . . . 0.0 110.15 -179.979 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.553 ' HB1' ' O ' ' A' ' 45' ' ' LEU . . . -109.83 159.57 17.1 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.353 -0.842 . . . . 0.0 110.146 179.929 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.494 ' HG3' ' HA ' ' A' ' 48' ' ' ALA . 60.7 mmtt -124.02 124.74 43.22 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.211 -0.931 . . . . 0.0 110.269 179.999 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' CYS . . . . . 0.503 ' HA ' ' O ' ' A' ' 43' ' ' GLN . 60.9 m -55.11 155.13 4.92 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.229 -0.919 . . . . 0.0 110.139 179.939 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' CYS . . . . . 0.501 ' N ' ' O ' ' A' ' 43' ' ' GLN . 91.8 m -148.13 114.6 5.95 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.176 -0.952 . . . . 0.0 110.284 179.965 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.473 ' HB3' ' NE2' ' A' ' 56' ' ' GLN . 80.4 tttt . . . . . 0 N--CA 1.491 1.583 0 CA-C-O 118.019 -0.991 . . . . 0.0 110.215 -179.971 . . . . . . . . 1 1 . 1 stop_ save_